data_2mbb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mbb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.626 0.727 . . . . 0.0 110.964 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.41 9.59 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.74 145.05 52.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.18 20.7 36.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -69.09 144.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.157 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -103.86 108.43 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -51.27 -50.16 59.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -53.07 -45.98 68.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.38 -33.21 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.77 -56.32 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -13.82 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -88.66 -27.49 21.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -75.66 158.84 82.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.651 0.738 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.14 31.97 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.359 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.75 -29.79 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.2 mm -78.84 -29.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -69.61 -26.58 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -88.68 -25.81 22.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.5 -40.14 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 mt -78.15 -30.86 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.69 -33.52 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.44 -21.3 66.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.78 23.98 40.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.414 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.736 0.303 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 134.05 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 31.7 pt -117.24 149.35 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -105.13 124.25 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.23 108.1 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.86 110.85 23.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -73.6 173.36 9.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -23.86 58.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.27 12.24 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.08 31.69 72.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.533 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -97.25 108.59 21.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.34 133.36 35.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.195 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.53 115.38 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.52 125.16 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -127.72 134.31 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.09 102.93 15.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.19 -179.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.75 160.6 67.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -10.67 29.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.398 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.1 m -98.18 -24.89 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.91 174.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.86 156.52 21.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.56 -34.73 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -55.68 -35.42 66.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -39.92 69.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 46.2 t -65.66 -42.42 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.145 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -63.65 -42.4 98.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.61 73.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -56.64 -50.1 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.6 -31.17 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -63.57 -45.71 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -4.6 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -99.09 -56.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -100.31 -48.43 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.14 32.26 2.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.64 130.04 23.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.654 0.74 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 164.31 35.07 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.706 2.271 . . . . 0.0 112.385 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -8.04 22.59 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.14 -30.35 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.53 -1.38 14.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -92.45 128.78 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -133.75 140.96 47.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.4 151.06 26.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.5 mm -137.9 117.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -148.22 143.32 26.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.79 13.82 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.28 3.88 74.94 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 158.5 44.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.745 0.307 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.02 145.54 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.4 mt -96.14 163.24 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.73 157.27 28.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.94 -13.64 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.47 39.52 2.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -152.58 169.72 21.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.4 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.34 152.98 20.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.134 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 32.8 mt -56.5 -46.47 80.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.6 t -58.87 -25.07 62.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.02 -32.14 73.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -98.64 11.88 37.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.06 31.74 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 13.4 mm -68.89 95.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -84.5 -179.09 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 150.33 48.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 54.45 27.02 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.62 134.63 54.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -87.47 86.78 7.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.62 158.33 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -130.76 117.67 19.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 8.5 tp -87.11 128.98 35.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.59 148.19 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.08 127.36 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 mt . . . . . 0 C--O 1.23 0.04 0 CA-C-O 121.654 0.74 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 174.52 9.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.624 2.216 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.0 145.28 51.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.39 20.72 38.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 144.9 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 111.184 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -102.76 106.37 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -50.64 -52.65 37.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -51.55 -37.23 48.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.7 t -76.85 -33.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -56.57 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -13.79 60.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -90.17 -18.27 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt -87.92 157.39 51.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 165.33 31.37 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.383 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.02 -27.94 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.099 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -43.42 95.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.39 -28.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -69.59 -23.95 63.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.2 -26.7 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.17 -37.85 63.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.05 -42.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.71 -34.46 67.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 t -65.16 -21.9 66.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.98 14.93 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.749 0.309 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -95.54 134.18 38.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 25.8 pt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -105.49 124.47 49.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 11.3 t -107.22 108.16 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.97 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.1 p -71.63 174.71 6.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -25.42 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 4.7 p -88.75 10.81 19.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.52 30.16 69.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -94.58 108.71 20.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.22 132.54 35.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.8 mt -129.48 111.45 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.02 128.54 34.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.6 mt -132.36 134.19 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -90.21 103.03 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.7 m -130.77 -179.51 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -132.21 160.32 68.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.649 0.738 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 51.8 p -97.11 -24.79 15.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -61.65 175.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.23 156.85 20.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.3 mm -53.56 -27.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.64 -29.85 71.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -37.56 44.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.87 -49.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -60.72 -34.61 74.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.44 98.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -57.24 -46.91 82.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.76 -36.87 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -58.7 -44.87 90.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -4.75 44.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -98.44 -56.6 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -101.4 -47.87 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.11 26.48 3.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.7 mt -98.08 128.88 32.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.124 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 164.3 35.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.575 2.184 . . . . 0.0 112.355 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.94 -29.37 25.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.55 -5.34 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -88.92 130.44 35.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -133.81 141.18 47.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.87 149.79 29.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.8 mm -135.85 118.78 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -149.27 142.71 25.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.7 14.91 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.73 17.95 64.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.45 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.34 171.62 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -91.43 139.53 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.17 151.26 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.43 155.32 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -78.25 -4.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -106.12 39.55 2.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -152.44 169.44 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 152.08 20.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 64.9 mt -56.33 -43.8 79.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 t -57.36 -23.63 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.28 -32.97 74.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -97.41 10.25 40.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 62.45 35.79 14.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.5 mm -68.69 95.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -84.87 167.37 16.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.57 148.55 9.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 55.56 26.56 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.13 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 85.47 6.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.02 159.29 21.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -129.32 129.56 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.7 tt -96.03 134.7 38.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.89 140.35 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.18 129.8 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.681 0.753 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 173.76 10.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 0.0 112.265 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.04 145.26 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.3 20.69 37.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.552 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.04 144.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -103.55 108.96 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -51.25 -52.05 48.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -51.41 -45.72 62.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.0 t -69.72 -33.13 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.14 -56.02 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -13.84 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -88.83 -25.93 21.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -78.43 158.67 76.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 165.13 32.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.62 -30.42 44.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -61.96 -41.38 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.6 mm -78.88 -27.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -69.67 -45.69 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.77 -29.44 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.81 -43.02 80.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.4 mt -77.91 -30.6 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.2 -35.72 74.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -65.45 -20.78 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.14 18.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -94.84 137.78 33.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 10.0 pt -120.59 147.19 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.54 121.93 44.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.7 107.95 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 109.55 22.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.8 p -71.43 172.41 9.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.62 -24.0 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.21 10.12 23.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.3 66.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.508 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -101.89 108.88 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.02 132.71 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 4.1 mt -128.52 110.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 127.52 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 7.9 mt -133.08 134.1 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.36 102.4 15.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 22.9 m -128.03 -179.24 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.126 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -134.75 160.38 68.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.628 0.728 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -11.23 30.4 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.26 . . . . 0.0 112.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 p -97.16 -26.42 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.76 173.14 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.02 156.96 20.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -52.14 -31.22 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.96 -32.57 70.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -38.17 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.11 -49.06 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -59.32 -37.02 76.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.18 70.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -56.5 -43.06 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.33 -34.31 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.168 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -62.11 -48.08 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.12 -8.36 52.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -95.21 -56.33 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -100.35 -49.2 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.33 33.32 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.5 mt -106.41 130.68 22.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.605 0.717 . . . . 0.0 111.19 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 163.31 38.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.4 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -8.18 22.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -84.95 -30.44 24.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.66 -1.67 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -91.97 126.85 37.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -133.79 135.17 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 155.92 17.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 29.0 mm -140.56 117.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -146.6 145.05 29.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.83 14.46 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.63 15.51 68.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -133.6 -176.07 4.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -107.58 127.87 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.6 mt -84.48 153.06 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.34 163.31 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -81.97 -0.47 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.68 39.89 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.54 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -152.52 164.98 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.32 150.49 20.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.73 -48.78 72.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -54.72 -26.18 32.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.4 -28.2 68.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -98.86 11.88 37.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 63.96 31.25 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.73 106.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.9 168.43 9.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.18 142.0 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.05 28.86 18.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 131.57 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.55 87.8 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.9 mp -89.3 159.25 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -128.66 122.98 32.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.07 122.4 33.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 13.8 t -120.59 147.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.162 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.76 132.09 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.62 0.724 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 175.16 8.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.288 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.18 145.09 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.96 20.63 34.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.531 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.65 144.6 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -104.28 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -51.33 -51.29 55.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -51.44 -39.81 58.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.36 -33.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.11 -56.14 11.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -14.8 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.17 -25.57 21.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.58 157.82 79.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.27 31.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.702 2.268 . . . . 0.0 112.363 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.77 -26.89 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -64.73 -42.56 95.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.2 mm -78.41 -29.58 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.73 -25.89 64.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.97 -24.69 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -72.29 -39.74 68.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.1 mt -78.26 -34.86 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.15 -32.43 73.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -67.83 -18.4 64.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.59 37.38 17.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.853 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.06 134.1 42.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -117.38 149.9 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -106.58 128.56 54.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.29 107.75 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.92 111.04 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.2 p -72.76 174.26 7.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -25.53 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.4 p -88.04 8.14 28.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.7 31.98 59.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -97.52 108.88 21.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.26 133.81 35.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.95 111.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 128.14 32.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -130.71 134.25 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.1 104.02 16.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.61 -179.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 160.87 65.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -11.73 31.44 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -28.98 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.4 175.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.6 157.97 22.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.13 -25.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.69 -35.47 80.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.17 -39.16 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.39 -39.83 92.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.78 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.56 -50.15 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 69.9 mt -53.31 -33.41 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -60.41 -48.58 81.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -72.6 -7.34 49.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -95.37 -54.59 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.34 -48.91 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.38 29.97 2.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.52 130.54 23.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.515 0.674 . . . . 0.0 111.105 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 163.78 36.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.703 2.268 . . . . 0.0 112.428 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -7.88 22.17 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.802 2.335 . . . . 0.0 112.335 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -85.91 -30.54 22.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.29 -0.46 15.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.43 131.91 43.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -133.73 147.12 51.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.06 150.43 35.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 22.7 mm -136.8 115.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.74 144.25 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.19 13.29 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.5 5.09 72.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 163.47 30.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.78 145.9 30.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mt -98.32 154.43 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -111.67 155.61 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.44 -5.39 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.39 2.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -152.53 169.42 22.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 149.61 23.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 44.7 mt -55.2 -47.59 75.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -57.39 -25.68 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.08 -30.87 71.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -98.81 11.04 39.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.9 m120 63.98 32.49 13.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.3 mm -68.77 95.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -86.98 170.64 11.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 152.17 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 53.64 27.45 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.78 133.48 54.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -90.14 85.77 6.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.58 159.63 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -128.11 122.77 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.8 tp -89.74 122.27 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.91 147.93 23.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.71 135.65 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.554 0.692 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 174.11 10.03 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.719 2.279 . . . . 0.0 112.339 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.42 146.32 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.51 21.03 33.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.2 p -71.6 145.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.41 108.85 20.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -51.39 -52.09 48.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -51.4 -40.05 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.2 t -76.04 -33.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.097 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.23 -56.35 10.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -15.26 60.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -88.81 -27.49 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.3 mt -75.88 158.29 82.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.637 0.732 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 165.16 31.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.35 -29.19 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.19 -39.69 95.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.9 -29.65 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.56 -32.48 74.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.84 -42.93 76.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.5 mt -77.91 -29.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -61.77 -38.9 89.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -65.58 -25.08 67.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.42 55.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.3 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.63 133.79 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.67 148.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -104.85 126.87 52.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.02 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.94 111.17 23.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.824 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.3 p -73.14 175.0 7.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -23.9 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 1.2 p -90.07 7.66 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.41 65.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -91.76 109.47 20.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.71 132.37 35.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.194 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.46 111.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.06 127.61 32.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.4 mt -129.9 134.3 47.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.47 102.46 15.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.44 -179.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -131.94 160.34 68.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.628 0.728 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -10.16 27.86 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -99.54 -24.6 14.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.38 175.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.15 155.07 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -29.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.27 -34.2 74.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -37.91 67.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.66 -42.7 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.139 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -64.37 -38.93 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.7 87.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -57.35 -49.86 74.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.33 -32.72 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.53 -47.53 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.69 -4.74 42.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -96.68 -50.34 4.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -106.94 -47.31 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.79 29.59 2.82 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.17 132.24 21.33 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.515 0.674 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 164.83 33.03 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.633 2.222 . . . . 0.0 112.375 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -6.45 18.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.695 2.263 . . . . 0.0 112.336 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -90.17 -23.74 21.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.02 -7.73 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 130.11 35.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -133.69 132.38 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.73 149.1 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 26.1 mm -136.38 119.72 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -148.23 142.09 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.84 14.99 9.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.082 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.02 12.4 68.28 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.79 21.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.87 143.72 26.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.88 148.34 24.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -108.2 157.41 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.15 -16.11 61.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.68 38.14 3.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -152.59 168.54 25.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.36 154.39 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.6 mt -57.8 -48.67 79.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.0 t -54.41 -27.28 35.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.32 -34.51 72.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -98.15 9.85 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.76 40.36 7.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.28 95.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.25 167.34 16.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 146.68 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 58.83 26.43 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.97 133.87 55.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.95 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.09 159.3 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -129.42 118.8 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 2.8 tp -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 26.8 t -112.73 148.14 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.14 130.97 35.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.896 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.587 0.708 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.16 8.46 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.08 147.01 52.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.84 21.11 28.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.52 145.34 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -103.81 106.14 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -50.06 -52.97 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.5 -38.99 47.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -76.72 -33.24 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.57 -56.56 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -13.95 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -88.93 -25.88 21.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.8 mt -78.13 158.41 77.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.661 0.744 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.17 31.91 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.56 -31.45 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.78 -42.48 93.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.94 -29.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.76 -27.69 65.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.1 -26.76 23.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.88 -40.2 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.13 -31.55 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.7 -38.34 90.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -65.43 -23.6 66.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.08 -1.95 65.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.51 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.714 0.293 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.35 136.19 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.27 148.67 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.178 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.15 121.5 43.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.09 108.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 111.96 23.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.2 p -74.42 172.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -24.52 62.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 1.9 p -89.61 12.22 17.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.02 89.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -108.23 110.96 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.31 134.43 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.85 112.11 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.69 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.42 134.84 46.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -89.83 104.4 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.45 174.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -125.71 160.95 53.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -8.58 23.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.55 -24.01 14.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -62.3 175.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.13 154.97 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -51.29 -35.05 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.87 -34.42 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -38.96 67.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.92 -43.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.172 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -62.47 -41.65 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.29 -42.17 73.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -58.55 -48.17 81.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.58 -31.3 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -48.54 79.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.04 -5.04 41.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -96.72 -51.29 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -105.75 -47.42 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.08 27.64 3.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.541 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.61 132.38 21.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.23 31.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -6.93 19.78 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.737 2.291 . . . . 0.0 112.29 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.35 -21.39 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.95 -8.69 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.31 130.82 34.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -134.01 128.4 34.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.61 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.1 mm -136.92 114.92 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -143.16 143.05 31.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.46 15.14 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.86 75.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.14 168.86 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.728 0.299 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -89.39 142.77 27.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.37 151.32 20.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 161.01 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.58 -9.88 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.65 2.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.53 169.66 22.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.381 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.4 151.54 21.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 57.3 mt -56.19 -45.22 79.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.2 t -56.08 -24.1 37.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.789 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.16 -30.58 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -98.41 9.88 42.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.4 34.09 13.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.92 100.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -95.11 170.67 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.37 144.22 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 58.11 28.24 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.69 125.4 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -80.84 85.7 6.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.39 158.52 20.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -129.69 119.86 24.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.99 128.05 36.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.81 144.62 35.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 134.12 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.563 0.697 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 174.97 8.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.712 2.275 . . . . 0.0 112.316 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.08 144.33 52.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 19.99 30.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.98 144.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -104.3 108.59 20.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -52.92 37.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -51.29 -38.61 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.12 -33.1 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.0 -55.98 10.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -14.27 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -88.64 -23.5 23.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -81.23 158.46 69.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 165.15 31.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.41 -31.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.15 -41.23 92.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.9 mm -78.99 -28.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.57 -47.73 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.28 -32.19 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.41 -41.69 84.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.5 mt -77.8 -33.99 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.38 -35.69 81.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 -23.22 66.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.64 -2.28 69.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.794 0.33 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.55 134.09 42.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.74 148.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -105.77 127.63 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.76 108.65 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 108.84 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 8.7 p -67.49 173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -27.97 66.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.8 p -83.53 -1.41 53.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.36 31.74 24.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -98.77 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.364 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.67 134.3 35.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.099 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.57 114.43 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 125.16 29.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -129.09 134.11 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.06 102.66 15.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.77 178.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.88 160.33 69.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.73 24.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.1 p -110.27 17.33 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -100.2 173.28 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.26 149.57 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.2 mm -51.64 -35.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -61.25 -34.35 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.72 -45.76 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -38.41 82.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -49.99 70.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -57.43 -39.73 76.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.84 -28.1 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.66 -47.98 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.66 -7.74 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -96.11 -56.01 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -99.18 -48.87 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 33.15 1.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 5.7 mt -112.45 131.21 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.728 . . . . 0.0 111.096 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.86 163.52 38.05 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.374 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -1.65 8.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.64 2.227 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -99.4 -26.15 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.01 -5.71 13.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.96 136.01 51.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.29 147.87 49.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -113.8 135.6 53.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 20.7 mm -119.59 131.66 71.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.52 144.03 27.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.37 15.15 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 17.97 70.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 166.4 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.667 0.27 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -94.39 110.12 21.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.34 163.62 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.48 153.13 48.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.88 -9.91 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.74 35.72 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -152.69 168.51 25.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 158.44 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 25.9 mt -58.28 -41.12 83.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -63.26 -22.16 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.26 -35.91 82.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -98.94 17.03 20.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.36 35.53 26.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 9.0 mm -68.6 95.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.96 -174.21 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.17 152.93 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 54.15 26.78 6.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.75 132.36 51.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -91.23 89.59 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.0 mp -91.93 165.27 13.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -129.6 145.35 51.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 3.4 tt -105.38 133.05 50.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.44 143.9 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.16 135.37 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.825 -179.978 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.607 0.718 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 173.64 10.72 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 144.88 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.99 20.66 34.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.23 146.24 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 0.0 111.1 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -104.31 106.62 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -49.38 -52.46 28.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -51.64 -38.08 53.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.03 -33.28 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.92 -56.58 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -13.2 61.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.44 -23.88 23.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.99 159.16 69.07 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.3 31.53 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.291 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.93 -33.68 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.72 -43.58 85.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.69 -28.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -70.4 -37.26 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.22 -30.2 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.44 -51.75 18.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.5 -28.85 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.41 -23.35 57.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.6 m -76.79 -19.34 57.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 14.44 59.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.492 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.317 . . . . 0.0 110.983 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.74 0.305 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -95.02 134.99 37.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 25.3 pt -117.9 148.77 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.159 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.9 122.31 45.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.57 108.36 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.47 112.65 24.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.1 p -73.3 171.69 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.235 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -27.4 65.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.4 p -84.64 0.7 49.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.93 39.34 13.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.372 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.3 131.77 35.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.37 110.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 131.6 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -135.87 133.95 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.81 105.81 18.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.0 171.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.47 160.33 40.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.92 33.88 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.611 2.207 . . . . 0.0 112.372 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 -25.33 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.1 175.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.2 p -111.98 156.83 21.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.142 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mm -51.59 -33.63 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.65 -35.08 67.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.949 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -39.28 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.1 -44.1 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -62.84 -41.73 99.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.22 -42.19 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.8 -48.62 79.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 14.5 mt -54.66 -31.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -61.48 -49.02 78.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.3 -5.28 41.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -95.74 -53.56 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -104.7 -46.2 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.15 24.2 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.0 mt -98.32 132.27 24.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.61 0.719 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 167.8 23.25 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.74 2.293 . . . . 0.0 112.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.67 19.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.03 -23.47 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.14 0.58 14.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 128.17 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -133.89 133.45 41.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.01 141.09 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.73 116.34 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.59 144.2 34.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.29 15.17 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.55 8.61 73.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.445 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 172.82 12.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.74 142.8 26.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.2 161.22 14.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -118.05 157.42 26.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.02 -8.36 58.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.4 39.62 2.71 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -152.53 169.87 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.2 151.09 22.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 71.5 mt -56.24 -45.42 80.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -55.63 -26.51 44.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.55 -26.8 65.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -98.8 7.72 45.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.9 m120 64.66 33.7 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.53 109.17 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.11 168.44 9.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 145.31 9.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 58.53 28.31 16.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.77 130.01 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -86.66 81.94 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.36 159.82 21.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -129.42 115.91 18.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 2.0 tp -83.85 116.56 22.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.9 148.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.84 126.82 31.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.677 0.751 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 174.69 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.708 2.272 . . . . 0.0 112.324 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.12 145.99 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.05 21.03 29.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.37 143.73 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.27 110.59 22.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.77 -52.89 45.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.91 -43.24 59.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.31 -32.83 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.13 -56.99 9.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -15.29 62.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -88.14 -15.97 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.05 155.24 60.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 165.15 32.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.642 2.228 . . . . 0.0 112.345 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 -33.67 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.97 -38.86 76.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.83 -44.04 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -51.46 -46.21 63.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -28.32 62.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -71.5 -41.14 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.18 -32.32 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.47 -39.03 93.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.9 m -65.2 -22.91 66.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.15 37.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.922 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.812 0.339 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.39 134.07 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 25.0 pt -117.76 150.1 19.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -106.16 126.49 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.23 107.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.08 110.97 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.0 p -73.17 174.21 8.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -22.95 64.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.99 17.4 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.16 49.93 72.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -118.44 107.84 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 133.03 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.27 107.19 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.54 132.29 43.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -137.28 134.09 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -88.02 102.19 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.81 178.99 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.15 160.18 69.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -11.09 30.18 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.403 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -26.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.65 169.44 4.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.47 157.56 17.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.1 mm -53.71 -31.96 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -60.15 -31.33 70.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -36.36 57.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.57 -48.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -62.1 -30.46 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.29 -50.52 73.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -56.18 -42.08 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.55 -34.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -61.89 -47.74 83.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -71.45 -8.18 52.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -95.48 -56.37 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -99.8 -49.24 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.89 2.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.0 mt -105.27 130.96 22.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.64 0.733 . . . . 0.0 111.087 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 163.69 37.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 0.0 112.332 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -7.64 21.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.5 -31.11 22.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -112.51 0.63 15.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.72 127.05 40.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -133.88 136.13 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.09 136.27 44.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.4 mm -117.91 114.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -144.65 143.87 30.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.68 15.08 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.83 22.26 55.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.534 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 177.99 9.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -97.9 140.93 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mt -97.63 147.68 24.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -105.9 166.2 10.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -82.07 -18.6 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -91.51 40.49 2.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -152.97 167.88 27.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.93 152.43 21.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.09 -47.42 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 t -55.75 -25.4 40.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.6 -30.42 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -98.65 12.49 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.61 33.79 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.2 mm -68.69 95.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.42 166.07 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.35 149.79 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 54.99 27.51 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.61 134.47 54.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.4 m -91.95 86.0 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.0 mp -87.03 157.19 19.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -128.42 117.24 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 8.5 tp -83.67 133.26 34.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.22 142.63 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 134.2 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.908 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.595 0.712 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.01 11.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.6 146.16 50.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 20.73 38.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.6 143.81 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -104.57 109.39 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -51.32 -53.53 35.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -50.45 -39.78 48.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.87 -33.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -56.08 12.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -14.03 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -87.99 -28.41 21.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.92 158.31 77.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.705 . . . . 0.0 110.953 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.28 31.49 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.34 -31.91 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.23 -42.28 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.9 mm -77.93 -27.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.55 -50.71 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.46 -32.71 74.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.57 -47.09 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.835 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 52.0 mt -70.35 -43.17 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.86 -33.79 70.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.27 -23.52 67.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.44 25.39 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.886 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.59 134.81 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -117.7 148.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.3 121.42 43.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.4 t -105.09 113.05 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.09 114.0 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.6 p -77.77 170.71 16.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -22.43 54.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.22 23.54 5.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 55.15 55.35 28.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -121.58 108.97 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 132.3 35.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.8 mt -130.29 109.6 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.3 m -77.4 127.14 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.203 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.7 mt -129.63 134.36 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.37 102.23 14.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.54 -179.49 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -131.24 160.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.751 . . . . 0.0 110.831 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -13.74 35.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -95.93 -24.88 16.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.67 173.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.01 154.56 23.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.06 -31.14 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.72 -35.17 72.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -42.13 64.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.89 -42.17 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.97 -41.65 97.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.27 72.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -57.79 -49.89 75.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 62.3 mt -54.05 -32.11 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -61.68 -47.18 86.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.52 -4.68 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -97.4 -56.48 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -101.51 -48.4 4.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.55 35.03 1.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 mt -107.52 130.61 22.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.669 0.747 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 163.41 38.37 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.603 2.202 . . . . 0.0 112.415 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 -7.42 21.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.36 -29.72 24.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.36 -3.43 14.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -88.79 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -133.85 147.98 51.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.35 148.87 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 25.1 mm -136.89 120.31 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.079 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -146.03 140.77 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.95 14.31 9.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.58 15.61 63.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 171.63 14.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.71 134.1 37.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.7 mt -93.78 143.58 26.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -102.2 167.69 9.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -82.26 -20.27 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.16 45.04 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.399 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -153.02 169.67 22.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.42 152.08 23.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.75 -45.14 82.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -58.17 -22.93 53.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.62 -29.85 67.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -98.43 10.06 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.73 33.31 13.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.3 mm -68.75 97.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -88.91 167.34 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 143.5 12.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 58.69 29.61 18.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.87 130.6 47.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -83.11 84.45 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.33 159.62 20.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -129.08 127.55 41.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.65 119.52 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.82 147.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 137.24 37.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.918 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 174.99 8.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -69.55 144.98 52.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.27 20.36 35.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.445 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.51 142.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -102.33 110.62 22.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -51.64 -52.62 46.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -51.33 -47.77 62.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.51 -33.2 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.18 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.05 -56.16 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.832 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -13.67 60.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -88.1 -20.21 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.8 157.6 60.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 162.53 41.67 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.14 -33.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -58.99 -41.23 87.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.0 mm -78.21 -27.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.64 -50.55 43.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.74 -32.91 74.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.69 -50.37 67.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.4 -30.73 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.28 -35.14 77.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.78 -23.75 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.87 29.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.6 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.87 133.79 38.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 17.9 pt -116.37 150.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -106.35 123.18 47.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 t -107.62 108.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 111.61 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.0 p -75.38 171.02 14.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.78 -23.2 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.1 p -93.91 25.17 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.0 51.76 44.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -116.55 108.99 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 131.34 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.194 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.95 106.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 111.101 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.84 126.52 31.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.91 134.11 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.58 101.04 13.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 m -128.04 -179.48 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -134.08 160.78 67.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.715 0.769 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.35 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -21.63 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.13 175.17 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.32 157.36 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.24 -26.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -65.29 -29.38 70.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.33 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.13 -47.42 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -63.46 -36.95 85.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.62 -50.27 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -56.46 -42.11 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.91 -29.33 30.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -66.6 -46.51 75.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.33 -5.08 42.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -96.82 -52.94 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -102.94 -47.1 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.78 3.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.2 mt -104.58 132.23 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.695 0.76 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 167.39 24.66 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -7.34 20.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.72 -21.66 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.0 -11.32 13.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.57 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -133.61 121.02 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 134.56 34.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.1 119.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.54 14.91 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.18 21.85 53.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.63 169.12 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.15 139.19 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.0 mt -94.02 152.73 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.972 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -106.27 159.33 16.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.55 -0.21 41.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.01 3.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -146.37 169.87 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.28 151.5 22.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.35 -35.43 69.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -67.11 -21.38 65.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.02 -32.24 68.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.39 8.35 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 63.07 35.82 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 15.0 mm -68.55 95.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -83.21 162.62 21.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 146.71 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.29 24.7 13.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.5 136.44 56.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -90.2 84.3 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.22 160.88 22.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -130.66 119.59 22.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 3.5 tp -90.17 115.48 27.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.54 148.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.9 124.46 28.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.96 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.608 0.718 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 174.66 9.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.48 146.41 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.98 21.25 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.66 144.76 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.74 115.59 30.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -54.76 -55.06 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.79 -45.72 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.1 t -70.87 -32.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.35 -57.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.61 59.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -88.17 -18.89 27.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.69 153.6 73.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.32 31.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.367 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.03 -34.07 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.07 -38.78 77.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mm -78.89 -45.77 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -51.38 -50.77 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -32.39 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -69.54 -40.75 76.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.22 -30.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.17 -37.26 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -25.01 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.63 24.41 25.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.463 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -98.39 138.98 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.86 147.97 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -104.21 123.7 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -105.07 108.12 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 109.24 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.1 p -69.19 174.33 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.166 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -26.01 65.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.6 p -86.24 3.05 44.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.139 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.12 49.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -94.9 108.42 20.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.335 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.03 131.11 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.38 116.23 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 7.5 m -78.48 128.11 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.2 mp -125.61 133.44 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.2 99.07 11.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.2 -179.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -127.99 160.56 60.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -8.84 24.62 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.685 2.256 . . . . 0.0 112.296 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.3 m -102.15 -24.8 13.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -60.46 175.03 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.68 156.67 19.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.5 mm -53.34 -30.73 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.06 -40.25 84.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -41.87 90.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.01 -46.12 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -60.48 -41.91 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.91 70.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -63.07 -42.37 99.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.74 -28.75 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.78 -44.73 73.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.54 -5.77 44.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -99.55 -54.57 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.11 -48.0 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.37 19.81 6.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 8.1 mt -94.1 132.56 29.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.17 25.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.13 20.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.623 2.216 . . . . 0.0 112.366 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -90.07 -20.68 22.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -113.21 -14.88 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.91 126.8 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . 0.468 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 3.2 ttm180 -134.0 118.29 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.26 147.68 24.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.8 mm -135.96 115.65 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -141.12 141.93 34.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.81 14.29 9.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.21 15.14 65.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -134.31 170.3 15.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . 0.405 HE21 ' NE ' ' B' ' 242' ' ' ARG . 9.5 mt-30 -94.85 128.69 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mt -86.21 155.62 20.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.85 157.16 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.93 -6.51 52.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -103.45 41.22 2.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -152.65 168.52 25.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 148.33 25.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 69.6 mt -53.53 -44.39 69.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.2 t -57.68 -26.59 61.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.86 -33.2 75.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.4 6.72 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 4.2 m120 63.6 36.77 10.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 12.5 mm -68.73 96.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -82.99 166.58 18.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.33 149.4 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 54.22 26.27 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 143.28 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.06 86.92 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.36 158.88 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -133.01 115.07 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.59 134.67 34.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.81 146.85 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.2 127.15 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.468 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.1 mtt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.557 0.694 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 175.01 8.68 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.754 2.303 . . . . 0.0 112.347 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.68 144.45 51.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.41 20.68 30.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.4 145.42 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.169 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -104.47 108.39 19.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -51.64 -53.28 40.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -50.11 -43.21 51.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.7 t -70.85 -32.69 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -56.88 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -14.27 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.97 -23.25 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.85 158.96 69.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.644 0.735 . . . . 0.0 110.846 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 165.27 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.288 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.86 -32.78 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.92 -43.52 94.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.89 -29.1 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.74 -25.96 64.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -89.71 -25.97 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.83 -38.85 64.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.07 -40.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -37.59 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.06 -25.75 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.63 61.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 pttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.733 0.302 . . . . 0.0 110.953 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.76 0.314 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.37 134.09 41.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 pt -117.03 150.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -106.75 130.55 54.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -113.06 107.89 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.66 110.48 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.3 p -71.51 174.28 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.69 -25.73 63.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.55 5.8 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.206 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.35 29.34 58.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -94.73 108.83 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.06 133.5 35.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.52 111.68 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.49 128.2 33.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -131.4 134.19 46.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -90.22 103.9 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.06 -179.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -132.2 160.73 66.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -12.11 32.11 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.72 2.28 . . . . 0.0 112.312 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.1 p -97.96 -25.31 15.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.42 175.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -112.8 157.64 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.86 -29.24 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.49 -30.28 70.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -38.07 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.0 t -67.21 -51.73 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -59.26 -35.04 72.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.25 92.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.06 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.64 -46.78 83.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.6 mt -54.41 -32.8 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -61.79 -47.28 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.14 -5.4 44.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -97.18 -54.52 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.38 -48.72 3.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.7 34.88 1.64 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.531 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 7.7 mt -108.45 131.32 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 164.58 33.98 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.632 2.221 . . . . 0.0 112.345 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -6.98 19.9 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.76 -30.84 19.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.73 6.36 16.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.63 125.75 52.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -134.7 148.0 50.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.828 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.36 133.9 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.4 mm -111.78 123.65 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -151.64 144.75 24.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.14 15.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.49 8.17 74.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.441 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.15 157.99 44.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -77.31 146.77 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.7 163.31 13.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -118.28 154.01 32.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -76.25 -5.54 47.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.805 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.81 39.28 2.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.506 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -152.69 169.89 21.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 152.71 21.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.192 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 52.8 mt -56.92 -43.82 81.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.0 t -60.69 -26.37 67.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -63.83 -31.65 72.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.79 9.73 42.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 63.72 34.89 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 15.9 mm -68.58 96.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -82.95 165.68 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 150.77 7.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 55.82 26.03 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.45 133.72 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.99 88.33 7.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.18 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -89.32 158.82 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -127.99 125.63 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 4.6 tp -92.58 125.61 37.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.78 149.26 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.44 144.03 25.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.68 0.752 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.56 10.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.01 146.15 51.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.15 20.7 36.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.43 143.57 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 111.098 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -102.84 108.63 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -51.68 -52.65 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.36 -38.69 54.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.15 -33.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.36 -56.3 11.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -14.85 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -87.37 -25.91 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.4 158.06 76.95 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.628 0.728 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 164.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.367 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.13 -28.36 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.3 -42.56 99.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.85 -27.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.73 -42.88 77.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -27.03 60.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.47 -41.19 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.08 -34.12 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.47 -35.82 82.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.96 20.82 41.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.77 0.319 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -98.2 134.4 41.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 23.3 pt -118.39 151.75 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -106.45 123.35 47.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.7 113.0 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 112.14 24.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.2 p -75.9 171.18 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.56 -22.01 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.3 23.56 5.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 53.76 38.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -120.04 108.31 14.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.91 130.91 35.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.7 mt -129.66 112.41 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.42 130.45 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.8 mt -132.53 134.55 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.24 104.66 17.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.91 178.48 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.69 160.75 61.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -13.94 35.31 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 5.7 m -96.23 -24.45 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.39 175.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.07 156.49 21.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.2 -28.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -62.98 -31.19 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -38.05 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 88.2 t -67.41 -48.17 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -60.59 -38.94 86.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.55 76.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -58.91 -48.07 82.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.1 mt -55.23 -31.02 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.062 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -62.7 -47.55 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.81 -5.08 44.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -97.27 -56.5 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.81 -48.63 4.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.56 35.34 1.59 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 11.3 mt -108.17 130.54 22.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.734 . . . . 0.0 111.104 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 163.44 38.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.241 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -7.95 22.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.53 -30.15 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.6 -3.22 14.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -89.31 131.35 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -133.75 147.52 51.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.36 146.53 42.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.9 mm -133.69 120.67 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -148.4 141.3 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.33 14.02 9.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.051 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.63 64.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.495 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -134.78 176.07 8.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.709 0.29 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.5 131.7 47.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.2 mt -86.66 158.73 19.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.45 162.13 18.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.48 0.73 41.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.48 42.86 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -152.75 167.96 27.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.0 110.835 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.57 147.25 26.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 80.2 mt -52.46 -44.37 65.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -56.61 -26.07 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -67.72 -31.41 71.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.53 6.5 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 6.0 m120 63.83 35.66 10.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 12.2 mm -68.54 96.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -83.22 163.9 20.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.48 148.44 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 58.98 22.84 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.46 144.68 30.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -103.43 92.24 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.31 162.75 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -130.14 116.04 17.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.5 tp -83.9 125.45 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 15.5 t -124.85 146.88 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 135.4 37.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.598 0.713 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 173.84 10.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.681 2.254 . . . . 0.0 112.393 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.72 146.8 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.2 20.91 30.44 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.12 143.92 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 111.069 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -103.4 107.85 18.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -51.44 -51.8 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -51.2 -40.41 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.795 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.6 t -76.42 -33.04 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.99 -56.08 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -14.4 60.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -89.4 -23.4 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.4 158.23 71.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.24 31.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.342 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.55 -32.31 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -58.85 -41.42 86.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.8 mm -79.08 -29.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.68 -30.8 68.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.23 -29.07 31.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -73.2 -38.93 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 -26.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -39.88 80.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.58 -22.15 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.09 28.84 24.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.99 134.21 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.35 148.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.187 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -105.22 121.97 44.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.18 108.0 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.88 110.53 23.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.3 p -72.07 174.77 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -24.54 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -89.97 8.25 33.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.09 63.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -93.18 110.54 22.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.28 132.71 35.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.22 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 5.6 mt -129.8 106.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.74 133.12 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -137.21 134.13 35.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -89.19 100.94 13.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.49 175.73 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.55 160.29 63.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.628 0.727 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -11.45 30.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.736 2.291 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -27.14 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -61.98 175.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -113.44 158.45 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.4 mm -52.07 -33.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.34 -31.72 66.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -36.28 46.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -70.43 -51.23 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.97 -33.91 71.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.49 73.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -55.66 -43.22 76.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.17 -32.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -63.46 -45.59 90.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -74.72 -5.83 45.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.93 -48.19 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -108.37 -48.65 3.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.57 1.71 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.36 132.13 21.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.621 0.724 . . . . 0.0 111.18 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 163.4 38.44 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.362 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.378 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.19 -22.87 18.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.18 -5.56 13.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.68 131.3 37.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -133.89 124.49 26.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 134.18 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.13 115.19 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -143.04 145.19 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.53 15.45 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.26 20.63 58.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 173.88 12.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 140.82 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.7 mt -96.24 153.28 17.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.41 161.79 14.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 0.37 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.75 41.44 2.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -152.5 168.57 25.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.964 0.412 . . . . 0.0 110.84 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.98 151.36 21.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.42 -47.33 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.8 t -55.43 -25.15 34.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.79 -28.8 67.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -98.67 11.21 39.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 63.82 33.47 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.81 97.82 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -93.52 170.21 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.72 143.89 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 58.21 29.02 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.58 126.57 27.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -84.6 83.92 7.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.5 mp -85.75 160.76 19.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -129.0 119.9 25.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 6.1 tp -89.21 120.97 31.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 18.8 t -118.83 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.19 135.2 39.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.591 0.71 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 174.61 9.14 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 0.0 112.394 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.02 144.66 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.84 18.71 40.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.62 142.88 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 111.138 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -103.36 109.71 21.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.41 -53.01 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -51.27 -37.84 49.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.62 -33.29 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.74 -56.23 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -14.78 59.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -87.55 -23.93 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.6 mt -81.34 157.74 70.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.709 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.12 31.99 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.399 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.17 -34.4 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -58.15 -39.94 80.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.56 -32.64 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -64.8 -49.9 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -65.25 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.31 -43.1 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.24 -31.37 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.92 -35.23 76.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -65.25 -24.39 67.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.1 18.57 49.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.801 0.334 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.18 133.77 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.25 147.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -104.99 125.05 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.04 109.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.65 111.15 23.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.4 p -71.78 174.24 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -23.4 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.3 p -89.48 7.56 35.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.59 35.2 52.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -102.81 112.35 25.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.24 134.66 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.8 mt -130.75 110.86 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 132.3 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 5.9 mt -136.45 134.03 37.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.28 102.17 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.37 179.96 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -137.18 161.34 61.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -14.74 36.81 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.727 2.285 . . . . 0.0 112.379 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -26.8 16.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -61.98 174.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.09 152.23 24.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -50.2 -30.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 -37.98 86.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.18 96.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.06 -50.98 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -57.24 -38.68 74.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.07 -50.23 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.134 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -56.42 -43.17 79.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.29 -28.79 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.129 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.2 -45.96 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -74.66 -5.34 42.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -97.01 -49.56 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.66 -48.27 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.75 34.9 1.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.6 mt -110.14 132.66 21.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.149 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.91 164.5 34.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.632 2.222 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -5.0 15.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.62 2.213 . . . . 0.0 112.344 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.78 -24.91 17.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.47 -2.15 13.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.99 129.81 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . 0.423 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 8.1 ttm180 -133.9 122.43 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -103.5 133.81 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 15.8 mm -114.68 141.52 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -156.64 137.4 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 14.63 9.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.82 16.16 60.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -136.75 168.6 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.01 122.09 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.25 152.48 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 161.13 16.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.94 -12.38 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.4 3.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -152.9 170.75 19.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.356 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.94 158.08 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.29 -50.61 69.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 44.4 t -57.47 -30.45 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.83 -37.5 63.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.85 16.48 22.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.17 32.42 19.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 8.6 mm -68.15 95.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 147.43 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 59.72 25.62 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.67 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -92.39 84.24 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.205 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.33 162.99 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -129.81 129.08 43.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.06 131.21 42.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 19.6 t -133.81 148.19 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.37 128.06 33.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . 0.423 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.8 mtt180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.593 0.711 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 175.06 8.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.54 147.27 51.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.33 21.01 31.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.82 145.28 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.152 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -104.31 107.34 18.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -50.89 -53.88 28.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.44 -40.76 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.75 -32.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.7 -56.81 10.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -14.74 61.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -87.66 -23.75 24.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.83 157.55 69.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.611 0.72 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.21 31.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 0.0 112.362 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.6 -29.95 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -61.73 -40.59 95.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.0 mm -79.19 -27.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.7 -47.88 61.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.89 -33.05 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.92 -42.56 85.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.5 mt -77.47 -37.14 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.49 -32.83 63.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -71.48 -24.56 62.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.16 -15.61 58.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.14 135.65 42.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 pt -117.09 148.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.85 126.29 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.837 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -108.78 108.19 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.64 110.34 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.1 p -71.95 174.06 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -25.12 63.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.43 3.19 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.81 24.77 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -89.89 109.91 20.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.72 130.93 34.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mt -128.32 113.68 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 10.2 m -78.61 127.69 32.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.8 mp -126.36 133.4 51.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.62 98.58 10.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.77 -179.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.22 160.77 55.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -8.65 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.65 2.233 . . . . 0.0 112.384 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.77 -25.5 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.77 174.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.76 163.38 14.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mm -59.3 -40.79 82.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -52.37 -29.76 25.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.72 44.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.07 -47.42 85.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -58.01 -39.17 77.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.81 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -57.2 -42.06 80.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.37 -30.61 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -66.74 -43.92 82.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -97.93 -47.96 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -109.51 -48.52 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.96 32.91 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.35 132.86 20.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.701 0.763 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 162.62 41.34 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.248 . . . . 0.0 112.363 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -4.6 14.32 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.687 2.258 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.56 -27.0 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -113.43 -2.34 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 127.43 40.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -134.31 145.51 49.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 155.96 27.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.5 mm -137.67 114.05 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -144.43 145.77 32.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.08 14.41 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.07 39.4 16.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.64 20.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.282 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.49 126.67 35.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.47 163.69 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -131.1 157.64 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -82.2 1.06 38.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.75 37.69 3.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -153.1 169.88 21.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 157.15 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 39.1 mt -60.01 -43.43 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t -59.14 -20.58 54.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.92 -32.13 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -98.44 10.57 40.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 63.57 33.94 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 mm -68.69 100.71 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . 0.405 ' N ' ' HG ' ' B' ' 265' ' ' SER . 1.8 mt-30 -98.5 175.98 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -54.95 145.06 21.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 57.95 28.5 16.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 265' ' ' SER . . . . . 0.405 ' HG ' ' N ' ' B' ' 262' ' ' GLN . 0.4 OUTLIER -58.05 128.69 38.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -87.81 84.3 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.6 mp -88.57 161.12 17.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.73 121.78 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.2 tp -90.17 108.03 19.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.94 148.77 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 135.03 35.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.808 -179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.628 0.728 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 175.14 8.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.686 2.258 . . . . 0.0 112.335 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.22 146.09 52.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.53 20.67 31.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.74 144.48 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 111.173 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.28 108.92 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.71 -50.69 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -39.12 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.63 -33.51 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -66.86 -56.17 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -15.07 61.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.0 -26.8 23.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.7 mt -79.5 158.18 74.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 153.31 68.55 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.696 2.264 . . . . 0.0 112.264 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.49 -29.83 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -60.61 -41.56 95.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.2 mm -76.28 -30.97 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.85 -42.47 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.57 -31.72 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -74.08 -54.58 7.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.6 -40.97 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -30.22 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -66.09 -24.66 66.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 9.35 63.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -94.83 133.91 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.0 pt -116.75 149.66 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.07 124.34 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.47 108.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 113.19 24.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.0 p -76.91 174.7 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.68 -22.58 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -92.72 17.7 9.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.3 97.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -104.72 108.01 19.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 132.48 35.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.49 108.79 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 130.47 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 7.7 mt -135.88 135.83 40.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -89.27 101.82 14.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 25.3 m -128.22 -178.95 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.08 160.45 68.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -11.44 30.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.655 2.237 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.2 m -98.1 -25.54 14.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.5 174.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.4 p -111.25 155.98 22.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 48.2 mm -50.57 -36.92 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -53.25 -36.68 61.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -34.25 65.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.94 -46.86 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -64.76 -35.63 81.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.932 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.97 76.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -59.31 -43.61 92.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 42.3 mt -56.54 -29.45 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.86 -48.73 73.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.21 -8.08 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -96.73 -56.34 2.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -96.14 -49.48 5.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 20.9 5.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mt -99.22 134.05 21.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 166.42 27.79 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -7.85 22.11 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.36 -23.01 28.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.47 -8.57 13.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.19 127.19 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -134.21 118.0 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.36 150.37 29.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 268' ' ' HIS . 30.3 mm -137.98 114.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.185 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -145.87 144.41 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.84 15.08 8.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.6 5.67 78.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.498 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.5 170.4 13.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.739 0.304 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -95.2 139.8 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.45 155.71 18.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -111.57 161.8 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -81.68 -0.9 44.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.46 41.07 2.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.429 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -152.85 169.75 22.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.47 153.25 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.41 -44.87 84.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.6 t -58.88 -24.48 62.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.09 -32.47 73.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.814 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -98.7 12.5 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 64.02 33.79 11.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.81 95.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.87 174.14 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 147.53 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 55.94 25.02 8.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.66 133.11 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -85.32 86.04 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.9 157.24 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . 0.404 ' HB2' ' HB ' ' B' ' 244' ' ' ILE . 3.0 m170 -130.46 121.44 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.98 127.16 37.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.49 148.46 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.73 130.08 38.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 174.22 9.74 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 147.71 50.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.81 20.88 34.58 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.45 142.55 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -101.87 108.11 19.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -50.59 -51.92 43.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.18 -40.08 57.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.0 t -76.42 -32.92 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.71 -56.6 8.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -15.78 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -87.55 -22.78 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.96 158.04 68.05 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.729 2.286 . . . . 0.0 112.324 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.93 -31.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.13 -38.76 87.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.79 -31.08 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -67.73 -49.94 59.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -32.9 74.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.6 -43.4 80.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.7 mt -74.6 -44.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -30.18 71.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -64.91 -27.6 68.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.97 41.82 5.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -95.51 138.5 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.67 147.17 24.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -105.36 127.51 53.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 16.2 t -109.86 108.19 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 112.47 24.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -74.92 175.5 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -24.45 62.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.96 8.38 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.17 69.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -89.66 108.49 19.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.43 131.85 35.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.5 mt -128.91 115.23 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 5.8 m -79.44 128.46 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.8 mp -126.67 134.1 50.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.13 98.86 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.37 -179.04 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.077 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -130.58 160.56 65.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -9.29 25.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.248 . . . . 0.0 112.39 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -100.6 -24.88 14.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -63.4 175.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.0 157.93 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.07 -32.52 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -56.74 -35.85 69.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -43.11 63.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.15 -43.38 98.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.169 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -61.26 -42.14 98.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.921 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.51 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -63.66 -42.21 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.14 -29.37 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.148 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -67.06 -44.73 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.38 -4.98 45.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -99.29 -56.01 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -98.79 -48.66 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.66 19.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.14 134.39 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.585 0.707 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.6 18.57 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.68 2.253 . . . . 0.0 112.302 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -7.2 20.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.35 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.85 -19.03 25.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.21 -15.54 12.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 129.67 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -132.93 112.49 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.72 134.67 34.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.0 mm -121.41 116.2 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -140.45 142.56 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.17 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.06 12.56 67.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 174.14 10.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -94.74 144.07 25.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.68 155.59 16.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -111.63 159.95 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.67 -1.78 43.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -109.55 40.66 2.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -152.59 169.39 22.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.25 152.73 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.8 -47.06 83.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -55.27 -26.0 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -68.13 -27.64 66.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -98.58 9.12 43.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.47 32.72 11.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.04 97.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -89.5 167.31 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -51.2 141.46 14.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 59.13 27.4 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 131.64 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.32 88.87 7.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.19 160.1 17.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -129.67 127.58 40.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 118.31 35.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.3 t -116.64 141.13 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.101 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.73 128.08 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.907 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.641 0.734 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 172.78 11.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.36 145.92 52.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.95 36.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.73 141.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -50.29 -56.29 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -50.16 -62.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -53.05 -32.18 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.158 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.72 -57.84 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -72.37 -7.67 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -89.33 -18.22 27.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.03 158.0 44.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 159.14 54.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.37 -29.28 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.06 -40.11 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.32 -43.08 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -55.6 -50.7 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -64.08 -33.28 75.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.17 -43.1 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.71 -35.47 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -33.6 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.944 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -23.74 67.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.72 58.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.784 0.326 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.74 133.97 37.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 pt -116.64 148.56 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.3 126.52 52.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.07 107.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 112.54 24.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -77.14 172.44 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -22.03 59.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.9 p -94.29 25.29 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.52 50.84 51.56 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -118.25 108.24 14.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.1 134.41 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.5 mt -130.15 108.17 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.07 130.15 37.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.82 133.65 41.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.8 100.29 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.86 -179.38 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -129.84 160.81 63.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -12.04 32.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.3 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.19 175.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.8 156.07 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.8 mm -51.38 -30.28 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.43 -38.79 85.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -38.78 88.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.17 -36.92 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -71.01 -38.81 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.01 75.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -54.52 -45.24 73.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 mt -53.93 -33.35 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -63.64 -46.64 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.59 -6.08 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -96.87 -53.73 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -101.99 -49.05 4.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.01 31.68 2.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.0 mt -105.68 130.65 22.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.519 0.676 . . . . 0.0 111.142 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 162.96 40.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.629 2.219 . . . . 0.0 112.38 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.4 -28.85 23.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.8 -2.3 14.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -94.76 128.39 41.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -133.33 136.98 45.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.6 155.83 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.8 mm -140.07 115.4 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -146.35 143.83 29.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.45 14.92 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.29 14.84 70.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -132.6 -175.64 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.308 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -107.51 125.96 51.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt -82.54 160.27 22.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.48 161.41 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.17 0.58 40.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.12 43.82 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -152.52 169.4 22.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.47 147.06 26.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 70.6 mt -52.65 -44.98 66.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -57.45 -28.0 62.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.2 -32.82 74.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.63 8.18 44.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.989 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.0 m120 63.32 36.22 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.6 mm -68.79 95.56 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -83.05 163.84 20.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.16 145.55 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.07 26.46 15.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 135.51 54.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -89.2 83.91 6.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.86 155.51 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -128.93 121.91 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 2.9 tp -91.72 126.3 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.78 148.15 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.79 134.85 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -179.998 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.818 0.257 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.1 mt -108.17 45.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.8 m -91.68 -24.43 19.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -120.23 93.57 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -111.37 153.27 44.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.626 0.727 . . . . 0.0 110.964 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.41 9.59 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.74 145.05 52.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.18 20.7 36.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 p -69.09 144.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.157 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -103.86 108.43 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -51.27 -50.16 59.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -53.07 -45.98 68.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.38 -33.21 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.77 -56.32 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -13.82 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -88.66 -27.49 21.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -75.66 158.84 82.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.651 0.738 . . . . 0.0 110.912 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.14 31.97 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.359 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.75 -29.79 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.2 mm -78.84 -29.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -69.61 -26.58 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -88.68 -25.81 22.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.5 -40.14 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.1 mt -78.15 -30.86 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -70.69 -33.52 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.44 -21.3 66.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.78 23.98 40.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.414 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -111.86 -177.98 3.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m 53.89 70.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -132.82 97.17 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -110.93 -44.59 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.806 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -53.65 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -116.33 174.33 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -99.43 129.71 45.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.32 152.43 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -103.75 75.3 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.736 0.303 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 134.05 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 31.7 pt -117.24 149.35 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -105.13 124.25 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.23 108.1 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.86 110.85 23.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.2 p -73.6 173.36 9.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -23.86 58.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.27 12.24 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.08 31.69 72.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.533 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -97.25 108.59 21.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.34 133.36 35.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.195 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.53 115.38 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.52 125.16 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -127.72 134.31 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.09 102.93 15.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 18.1 m -131.19 -179.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -132.75 160.6 67.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 110.924 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -10.67 29.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.398 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.1 m -98.18 -24.89 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.91 174.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.86 156.52 21.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.56 -34.73 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -55.68 -35.42 66.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -39.92 69.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 46.2 t -65.66 -42.42 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.145 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 3.2 mtmm -63.65 -42.4 98.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.964 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.61 73.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -56.64 -50.1 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.6 -31.17 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -63.57 -45.71 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -4.6 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -99.09 -56.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -100.31 -48.43 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.14 32.26 2.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.64 130.04 23.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.654 0.74 . . . . 0.0 111.088 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 164.31 35.07 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.706 2.271 . . . . 0.0 112.385 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -8.04 22.59 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.14 -30.35 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.53 -1.38 14.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -92.45 128.78 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -133.75 140.96 47.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.4 151.06 26.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.5 mm -137.9 117.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -148.22 143.32 26.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.79 13.82 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.28 3.88 74.94 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 158.5 44.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.745 0.307 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.02 145.54 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.4 mt -96.14 163.24 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.73 157.27 28.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.94 -13.64 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.47 39.52 2.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -152.58 169.72 21.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.4 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.34 152.98 20.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.134 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 32.8 mt -56.5 -46.47 80.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.6 t -58.87 -25.07 62.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.02 -32.14 73.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -98.64 11.88 37.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.06 31.74 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 13.4 mm -68.89 95.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -84.5 -179.09 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 150.33 48.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 54.45 27.02 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.62 134.63 54.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -87.47 86.78 7.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.62 158.33 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -130.76 117.67 19.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 8.5 tp -87.11 128.98 35.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 13.9 t -126.59 148.19 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.08 127.36 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -85.81 167.84 14.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -49.24 123.07 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.79 154.53 40.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -51.66 -56.68 14.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.398 -179.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.232 0.221 0 CA-C-O 120.872 0.28 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.99 178.53 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 67.1 m -75.6 -59.1 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 m -144.55 109.35 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.1 mt -111.33 152.25 43.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.922 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 174.52 9.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.624 2.216 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.0 145.28 51.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.39 20.72 38.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.27 144.9 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 111.184 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -102.76 106.37 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -50.64 -52.65 37.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -51.55 -37.23 48.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 74.7 t -76.85 -33.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -56.57 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -13.79 60.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -90.17 -18.27 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.3 mt -87.92 157.39 51.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 0.0 110.906 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.79 165.33 31.37 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.383 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.02 -27.94 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.099 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -43.42 95.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.7 mm -79.39 -28.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -69.59 -23.95 63.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.2 -26.7 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.17 -37.85 63.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.05 -42.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.71 -34.46 67.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 t -65.16 -21.9 66.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.98 14.93 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt -98.48 -176.48 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.09 70.14 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -131.15 69.52 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -100.02 -35.72 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.33 -50.28 59.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.29 174.27 10.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -117.48 157.55 26.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.27 105.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -81.11 95.46 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.749 0.309 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -95.54 134.18 38.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 25.8 pt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -105.49 124.47 49.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 11.3 t -107.22 108.16 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.97 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.1 p -71.63 174.71 6.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -25.42 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 4.7 p -88.75 10.81 19.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.52 30.16 69.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -94.58 108.71 20.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.22 132.54 35.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.8 mt -129.48 111.45 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.02 128.54 34.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.6 mt -132.36 134.19 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -90.21 103.03 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.7 m -130.77 -179.51 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -132.21 160.32 68.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.649 0.738 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 51.8 p -97.11 -24.79 15.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -61.65 175.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.23 156.85 20.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.3 mm -53.56 -27.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.64 -29.85 71.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -37.56 44.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.87 -49.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -60.72 -34.61 74.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.44 98.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.4 mttt -57.24 -46.91 82.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 71.1 mt -53.76 -36.87 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -58.7 -44.87 90.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -4.75 44.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.0 mmmt -98.44 -56.6 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -101.4 -47.87 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.11 26.48 3.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.7 mt -98.08 128.88 32.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.124 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 164.3 35.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.575 2.184 . . . . 0.0 112.355 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.94 -29.37 25.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.55 -5.34 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -88.92 130.44 35.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -133.81 141.18 47.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.9 mp -109.87 149.79 29.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.8 mm -135.85 118.78 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.166 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -149.27 142.71 25.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.7 14.91 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.73 17.95 64.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.45 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.34 171.62 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -91.43 139.53 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mt -94.17 151.26 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.43 155.32 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -78.25 -4.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -106.12 39.55 2.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -152.44 169.44 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.72 152.08 20.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 64.9 mt -56.33 -43.8 79.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 t -57.36 -23.63 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.28 -32.97 74.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -97.41 10.25 40.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 62.45 35.79 14.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.5 mm -68.69 95.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -84.87 167.37 16.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.57 148.55 9.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 55.56 26.56 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.13 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 85.47 6.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.02 159.29 21.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -129.32 129.56 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.7 tt -96.03 134.7 38.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 17.2 t -133.89 140.35 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.18 129.8 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -90.28 165.5 13.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.72 124.67 12.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -95.37 137.22 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 146.39 -17.81 1.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.793 0.247 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.6 mt -106.15 48.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.5 m -89.76 -26.71 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -118.17 93.72 4.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.3 mt -111.2 153.58 43.92 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.681 0.753 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 173.76 10.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 0.0 112.265 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.04 145.26 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.3 20.69 37.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.552 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.04 144.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 62.6 t0 -103.55 108.96 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -51.25 -52.05 48.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -51.41 -45.72 62.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 67.0 t -69.72 -33.13 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -67.14 -56.02 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -13.84 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -88.83 -25.93 21.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.3 mt -78.43 158.67 76.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 165.13 32.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.62 -30.42 44.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -61.96 -41.38 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.6 mm -78.88 -27.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -69.67 -45.69 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.77 -29.44 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.81 -43.02 80.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 39.4 mt -77.91 -30.6 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.2 -35.72 74.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -65.45 -20.78 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.14 18.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.42 179.42 3.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.882 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 p 45.72 65.64 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -140.18 82.54 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -23.77 8.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -51.54 -48.48 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -127.37 174.41 9.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.27 127.62 32.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.92 179.72 1.44 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.529 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.64 88.41 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -94.84 137.78 33.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 10.0 pt -120.59 147.19 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -105.54 121.93 44.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.7 107.95 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.29 109.55 22.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.8 p -71.43 172.41 9.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.62 -24.0 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.21 10.12 23.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.3 66.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.508 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -101.89 108.88 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.02 132.71 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 4.1 mt -128.52 110.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 127.52 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 7.9 mt -133.08 134.1 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.36 102.4 15.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 22.9 m -128.03 -179.24 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.126 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -134.75 160.38 68.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.628 0.728 . . . . 0.0 110.884 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -11.23 30.4 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.26 . . . . 0.0 112.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 p -97.16 -26.42 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.76 173.14 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.02 156.96 20.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -52.14 -31.22 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.96 -32.57 70.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -38.17 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.11 -49.06 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -59.32 -37.02 76.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.18 70.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -56.5 -43.06 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 80.5 mt -55.33 -34.31 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.168 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -62.11 -48.08 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.12 -8.36 52.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -95.21 -56.33 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -100.35 -49.2 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.33 33.32 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.5 mt -106.41 130.68 22.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.605 0.717 . . . . 0.0 111.19 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 163.31 38.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.4 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -8.18 22.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -84.95 -30.44 24.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.66 -1.67 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -91.97 126.85 37.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -133.79 135.17 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.14 155.92 17.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 29.0 mm -140.56 117.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -146.6 145.05 29.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.83 14.46 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.63 15.51 68.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -133.6 -176.07 4.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -107.58 127.87 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.6 mt -84.48 153.06 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.34 163.31 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -81.97 -0.47 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.68 39.89 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.54 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -152.52 164.98 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.32 150.49 20.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 52.2 mt -54.73 -48.78 72.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -54.72 -26.18 32.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.4 -28.2 68.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -98.86 11.88 37.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 63.96 31.25 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.0 mm -68.73 106.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.9 168.43 9.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.18 142.0 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.05 28.86 18.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 131.57 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.55 87.8 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.9 mp -89.3 159.25 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.5 m170 -128.66 122.98 32.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 8.7 tp -90.07 122.4 33.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 13.8 t -120.59 147.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.162 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.76 132.09 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -91.09 163.17 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -50.43 128.92 21.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 43.7 tpt85 -100.36 129.17 46.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -89.56 48.7 3.35 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.455 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.428 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.843 0.268 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.4 mt -110.67 47.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.03 -22.73 17.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.58 93.77 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 mt -111.28 153.02 44.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 0.0 110.859 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 175.16 8.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.288 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.18 145.09 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.96 20.63 34.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.531 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.65 144.6 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -104.28 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -51.33 -51.29 55.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -51.44 -39.81 58.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.36 -33.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.11 -56.14 11.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -14.8 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.17 -25.57 21.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.58 157.82 79.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 165.27 31.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.702 2.268 . . . . 0.0 112.363 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.77 -26.89 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -64.73 -42.56 95.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.2 mm -78.41 -29.58 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.73 -25.89 64.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.97 -24.69 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -72.29 -39.74 68.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.1 mt -78.26 -34.86 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.15 -32.43 73.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -67.83 -18.4 64.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.59 37.38 17.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -119.36 -175.91 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 p 46.8 66.02 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.818 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.0 81.8 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.87 -19.92 13.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.93 -57.13 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -120.45 173.97 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -80.4 111.23 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.99 168.41 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -103.4 133.36 48.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.837 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.897 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.06 134.1 42.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -117.38 149.9 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -106.58 128.56 54.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.29 107.75 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.92 111.04 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.2 p -72.76 174.26 7.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.144 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -25.53 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.4 p -88.04 8.14 28.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.7 31.98 59.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -97.52 108.88 21.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.26 133.81 35.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.95 111.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 128.14 32.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -130.71 134.25 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.1 104.02 16.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 25.1 m -131.61 -179.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -131.35 160.87 65.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -11.73 31.44 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -28.98 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.4 175.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.6 157.97 22.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.13 -25.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.69 -35.47 80.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 91.0 t -69.17 -39.16 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.39 -39.83 92.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.78 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -56.56 -50.15 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 69.9 mt -53.31 -33.41 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -60.41 -48.58 81.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -72.6 -7.34 49.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -95.37 -54.59 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.34 -48.91 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.38 29.97 2.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.2 mt -102.52 130.54 23.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.515 0.674 . . . . 0.0 111.105 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 163.78 36.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.703 2.268 . . . . 0.0 112.428 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -7.88 22.17 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.802 2.335 . . . . 0.0 112.335 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -85.91 -30.54 22.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.29 -0.46 15.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.43 131.91 43.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -133.73 147.12 51.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.7 mp -115.06 150.43 35.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 22.7 mm -136.8 115.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -145.74 144.25 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.19 13.29 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.5 5.09 72.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 163.47 30.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.78 145.9 30.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mt -98.32 154.43 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -111.67 155.61 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.44 -5.39 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.39 2.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -152.53 169.42 22.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.876 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 149.61 23.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 44.7 mt -55.2 -47.59 75.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -57.39 -25.68 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.08 -30.87 71.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -98.81 11.04 39.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.9 m120 63.98 32.49 13.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.3 mm -68.77 95.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -86.98 170.64 11.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 152.17 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 53.64 27.45 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.78 133.48 54.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -90.14 85.77 6.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.58 159.63 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -128.11 122.77 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.8 tp -89.74 122.27 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 10.8 t -119.91 147.93 23.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.71 135.65 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -97.03 166.45 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -51.95 130.33 29.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -95.07 98.55 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -160.75 24.4 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.838 0.266 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.9 mt -108.46 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.0 m -93.47 -22.87 18.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -121.57 93.49 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.9 mt -111.42 153.05 44.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.554 0.692 . . . . 0.0 110.996 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 174.11 10.03 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.719 2.279 . . . . 0.0 112.339 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.42 146.32 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.51 21.03 33.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.2 p -71.6 145.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.41 108.85 20.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -51.39 -52.09 48.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -51.4 -40.05 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 80.2 t -76.04 -33.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.097 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.23 -56.35 10.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -15.26 60.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -88.81 -27.49 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.3 mt -75.88 158.29 82.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.637 0.732 . . . . 0.0 110.906 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 165.16 31.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.35 -29.19 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.19 -39.69 95.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 36.8 mm -78.9 -29.65 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.56 -32.48 74.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.84 -42.93 76.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.5 mt -77.91 -29.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -61.77 -38.9 89.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -65.58 -25.08 67.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.42 55.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.88 -176.52 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.911 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m 54.25 70.21 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.9 ptt85 -139.09 69.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -97.35 -33.39 11.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -50.37 -53.62 27.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -130.09 174.06 10.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -102.51 135.78 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.978 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.48 106.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 76.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.3 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.63 133.79 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 17.0 pt -116.67 148.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.108 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -104.85 126.87 52.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.02 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.075 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.94 111.17 23.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.824 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.3 p -73.14 175.0 7.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -23.9 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 1.2 p -90.07 7.66 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.41 65.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -91.76 109.47 20.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.71 132.37 35.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.194 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.46 111.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.06 127.61 32.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.4 mt -129.9 134.3 47.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.47 102.46 15.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.44 -179.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -131.94 160.34 68.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.628 0.728 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -10.16 27.86 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -99.54 -24.6 14.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.38 175.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.15 155.07 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.5 mm -52.11 -29.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.27 -34.2 74.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -37.91 67.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 62.2 t -69.66 -42.7 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.139 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -64.37 -38.93 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.7 87.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -57.35 -49.86 74.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 65.7 mt -53.33 -32.72 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.53 -47.53 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.69 -4.74 42.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -96.68 -50.34 4.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.852 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -106.94 -47.31 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.79 29.59 2.82 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.17 132.24 21.33 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.515 0.674 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 164.83 33.03 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.633 2.222 . . . . 0.0 112.375 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -6.45 18.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.695 2.263 . . . . 0.0 112.336 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -90.17 -23.74 21.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.02 -7.73 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.12 130.11 35.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -133.69 132.38 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.9 mp -101.73 149.1 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 26.1 mm -136.38 119.72 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -148.23 142.09 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.84 14.99 9.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.082 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.02 12.4 68.28 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.79 21.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.87 143.72 26.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.4 mt -99.88 148.34 24.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -108.2 157.41 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.15 -16.11 61.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.68 38.14 3.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -152.59 168.54 25.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.36 154.39 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 49.6 mt -57.8 -48.67 79.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.0 t -54.41 -27.28 35.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.32 -34.51 72.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -98.15 9.85 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.76 40.36 7.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.0 mm -72.28 95.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.25 167.34 16.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 146.68 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 58.83 26.43 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.97 133.87 55.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.95 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -84.09 159.3 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -129.42 118.8 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 2.8 tp -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 26.8 t -112.73 148.14 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.14 130.97 35.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -92.25 163.76 13.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.2 121.66 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -100.34 116.96 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -111.61 -26.67 4.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.454 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 CA-C-O 120.83 0.263 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mt -92.67 47.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 67.3 m -88.17 -25.33 22.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 m -118.93 94.18 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -111.01 152.56 43.74 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.587 0.708 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.16 8.46 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.08 147.01 52.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.84 21.11 28.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.506 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.52 145.34 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 111.112 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -103.81 106.14 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -50.06 -52.97 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.5 -38.99 47.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.9 t -76.72 -33.24 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.57 -56.56 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -13.95 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -88.93 -25.88 21.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 25.8 mt -78.13 158.41 77.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.661 0.744 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.17 31.91 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.56 -31.45 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.78 -42.48 93.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.94 -29.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -69.76 -27.69 65.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.1 -26.76 23.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.88 -40.2 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.5 mt -78.13 -31.55 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -62.7 -38.34 90.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -65.43 -23.6 66.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.08 -1.95 65.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.51 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -78.2 -176.71 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 m 53.31 70.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 78.43 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -117.71 -32.45 4.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.11 -43.08 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -136.96 174.27 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -113.06 160.1 18.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.13 113.62 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -55.21 135.37 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.714 0.293 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.35 136.19 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 29.8 pt -118.27 148.67 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.178 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -105.15 121.5 43.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.09 108.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.13 111.96 23.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.909 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.2 p -74.42 172.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.138 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.87 -24.52 62.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 1.9 p -89.61 12.22 17.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.02 89.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -108.23 110.96 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.31 134.43 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 4.0 mt -129.85 112.11 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.69 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.8 mt -131.42 134.84 46.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -89.83 104.4 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 m -134.45 174.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -125.71 160.95 53.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -8.58 23.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.55 -24.01 14.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -62.3 175.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.13 154.97 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -51.29 -35.05 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.87 -34.42 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -38.96 67.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.92 -43.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.172 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -62.47 -41.65 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.29 -42.17 73.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -58.55 -48.17 81.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.58 -31.3 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -48.54 79.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.04 -5.04 41.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -96.72 -51.29 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -105.75 -47.42 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.08 27.64 3.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.541 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 11.9 mt -101.61 132.38 21.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 111.107 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.23 31.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -6.93 19.78 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.737 2.291 . . . . 0.0 112.29 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.35 -21.39 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.95 -8.69 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.31 130.82 34.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 4.0 ttm180 -134.01 128.4 34.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.61 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.1 mm -136.92 114.92 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 19.5 t80 -143.16 143.05 31.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.46 15.14 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.86 75.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.14 168.86 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.728 0.299 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -89.39 142.77 27.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.37 151.32 20.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 161.01 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.58 -9.88 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.65 2.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.53 169.66 22.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.381 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.4 151.54 21.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 57.3 mt -56.19 -45.22 79.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.2 t -56.08 -24.1 37.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.789 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.16 -30.58 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -98.41 9.88 42.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.4 34.09 13.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.92 100.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.127 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -95.11 170.67 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.37 144.22 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 58.11 28.24 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.69 125.4 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -80.84 85.7 6.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -85.39 158.52 20.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -129.69 119.86 24.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 7.5 tp -89.99 128.05 36.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.81 144.62 35.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.3 134.12 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -96.69 162.87 13.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -49.85 127.06 15.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -101.18 137.72 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -79.15 57.63 4.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.496 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.848 0.27 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.5 mp -71.72 81.48 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.17 -22.45 9.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -132.47 100.87 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.826 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.2 mt -110.65 153.16 43.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.924 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 174.97 8.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.712 2.275 . . . . 0.0 112.316 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.08 144.33 52.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 19.99 30.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.98 144.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -104.3 108.59 20.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -52.92 37.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -51.29 -38.61 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.9 t -76.12 -33.1 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -68.0 -55.98 10.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -14.27 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -88.64 -23.5 23.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.7 mt -81.23 158.46 69.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 165.15 31.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.41 -31.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.15 -41.23 92.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.9 mm -78.99 -28.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.57 -47.73 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.28 -32.19 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.41 -41.69 84.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 56.5 mt -77.8 -33.99 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.38 -35.69 81.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 -23.22 66.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.64 -2.28 69.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -75.7 -176.33 3.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.0 p 46.99 70.75 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.99 70.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.813 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -92.44 -45.55 8.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -53.09 -66.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -106.45 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.92 126.11 35.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.34 172.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -155.38 95.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.794 0.33 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.55 134.09 42.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 24.3 pt -118.74 148.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -105.77 127.63 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.76 108.65 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.3 108.84 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 8.7 p -67.49 173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -27.97 66.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.8 p -83.53 -1.41 53.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.36 31.74 24.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -98.77 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.364 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.67 134.3 35.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.099 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.57 114.43 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 125.16 29.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -129.09 134.11 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.06 102.66 15.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.77 178.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -132.88 160.33 69.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.73 24.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.1 p -110.27 17.33 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -100.2 173.28 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.26 149.57 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.2 mm -51.64 -35.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -61.25 -34.35 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 88.5 t -66.72 -45.76 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.94 -38.41 82.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -49.99 70.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -57.43 -39.73 76.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 86.0 mt -58.84 -28.1 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.66 -47.98 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.66 -7.74 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -96.11 -56.01 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -99.18 -48.87 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 33.15 1.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 5.7 mt -112.45 131.21 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.728 . . . . 0.0 111.096 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.86 163.52 38.05 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.374 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -1.65 8.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.64 2.227 . . . . 0.0 112.338 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -99.4 -26.15 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.01 -5.71 13.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -111.96 136.01 51.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.29 147.87 49.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -113.8 135.6 53.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 20.7 mm -119.59 131.66 71.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.52 144.03 27.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.37 15.15 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 17.97 70.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 166.4 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.667 0.27 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -94.39 110.12 21.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.34 163.62 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.48 153.13 48.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.88 -9.91 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.74 35.72 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -152.69 168.51 25.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.01 158.44 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.134 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 25.9 mt -58.28 -41.12 83.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -63.26 -22.16 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.26 -35.91 82.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -98.94 17.03 20.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.36 35.53 26.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 9.0 mm -68.6 95.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.96 -174.21 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.17 152.93 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 54.15 26.78 6.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.75 132.36 51.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -91.23 89.59 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.0 mp -91.93 165.27 13.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -129.6 145.35 51.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 3.4 tt -105.38 133.05 50.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 5.2 t -133.44 143.9 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.16 135.37 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -90.25 167.18 12.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -52.5 131.63 34.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -132.01 111.33 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -113.94 45.66 1.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.467 -179.895 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.803 0.251 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.5 mp -130.92 78.4 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.48 -19.82 9.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 m -131.9 99.72 4.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -110.96 152.88 43.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.607 0.718 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 173.64 10.72 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 144.88 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.99 20.66 34.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.23 146.24 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 0.0 111.1 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -104.31 106.62 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -49.38 -52.46 28.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -51.64 -38.08 53.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 96.3 t -76.03 -33.28 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -64.92 -56.58 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -13.2 61.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.44 -23.88 23.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.1 mt -80.99 159.16 69.07 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.915 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.3 31.53 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.291 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.93 -33.68 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.72 -43.58 85.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.69 -28.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -70.4 -37.26 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.22 -30.2 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.44 -51.75 18.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.6 mt -62.5 -28.85 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -75.41 -23.35 57.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.6 m -76.79 -19.34 57.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 14.44 59.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.492 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.59 -176.13 3.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.317 . . . . 0.0 110.983 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.64 70.76 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -134.15 87.66 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -120.36 -32.15 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.41 -60.27 3.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -107.6 174.6 5.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -86.62 145.13 26.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.14 170.28 0.29 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -84.61 134.59 34.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.74 0.305 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -95.02 134.99 37.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 25.3 pt -117.9 148.77 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.159 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -104.9 122.31 45.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.57 108.36 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.47 112.65 24.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.1 p -73.3 171.69 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.235 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.25 -27.4 65.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.4 p -84.64 0.7 49.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.93 39.34 13.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.372 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.3 131.77 35.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -129.37 110.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 131.6 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -135.87 133.95 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.81 105.81 18.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.0 171.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -118.47 160.33 40.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.926 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.92 33.88 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.611 2.207 . . . . 0.0 112.372 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 -25.33 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.1 175.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.2 p -111.98 156.83 21.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.142 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 48.4 mm -51.59 -33.63 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.65 -35.08 67.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.949 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -39.28 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 56.0 t -67.1 -44.1 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -62.84 -41.73 99.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.22 -42.19 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -57.8 -48.62 79.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 14.5 mt -54.66 -31.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -61.48 -49.02 78.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.3 -5.28 41.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 17.1 mmmt -95.74 -53.56 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -104.7 -46.2 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.15 24.2 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.0 mt -98.32 132.27 24.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.61 0.719 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 167.8 23.25 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.74 2.293 . . . . 0.0 112.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.67 19.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.03 -23.47 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.14 0.58 14.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.8 128.17 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -133.89 133.45 41.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -101.01 141.09 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.73 116.34 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.59 144.2 34.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.29 15.17 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.55 8.61 73.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.445 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 172.82 12.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.74 142.8 26.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.9 mt -96.2 161.22 14.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -118.05 157.42 26.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.02 -8.36 58.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.4 39.62 2.71 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -152.53 169.87 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.2 151.09 22.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 71.5 mt -56.24 -45.42 80.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -55.63 -26.51 44.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.55 -26.8 65.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -98.8 7.72 45.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.9 m120 64.66 33.7 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 18.4 mm -69.53 109.17 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.11 168.44 9.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 145.31 9.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 58.53 28.31 16.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.77 130.01 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -86.66 81.94 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -83.36 159.82 21.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -129.42 115.91 18.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 2.0 tp -83.85 116.56 22.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 15.0 t -112.9 148.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.84 126.82 31.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -84.12 167.46 16.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -55.16 121.73 9.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.3 112.55 23.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -105.27 23.79 29.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.808 0.253 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 7.1 mp -128.06 73.48 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.2 m -117.04 -16.38 10.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -135.48 100.55 4.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -110.95 152.65 43.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.677 0.751 . . . . 0.0 110.889 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 174.69 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.708 2.272 . . . . 0.0 112.324 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.12 145.99 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.05 21.03 29.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.37 143.73 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 111.153 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.27 110.59 22.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.77 -52.89 45.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.91 -43.24 59.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.31 -32.83 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -65.13 -56.99 9.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -15.29 62.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -88.14 -15.97 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.05 155.24 60.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 165.15 32.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.642 2.228 . . . . 0.0 112.345 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 -33.67 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.97 -38.86 76.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.5 mm -78.83 -44.04 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -51.46 -46.21 63.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -28.32 62.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -71.5 -41.14 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.18 -32.32 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -63.47 -39.03 93.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.9 m -65.2 -22.91 66.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.15 37.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -102.41 -177.2 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.922 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.3 m 51.74 57.66 6.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.7 81.89 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.32 -29.95 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -65.68 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -103.8 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -119.97 158.22 27.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.01 105.86 0.28 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.9 mttm -74.67 90.16 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.812 0.339 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.39 134.07 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 25.0 pt -117.76 150.1 19.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -106.16 126.49 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.23 107.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.08 110.97 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.0 p -73.17 174.21 8.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -22.95 64.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.99 17.4 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.16 49.93 72.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -118.44 107.84 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 133.03 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.27 107.19 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.54 132.29 43.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -137.28 134.09 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -88.02 102.19 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 26.2 m -127.81 178.99 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -135.15 160.18 69.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -11.09 30.18 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.403 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -26.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.65 169.44 4.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.47 157.56 17.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.1 mm -53.71 -31.96 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -60.15 -31.33 70.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -36.36 57.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.57 -48.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -62.1 -30.46 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.29 -50.52 73.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -56.18 -42.08 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 57.6 mt -55.55 -34.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -61.89 -47.74 83.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -71.45 -8.18 52.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -95.48 -56.37 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -99.8 -49.24 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.89 2.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.0 mt -105.27 130.96 22.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.64 0.733 . . . . 0.0 111.087 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 163.69 37.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 0.0 112.332 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -7.64 21.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.5 -31.11 22.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -112.51 0.63 15.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.72 127.05 40.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -133.88 136.13 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.09 136.27 44.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.4 mm -117.91 114.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -144.65 143.87 30.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.907 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.68 15.08 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.83 22.26 55.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.534 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 177.99 9.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -97.9 140.93 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.2 mt -97.63 147.68 24.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -105.9 166.2 10.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -82.07 -18.6 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -91.51 40.49 2.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -152.97 167.88 27.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.93 152.43 21.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 65.2 mt -55.09 -47.42 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 t -55.75 -25.4 40.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.6 -30.42 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -98.65 12.49 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.61 33.79 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 16.2 mm -68.69 95.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.42 166.07 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.35 149.79 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 54.99 27.51 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.61 134.47 54.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.4 m -91.95 86.0 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.0 mp -87.03 157.19 19.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -128.42 117.24 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 8.5 tp -83.67 133.26 34.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.9 t -134.22 142.63 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 134.2 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -92.74 159.0 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -51.5 123.16 9.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.73 113.09 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -158.99 22.2 0.3 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.85 0.271 . . . . 0.0 112.354 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -101.64 136.27 41.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.32 -19.13 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.8 m -139.22 95.53 2.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.781 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mt -111.04 153.44 43.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.595 0.712 . . . . 0.0 110.946 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.01 11.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.6 146.16 50.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.4 20.73 38.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.6 143.81 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -104.57 109.39 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -51.32 -53.53 35.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -50.45 -39.78 48.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -74.87 -33.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.72 -56.08 12.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -14.03 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -87.99 -28.41 21.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.92 158.31 77.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.705 . . . . 0.0 110.953 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.28 31.49 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.34 -31.91 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.23 -42.28 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.9 mm -77.93 -27.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.55 -50.71 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.46 -32.71 74.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.57 -47.09 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.835 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 52.0 mt -70.35 -43.17 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.86 -33.79 70.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.27 -23.52 67.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.44 25.39 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -109.44 -176.68 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.886 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p 47.09 70.47 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 71.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -112.19 -21.5 11.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -53.67 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.03 174.07 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -109.16 147.73 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.72 105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -72.54 81.42 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.59 134.81 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -117.7 148.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -105.3 121.42 43.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.4 t -105.09 113.05 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.09 114.0 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.6 p -77.77 170.71 16.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -22.43 54.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.22 23.54 5.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 55.15 55.35 28.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -121.58 108.97 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.7 132.3 35.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.8 mt -130.29 109.6 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.3 m -77.4 127.14 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.203 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.7 mt -129.63 134.36 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.37 102.23 14.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 23.0 m -131.54 -179.49 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -131.24 160.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.751 . . . . 0.0 110.831 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -13.74 35.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -95.93 -24.88 16.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -61.67 173.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.01 154.56 23.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.06 -31.14 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.72 -35.17 72.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -42.13 64.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 57.3 t -62.89 -42.17 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -63.97 -41.65 97.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.27 72.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -57.79 -49.89 75.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 62.3 mt -54.05 -32.11 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -61.68 -47.18 86.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.52 -4.68 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -97.4 -56.48 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -101.51 -48.4 4.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.55 35.03 1.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.7 mt -107.52 130.61 22.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.669 0.747 . . . . 0.0 111.132 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 163.41 38.37 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.603 2.202 . . . . 0.0 112.415 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 -7.42 21.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.36 -29.72 24.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.36 -3.43 14.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -88.79 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -133.85 147.98 51.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.2 mp -117.35 148.87 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 25.1 mm -136.89 120.31 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.079 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 20.7 t80 -146.03 140.77 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.95 14.31 9.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.58 15.61 63.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 171.63 14.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.71 134.1 37.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.7 mt -93.78 143.58 26.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -102.2 167.69 9.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -82.26 -20.27 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.16 45.04 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.399 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -153.02 169.67 22.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.42 152.08 23.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 68.2 mt -56.75 -45.14 82.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -58.17 -22.93 53.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.62 -29.85 67.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -98.43 10.06 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.73 33.31 13.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.3 mm -68.75 97.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -88.91 167.34 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 143.5 12.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 58.69 29.61 18.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.87 130.6 47.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -83.11 84.45 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.33 159.62 20.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -129.08 127.55 41.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 9.0 tp -96.65 119.52 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 12.7 t -117.82 147.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.087 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.08 137.24 37.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -96.53 162.25 13.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -50.92 124.33 11.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -100.41 96.4 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 94.47 -28.03 12.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.437 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.512 -179.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.187 0 CA-C-O 120.76 0.233 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.3 mt -85.81 52.61 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.3 m -87.86 -28.01 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.7 m -115.82 93.67 4.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.9 mt -111.17 153.24 44.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 174.99 8.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -69.55 144.98 52.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.27 20.36 35.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.445 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.51 142.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -102.33 110.62 22.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -51.64 -52.62 46.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -51.33 -47.77 62.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.7 t -67.51 -33.2 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.18 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -68.05 -56.16 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.832 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -13.67 60.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -88.1 -20.21 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.1 mt -84.8 157.6 60.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 162.53 41.67 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.14 -33.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -58.99 -41.23 87.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.0 mm -78.21 -27.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -69.64 -50.55 43.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.74 -32.91 74.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.69 -50.37 67.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.4 -30.73 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -68.28 -35.14 77.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.78 -23.75 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.87 29.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -108.09 -176.36 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 p 46.83 70.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 104.6 8.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.89 -178.68 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.968 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.25 -66.51 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -95.36 173.7 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -89.72 145.75 24.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.85 174.45 1.62 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 75.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.6 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.87 133.79 38.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 17.9 pt -116.37 150.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -106.35 123.18 47.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 t -107.62 108.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 111.61 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.0 p -75.38 171.02 14.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.78 -23.2 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.1 p -93.91 25.17 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.0 51.76 44.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -116.55 108.99 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 131.34 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.194 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.6 mt -129.95 106.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 111.101 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.84 126.52 31.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 9.1 mt -129.91 134.11 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.58 101.04 13.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 21.9 m -128.04 -179.48 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.173 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -134.08 160.78 67.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.715 0.769 . . . . 0.0 110.894 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.35 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -21.63 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -64.13 175.17 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.32 157.36 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.6 mm -54.24 -26.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -65.29 -29.38 70.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.33 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.13 -47.42 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.064 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -63.46 -36.95 85.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.62 -50.27 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -56.46 -42.11 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.91 -29.33 30.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -66.6 -46.51 75.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.33 -5.08 42.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 16.9 mmmt -96.82 -52.94 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -102.94 -47.1 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.78 3.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.2 mt -104.58 132.23 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.695 0.76 . . . . 0.0 111.14 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 167.39 24.66 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -7.34 20.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.72 -21.66 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.0 -11.32 13.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.26 126.57 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -133.61 121.02 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -92.84 134.56 34.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 29.8 mm -121.1 119.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 16.7 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.54 14.91 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.18 21.85 53.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.63 169.12 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.15 139.19 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.0 mt -94.02 152.73 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.972 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -106.27 159.33 16.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.55 -0.21 41.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.01 3.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -146.37 169.87 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.28 151.5 22.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 72.9 mt -57.35 -35.43 69.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -67.11 -21.38 65.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.02 -32.24 68.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -96.39 8.35 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 63.07 35.82 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 15.0 mm -68.55 95.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -83.21 162.62 21.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 146.71 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.29 24.7 13.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.5 136.44 56.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -90.2 84.3 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -82.22 160.88 22.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -130.66 119.59 22.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 3.5 tp -90.17 115.48 27.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.54 148.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.9 124.46 28.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.9 mtt180 -86.66 164.51 16.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -48.97 119.99 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -101.58 108.04 19.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.812 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -141.57 28.54 2.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 -179.904 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.793 0.247 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.74 179.08 4.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.76 -59.37 2.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 t -144.37 110.45 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 2.8 mt -110.98 152.32 43.56 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 0.0 111.0 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 174.66 9.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.48 146.41 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.98 21.25 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -69.66 144.76 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.071 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.74 115.59 30.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -54.76 -55.06 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.79 -45.72 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.1 t -70.87 -32.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -68.35 -57.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.61 59.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -88.17 -18.89 27.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.69 153.6 73.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 165.32 31.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.367 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.03 -34.07 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.07 -38.78 77.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mm -78.89 -45.77 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -51.38 -50.77 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -32.39 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -69.54 -40.75 76.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.3 mt -78.22 -30.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.17 -37.26 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -25.01 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.63 24.41 25.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.463 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -179.01 3.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.3 m 51.28 59.62 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.48 77.23 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.44 -23.21 8.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -51.62 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -105.25 174.18 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -96.76 128.12 43.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.24 132.21 33.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 94.14 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.958 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -98.39 138.98 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.86 147.97 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -104.21 123.7 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -105.07 108.12 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.51 109.24 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.1 p -69.19 174.33 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.166 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -26.01 65.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.6 p -86.24 3.05 44.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.139 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.12 49.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -94.9 108.42 20.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.335 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.03 131.11 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.1 mt -129.38 116.23 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 7.5 m -78.48 128.11 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.157 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.2 mp -125.61 133.44 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.2 99.07 11.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 14.7 m -131.2 -179.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -127.99 160.56 60.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -8.84 24.62 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.685 2.256 . . . . 0.0 112.296 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.3 m -102.15 -24.8 13.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -60.46 175.03 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.68 156.67 19.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.5 mm -53.34 -30.73 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.06 -40.25 84.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -41.87 90.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.01 -46.12 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -60.48 -41.91 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.91 70.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -63.07 -42.37 99.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 52.7 mt -57.74 -28.75 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.78 -44.73 73.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.54 -5.77 44.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -99.55 -54.57 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.11 -48.0 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.37 19.81 6.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 8.1 mt -94.1 132.56 29.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.181 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.17 25.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.13 20.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.623 2.216 . . . . 0.0 112.366 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -90.07 -20.68 22.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -113.21 -14.88 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.91 126.8 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . 0.468 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 3.2 ttm180 -134.0 118.29 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.26 147.68 24.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.8 mm -135.96 115.65 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -141.12 141.93 34.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.81 14.29 9.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.21 15.14 65.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -134.31 170.3 15.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . 0.405 HE21 ' NE ' ' B' ' 242' ' ' ARG . 9.5 mt-30 -94.85 128.69 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.5 mt -86.21 155.62 20.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.85 157.16 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.93 -6.51 52.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -103.45 41.22 2.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -152.65 168.52 25.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 148.33 25.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 69.6 mt -53.53 -44.39 69.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.2 t -57.68 -26.59 61.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.86 -33.2 75.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.4 6.72 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 4.2 m120 63.6 36.77 10.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 12.5 mm -68.73 96.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -82.99 166.58 18.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.33 149.4 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 54.22 26.27 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 143.28 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.06 86.92 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.36 158.88 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -133.01 115.07 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.59 134.67 34.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.939 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 39.8 t -132.81 146.85 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.2 127.15 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.468 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.1 mtt180 -88.96 163.91 15.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -50.75 136.05 22.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -99.41 141.97 31.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 154.66 -19.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.914 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.815 0.256 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -117.18 136.6 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -119.4 -21.73 7.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.84 93.62 3.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.0 mt -112.49 152.47 44.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.557 0.694 . . . . 0.0 110.949 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 175.01 8.68 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.754 2.303 . . . . 0.0 112.347 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.68 144.45 51.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.41 20.68 30.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.4 145.42 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.169 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -104.47 108.39 19.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -51.64 -53.28 40.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -50.11 -43.21 51.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.7 t -70.85 -32.69 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.72 -56.88 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -14.27 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.97 -23.25 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.8 mt -80.85 158.96 69.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.644 0.735 . . . . 0.0 110.846 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 165.27 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.288 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.86 -32.78 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.92 -43.52 94.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.3 mm -78.89 -29.1 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.74 -25.96 64.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -89.71 -25.97 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.83 -38.85 64.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.1 mt -78.07 -40.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.87 -37.59 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.06 -25.75 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.63 61.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -70.99 -175.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.733 0.302 . . . . 0.0 110.953 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m 57.96 69.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -139.6 90.68 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -112.0 -30.86 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -60.52 -63.93 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -109.28 166.22 11.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -86.95 124.0 32.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.56 169.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -129.15 91.83 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.76 0.314 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.37 134.09 41.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 31.6 pt -117.03 150.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -106.75 130.55 54.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -113.06 107.89 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.66 110.48 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.3 p -71.51 174.28 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.69 -25.73 63.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.55 5.8 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.206 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.35 29.34 58.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -94.73 108.83 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.06 133.5 35.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.0 mt -129.52 111.68 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.49 128.2 33.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -131.4 134.19 46.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -90.22 103.9 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.06 -179.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -132.2 160.73 66.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -12.11 32.11 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.72 2.28 . . . . 0.0 112.312 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.1 p -97.96 -25.31 15.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.42 175.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -112.8 157.64 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 48.5 mm -52.86 -29.24 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.49 -30.28 70.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -38.07 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.0 t -67.21 -51.73 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -59.26 -35.04 72.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.25 92.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.06 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.64 -46.78 83.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 44.6 mt -54.41 -32.8 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -61.79 -47.28 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.14 -5.4 44.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -97.18 -54.52 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.38 -48.72 3.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.7 34.88 1.64 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.531 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 7.7 mt -108.45 131.32 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 0.0 111.085 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 164.58 33.98 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.632 2.221 . . . . 0.0 112.345 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -6.98 19.9 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.76 -30.84 19.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.73 6.36 16.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -116.63 125.75 52.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -134.7 148.0 50.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.828 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.36 133.9 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.4 mm -111.78 123.65 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -151.64 144.75 24.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.936 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.14 15.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.49 8.17 74.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.441 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.15 157.99 44.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -77.31 146.77 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.8 mt -94.7 163.31 13.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -118.28 154.01 32.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -76.25 -5.54 47.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.805 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.81 39.28 2.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.506 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -152.69 169.89 21.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 152.71 21.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.192 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 52.8 mt -56.92 -43.82 81.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.0 t -60.69 -26.37 67.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -63.83 -31.65 72.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.79 9.73 42.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 63.72 34.89 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 15.9 mm -68.58 96.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -82.95 165.68 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 150.77 7.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 55.82 26.03 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.45 133.72 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.99 88.33 7.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.18 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -89.32 158.82 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -127.99 125.63 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 4.6 tp -92.58 125.61 37.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.1 t -121.78 149.26 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.44 144.03 25.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -105.12 169.27 8.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -48.96 127.31 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 39.6 tpt85 -116.85 99.82 7.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -141.22 15.28 2.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.814 0.256 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.78 77.25 9.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.53 -18.78 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -131.31 97.79 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.9 mt -110.98 153.05 43.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.68 0.752 . . . . 0.0 110.932 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.56 10.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.01 146.15 51.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.15 20.7 36.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.43 143.57 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 111.098 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -102.84 108.63 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -51.68 -52.65 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.36 -38.69 54.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -76.15 -33.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -66.36 -56.3 11.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -14.85 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -87.37 -25.91 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 28.7 mt -78.4 158.06 76.95 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.628 0.728 . . . . 0.0 110.933 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 164.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.367 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.13 -28.36 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.3 -42.56 99.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.8 mm -78.85 -27.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.73 -42.88 77.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -27.03 60.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.47 -41.19 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.08 -34.12 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.47 -35.82 82.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.96 20.82 41.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt -99.76 -176.64 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.4 p 46.48 67.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.796 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.4 ptt85 -139.3 91.51 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -109.58 -33.13 6.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -59.18 -57.85 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -116.17 174.62 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -108.45 150.76 26.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.47 172.88 0.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.528 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -123.98 87.33 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.77 0.319 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -98.2 134.4 41.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 23.3 pt -118.39 151.75 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -106.45 123.35 47.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.7 113.0 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.85 112.14 24.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 3.2 p -75.9 171.18 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.56 -22.01 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.3 23.56 5.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 53.76 38.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -120.04 108.31 14.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.91 130.91 35.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.171 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.7 mt -129.66 112.41 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.42 130.45 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.8 mt -132.53 134.55 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.24 104.66 17.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 28.5 m -133.91 178.48 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.69 160.75 61.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -13.94 35.31 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 5.7 m -96.23 -24.45 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.39 175.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.07 156.49 21.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.1 mm -53.2 -28.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -62.98 -31.19 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -38.05 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 88.2 t -67.41 -48.17 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 1.1 ptpt -60.59 -38.94 86.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.55 76.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 8.4 mttt -58.91 -48.07 82.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.1 mt -55.23 -31.02 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.062 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -62.7 -47.55 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.81 -5.08 44.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -97.27 -56.5 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.81 -48.63 4.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.56 35.34 1.59 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 11.3 mt -108.17 130.54 22.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.734 . . . . 0.0 111.104 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 163.44 38.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.241 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -7.95 22.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.53 -30.15 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.6 -3.22 14.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -89.31 131.35 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -133.75 147.52 51.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.9 mp -116.36 146.53 42.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.9 mm -133.69 120.67 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -148.4 141.3 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.33 14.02 9.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.051 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.63 64.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.495 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -134.78 176.07 8.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.709 0.29 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.5 131.7 47.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 5.2 mt -86.66 158.73 19.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.45 162.13 18.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.48 0.73 41.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.48 42.86 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -152.75 167.96 27.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.0 110.835 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.57 147.25 26.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 80.2 mt -52.46 -44.37 65.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -56.61 -26.07 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -67.72 -31.41 71.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -95.53 6.5 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 6.0 m120 63.83 35.66 10.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 12.2 mm -68.54 96.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.145 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -83.22 163.9 20.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.48 148.44 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 58.98 22.84 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.46 144.68 30.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -103.43 92.24 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.31 162.75 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -130.14 116.04 17.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 10.5 tp -83.9 125.45 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 15.5 t -124.85 146.88 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 135.4 37.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 -95.59 167.25 11.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -51.35 126.46 17.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -103.63 120.13 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.01 37.18 2.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.499 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.427 -179.884 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.791 0.246 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.48 47.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 m -70.77 -21.4 62.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -108.37 94.0 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.0 mt -107.95 152.48 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 173.84 10.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.681 2.254 . . . . 0.0 112.393 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.72 146.8 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.2 20.91 30.44 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.12 143.92 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 111.069 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -103.4 107.85 18.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -51.44 -51.8 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -51.2 -40.41 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.795 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.6 t -76.42 -33.04 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.99 -56.08 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -14.4 60.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -89.4 -23.4 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.9 mt -80.4 158.23 71.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.24 31.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.342 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.55 -32.31 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -58.85 -41.42 86.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.8 mm -79.08 -29.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.68 -30.8 68.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.23 -29.07 31.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -73.2 -38.93 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 -26.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -39.88 80.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.58 -22.15 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.09 28.84 24.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.72 -176.23 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p 46.2 70.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -133.46 69.88 1.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -100.34 -29.53 12.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -50.39 -46.93 56.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.69 174.29 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -96.21 116.2 28.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.15 122.27 13.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.52 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.04 87.65 3.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.99 134.21 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 29.9 pt -115.35 148.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.187 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -105.22 121.97 44.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.18 108.0 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.88 110.53 23.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 6.3 p -72.07 174.77 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -24.54 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -89.97 8.25 33.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.09 63.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -93.18 110.54 22.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.28 132.71 35.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.22 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 5.6 mt -129.8 106.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.74 133.12 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -137.21 134.13 35.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -89.19 100.94 13.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.49 175.73 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -128.55 160.29 63.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.628 0.727 . . . . 0.0 110.917 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -11.45 30.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.736 2.291 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -27.14 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -61.98 175.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -113.44 158.45 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.4 mm -52.07 -33.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.34 -31.72 66.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -36.28 46.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 99.0 t -70.43 -51.23 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.97 -33.91 71.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.49 73.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -55.66 -43.22 76.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 63.0 mt -55.17 -32.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -63.46 -45.59 90.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -74.72 -5.83 45.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.93 -48.19 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -108.37 -48.65 3.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.57 1.71 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 11.6 mt -108.36 132.13 21.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.621 0.724 . . . . 0.0 111.18 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 163.4 38.44 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.362 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.378 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.19 -22.87 18.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.18 -5.56 13.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.68 131.3 37.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -133.89 124.49 26.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -97.42 134.18 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.13 115.19 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -143.04 145.19 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.53 15.45 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.26 20.63 58.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 173.88 12.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 140.82 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 3.7 mt -96.24 153.28 17.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.41 161.79 14.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 0.37 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.75 41.44 2.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -152.5 168.57 25.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.964 0.412 . . . . 0.0 110.84 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.98 151.36 21.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 55.5 mt -56.42 -47.33 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.8 t -55.43 -25.15 34.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.79 -28.8 67.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -98.67 11.21 39.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 63.82 33.47 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 13.8 mm -71.81 97.82 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -93.52 170.21 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.72 143.89 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 58.21 29.02 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.58 126.57 27.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -84.6 83.92 7.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.5 mp -85.75 160.76 19.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.1 m170 -129.0 119.9 25.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 6.1 tp -89.21 120.97 31.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 18.8 t -118.83 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.19 135.2 39.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -97.63 165.78 11.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -51.03 124.23 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -109.15 102.54 11.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 88.34 -47.62 3.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.47 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.876 0.282 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.7 mt -89.81 48.33 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.64 -25.55 19.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.8 m -120.6 93.9 4.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.914 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.4 mt -110.94 153.12 43.93 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.591 0.71 . . . . 0.0 110.967 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 174.61 9.14 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 0.0 112.394 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.02 144.66 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.84 18.71 40.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -67.62 142.88 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 111.138 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -103.36 109.71 21.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.41 -53.01 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -51.27 -37.84 49.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.8 t -76.62 -33.29 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.74 -56.23 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -14.78 59.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -87.55 -23.93 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.6 mt -81.34 157.74 70.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.709 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.12 31.99 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.399 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.17 -34.4 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -58.15 -39.94 80.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.7 mm -78.56 -32.64 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.203 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -64.8 -49.9 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -65.25 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.31 -43.1 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.24 -31.37 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.92 -35.23 76.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -65.25 -24.39 67.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.1 18.57 49.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -99.08 179.99 4.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 80.6 p 46.13 66.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -140.15 80.92 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.9 -5.2 9.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -50.93 20.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -117.64 174.12 6.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -69.37 109.59 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.94 115.77 6.38 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -62.83 94.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.801 0.334 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.18 133.77 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.9 pt -116.25 147.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -104.99 125.05 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.04 109.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.65 111.15 23.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.4 p -71.78 174.24 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -23.4 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.3 p -89.48 7.56 35.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.59 35.2 52.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -102.81 112.35 25.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.24 134.66 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.8 mt -130.75 110.86 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.81 132.3 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 5.9 mt -136.45 134.03 37.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.28 102.17 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 27.7 m -127.37 179.96 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -137.18 161.34 61.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -14.74 36.81 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.727 2.285 . . . . 0.0 112.379 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -26.8 16.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -61.98 174.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.09 152.23 24.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -50.2 -30.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 -37.98 86.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.18 96.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 96.9 t -66.06 -50.98 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -57.24 -38.68 74.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.07 -50.23 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.134 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -56.42 -43.17 79.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 75.8 mt -56.29 -28.79 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.129 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.2 -45.96 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -74.66 -5.34 42.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.5 mmmt -97.01 -49.56 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.66 -48.27 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.75 34.9 1.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.6 mt -110.14 132.66 21.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.149 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.91 164.5 34.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.632 2.222 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -5.0 15.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.62 2.213 . . . . 0.0 112.344 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.78 -24.91 17.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . 0.404 ' NE2' HH11 ' B' ' 274' ' ' ARG . 1.6 mp0 -113.47 -2.15 13.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.99 129.81 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . 0.423 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 8.1 ttm180 -133.9 122.43 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -103.5 133.81 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 15.8 mm -114.68 141.52 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -156.64 137.4 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 14.63 9.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.82 16.16 60.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -136.75 168.6 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.01 122.09 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.25 152.48 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 161.13 16.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.94 -12.38 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.4 3.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -152.9 170.75 19.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.356 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.94 158.08 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.29 -50.61 69.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 44.4 t -57.47 -30.45 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.83 -37.5 63.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -98.85 16.48 22.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.17 32.42 19.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 8.6 mm -68.15 95.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 147.43 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 59.72 25.62 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.67 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -92.39 84.24 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.205 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.33 162.99 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.6 m170 -129.81 129.08 43.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.06 131.21 42.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 19.6 t -133.81 148.19 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.37 128.06 33.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . 0.423 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.8 mtt180 -88.45 165.21 15.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.07 127.12 18.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . 0.404 HH11 ' NE2' ' B' ' 240' ' ' GLN . 18.5 tpt180 -91.71 99.1 12.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -113.88 37.31 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.886 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.219 0 CA-C-O 120.861 0.275 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mt -89.09 49.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.9 m -92.57 -16.9 25.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.95 96.25 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 mt -110.68 152.32 43.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.593 0.711 . . . . 0.0 110.921 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 175.06 8.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.54 147.27 51.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.33 21.01 31.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 p -73.82 145.28 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.152 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -104.31 107.34 18.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -50.89 -53.88 28.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.44 -40.76 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.2 t -75.75 -32.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -65.7 -56.81 10.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -14.74 61.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -87.66 -23.75 24.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.83 157.55 69.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.611 0.72 . . . . 0.0 110.957 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.21 31.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 0.0 112.362 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.6 -29.95 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -61.73 -40.59 95.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 40.0 mm -79.19 -27.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.7 -47.88 61.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.89 -33.05 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.92 -42.56 85.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.5 mt -77.47 -37.14 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.49 -32.83 63.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -71.48 -24.56 62.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.16 -15.61 58.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.16 -176.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 m 55.71 64.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -140.06 70.33 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.4 -29.13 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -50.71 -47.93 58.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -135.25 174.56 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -117.29 152.46 34.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.08 105.71 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.55 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.5 96.04 9.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.861 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.14 135.65 42.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 21.5 pt -117.09 148.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.85 126.29 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.837 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -108.78 108.19 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.64 110.34 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 7.1 p -71.95 174.06 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -25.12 63.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.43 3.19 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.81 24.77 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -89.89 109.91 20.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.72 130.93 34.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.15 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mt -128.32 113.68 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 10.2 m -78.61 127.69 32.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.8 mp -126.36 133.4 51.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.62 98.58 10.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.77 -179.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.085 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.22 160.77 55.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -8.65 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.65 2.233 . . . . 0.0 112.384 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.77 -25.5 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.77 174.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.76 163.38 14.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.8 mm -59.3 -40.79 82.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -52.37 -29.76 25.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.72 44.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 48.7 t -66.07 -47.42 85.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -58.01 -39.17 77.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.81 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -57.2 -42.06 80.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 67.8 mt -56.37 -30.61 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -66.74 -43.92 82.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 22.3 mmmt -97.93 -47.96 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -109.51 -48.52 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.96 32.91 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.35 132.86 20.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.701 0.763 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 162.62 41.34 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.248 . . . . 0.0 112.363 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -4.6 14.32 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.687 2.258 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.56 -27.0 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -113.43 -2.34 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 127.43 40.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -134.31 145.51 49.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.3 155.96 27.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.5 mm -137.67 114.05 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -144.43 145.77 32.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.08 14.41 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.07 39.4 16.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.64 20.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.282 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.49 126.67 35.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.47 163.69 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -131.1 157.64 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -82.2 1.06 38.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.75 37.69 3.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -153.1 169.88 21.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 157.15 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 39.1 mt -60.01 -43.43 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t -59.14 -20.58 54.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.92 -32.13 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -98.44 10.57 40.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 63.57 33.94 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 mm -68.69 100.71 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . 0.405 ' N ' ' HG ' ' B' ' 265' ' ' SER . 1.8 mt-30 -98.5 175.98 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -54.95 145.06 21.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 57.95 28.5 16.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' SER . . . . . 0.405 ' HG ' ' N ' ' B' ' 262' ' ' GLN . 0.4 OUTLIER -58.05 128.69 38.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -87.81 84.3 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 2.6 mp -88.57 161.12 17.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.73 121.78 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.2 tp -90.17 108.03 19.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 21.8 t -104.94 148.77 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.26 135.03 35.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -94.89 163.84 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -50.45 122.29 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -103.78 123.18 46.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -112.37 56.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.449 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.855 0.273 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.1 mt -84.44 54.06 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.28 -19.34 13.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 93.8 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.5 mt -110.21 152.71 43.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 0.0 110.893 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 175.14 8.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.686 2.258 . . . . 0.0 112.335 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.22 146.09 52.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.53 20.67 31.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.9 p -70.74 144.48 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 111.173 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.28 108.92 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.71 -50.69 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -39.12 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.4 t -76.63 -33.51 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -66.86 -56.17 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -15.07 61.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.0 -26.8 23.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.7 mt -79.5 158.18 74.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 153.31 68.55 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.696 2.264 . . . . 0.0 112.264 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.49 -29.83 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -60.61 -41.56 95.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.2 mm -76.28 -30.97 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.85 -42.47 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.57 -31.72 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -74.08 -54.58 7.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.6 -40.97 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -30.22 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -66.09 -24.66 66.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 9.35 63.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -93.07 176.63 6.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.6 p 46.53 61.33 2.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -140.32 81.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.6 -25.91 7.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -51.79 -53.93 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -120.8 173.97 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -67.87 105.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.47 172.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -103.49 132.11 50.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 179.857 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -94.83 133.91 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.0 pt -116.75 149.66 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -106.07 124.34 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.47 108.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.0 113.19 24.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.0 p -76.91 174.7 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.68 -22.58 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -92.72 17.7 9.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.3 97.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -104.72 108.01 19.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.69 132.48 35.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.49 108.79 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 130.47 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 7.7 mt -135.88 135.83 40.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -89.27 101.82 14.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 25.3 m -128.22 -178.95 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -135.08 160.45 68.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -11.44 30.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.655 2.237 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.2 m -98.1 -25.54 14.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -63.5 174.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.4 p -111.25 155.98 22.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 48.2 mm -50.57 -36.92 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -53.25 -36.68 61.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -34.25 65.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.94 -46.86 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -64.76 -35.63 81.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.932 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.97 76.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -59.31 -43.61 92.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 42.3 mt -56.54 -29.45 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.86 -48.73 73.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.21 -8.08 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -96.73 -56.34 2.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -96.14 -49.48 5.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 20.9 5.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 1.1 mt -99.22 134.05 21.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.85 166.42 27.79 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -7.85 22.11 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.36 -23.01 28.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -112.47 -8.57 13.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.19 127.19 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -134.21 118.0 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.36 150.37 29.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 268' ' ' HIS . 30.3 mm -137.98 114.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.185 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -145.87 144.41 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.84 15.08 8.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.6 5.67 78.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.498 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.5 170.4 13.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.739 0.304 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -95.2 139.8 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mt -91.45 155.71 18.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -111.57 161.8 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -81.68 -0.9 44.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.46 41.07 2.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.429 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -152.85 169.75 22.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.47 153.25 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 41.9 mt -57.41 -44.87 84.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.6 t -58.88 -24.48 62.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.09 -32.47 73.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.814 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -98.7 12.5 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 64.02 33.79 11.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 9.1 mm -70.81 95.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.87 174.14 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 147.53 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 55.94 25.02 8.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.66 133.11 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -85.32 86.04 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -81.9 157.24 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . 0.404 ' HB2' ' HB ' ' B' ' 244' ' ' ILE . 3.0 m170 -130.46 121.44 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 4.4 tp -91.98 127.16 37.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 11.6 t -125.49 148.46 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.73 130.08 38.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -91.72 161.97 14.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -50.16 127.72 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -91.85 100.3 13.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.52 20.62 2.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.54 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.495 -179.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.822 0.259 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.0 mt -78.68 58.47 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 31.9 m -110.6 -17.62 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -135.78 93.75 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 -179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 mt -108.68 152.86 42.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 174.22 9.74 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 147.71 50.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.81 20.88 34.58 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.488 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.45 142.55 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -101.87 108.11 19.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -50.59 -51.92 43.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.18 -40.08 57.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 87.0 t -76.42 -32.92 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.71 -56.6 8.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -15.78 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -87.55 -22.78 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.7 mt -81.96 158.04 68.05 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.729 2.286 . . . . 0.0 112.324 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.93 -31.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.13 -38.76 87.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.0 mm -78.79 -31.08 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -67.73 -49.94 59.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -32.9 74.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.6 -43.4 80.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.7 mt -74.6 -44.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -30.18 71.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -64.91 -27.6 68.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.97 41.82 5.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 -177.91 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p 46.13 64.62 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.19 78.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -21.68 9.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.815 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -48.61 75.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -125.84 174.38 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -106.82 150.01 26.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.971 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.1 105.87 0.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -87.72 110.73 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 179.86 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -95.51 138.5 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.67 147.17 24.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -105.36 127.51 53.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 16.2 t -109.86 108.19 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.24 112.47 24.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 5.6 p -74.92 175.5 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.07 -24.45 62.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.96 8.38 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.17 69.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -89.66 108.49 19.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.43 131.85 35.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.181 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.5 mt -128.91 115.23 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 5.8 m -79.44 128.46 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 10.8 mp -126.67 134.1 50.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.13 98.86 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 18.9 m -131.37 -179.04 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.077 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -130.58 160.56 65.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -9.29 25.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.248 . . . . 0.0 112.39 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -100.6 -24.88 14.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -63.4 175.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.0 157.93 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.07 -32.52 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -56.74 -35.85 69.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -43.11 63.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.15 -43.38 98.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.169 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -61.26 -42.14 98.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.921 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.51 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -63.66 -42.21 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 45.1 mt -59.14 -29.37 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.148 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -67.06 -44.73 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.38 -4.98 45.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 22.0 mmmt -99.29 -56.01 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -98.79 -48.66 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.66 19.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.14 134.39 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.585 0.707 . . . . 0.0 111.142 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 169.6 18.57 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.68 2.253 . . . . 0.0 112.302 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -7.2 20.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.35 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.85 -19.03 25.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.21 -15.54 12.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 129.67 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -132.93 112.49 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.72 134.67 34.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.0 mm -121.41 116.2 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -140.45 142.56 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.17 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.06 12.56 67.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 174.14 10.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -94.74 144.07 25.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 4.1 mt -97.68 155.59 16.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -111.63 159.95 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.67 -1.78 43.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -109.55 40.66 2.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -152.59 169.39 22.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.25 152.73 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 63.8 mt -57.8 -47.06 83.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -55.27 -26.0 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -68.13 -27.64 66.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -98.58 9.12 43.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.47 32.72 11.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.04 97.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -89.5 167.31 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -51.2 141.46 14.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 59.13 27.4 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 131.64 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.32 88.87 7.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.19 160.1 17.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -129.67 127.58 40.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 5.2 tp -99.69 118.31 35.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 4.3 t -116.64 141.13 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.101 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.73 128.08 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -90.42 163.67 14.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -51.17 131.02 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -96.78 101.79 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -123.16 18.19 7.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.485 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.83 0.262 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.3 mt -99.89 50.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.2 m -103.27 -18.63 14.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.71 94.37 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 1.1 mt -111.54 152.28 43.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.641 0.734 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 172.78 11.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.36 145.92 52.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.95 36.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.1 p -70.73 141.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.182 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -50.29 -56.29 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -50.16 -62.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.4 t -53.05 -32.18 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.158 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -63.72 -57.84 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -72.37 -7.67 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -89.33 -18.22 27.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 41.5 mt -90.03 158.0 44.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 159.14 54.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.37 -29.28 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.06 -40.11 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.7 mm -79.32 -43.08 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -55.6 -50.7 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -64.08 -33.28 75.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.17 -43.1 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.2 mt -72.71 -35.47 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -33.6 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.944 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -23.74 67.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.72 58.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -96.68 -176.36 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 p 46.01 62.39 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.38 85.92 2.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -117.42 -27.56 6.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.4 -63.88 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -108.05 170.6 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -64.17 114.18 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.23 169.66 6.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -141.68 99.65 3.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.784 0.326 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.784 0.326 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.74 133.97 37.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 17.7 pt -116.64 148.56 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -105.3 126.52 52.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.07 107.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.97 112.54 24.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' THR . . . . . . . . . . . . . 2.7 p -77.14 172.44 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -22.03 59.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.9 p -94.29 25.29 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.52 50.84 51.56 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -118.25 108.24 14.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.1 134.41 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.5 mt -130.15 108.17 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.07 130.15 37.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.82 133.65 41.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.8 100.29 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . . . . . . . . . 16.3 m -129.86 -179.38 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -129.84 160.81 63.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -12.04 32.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.3 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.19 175.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.8 156.07 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.8 mm -51.38 -30.28 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.43 -38.79 85.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -38.78 88.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' VAL . . . . . . . . . . . . . 48.0 t -73.17 -36.92 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -71.01 -38.81 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.01 75.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 42.8 mttm -54.52 -45.24 73.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 46.3 mt -53.93 -33.35 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -63.64 -46.64 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.59 -6.08 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -96.87 -53.73 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -101.99 -49.05 4.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.01 31.68 2.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 9.0 mt -105.68 130.65 22.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.519 0.676 . . . . 0.0 111.142 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 162.96 40.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.629 2.219 . . . . 0.0 112.38 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.4 -28.85 23.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.8 -2.3 14.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -94.76 128.39 41.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -133.33 136.98 45.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.6 155.83 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.8 mm -140.07 115.4 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -146.35 143.83 29.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.45 14.92 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.29 14.84 70.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -132.6 -175.64 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.308 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -107.51 125.96 51.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' LEU . . . . . . . . . . . . . 6.9 mt -82.54 160.27 22.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.48 161.41 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.17 0.58 40.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.12 43.82 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -152.52 169.4 22.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.47 147.06 26.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 70.6 mt -52.65 -44.98 66.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -57.45 -28.0 62.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.2 -32.82 74.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -96.63 8.18 44.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.989 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.0 m120 63.32 36.22 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' ILE . . . . . . . . . . . . . 14.6 mm -68.79 95.56 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -83.05 163.84 20.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.16 145.55 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.07 26.46 15.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 135.51 54.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -89.2 83.91 6.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.86 155.51 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -128.93 121.91 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' LEU . . . . . . . . . . . . . 2.9 tp -91.72 126.3 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' VAL . . . . . . . . . . . . . 21.9 t -123.78 148.15 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.79 134.85 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' ARG . . . . . . . . . . . . . 8.8 mtt180 -95.39 167.02 11.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -53.27 125.68 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.957 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -93.53 98.82 11.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.56 25.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.8 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.626 0.727 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.41 9.59 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.74 145.05 52.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.18 20.7 36.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.8 p -69.09 144.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -103.86 108.43 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -51.27 -50.16 59.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -53.07 -45.98 68.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.38 -33.21 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.439 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.5 t80 -66.77 -56.32 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -13.82 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -88.66 -27.49 21.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.98 HD13 HG21 ' A' ' 82' ' ' ILE . 22.1 mt -75.66 158.84 82.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.651 0.738 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.14 31.97 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.359 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.75 -29.79 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.98 HG21 HD13 ' A' ' 78' ' ' LEU . 39.2 mm -78.84 -29.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.448 ' O ' HD23 ' A' ' 87' ' ' LEU . 47.8 mt-30 -69.61 -26.58 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -88.68 -25.81 22.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.5 -40.14 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG21 ' HE1' ' A' ' 75' ' ' PHE . 17.1 mt -78.15 -30.86 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.7 mm? -70.69 -33.52 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.44 -21.3 66.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.78 23.98 40.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.414 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.736 0.303 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 134.05 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.443 HD11 HG13 ' B' ' 226' ' ' VAL . 31.7 pt -117.24 149.35 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.1 m-85 -105.13 124.25 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 205' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 215' ' ' LEU . 21.3 t -106.23 108.1 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.719 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.86 110.85 23.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.672 HG22 HD23 ' B' ' 269' ' ' LEU . 5.2 p -73.6 173.36 9.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -23.86 58.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.27 12.24 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.08 31.69 72.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.533 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -97.25 108.59 21.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.719 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.34 133.36 35.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.74 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.53 115.38 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.52 125.16 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 205' ' ' VAL . 9.9 mt -127.72 134.31 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.09 102.93 15.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.757 HG11 HG22 ' B' ' 226' ' ' VAL . 18.1 m -131.19 -179.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.9 mt-10 -132.75 160.6 67.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -10.67 29.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.398 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.1 m -98.18 -24.89 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 255' ' ' THR . 19.3 m-20 -63.91 174.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.86 156.52 21.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.56 -34.73 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -55.68 -35.42 66.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -39.92 69.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.781 HG21 HD21 ' B' ' 256' ' ' LEU . 46.2 t -65.66 -42.42 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.785 ' HG3' HD11 ' B' ' 243' ' ' LEU . 3.2 mtmm -63.65 -42.4 98.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.964 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.61 73.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -56.64 -50.1 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.6 -31.17 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -63.57 -45.71 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -4.6 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.74 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.5 mmmt -99.09 -56.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -100.31 -48.43 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.14 32.26 2.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.674 HD12 HD21 ' B' ' 269' ' ' LEU . 10.7 mt -104.64 130.04 23.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.654 0.74 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 164.31 35.07 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.706 2.271 . . . . 0.0 112.385 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -8.04 22.59 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.14 -30.35 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.53 -1.38 14.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -92.45 128.78 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.571 ' HD3' HD11 ' A' ' 82' ' ' ILE . 12.3 ttm180 -133.75 140.96 47.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.785 HD11 ' HG3' ' B' ' 227' ' ' LYS . 2.7 mp -108.4 151.06 26.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.575 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.5 mm -137.9 117.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.809 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.4 t80 -148.22 143.32 26.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.79 13.82 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.28 3.88 74.94 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.493 ' CE ' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -135.86 158.5 44.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.745 0.307 . . . . 0.0 110.862 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.02 145.54 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.809 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.4 mt -96.14 163.24 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.73 157.27 28.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.94 -13.64 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.47 39.52 2.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -152.58 169.72 21.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.4 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.464 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -102.34 152.98 20.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.134 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.781 HD21 HG21 ' B' ' 226' ' ' VAL . 32.8 mt -56.5 -46.47 80.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.6 t -58.87 -25.07 62.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.02 -32.14 73.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.452 ' CG ' HD22 ' B' ' 250' ' ' LEU . 71.9 m-85 -98.64 11.88 37.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.06 31.74 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.626 HG21 HD22 ' B' ' 256' ' ' LEU . 13.4 mm -68.89 95.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -84.5 -179.09 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 150.33 48.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 54.45 27.02 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.62 134.63 54.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -87.47 86.78 7.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.62 158.33 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.76 117.67 19.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.674 HD21 HD12 ' B' ' 236' ' ' ILE . 8.5 tp -87.11 128.98 35.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 82' ' ' ILE . 13.9 t -126.59 148.19 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.412 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -81.08 127.36 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.412 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.4 mtt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.708 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.1 mt . . . . . 0 C--O 1.23 0.04 0 CA-C-O 121.654 0.74 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 174.52 9.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.624 2.216 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.0 145.28 51.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.39 20.72 38.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.708 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -70.27 144.9 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.569 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.1 t0 -102.76 106.37 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -50.64 -52.65 37.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -51.55 -37.23 48.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 71' ' ' ASP . 74.7 t -76.85 -33.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -56.57 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -13.79 60.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -90.17 -18.27 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.846 HD13 HG21 ' A' ' 82' ' ' ILE . 41.3 mt -87.92 157.39 51.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 52.9 Cg_endo -69.79 165.33 31.37 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.383 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.02 -27.94 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.099 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -43.42 95.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.846 HG21 HD13 ' A' ' 78' ' ' LEU . 44.7 mm -79.39 -28.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 87' ' ' LEU . 34.1 mt-30 -69.59 -23.95 63.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.2 -26.7 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.17 -37.85 63.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.05 -42.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.6 mm? -56.71 -34.46 67.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 t -65.16 -21.9 66.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.98 14.93 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.749 0.309 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -95.54 134.18 38.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.446 HD11 HG13 ' B' ' 226' ' ' VAL . 25.8 pt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.438 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.7 m-85 -105.49 124.47 49.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 205' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' B' ' 269' ' ' LEU . 11.3 t -107.22 108.16 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.97 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.647 HG22 ' HB3' ' B' ' 269' ' ' LEU . 6.1 p -71.63 174.71 6.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -25.42 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 4.7 p -88.75 10.81 19.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.52 30.16 69.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -94.58 108.71 20.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.611 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.22 132.54 35.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.504 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -129.48 111.45 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.02 128.54 34.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 9.6 mt -132.36 134.19 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -90.21 103.03 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.859 HG11 HG22 ' B' ' 226' ' ' VAL . 21.7 m -130.77 -179.51 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.4 mt-10 -132.21 160.32 68.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.649 0.738 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 51.8 p -97.11 -24.79 15.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.4 ' O ' HG22 ' B' ' 255' ' ' THR . 41.0 m-20 -61.65 175.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.23 156.85 20.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.3 mm -53.56 -27.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.64 -29.85 71.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -37.56 44.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.868 HG21 HD21 ' B' ' 256' ' ' LEU . 94.9 t -67.87 -49.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -60.72 -34.61 74.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.44 98.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' B' ' 217' ' ' VAL . 9.4 mttt -57.24 -46.91 82.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' B' ' 269' ' ' LEU . 71.1 mt -53.76 -36.87 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -58.7 -44.87 90.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -4.75 44.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.504 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.0 mmmt -98.44 -56.6 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -101.4 -47.87 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.11 26.48 3.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.7 mt -98.08 128.88 32.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.124 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 164.3 35.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.575 2.184 . . . . 0.0 112.355 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.94 -29.37 25.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 13.0 mp0 -112.55 -5.34 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.451 ' OE1' HD12 ' B' ' 230' ' ' ILE . 11.1 tt0 -88.92 130.44 35.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.447 ' HD3' HD11 ' A' ' 82' ' ' ILE . 3.3 ttm180 -133.81 141.18 47.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.612 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -109.87 149.79 29.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.612 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.8 mm -135.85 118.78 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.166 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.713 ' HB3' HD21 ' B' ' 250' ' ' LEU . 25.8 t80 -149.27 142.71 25.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.7 14.91 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.73 17.95 64.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.45 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.34 171.62 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -91.43 139.53 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -94.17 151.26 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.43 155.32 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -78.25 -4.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -106.12 39.55 2.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -152.44 169.44 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.4 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -99.72 152.08 20.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.868 HD21 HG21 ' B' ' 226' ' ' VAL . 64.9 mt -56.33 -43.8 79.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 t -57.36 -23.63 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.28 -32.97 74.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.589 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.9 m-85 -97.41 10.25 40.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 62.45 35.79 14.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 245' ' ' PHE . 14.5 mm -68.69 95.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -84.87 167.37 16.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.57 148.55 9.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 55.56 26.56 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.13 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 85.47 6.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.461 HD11 HD11 ' B' ' 250' ' ' LEU . 3.9 mm? -84.02 159.29 21.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.495 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -129.32 129.56 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.647 ' HB3' HG22 ' B' ' 207' ' ' THR . 5.7 tt -96.03 134.7 38.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.817 HG11 HG23 ' A' ' 82' ' ' ILE . 17.2 t -133.89 140.35 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.434 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -75.18 129.8 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.434 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.5 mtt180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.3 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.681 0.753 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 173.76 10.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 0.0 112.265 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.04 145.26 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.3 20.69 37.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.552 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.04 144.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' HG23 ' A' ' 74' ' ' VAL . 62.6 t0 -103.55 108.96 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -51.25 -52.05 48.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -51.41 -45.72 62.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.464 HG23 ' OD2' ' A' ' 71' ' ' ASP . 67.0 t -69.72 -33.13 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.2 t80 -67.14 -56.02 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -13.84 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -88.83 -25.93 21.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.045 HD13 HG21 ' A' ' 82' ' ' ILE . 24.3 mt -78.43 158.67 76.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 165.13 32.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.62 -30.42 44.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -61.96 -41.38 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.045 HG21 HD13 ' A' ' 78' ' ' LEU . 39.6 mm -78.88 -27.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 87' ' ' LEU . 17.7 mt-30 -69.67 -45.69 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.77 -29.44 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.81 -43.02 80.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.475 HG21 ' HE1' ' A' ' 75' ' ' PHE . 39.4 mt -77.91 -30.6 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.8 mm? -70.2 -35.72 74.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -65.45 -20.78 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.14 18.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -94.84 137.78 33.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 10.0 pt -120.59 147.19 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.3 m-85 -105.54 121.93 44.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.7 107.95 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.649 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.29 109.55 22.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 5.8 p -71.43 172.41 9.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.62 -24.0 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -89.21 10.12 23.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.3 66.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.508 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -101.89 108.88 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.649 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.02 132.71 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.1 mt -128.52 110.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 127.52 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 7.9 mt -133.08 134.1 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.36 102.4 15.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.927 HG11 HG22 ' B' ' 226' ' ' VAL . 22.9 m -128.03 -179.24 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.597 ' O ' HD12 ' B' ' 256' ' ' LEU . 9.7 mt-10 -134.75 160.38 68.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.628 0.728 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -11.23 30.4 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.26 . . . . 0.0 112.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 p -97.16 -26.42 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.76 173.14 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.02 156.96 20.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -52.14 -31.22 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.96 -32.57 70.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -38.17 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.927 HG22 HG11 ' B' ' 217' ' ' VAL . 65.1 t -67.11 -49.06 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' B' ' 230' ' ' ILE . 1.7 ptpt -59.32 -37.02 76.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.18 70.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.0 mttm -56.5 -43.06 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' B' ' 227' ' ' LYS . 80.5 mt -55.33 -34.31 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.168 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -62.11 -48.08 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.12 -8.36 52.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -95.21 -56.33 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -100.35 -49.2 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.33 33.32 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.682 HD12 HD21 ' B' ' 269' ' ' LEU . 9.5 mt -106.41 130.68 22.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.605 0.717 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 163.31 38.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.4 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -8.18 22.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -84.95 -30.44 24.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.66 -1.67 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -91.97 126.85 37.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -133.79 135.17 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 244' ' ' ILE . 0.7 OUTLIER -101.14 155.92 17.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 82' ' ' ILE . 29.0 mm -140.56 117.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.749 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.1 t80 -146.6 145.05 29.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.83 14.46 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.63 15.51 68.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -133.6 -176.07 4.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -107.58 127.87 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.6 mt -84.48 153.06 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.34 163.31 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -81.97 -0.47 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.68 39.89 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.54 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -152.52 164.98 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.32 150.49 20.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.797 HD21 HG21 ' B' ' 226' ' ' VAL . 52.2 mt -54.73 -48.78 72.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -54.72 -26.18 32.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.4 -28.2 68.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.639 ' CG ' HD22 ' B' ' 250' ' ' LEU . 86.7 m-85 -98.86 11.88 37.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 63.96 31.25 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.485 HD12 HD11 ' B' ' 267' ' ' LEU . 16.0 mm -68.73 106.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.9 168.43 9.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.18 142.0 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.05 28.86 18.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 131.57 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.55 87.8 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.485 HD11 HD12 ' B' ' 261' ' ' ILE . 2.9 mp -89.3 159.25 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.413 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -128.66 122.98 32.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.682 HD21 HD12 ' B' ' 236' ' ' ILE . 8.7 tp -90.07 122.4 33.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 82' ' ' ILE . 13.8 t -120.59 147.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.476 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.76 132.09 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.476 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.9 mtt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.709 ' HB3' HG11 ' A' ' 70' ' ' VAL . 7.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.62 0.724 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 175.16 8.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.288 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.18 145.09 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.96 20.63 34.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.531 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.5 p -68.65 144.6 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -104.28 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -51.33 -51.29 55.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -51.44 -39.81 58.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.36 -33.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.11 -56.14 11.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -14.8 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.17 -25.57 21.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 82' ' ' ILE . 21.4 mt -77.58 157.82 79.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.6 Cg_endo -69.76 165.27 31.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.702 2.268 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.77 -26.89 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -64.73 -42.56 95.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 78' ' ' LEU . 41.2 mm -78.41 -29.58 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.73 -25.89 64.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.97 -24.69 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -72.29 -39.74 68.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.1 mt -78.26 -34.86 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.15 -32.43 73.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -67.83 -18.4 64.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.59 37.38 17.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.853 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.06 134.1 42.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -117.38 149.9 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.0 m-85 -106.58 128.56 54.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.29 107.75 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.92 111.04 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -72.76 174.26 7.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -25.53 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.4 p -88.04 8.14 28.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.7 31.98 59.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -97.52 108.88 21.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.634 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.26 133.81 35.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.56 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.7 mt -129.95 111.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 128.14 32.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.492 HD21 HG22 ' B' ' 213' ' ' ILE . 9.9 mt -130.71 134.25 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.1 104.02 16.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 226' ' ' VAL . 25.1 m -131.61 -179.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.564 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.5 mt-10 -131.35 160.87 65.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -11.73 31.44 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -28.98 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.4 175.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.503 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.8 OUTLIER -114.6 157.97 22.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.13 -25.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.69 -35.47 80.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 217' ' ' VAL . 91.0 t -69.17 -39.16 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.39 -39.83 92.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.78 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.529 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.5 mttt -56.56 -50.15 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 69.9 mt -53.31 -33.41 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -60.41 -48.58 81.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -72.6 -7.34 49.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.56 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.6 mmmt -95.37 -54.59 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.34 -48.91 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.38 29.97 2.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.492 HD12 HD21 ' B' ' 269' ' ' LEU . 9.2 mt -102.52 130.54 23.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.515 0.674 . . . . 0.0 111.105 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 163.78 36.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.703 2.268 . . . . 0.0 112.428 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -7.88 22.17 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.802 2.335 . . . . 0.0 112.335 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -85.91 -30.54 22.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.29 -0.46 15.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.43 131.91 43.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.47 ' HD3' HD11 ' A' ' 82' ' ' ILE . 17.5 ttm180 -133.73 147.12 51.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.611 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.7 mp -115.06 150.43 35.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 243' ' ' LEU . 22.7 mm -136.8 115.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.791 ' HB3' HD21 ' B' ' 250' ' ' LEU . 40.4 t80 -145.74 144.25 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.19 13.29 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.5 5.09 72.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.482 ' HE2' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -137.05 163.47 30.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.928 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.78 145.9 30.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -98.32 154.43 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -111.67 155.61 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.44 -5.39 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.39 2.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ARG . . . . . 0.503 ' O ' HG22 ' B' ' 222' ' ' THR . 5.3 ttt180 -152.53 169.42 22.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 149.61 23.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.73 HD21 HG21 ' B' ' 226' ' ' VAL . 44.7 mt -55.2 -47.59 75.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -57.39 -25.68 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.08 -30.87 71.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -98.81 11.04 39.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.9 m120 63.98 32.49 13.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.535 HG21 HD22 ' B' ' 256' ' ' LEU . 14.3 mm -68.77 95.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -86.98 170.64 11.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 152.17 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 53.64 27.45 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.78 133.48 54.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -90.14 85.77 6.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.58 159.63 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.401 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.9 OUTLIER -128.11 122.77 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.633 HD23 HG22 ' B' ' 207' ' ' THR . 5.8 tp -89.74 122.27 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.781 HG11 HD12 ' A' ' 82' ' ' ILE . 10.8 t -119.91 147.93 23.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.71 135.65 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.4 mtt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.734 ' HB3' HG11 ' A' ' 70' ' ' VAL . 4.9 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.554 0.692 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 174.11 10.03 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.719 2.279 . . . . 0.0 112.339 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.42 146.32 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.51 21.03 33.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.2 p -71.6 145.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.41 108.85 20.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -51.39 -52.09 48.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -51.4 -40.05 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' HE2' ' B' ' 206' ' ' LYS . 80.2 t -76.04 -33.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.097 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.23 -56.35 10.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -15.26 60.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -88.81 -27.49 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.995 HD13 HG21 ' A' ' 82' ' ' ILE . 28.3 mt -75.88 158.29 82.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.637 0.732 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' HG21 ' B' ' 244' ' ' ILE . 54.0 Cg_endo -69.73 165.16 31.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.35 -29.19 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.19 -39.69 95.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.995 HG21 HD13 ' A' ' 78' ' ' LEU . 36.8 mm -78.9 -29.65 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.142 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 63.4 mt-30 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.56 -32.48 74.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.84 -42.93 76.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.5 mt -77.91 -29.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -61.77 -38.9 89.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -65.58 -25.08 67.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.42 55.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.3 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.63 133.79 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.479 HD11 HG13 ' B' ' 226' ' ' VAL . 17.0 pt -116.67 148.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -104.85 126.87 52.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' VAL . . . . . 0.468 HG21 HD11 ' B' ' 215' ' ' LEU . 21.2 t -110.02 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.448 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.94 111.17 23.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.824 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.754 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -73.14 175.0 7.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -23.9 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.2 p -90.07 7.66 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.41 65.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -91.76 109.47 20.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.424 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.71 132.37 35.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.194 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.46 111.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.06 127.61 32.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.468 HD11 HG21 ' B' ' 205' ' ' VAL . 9.4 mt -129.9 134.3 47.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.47 102.46 15.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.911 HG11 HG22 ' B' ' 226' ' ' VAL . 21.6 m -131.44 -179.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.557 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -131.94 160.34 68.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.628 0.728 . . . . 0.0 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -10.16 27.86 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -99.54 -24.6 14.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.38 175.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.15 155.07 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' B' ' 256' ' ' LEU . 50.5 mm -52.11 -29.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.27 -34.2 74.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -72.7 -37.91 67.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 217' ' ' VAL . 62.2 t -69.66 -42.7 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -64.37 -38.93 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.7 87.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.0 mttt -57.35 -49.86 74.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.411 HG21 HD22 ' B' ' 269' ' ' LEU . 65.7 mt -53.33 -32.72 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.53 -47.53 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.69 -4.74 42.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.1 mmmt -96.68 -50.34 4.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -106.94 -47.31 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.79 29.59 2.82 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.17 132.24 21.33 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.515 0.674 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 164.83 33.03 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.633 2.222 . . . . 0.0 112.375 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -6.45 18.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.695 2.263 . . . . 0.0 112.336 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -90.17 -23.74 21.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -113.02 -7.73 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.546 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -89.12 130.11 35.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -133.69 132.38 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.9 mp -101.73 149.1 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 26.1 mm -136.38 119.72 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.726 ' HB3' HD21 ' B' ' 250' ' ' LEU . 30.2 t80 -148.23 142.09 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.84 14.99 9.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.082 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.02 12.4 68.28 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.79 21.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.87 143.72 26.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' B' ' 245' ' ' PHE . 2.4 mt -99.88 148.34 24.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -108.2 157.41 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.15 -16.11 61.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.68 38.14 3.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -152.59 168.54 25.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.36 154.39 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.817 HD21 HG21 ' B' ' 226' ' ' VAL . 49.6 mt -57.8 -48.67 79.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.0 t -54.41 -27.28 35.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.32 -34.51 72.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.0 m-85 -98.15 9.85 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.76 40.36 7.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CD2' ' B' ' 245' ' ' PHE . 16.0 mm -72.28 95.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.25 167.34 16.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 146.68 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 58.83 26.43 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.97 133.87 55.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.95 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.488 HD11 HD11 ' B' ' 250' ' ' LEU . 3.7 mm? -84.09 159.3 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.412 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -129.42 118.8 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.754 HD23 HG22 ' B' ' 207' ' ' THR . 2.8 tp -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.825 HG11 HD12 ' A' ' 82' ' ' ILE . 26.8 t -112.73 148.14 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.453 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -80.14 130.97 35.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.453 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.9 mtt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.768 ' CB ' HG11 ' A' ' 70' ' ' VAL . 9.2 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.587 0.708 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.16 8.46 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.08 147.01 52.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' B' ' 209' ' ' THR . . . 55.84 21.11 28.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.506 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.7 p -72.52 145.34 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 111.112 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.1 t0 -103.81 106.14 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -50.06 -52.97 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.5 -38.99 47.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.497 HG23 ' OD2' ' A' ' 71' ' ' ASP . 98.9 t -76.72 -33.24 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 66' ' ' LEU . 1.5 t80 -65.57 -56.56 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -13.95 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -88.93 -25.88 21.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 82' ' ' ILE . 25.8 mt -78.13 158.41 77.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.661 0.744 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.17 31.91 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.56 -31.45 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.78 -42.48 93.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.922 HG21 HD13 ' A' ' 78' ' ' LEU . 37.0 mm -78.94 -29.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.603 ' O ' HD23 ' A' ' 87' ' ' LEU . 65.6 mt-30 -69.76 -27.69 65.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.1 -26.76 23.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.88 -40.2 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.41 HG21 ' HE2' ' A' ' 75' ' ' PHE . 65.5 mt -78.13 -31.55 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -62.7 -38.34 90.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -65.43 -23.6 66.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.08 -1.95 65.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.51 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.714 0.293 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.35 136.19 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.8 pt -118.27 148.67 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.178 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' B' ' 212' ' ' THR . 12.9 m-85 -105.15 121.5 43.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.09 108.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.13 111.96 23.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.909 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.816 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -74.42 172.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.401 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -58.87 -24.52 62.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.9 p -89.61 12.22 17.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.02 89.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -108.23 110.96 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.772 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -82.31 134.43 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.704 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.0 mt -129.85 112.11 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.69 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.456 HD21 HG22 ' B' ' 213' ' ' ILE . 9.8 mt -131.42 134.84 46.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -89.83 104.4 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.945 HG11 HG22 ' B' ' 226' ' ' VAL . 21.2 m -134.45 174.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.535 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.8 mt-10 -125.71 160.95 53.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -8.58 23.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.55 -24.01 14.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.436 ' O ' HG22 ' B' ' 255' ' ' THR . 20.9 m-20 -62.3 175.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.13 154.97 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -51.29 -35.05 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.87 -34.42 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -38.96 67.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.945 HG22 HG11 ' B' ' 217' ' ' VAL . 62.9 t -67.92 -43.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.172 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.532 ' HD2' HD11 ' B' ' 243' ' ' LEU . 7.8 mtpm? -62.47 -41.65 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.29 -42.17 73.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.41 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.7 mttt -58.55 -48.17 81.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.58 -31.3 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -48.54 79.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.04 -5.04 41.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.704 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.72 -51.29 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -105.75 -47.42 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.08 27.64 3.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.541 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.445 HD12 HD21 ' B' ' 269' ' ' LEU . 11.9 mt -101.61 132.38 21.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.23 31.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -6.93 19.78 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.737 2.291 . . . . 0.0 112.29 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.35 -21.39 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -112.95 -8.69 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -87.31 130.82 34.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.554 ' HD3' HD11 ' A' ' 82' ' ' ILE . 4.0 ttm180 -134.01 128.4 34.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.2 mp -98.61 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.1 mm -136.92 114.92 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.699 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.5 t80 -143.16 143.05 31.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.46 15.14 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.86 75.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.14 168.86 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.728 0.299 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -89.39 142.77 27.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.3 mt -97.37 151.32 20.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 161.01 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.58 -9.88 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.65 2.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.53 169.66 22.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.381 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.436 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -101.4 151.54 21.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 57.3 mt -56.19 -45.22 79.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.2 t -56.08 -24.1 37.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.789 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.16 -30.58 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' B' ' 250' ' ' LEU . 49.7 m-85 -98.41 9.88 42.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.4 34.09 13.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.524 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.4 mm -68.92 100.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -95.11 170.67 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.37 144.22 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 58.11 28.24 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.438 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.69 125.4 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -80.84 85.7 6.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.59 HD11 HD11 ' B' ' 250' ' ' LEU . 3.0 mm? -85.39 158.52 20.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.435 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -129.69 119.86 24.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.816 HD23 HG22 ' B' ' 207' ' ' THR . 7.5 tp -89.99 128.05 36.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 82' ' ' ILE . 21.2 t -125.81 144.62 35.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.498 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -76.3 134.12 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.498 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.719 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.2 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.563 0.697 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 174.97 8.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.712 2.275 . . . . 0.0 112.316 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.08 144.33 52.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 19.99 30.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -65.98 144.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -104.3 108.59 20.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -52.92 37.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -51.29 -38.61 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.466 HG23 ' CG ' ' A' ' 71' ' ' ASP . 96.9 t -76.12 -33.1 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HE2' HG21 ' A' ' 86' ' ' ILE . 1.5 t80 -68.0 -55.98 10.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -14.27 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -88.64 -23.5 23.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.973 HD13 HG21 ' A' ' 82' ' ' ILE . 22.7 mt -81.23 158.46 69.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 165.15 31.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.41 -31.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.15 -41.23 92.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.973 HG21 HD13 ' A' ' 78' ' ' LEU . 35.9 mm -78.99 -28.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.57 -47.73 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.28 -32.19 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.41 -41.69 84.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 75' ' ' PHE . 56.5 mt -77.8 -33.99 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.38 -35.69 81.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 -23.22 66.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.64 -2.28 69.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.794 0.33 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.55 134.09 42.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.621 HD12 HD13 ' B' ' 267' ' ' LEU . 24.3 pt -118.74 148.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.538 ' HB3' HG22 ' B' ' 212' ' ' THR . 6.8 m-85 -105.77 127.63 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.76 108.65 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.3 108.84 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.568 HG22 ' HB3' ' B' ' 269' ' ' LEU . 8.7 p -67.49 173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -27.97 66.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.8 p -83.53 -1.41 53.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.36 31.74 24.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -98.77 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.364 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.678 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -81.67 134.3 35.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.099 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.57 114.43 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 125.16 29.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.505 HD11 HG12 ' B' ' 230' ' ' ILE . 8.6 mt -129.09 134.11 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.06 102.66 15.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 226' ' ' VAL . 22.6 m -127.77 178.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.604 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.8 mt-10 -132.88 160.33 69.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.73 24.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.1 p -110.27 17.33 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.68 ' O ' HG22 ' B' ' 255' ' ' THR . 24.0 m-20 -100.2 173.28 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.26 149.57 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.867 HD12 HD23 ' B' ' 250' ' ' LEU . 46.2 mm -51.64 -35.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -61.25 -34.35 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 217' ' ' VAL . 88.5 t -66.72 -45.76 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.2 OUTLIER -59.94 -38.41 82.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -49.99 70.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.728 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -57.43 -39.73 76.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 227' ' ' LYS . 86.0 mt -58.84 -28.1 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.66 -47.98 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.66 -7.74 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -96.11 -56.01 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -99.18 -48.87 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 33.15 1.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 5.7 mt -112.45 131.21 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.728 . . . . 0.0 111.096 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' B' ' 240' ' ' GLN . 54.0 Cg_endo -69.86 163.52 38.05 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.374 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 238' ' ' PRO . . . . . 0.429 ' HA ' ' HG2' ' B' ' 241' ' ' GLN . 54.1 Cg_endo -69.73 -1.65 8.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.64 2.227 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -99.4 -26.15 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' B' ' 237' ' ' PRO . 1.2 mp0 -113.01 -5.71 13.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.429 ' HG2' ' HA ' ' B' ' 238' ' ' PRO . 2.8 pt20 -111.96 136.01 51.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.29 147.87 49.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.516 HD23 ' H ' ' B' ' 243' ' ' LEU . 2.1 pt? -113.8 135.6 53.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 82' ' ' ILE . 20.7 mm -119.59 131.66 71.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.507 ' CD2' HD13 ' B' ' 261' ' ' ILE . 56.9 t80 -148.52 144.03 27.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.37 15.15 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 17.97 70.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 166.4 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.667 0.27 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.39 110.12 21.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.867 HD23 HD12 ' B' ' 223' ' ' ILE . 9.4 mp -67.34 163.62 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.48 153.13 48.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.88 -9.91 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.74 35.72 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -152.69 168.51 25.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.68 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -103.01 158.44 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.134 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.745 HD21 HG21 ' B' ' 226' ' ' VAL . 25.9 mt -58.28 -41.12 83.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -63.26 -22.16 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.26 -35.91 82.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -98.94 17.03 20.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.36 35.53 26.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.589 HG21 HD22 ' B' ' 256' ' ' LEU . 9.0 mm -68.6 95.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.96 -174.21 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.17 152.93 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 54.15 26.78 6.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.75 132.36 51.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -91.23 89.59 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.621 HD13 HD12 ' B' ' 203' ' ' ILE . 4.0 mp -91.93 165.27 13.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -129.6 145.35 51.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.568 ' HB3' HG22 ' B' ' 207' ' ' THR . 3.4 tt -105.38 133.05 50.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.81 HG11 HG23 ' A' ' 82' ' ' ILE . 5.2 t -133.44 143.9 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.16 135.37 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.0 mtt180 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.687 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.9 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.607 0.718 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.8 Cg_endo -69.81 173.64 10.72 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 144.88 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.99 20.66 34.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.5 p -69.23 146.24 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 0.0 111.1 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.9 t0 -104.31 106.62 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -49.38 -52.46 28.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -51.64 -38.08 53.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' OD2' ' A' ' 71' ' ' ASP . 96.3 t -76.03 -33.28 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' HE2' HG21 ' A' ' 86' ' ' ILE . 1.2 t80 -64.92 -56.58 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -13.2 61.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -88.44 -23.88 23.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 82' ' ' ILE . 21.1 mt -80.99 159.16 69.07 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.3 31.53 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.291 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.93 -33.68 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.72 -43.58 85.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.815 HD12 HG11 ' B' ' 270' ' ' VAL . 30.9 mm -77.69 -28.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 87' ' ' LEU . 31.8 mt-30 -70.4 -37.26 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.22 -30.2 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.44 -51.75 18.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 75' ' ' PHE . 58.6 mt -62.5 -28.85 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.2 mm? -75.41 -23.35 57.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.6 m -76.79 -19.34 57.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 14.44 59.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.492 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.317 . . . . 0.0 110.983 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.74 0.305 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -95.02 134.99 37.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.426 HD11 HG13 ' B' ' 226' ' ' VAL . 25.3 pt -117.9 148.77 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.452 ' HB3' HG22 ' B' ' 212' ' ' THR . 18.7 m-85 -104.9 122.31 45.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.57 108.36 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.2 OUTLIER -97.47 112.65 24.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.772 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -73.3 171.69 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.235 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -59.25 -27.4 65.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.4 p -84.64 0.7 49.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.93 39.34 13.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.372 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.487 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.3 131.77 35.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.672 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.3 mt -129.37 110.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' THR . . . . . 0.452 ' O ' HD23 ' B' ' 215' ' ' LEU . 0.2 OUTLIER -78.46 131.6 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.512 HD21 HG22 ' B' ' 213' ' ' ILE . 8.1 mt -135.87 133.95 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.81 105.81 18.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.795 HG11 HG22 ' B' ' 226' ' ' VAL . 20.4 m -134.0 171.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.575 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.8 mt-10 -118.47 160.33 40.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.92 33.88 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.611 2.207 . . . . 0.0 112.372 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 -25.33 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.1 175.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.2 p -111.98 156.83 21.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.142 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.422 HG21 HD13 ' B' ' 243' ' ' LEU . 48.4 mm -51.59 -33.63 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.65 -35.08 67.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.949 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -39.28 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.839 HG21 HD21 ' B' ' 256' ' ' LEU . 56.0 t -67.1 -44.1 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' B' ' 230' ' ' ILE . 28.2 ttmt -62.84 -41.73 99.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.22 -42.19 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.518 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.6 mttt -57.8 -48.62 79.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' B' ' 227' ' ' LYS . 14.5 mt -54.66 -31.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -61.48 -49.02 78.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.3 -5.28 41.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.672 ' HE3' HG23 ' B' ' 213' ' ' ILE . 17.1 mmmt -95.74 -53.56 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -104.7 -46.2 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.15 24.2 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.0 mt -98.32 132.27 24.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.61 0.719 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 167.8 23.25 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.74 2.293 . . . . 0.0 112.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.67 19.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.03 -23.47 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 7.6 mp0 -113.14 0.58 14.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.624 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -100.8 128.17 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -133.89 133.45 41.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' B' ' 227' ' ' LYS . 1.1 mp -101.01 141.09 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.73 116.34 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.744 ' HB3' HD21 ' B' ' 250' ' ' LEU . 24.1 t80 -141.59 144.2 34.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.29 15.17 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.55 8.61 73.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.445 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 172.82 12.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.74 142.8 26.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.9 mt -96.2 161.22 14.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -118.05 157.42 26.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.02 -8.36 58.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.4 39.62 2.71 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -152.53 169.87 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.2 151.09 22.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.839 HD21 HG21 ' B' ' 226' ' ' VAL . 71.5 mt -56.24 -45.42 80.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -55.63 -26.51 44.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.55 -26.8 65.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 89.5 m-85 -98.8 7.72 45.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.9 m120 64.66 33.7 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.534 HD13 ' CD2' ' B' ' 245' ' ' PHE . 18.4 mm -69.53 109.17 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.11 168.44 9.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 145.31 9.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 58.53 28.31 16.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.412 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.6 OUTLIER -56.77 130.01 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -86.66 81.94 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.507 HD11 HD11 ' B' ' 250' ' ' LEU . 2.7 mm? -83.36 159.82 21.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.42 115.91 18.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.772 HD23 HG22 ' B' ' 207' ' ' THR . 2.0 tp -83.85 116.56 22.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 82' ' ' ILE . 15.0 t -112.9 148.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' B' ' 271' ' ' LEU . 0.3 OUTLIER -80.84 126.82 31.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' B' ' 240' ' ' GLN . 2.8 mtt-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.735 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.8 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.677 0.751 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 174.69 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.708 2.272 . . . . 0.0 112.324 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.12 145.99 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.05 21.03 29.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.735 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -70.37 143.73 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 111.153 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.27 110.59 22.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.77 -52.89 45.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.91 -43.24 59.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.31 -32.83 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD2' HD22 ' A' ' 66' ' ' LEU . 3.0 t80 -65.13 -56.99 9.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -15.29 62.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -88.14 -15.97 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -85.05 155.24 60.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.3 Cg_endo -69.83 165.15 32.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.642 2.228 . . . . 0.0 112.345 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 -33.67 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.97 -38.86 76.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 78' ' ' LEU . 8.5 mm -78.83 -44.04 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.582 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.2 mt-30 -51.46 -46.21 63.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -28.32 62.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -71.5 -41.14 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.18 -32.32 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.3 mm? -63.47 -39.03 93.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.9 m -65.2 -22.91 66.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.15 37.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.922 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.812 0.339 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.39 134.07 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.4 HD12 HD13 ' B' ' 267' ' ' LEU . 25.0 pt -117.76 150.1 19.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.2 m-85 -106.16 126.49 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.23 107.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.688 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.08 110.97 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.692 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -73.17 174.21 8.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.408 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -60.71 -22.95 64.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -90.99 17.4 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.16 49.93 72.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -118.44 107.84 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.688 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -81.09 133.03 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.656 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.27 107.19 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.54 132.29 43.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -137.28 134.09 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -88.02 102.19 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.805 HG11 HG22 ' B' ' 226' ' ' VAL . 26.2 m -127.81 178.99 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.616 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -135.15 160.18 69.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -11.09 30.18 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.403 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -26.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.65 169.44 4.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.47 157.56 17.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.1 mm -53.71 -31.96 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -60.15 -31.33 70.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -36.36 57.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.838 HG21 HD21 ' B' ' 256' ' ' LEU . 63.4 t -68.57 -48.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' B' ' 230' ' ' ILE . 7.4 ptpp? -62.1 -30.46 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.29 -50.52 73.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -56.18 -42.08 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' B' ' 227' ' ' LYS . 57.6 mt -55.55 -34.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -61.89 -47.74 83.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -71.45 -8.18 52.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.656 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -95.48 -56.37 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -99.8 -49.24 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.89 2.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.653 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.27 130.96 22.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.64 0.733 . . . . 0.0 111.087 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 163.69 37.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 0.0 112.332 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -7.64 21.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.5 -31.11 22.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -112.51 0.63 15.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.72 127.05 40.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -133.88 136.13 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.403 ' H ' HD12 ' B' ' 243' ' ' LEU . 1.1 mp -105.09 136.27 44.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.4 mm -117.91 114.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.3 t80 -144.65 143.87 30.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.68 15.08 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.83 22.26 55.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.534 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 177.99 9.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -97.9 140.93 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -97.63 147.68 24.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -105.9 166.2 10.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -82.07 -18.6 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -91.51 40.49 2.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -152.97 167.88 27.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.93 152.43 21.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 65.2 mt -55.09 -47.42 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 t -55.75 -25.4 40.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.6 -30.42 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.6 m-85 -98.65 12.49 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.61 33.79 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.539 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.2 mm -68.69 95.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.42 166.07 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.35 149.79 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 54.99 27.51 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.61 134.47 54.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.4 m -91.95 86.0 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.415 HD11 HD12 ' B' ' 261' ' ' ILE . 3.0 mp -87.03 157.19 19.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.42 117.24 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.692 HD23 HG22 ' B' ' 207' ' ' THR . 8.5 tp -83.67 133.26 34.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.813 HG11 HD12 ' A' ' 82' ' ' ILE . 4.9 t -134.22 142.63 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.524 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.99 134.2 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.524 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.8 mtt180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.75 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.0 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.595 0.712 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.01 11.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.6 146.16 50.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.4 20.73 38.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -70.6 143.81 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.542 ' OD2' HG23 ' A' ' 74' ' ' VAL . 66.0 t0 -104.57 109.39 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -51.32 -53.53 35.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -50.45 -39.78 48.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.542 HG23 ' OD2' ' A' ' 71' ' ' ASP . 91.0 t -74.87 -33.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -66.72 -56.08 12.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -14.03 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -87.99 -28.41 21.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 82' ' ' ILE . 27.7 mt -77.92 158.31 77.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.705 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.28 31.49 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.34 -31.91 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.23 -42.28 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 78' ' ' LEU . 37.9 mm -77.93 -27.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.55 -50.71 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.46 -32.71 74.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.57 -47.09 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.835 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG21 ' HE2' ' A' ' 75' ' ' PHE . 52.0 mt -70.35 -43.17 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.86 -33.79 70.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.27 -23.52 67.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.44 25.39 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.886 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.59 134.81 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -117.7 148.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.446 ' HB3' HG22 ' B' ' 212' ' ' THR . 14.4 m-85 -105.3 121.42 43.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.4 t -105.09 113.05 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -101.09 114.0 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 269' ' ' LEU . 3.6 p -77.77 170.71 16.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -22.43 54.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 69' ' ' GLY . 3.0 p -94.22 23.54 5.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 55.15 55.35 28.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -121.58 108.97 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.446 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.3 OUTLIER -81.7 132.3 35.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.684 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.29 109.6 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.3 m -77.4 127.14 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.203 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.476 HD21 HG22 ' B' ' 213' ' ' ILE . 10.7 mt -129.63 134.36 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.37 102.23 14.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 23.0 m -131.54 -179.49 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.609 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.3 mt-10 -131.24 160.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.751 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -13.74 35.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -95.93 -24.88 16.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.452 ' O ' HG22 ' B' ' 255' ' ' THR . 27.5 m-20 -61.67 173.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.01 154.56 23.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.06 -31.14 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.72 -35.17 72.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -42.13 64.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.84 HG22 HG11 ' B' ' 217' ' ' VAL . 57.3 t -62.89 -42.17 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.581 ' CD ' HD11 ' B' ' 243' ' ' LEU . 32.1 mtpt -63.97 -41.65 97.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.27 72.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.3 mttt -57.79 -49.89 75.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 62.3 mt -54.05 -32.11 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -61.68 -47.18 86.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.52 -4.68 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.684 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.1 mmmt -97.4 -56.48 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -101.51 -48.4 4.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.55 35.03 1.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.609 HD12 HD21 ' B' ' 269' ' ' LEU . 12.7 mt -107.52 130.61 22.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.669 0.747 . . . . 0.0 111.132 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 163.41 38.37 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.603 2.202 . . . . 0.0 112.415 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 -7.42 21.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.36 -29.72 24.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.36 -3.43 14.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -88.79 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -133.85 147.98 51.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.598 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.2 mp -117.35 148.87 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 243' ' ' LEU . 25.1 mm -136.89 120.31 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.079 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.731 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.7 t80 -146.03 140.77 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.95 14.31 9.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.58 15.61 63.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 171.63 14.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.71 134.1 37.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -93.78 143.58 26.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -102.2 167.69 9.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -82.26 -20.27 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.16 45.04 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.399 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -153.02 169.67 22.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.452 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.2 OUTLIER -105.42 152.08 23.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 68.2 mt -56.75 -45.14 82.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -58.17 -22.93 53.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.62 -29.85 67.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.601 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.9 m-85 -98.43 10.06 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.73 33.31 13.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.554 HD12 HD21 ' B' ' 267' ' ' LEU . 14.3 mm -68.75 97.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -88.91 167.34 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 143.5 12.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 58.69 29.61 18.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.87 130.6 47.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -83.11 84.45 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.554 HD21 HD12 ' B' ' 261' ' ' ILE . 3.6 mm? -84.33 159.62 20.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.403 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -129.08 127.55 41.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.704 HD23 HG22 ' B' ' 207' ' ' THR . 9.0 tp -96.65 119.52 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.768 HG11 HD12 ' A' ' 82' ' ' ILE . 12.7 t -117.82 147.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.517 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.08 137.24 37.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.517 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.2 mtt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.9 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 174.99 8.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -69.55 144.98 52.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.27 20.36 35.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.445 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.5 p -68.51 142.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG23 ' A' ' 74' ' ' VAL . 10.3 t0 -102.33 110.62 22.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -51.64 -52.62 46.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -51.33 -47.77 62.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.407 HG23 ' CG ' ' A' ' 71' ' ' ASP . 57.7 t -67.51 -33.2 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.18 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.6 t80 -68.05 -56.16 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -13.67 60.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.1 -20.21 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.051 HD13 HG21 ' A' ' 82' ' ' ILE . 36.1 mt -84.8 157.6 60.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 162.53 41.67 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.14 -33.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -58.99 -41.23 87.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.051 HG21 HD13 ' A' ' 78' ' ' LEU . 35.0 mm -78.21 -27.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.516 ' O ' HD23 ' A' ' 87' ' ' LEU . 27.7 mt-30 -69.64 -50.55 43.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.74 -32.91 74.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.69 -50.37 67.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 75' ' ' PHE . 27.7 mt -71.4 -30.73 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.0 mm? -68.28 -35.14 77.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.78 -23.75 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.87 29.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.6 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.87 133.79 38.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.459 HD11 HG13 ' B' ' 226' ' ' VAL . 17.9 pt -116.37 150.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -106.35 123.18 47.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 t -107.62 108.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 111.61 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -75.38 171.02 14.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.78 -23.2 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.1 p -93.91 25.17 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.0 51.76 44.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -116.55 108.99 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 131.34 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.194 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.583 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.95 106.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.84 126.52 31.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.409 HD21 HG22 ' B' ' 213' ' ' ILE . 9.1 mt -129.91 134.11 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.58 101.04 13.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 21.9 m -128.04 -179.48 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.173 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.57 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.4 mt-10 -134.08 160.78 67.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.715 0.769 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.35 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -21.63 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.415 ' O ' HG22 ' B' ' 255' ' ' THR . 29.3 m-20 -64.13 175.17 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.32 157.36 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.442 HG23 HD22 ' B' ' 243' ' ' LEU . 45.6 mm -54.24 -26.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -65.29 -29.38 70.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.33 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.86 HG21 HD21 ' B' ' 256' ' ' LEU . 87.0 t -69.13 -47.42 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.71 ' HA ' HD12 ' B' ' 230' ' ' ILE . 19.6 ptmt -63.46 -36.95 85.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.62 -50.27 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.706 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.6 mttm -56.46 -42.11 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' B' ' 227' ' ' LYS . 59.9 mt -56.91 -29.33 30.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -66.6 -46.51 75.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.33 -5.08 42.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.583 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.82 -52.94 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -102.94 -47.1 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.78 3.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.53 HD12 HD21 ' B' ' 269' ' ' LEU . 10.2 mt -104.58 132.23 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.695 0.76 . . . . 0.0 111.14 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 167.39 24.66 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -7.34 20.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.72 -21.66 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -113.0 -11.32 13.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.554 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -83.26 126.57 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.625 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.8 ttm180 -133.61 121.02 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.517 ' CB ' HD12 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -92.84 134.56 34.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.439 HD11 HD11 ' A' ' 82' ' ' ILE . 29.8 mm -121.1 119.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.746 ' HB3' HD21 ' B' ' 250' ' ' LEU . 16.7 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.54 14.91 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.18 21.85 53.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.63 169.12 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -89.15 139.19 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.0 mt -94.02 152.73 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.972 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -106.27 159.33 16.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.55 -0.21 41.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.01 3.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -146.37 169.87 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.415 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -103.28 151.5 22.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.86 HD21 HG21 ' B' ' 226' ' ' VAL . 72.9 mt -57.35 -35.43 69.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -67.11 -21.38 65.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.02 -32.24 68.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.477 ' CG ' HD22 ' B' ' 250' ' ' LEU . 78.8 m-85 -96.39 8.35 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 63.07 35.82 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.51 HD13 ' CD2' ' B' ' 245' ' ' PHE . 15.0 mm -68.55 95.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -83.21 162.62 21.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 146.71 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.29 24.7 13.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.5 136.44 56.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -90.2 84.3 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.462 HD11 HD11 ' B' ' 250' ' ' LEU . 4.1 mm? -82.22 160.88 22.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' B' ' 244' ' ' ILE . 0.5 OUTLIER -130.66 119.59 22.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 3.5 tp -90.17 115.48 27.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 82' ' ' ILE . 22.0 t -111.54 148.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.407 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -79.9 124.46 28.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.407 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.9 mtt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 2.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.608 0.718 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.7 Cg_endo -69.74 174.66 9.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.48 146.41 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.98 21.25 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.66 144.76 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.422 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.1 t0 -103.74 115.59 30.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -54.76 -55.06 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.79 -45.72 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 71' ' ' ASP . 50.1 t -70.87 -32.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CZ ' HD23 ' A' ' 66' ' ' LEU . 2.7 t80 -68.35 -57.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.61 59.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -88.17 -18.89 27.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.787 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -80.69 153.6 73.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.8 Cg_endo -69.75 165.32 31.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.367 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.03 -34.07 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.07 -38.78 77.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.787 HG21 HD23 ' A' ' 78' ' ' LEU . 9.6 mm -78.89 -45.77 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -51.38 -50.77 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -32.39 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -69.54 -40.75 76.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 82' ' ' ILE . 63.3 mt -78.22 -30.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.17 -37.26 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -25.01 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.63 24.41 25.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.463 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -98.39 138.98 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.86 147.97 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.56 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.8 m-85 -104.21 123.7 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -105.07 108.12 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.697 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.51 109.24 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.85 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -69.19 174.33 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.166 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -26.01 65.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.6 p -86.24 3.05 44.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.139 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.12 49.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -94.9 108.42 20.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.335 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.697 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.03 131.11 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.701 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.38 116.23 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' THR . . . . . 0.573 ' C ' HD12 ' B' ' 215' ' ' LEU . 7.5 m -78.48 128.11 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' B' ' 230' ' ' ILE . 10.2 mp -125.61 133.44 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.2 99.07 11.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.808 HG11 HG22 ' B' ' 226' ' ' VAL . 14.7 m -131.2 -179.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.554 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.7 mt-10 -127.99 160.56 60.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -8.84 24.62 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.685 2.256 . . . . 0.0 112.296 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.3 m -102.15 -24.8 13.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -60.46 175.03 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.68 156.67 19.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.5 mm -53.34 -30.73 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.06 -40.25 84.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -41.87 90.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.861 HG21 HD21 ' B' ' 256' ' ' LEU . 25.6 t -64.01 -46.12 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.655 ' HE3' HD11 ' B' ' 243' ' ' LEU . 22.4 ttmt -60.48 -41.91 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.91 70.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -63.07 -42.37 99.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.605 ' CG1' HD21 ' B' ' 215' ' ' LEU . 52.7 mt -57.74 -28.75 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.78 -44.73 73.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.54 -5.77 44.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.701 ' HE3' HG23 ' B' ' 213' ' ' ILE . 23.4 mmmt -99.55 -54.57 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.11 -48.0 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.37 19.81 6.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.559 HD12 HD21 ' B' ' 269' ' ' LEU . 8.1 mt -94.1 132.56 29.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.181 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.17 25.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.13 20.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.623 2.216 . . . . 0.0 112.366 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -90.07 -20.68 22.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -113.21 -14.88 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.91 126.8 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.509 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 3.2 ttm180 -134.0 118.29 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.655 HD11 ' HE3' ' B' ' 227' ' ' LYS . 0.8 OUTLIER -88.26 147.68 24.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 243' ' ' LEU . 21.8 mm -135.96 115.65 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.9 t80 -141.12 141.93 34.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.81 14.29 9.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.21 15.14 65.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -134.31 170.3 15.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -94.85 128.69 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.5 mt -86.21 155.62 20.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.85 157.16 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.93 -6.51 52.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -103.45 41.22 2.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -152.65 168.52 25.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 148.33 25.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.861 HD21 HG21 ' B' ' 226' ' ' VAL . 69.6 mt -53.53 -44.39 69.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.2 t -57.68 -26.59 61.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.86 -33.2 75.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.549 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.4 6.72 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 4.2 m120 63.6 36.77 10.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.556 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.5 mm -68.73 96.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -82.99 166.58 18.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.33 149.4 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 54.22 26.27 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 143.28 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.06 86.92 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -82.36 158.88 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.01 115.07 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.85 HD23 HG22 ' B' ' 207' ' ' THR . 10.2 tp -85.59 134.67 34.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 82' ' ' ILE . 39.8 t -132.81 146.85 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.449 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.2 127.15 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.509 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.1 mtt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.0 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.557 0.694 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 86' ' ' ILE . 53.8 Cg_endo -69.77 175.01 8.68 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.754 2.303 . . . . 0.0 112.347 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.68 144.45 51.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.41 20.68 30.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -66.4 145.42 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.169 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' CG ' HG23 ' A' ' 74' ' ' VAL . 12.5 t0 -104.47 108.39 19.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -51.64 -53.28 40.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -50.11 -43.21 51.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.448 HG13 ' CD2' ' B' ' 268' ' ' HIS . 99.7 t -70.85 -32.69 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -66.72 -56.88 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -14.27 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -89.97 -23.25 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 82' ' ' ILE . 20.8 mt -80.85 158.96 69.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.644 0.735 . . . . 0.0 110.846 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.1 Cg_endo -69.83 165.27 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.288 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.86 -32.78 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.92 -43.52 94.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 78' ' ' LEU . 34.3 mm -78.89 -29.1 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 87' ' ' LEU . 32.9 mt-30 -69.74 -25.96 64.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -89.71 -25.97 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.83 -38.85 64.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.457 HG21 ' HE2' ' A' ' 75' ' ' PHE . 50.1 mt -78.07 -40.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER -53.87 -37.59 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.06 -25.75 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.63 61.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 pttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.733 0.302 . . . . 0.0 110.953 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.76 0.314 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.37 134.09 41.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.589 HD11 HG13 ' B' ' 226' ' ' VAL . 31.6 pt -117.03 150.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.0 m-85 -106.75 130.55 54.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -113.06 107.89 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.66 110.48 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -71.51 174.28 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.69 -25.73 63.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.55 5.8 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.206 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.35 29.34 58.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -94.73 108.83 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.586 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.06 133.5 35.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.52 111.68 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.49 128.2 33.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.441 HD21 HG22 ' B' ' 213' ' ' ILE . 8.6 mt -131.4 134.19 46.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -90.22 103.9 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.914 HG11 HG22 ' B' ' 226' ' ' VAL . 24.3 m -130.06 -179.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.9 mt-10 -132.2 160.73 66.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -12.11 32.11 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.72 2.28 . . . . 0.0 112.312 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.1 p -97.96 -25.31 15.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.42 175.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -112.8 157.64 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.464 ' CG2' HD13 ' B' ' 243' ' ' LEU . 48.5 mm -52.86 -29.24 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.49 -30.28 70.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -38.07 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.914 HG22 HG11 ' B' ' 217' ' ' VAL . 96.0 t -67.21 -51.73 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' B' ' 230' ' ' ILE . 15.4 ptmt -59.26 -35.04 72.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.25 92.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.06 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.64 -46.78 83.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 227' ' ' LYS . 44.6 mt -54.41 -32.8 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -61.79 -47.28 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.14 -5.4 44.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -97.18 -54.52 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.38 -48.72 3.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.7 34.88 1.64 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.531 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.628 HD12 HD21 ' B' ' 269' ' ' LEU . 7.7 mt -108.45 131.32 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 164.58 33.98 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.632 2.221 . . . . 0.0 112.345 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -6.98 19.9 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.76 -30.84 19.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.522 ' O ' HD22 ' B' ' 271' ' ' LEU . 2.3 mp0 -113.73 6.36 16.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.562 ' HG3' HD13 ' B' ' 269' ' ' LEU . 8.4 tt0 -116.63 125.75 52.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -134.7 148.0 50.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.828 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.543 ' HB2' HD12 ' B' ' 250' ' ' LEU . 0.4 OUTLIER -105.36 133.9 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.4 mm -111.78 123.65 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.786 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.8 t80 -151.64 144.75 24.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.936 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' ALA . . . . . 0.575 ' HB3' ' HZ3' ' B' ' 248' ' ' LYS . . . 64.14 15.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.49 8.17 74.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.441 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' LYS . . . . . 0.575 ' HZ3' ' HB3' ' B' ' 246' ' ' ALA . 0.0 OUTLIER -141.15 157.99 44.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -77.31 146.77 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -94.7 163.31 13.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -118.28 154.01 32.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -76.25 -5.54 47.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.805 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.81 39.28 2.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.506 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -152.69 169.89 21.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 152.71 21.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.192 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.853 HD21 HG21 ' B' ' 226' ' ' VAL . 52.8 mt -56.92 -43.82 81.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.0 t -60.69 -26.37 67.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -63.83 -31.65 72.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.79 9.73 42.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 63.72 34.89 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.519 HD13 ' CE2' ' B' ' 245' ' ' PHE . 15.9 mm -68.58 96.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -82.95 165.68 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 150.77 7.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 55.82 26.03 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.45 133.72 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.99 88.33 7.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.18 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.527 HD13 HD12 ' B' ' 203' ' ' ILE . 3.7 mp -89.32 158.82 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.448 ' CD2' HG13 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -127.99 125.63 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 4.6 tp -92.58 125.61 37.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 82' ' ' ILE . 11.1 t -121.78 149.26 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.55 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -91.44 144.03 25.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.55 ' N ' HD13 ' B' ' 271' ' ' LEU . 38.0 mtt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.68 0.752 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.56 10.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.01 146.15 51.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.15 20.7 36.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -70.43 143.57 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 111.098 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.6 t0 -102.84 108.63 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -51.68 -52.65 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.36 -38.69 54.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG23 ' CG ' ' A' ' 71' ' ' ASP . 97.2 t -76.15 -33.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' CD2' HD22 ' A' ' 66' ' ' LEU . 1.5 t80 -66.36 -56.3 11.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -14.85 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -87.37 -25.91 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 82' ' ' ILE . 28.7 mt -78.4 158.06 76.95 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.628 0.728 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 164.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.367 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.13 -28.36 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.3 -42.56 99.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 78' ' ' LEU . 41.8 mm -78.85 -27.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.73 -42.88 77.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -27.03 60.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.47 -41.19 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.08 -34.12 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.47 -35.82 82.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.96 20.82 41.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.77 0.319 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -98.2 134.4 41.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.692 HD12 HD13 ' B' ' 267' ' ' LEU . 23.3 pt -118.39 151.75 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.522 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.0 m-85 -106.45 123.35 47.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.7 113.0 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.3 OUTLIER -100.85 112.14 24.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.657 HG22 HD23 ' B' ' 269' ' ' LEU . 3.2 p -75.9 171.18 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.56 -22.01 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.3 23.56 5.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 53.76 38.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -120.04 108.31 14.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.522 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -81.91 130.91 35.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.171 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.641 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.7 mt -129.66 112.41 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.42 130.45 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.8 mt -132.53 134.55 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.24 104.66 17.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.828 HG11 HG22 ' B' ' 226' ' ' VAL . 28.5 m -133.91 178.48 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.602 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.1 mt-10 -128.69 160.75 61.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -13.94 35.31 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 5.7 m -96.23 -24.45 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.39 175.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.07 156.49 21.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.466 HG22 ' HE2' ' B' ' 227' ' ' LYS . 49.1 mm -53.2 -28.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -62.98 -31.19 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -38.05 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.865 HG21 HD21 ' B' ' 256' ' ' LEU . 88.2 t -67.41 -48.17 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.466 ' HE2' HG22 ' B' ' 223' ' ' ILE . 1.1 ptpt -60.59 -38.94 86.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.55 76.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.497 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.4 mttt -58.91 -48.07 82.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.1 mt -55.23 -31.02 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.062 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -62.7 -47.55 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.81 -5.08 44.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.641 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.9 mmmt -97.27 -56.5 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.81 -48.63 4.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.56 35.34 1.59 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.673 HD12 HD21 ' B' ' 269' ' ' LEU . 11.3 mt -108.17 130.54 22.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.734 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 163.44 38.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.241 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -7.95 22.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.53 -30.15 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.6 -3.22 14.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -89.31 131.35 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -133.75 147.52 51.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.536 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -116.36 146.53 42.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.536 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.9 mm -133.69 120.67 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 39.2 t80 -148.4 141.3 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.33 14.02 9.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.051 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.63 64.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.495 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -134.78 176.07 8.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.709 0.29 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.5 131.7 47.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.2 mt -86.66 158.73 19.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.45 162.13 18.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.48 0.73 41.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.48 42.86 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -152.75 167.96 27.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.0 110.835 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.57 147.25 26.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 80.2 mt -52.46 -44.37 65.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -56.61 -26.07 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -67.72 -31.41 71.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.53 6.5 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 6.0 m120 63.83 35.66 10.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.2 mm -68.54 96.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -83.22 163.9 20.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.48 148.44 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 58.98 22.84 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.544 ' OG ' HD12 ' B' ' 267' ' ' LEU . 0.1 OUTLIER -56.46 144.68 30.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -103.43 92.24 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.692 HD13 HD12 ' B' ' 203' ' ' ILE . 1.4 mp -87.31 162.75 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.468 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -130.14 116.04 17.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.673 HD21 HD12 ' B' ' 236' ' ' ILE . 10.5 tp -83.9 125.45 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.786 HG11 HD12 ' A' ' 82' ' ' ILE . 15.5 t -124.85 146.88 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.441 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.14 135.4 37.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.441 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.2 mtt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.686 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.598 0.713 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 173.84 10.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.681 2.254 . . . . 0.0 112.393 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.72 146.8 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.2 20.91 30.44 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -71.12 143.92 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 111.069 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -103.4 107.85 18.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -51.44 -51.8 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -51.2 -40.41 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.795 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.424 HG13 ' NE2' ' B' ' 268' ' ' HIS . 63.6 t -76.42 -33.04 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.99 -56.08 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -14.4 60.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -89.4 -23.4 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.892 HD13 HG21 ' A' ' 82' ' ' ILE . 21.9 mt -80.4 158.23 71.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.24 31.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.342 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.55 -32.31 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -58.85 -41.42 86.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.892 HG21 HD13 ' A' ' 78' ' ' LEU . 34.8 mm -79.08 -29.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.68 -30.8 68.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.23 -29.07 31.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -73.2 -38.93 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 -26.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -39.88 80.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.58 -22.15 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.09 28.84 24.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.99 134.21 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.9 pt -115.35 148.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.187 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -105.22 121.97 44.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.18 108.0 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.88 110.53 23.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.679 HG22 HD23 ' B' ' 269' ' ' LEU . 6.3 p -72.07 174.77 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -24.54 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -89.97 8.25 33.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.09 63.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -93.18 110.54 22.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.442 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.28 132.71 35.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.22 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.403 HG23 ' HE3' ' B' ' 233' ' ' LYS . 5.6 mt -129.8 106.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.74 133.12 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -137.21 134.13 35.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -89.19 100.94 13.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.946 HG11 HG22 ' B' ' 226' ' ' VAL . 22.8 m -128.49 175.73 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.598 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.2 mt-10 -128.55 160.29 63.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.628 0.727 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -11.45 30.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.736 2.291 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -27.14 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 255' ' ' THR . 14.7 m-20 -61.98 175.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -113.44 158.45 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.4 mm -52.07 -33.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.34 -31.72 66.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -36.28 46.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.946 HG22 HG11 ' B' ' 217' ' ' VAL . 99.0 t -70.43 -51.23 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.5 OUTLIER -58.97 -33.91 71.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.49 73.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.711 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.4 mttm -55.66 -43.22 76.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' B' ' 227' ' ' LYS . 63.0 mt -55.17 -32.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -63.46 -45.59 90.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -74.72 -5.83 45.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.403 ' HE3' HG23 ' B' ' 213' ' ' ILE . 0.5 OUTLIER -97.93 -48.19 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -108.37 -48.65 3.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.57 1.71 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.477 HD12 HD21 ' B' ' 269' ' ' LEU . 11.6 mt -108.36 132.13 21.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.621 0.724 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 163.4 38.44 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.362 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.378 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.19 -22.87 18.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -113.18 -5.56 13.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -91.68 131.3 37.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.506 ' HD3' HD11 ' A' ' 82' ' ' ILE . 9.0 ttm180 -133.89 124.49 26.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.537 ' H ' HD12 ' B' ' 243' ' ' LEU . 0.6 OUTLIER -97.42 134.18 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.13 115.19 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.66 ' HB3' HD21 ' B' ' 250' ' ' LEU . 33.9 t80 -143.04 145.19 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.53 15.45 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.26 20.63 58.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 173.88 12.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 140.82 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -96.24 153.28 17.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.41 161.79 14.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 0.37 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.75 41.44 2.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -152.5 168.57 25.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.964 0.412 . . . . 0.0 110.84 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.485 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -98.98 151.36 21.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.869 HD21 HG21 ' B' ' 226' ' ' VAL . 55.5 mt -56.42 -47.33 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.8 t -55.43 -25.15 34.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.79 -28.8 67.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.63 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.1 m-85 -98.67 11.21 39.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 63.82 33.47 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 267' ' ' LEU . 13.8 mm -71.81 97.82 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -93.52 170.21 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.72 143.89 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 58.21 29.02 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.479 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.58 126.57 27.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -84.6 83.92 7.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.533 HD11 HD12 ' B' ' 261' ' ' ILE . 2.5 mp -85.75 160.76 19.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.424 ' NE2' HG13 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -129.0 119.9 25.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.679 HD23 HG22 ' B' ' 207' ' ' THR . 6.1 tp -89.21 120.97 31.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 82' ' ' ILE . 18.8 t -118.83 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.49 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -76.19 135.2 39.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.49 ' N ' HD13 ' B' ' 271' ' ' LEU . 6.4 mtt180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.688 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.4 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.591 0.71 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 174.61 9.14 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 0.0 112.394 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.02 144.66 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.84 18.71 40.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 66' ' ' LEU . 8.0 p -67.62 142.88 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -103.36 109.71 21.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.41 -53.01 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -51.27 -37.84 49.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' CG ' ' A' ' 71' ' ' ASP . 93.8 t -76.62 -33.29 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.3 t80 -67.74 -56.23 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -14.78 59.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -87.55 -23.93 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.05 HD13 HG21 ' A' ' 82' ' ' ILE . 34.6 mt -81.34 157.74 70.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.709 . . . . 0.0 110.934 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.12 31.99 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.399 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.17 -34.4 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -58.15 -39.94 80.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.05 HG21 HD13 ' A' ' 78' ' ' LEU . 31.7 mm -78.56 -32.64 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.203 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -64.8 -49.9 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -65.25 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.31 -43.1 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.451 HG21 ' HE1' ' A' ' 75' ' ' PHE . 55.9 mt -78.24 -31.37 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.92 -35.23 76.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -65.25 -24.39 67.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.1 18.57 49.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.801 0.334 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.18 133.77 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.603 HD12 HD13 ' B' ' 267' ' ' LEU . 27.9 pt -116.25 147.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -104.99 125.05 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.04 109.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.408 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -96.65 111.15 23.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.732 HG22 HD23 ' B' ' 269' ' ' LEU . 5.4 p -71.78 174.24 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -23.4 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.3 p -89.48 7.56 35.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.59 35.2 52.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -102.81 112.35 25.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.24 134.66 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.754 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.75 110.86 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 214' ' ' THR . . . . . 0.472 ' O ' HD23 ' B' ' 215' ' ' LEU . 1.0 OUTLIER -79.81 132.3 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.213 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 HG22 ' B' ' 213' ' ' ILE . 5.9 mt -136.45 134.03 37.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.28 102.17 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 1.052 HG11 HG22 ' B' ' 226' ' ' VAL . 27.7 m -127.37 179.96 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -137.18 161.34 61.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -14.74 36.81 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.727 2.285 . . . . 0.0 112.379 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -26.8 16.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.686 ' O ' HG22 ' B' ' 255' ' ' THR . 18.4 m-20 -61.98 174.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 255' ' ' THR . 0.2 OUTLIER -108.09 152.23 24.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -50.2 -30.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 -37.98 86.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.18 96.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 1.052 HG22 HG11 ' B' ' 217' ' ' VAL . 96.9 t -66.06 -50.98 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.61 ' HD3' HD22 ' B' ' 243' ' ' LEU . 12.6 mmmm -57.24 -38.68 74.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.07 -50.23 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.134 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.624 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.2 mttm -56.42 -43.17 79.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 227' ' ' LYS . 75.8 mt -56.29 -28.79 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.129 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.2 -45.96 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -74.66 -5.34 42.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.754 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.5 mmmt -97.01 -49.56 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.66 -48.27 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.75 34.9 1.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.6 mt -110.14 132.66 21.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.149 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.91 164.5 34.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.632 2.222 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -5.0 15.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.62 2.213 . . . . 0.0 112.344 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.78 -24.91 17.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.47 -2.15 13.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.99 129.81 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.462 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 8.1 ttm180 -133.9 122.43 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' B' ' 250' ' ' LEU . 2.3 pt? -103.5 133.81 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 82' ' ' ILE . 15.8 mm -114.68 141.52 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.738 ' HB3' HD21 ' B' ' 250' ' ' LEU . 41.7 t80 -156.64 137.4 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 14.63 9.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.82 16.16 60.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -136.75 168.6 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.01 122.09 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' B' ' 243' ' ' LEU . 2.3 mt -83.25 152.48 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 161.13 16.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.94 -12.38 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.4 3.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -152.9 170.75 19.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.356 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.686 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -102.94 158.08 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.884 HD11 HG21 ' B' ' 226' ' ' VAL . 4.1 mm? -55.29 -50.61 69.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 44.4 t -57.47 -30.45 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.83 -37.5 63.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.7 ' CD1' HD22 ' B' ' 250' ' ' LEU . 97.1 m-85 -98.85 16.48 22.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.17 32.42 19.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.701 HG21 HD12 ' B' ' 256' ' ' LEU . 8.6 mm -68.15 95.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 147.43 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 59.72 25.62 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.514 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.63 135.67 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -92.39 84.24 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.205 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.603 HD13 HD12 ' B' ' 203' ' ' ILE . 4.7 mp -86.33 162.99 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.462 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -129.81 129.08 43.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.732 HD23 HG22 ' B' ' 207' ' ' THR . 12.2 tp -96.06 131.21 42.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.596 HG11 HG23 ' A' ' 82' ' ' ILE . 19.6 t -133.81 148.19 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.424 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.37 128.06 33.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.462 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.8 mtt180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.756 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.593 0.711 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 175.06 8.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.54 147.27 51.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.33 21.01 31.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -73.82 145.28 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' CG ' HG23 ' A' ' 74' ' ' VAL . 14.2 t0 -104.31 107.34 18.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -50.89 -53.88 28.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.44 -40.76 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.444 HG22 ' HE2' ' B' ' 206' ' ' LYS . 65.2 t -75.75 -32.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.4 t80 -65.7 -56.81 10.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -14.74 61.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -87.66 -23.75 24.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.066 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.83 157.55 69.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.611 0.72 . . . . 0.0 110.957 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.8 Cg_endo -69.79 165.21 31.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 0.0 112.362 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.6 -29.95 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -61.73 -40.59 95.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.066 HG21 HD13 ' A' ' 78' ' ' LEU . 40.0 mm -79.19 -27.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.7 -47.88 61.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.89 -33.05 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.92 -42.56 85.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.477 HG21 ' HE1' ' A' ' 75' ' ' PHE . 57.5 mt -77.47 -37.14 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.49 -32.83 63.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -71.48 -24.56 62.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.16 -15.61 58.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.14 135.65 42.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 265' ' ' SER . 21.5 pt -117.09 148.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.85 126.29 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.837 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -108.78 108.19 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.444 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.64 110.34 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.583 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -71.95 174.06 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -25.12 63.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -87.43 3.19 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.81 24.77 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -89.89 109.91 20.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.427 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -83.72 130.93 34.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.15 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.699 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.9 mt -128.32 113.68 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' THR . . . . . 0.586 ' C ' HD12 ' B' ' 215' ' ' LEU . 10.2 m -78.61 127.69 32.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.659 HD21 HG13 ' B' ' 230' ' ' ILE . 10.8 mp -126.36 133.4 51.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.62 98.58 10.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.848 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -129.77 -179.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.475 ' O ' HD12 ' B' ' 256' ' ' LEU . 2.9 mt-10 -126.22 160.77 55.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -8.65 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.65 2.233 . . . . 0.0 112.384 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.77 -25.5 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.77 174.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' THR . . . . . 0.441 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -111.76 163.38 14.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.766 HD12 HD23 ' B' ' 250' ' ' LEU . 47.8 mm -59.3 -40.79 82.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -52.37 -29.76 25.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.72 44.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.848 HG22 HG11 ' B' ' 217' ' ' VAL . 48.7 t -66.07 -47.42 85.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.9 ttmt -58.01 -39.17 77.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.81 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.816 ' HE3' HG12 ' B' ' 217' ' ' VAL . 41.0 mttm -57.2 -42.06 80.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.659 HG13 HD21 ' B' ' 215' ' ' LEU . 67.8 mt -56.37 -30.61 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -66.74 -43.92 82.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.699 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.3 mmmt -97.93 -47.96 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -109.51 -48.52 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.96 32.91 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.35 132.86 20.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.701 0.763 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 162.62 41.34 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.248 . . . . 0.0 112.363 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -4.6 14.32 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.687 2.258 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.56 -27.0 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -113.43 -2.34 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 127.43 40.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.9 ttm180 -134.31 145.51 49.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.649 HD13 ' CB ' ' B' ' 250' ' ' LEU . 0.0 OUTLIER -116.3 155.96 27.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 82' ' ' ILE . 24.5 mm -137.67 114.05 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.473 ' CD1' HD13 ' B' ' 261' ' ' ILE . 31.5 t80 -144.43 145.77 32.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.08 14.41 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.07 39.4 16.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.64 20.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.282 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.49 126.67 35.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.766 HD23 HD12 ' B' ' 223' ' ' ILE . 7.0 mp -74.47 163.69 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -131.1 157.64 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -82.2 1.06 38.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.75 37.69 3.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 254' ' ' ARG . . . . . 0.441 ' O ' HG22 ' B' ' 222' ' ' THR . 6.9 ttt180 -153.1 169.88 21.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 157.15 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 39.1 mt -60.01 -43.43 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t -59.14 -20.58 54.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.92 -32.13 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.551 ' CE1' HD11 ' B' ' 223' ' ' ILE . 15.8 m-85 -98.44 10.57 40.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 63.57 33.94 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.676 HD12 HD11 ' B' ' 267' ' ' LEU . 10.8 mm -68.69 100.71 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.5 175.98 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -54.95 145.06 21.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 57.95 28.5 16.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 265' ' ' SER . . . . . 0.445 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -58.05 128.69 38.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -87.81 84.3 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.676 HD11 HD12 ' B' ' 261' ' ' ILE . 2.6 mp -88.57 161.12 17.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.447 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -127.73 121.78 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.583 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -90.17 108.03 19.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.769 HG11 HD12 ' A' ' 82' ' ' ILE . 21.8 t -104.94 148.77 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.505 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -81.26 135.03 35.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.505 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.1 mtt180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.752 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.5 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.628 0.728 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 175.14 8.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.686 2.258 . . . . 0.0 112.335 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.22 146.09 52.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.53 20.67 31.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.752 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.9 p -70.74 144.48 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.28 108.92 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.71 -50.69 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -39.12 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.426 HG22 ' HE2' ' B' ' 206' ' ' LYS . 88.4 t -76.63 -33.51 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.458 ' CD2' HD22 ' A' ' 66' ' ' LEU . 2.7 t80 -66.86 -56.17 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -15.07 61.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -87.0 -26.8 23.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.948 HD13 HG21 ' A' ' 82' ' ' ILE . 29.7 mt -79.5 158.18 74.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 153.31 68.55 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.696 2.264 . . . . 0.0 112.264 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.49 -29.83 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -60.61 -41.56 95.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 78' ' ' LEU . 30.2 mm -76.28 -30.97 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.85 -42.47 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.57 -31.72 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -74.08 -54.58 7.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.6 -40.97 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -30.22 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -66.09 -24.66 66.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 9.35 63.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -94.83 133.91 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.577 HD11 HG13 ' B' ' 226' ' ' VAL . 27.0 pt -116.75 149.66 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.482 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.0 m-85 -106.07 124.34 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.47 108.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.55 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.0 113.19 24.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.746 HG22 HD23 ' B' ' 269' ' ' LEU . 5.0 p -76.91 174.7 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.68 -22.58 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -92.72 17.7 9.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.3 97.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -104.72 108.01 19.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.55 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.69 132.48 35.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.686 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.8 mt -129.49 108.79 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 130.47 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' B' ' 229' ' ' LYS . 7.7 mt -135.88 135.83 40.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -89.27 101.82 14.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.783 HG11 HG22 ' B' ' 226' ' ' VAL . 25.3 m -128.22 -178.95 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.558 ' O ' HD12 ' B' ' 256' ' ' LEU . 8.7 mt-10 -135.08 160.45 68.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -11.44 30.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.655 2.237 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.2 m -98.1 -25.54 14.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.49 ' O ' HG22 ' B' ' 255' ' ' THR . 42.0 m-20 -63.5 174.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.4 p -111.25 155.98 22.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.494 HG22 ' HZ2' ' B' ' 227' ' ' LYS . 48.2 mm -50.57 -36.92 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -53.25 -36.68 61.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -34.25 65.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.926 HG21 HD21 ' B' ' 256' ' ' LEU . 98.6 t -69.94 -46.86 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 230' ' ' ILE . 8.7 ptpp? -64.76 -35.63 81.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.932 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.97 76.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' B' ' 215' ' ' LEU . 13.3 mttt -59.31 -43.61 92.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 227' ' ' LYS . 42.3 mt -56.54 -29.45 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.86 -48.73 73.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.21 -8.08 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.686 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -96.73 -56.34 2.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -96.14 -49.48 5.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 20.9 5.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.515 HD12 HD21 ' B' ' 269' ' ' LEU . 1.1 mt -99.22 134.05 21.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.415 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.4 Cg_endo -69.85 166.42 27.79 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -7.85 22.11 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.36 -23.01 28.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 6.9 mp0 -112.47 -8.57 13.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.6 HE21 ' HB2' ' B' ' 227' ' ' LYS . 1.1 tt0 -87.19 127.19 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -134.21 118.0 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.406 HD22 ' N ' ' B' ' 243' ' ' LEU . 3.7 mm? -80.36 150.37 29.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 78' ' ' LEU . 30.3 mm -137.98 114.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.185 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.479 ' HB3' HD21 ' B' ' 250' ' ' LEU . 21.5 t80 -145.87 144.41 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.84 15.08 8.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.6 5.67 78.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.498 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.5 170.4 13.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.739 0.304 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -95.2 139.8 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.502 HD22 ' CD1' ' B' ' 259' ' ' TYR . 1.5 mt -91.45 155.71 18.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -111.57 161.8 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -81.68 -0.9 44.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.46 41.07 2.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.429 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -152.85 169.75 22.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.49 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -99.47 153.25 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.926 HD21 HG21 ' B' ' 226' ' ' VAL . 41.9 mt -57.41 -44.87 84.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.6 t -58.88 -24.48 62.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.09 -32.47 73.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.814 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.502 ' CD1' HD22 ' B' ' 250' ' ' LEU . 45.2 m-85 -98.7 12.5 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 64.02 33.79 11.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.484 HD12 HD21 ' B' ' 267' ' ' LEU . 9.1 mm -70.81 95.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.87 174.14 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 147.53 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 55.94 25.02 8.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.66 133.11 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -85.32 86.04 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.484 HD21 HD12 ' B' ' 261' ' ' ILE . 4.0 mm? -81.9 157.24 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.44 ' HB2' ' HB ' ' B' ' 244' ' ' ILE . 0.2 OUTLIER -130.46 121.44 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.746 HD23 HG22 ' B' ' 207' ' ' THR . 4.4 tp -91.98 127.16 37.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 82' ' ' ILE . 11.6 t -125.49 148.46 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.484 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -75.73 130.08 38.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.484 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.718 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 174.22 9.74 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 147.71 50.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.81 20.88 34.58 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.488 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.718 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.1 p -74.45 142.55 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -101.87 108.11 19.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -50.59 -51.92 43.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.18 -40.08 57.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG22 ' HE2' ' B' ' 206' ' ' LYS . 87.0 t -76.42 -32.92 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.71 -56.6 8.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -15.78 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -87.55 -22.78 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.96 158.04 68.05 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.729 2.286 . . . . 0.0 112.324 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.93 -31.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.13 -38.76 87.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.033 HG21 HD13 ' A' ' 78' ' ' LEU . 33.0 mm -78.79 -31.08 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -67.73 -49.94 59.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -32.9 74.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.6 -43.4 80.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.7 mt -74.6 -44.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -30.18 71.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -64.91 -27.6 68.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.97 41.82 5.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -95.51 138.5 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.67 147.17 24.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.465 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.7 m-85 -105.36 127.51 53.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 16.2 t -109.86 108.19 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.555 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.24 112.47 24.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.699 HG22 HD23 ' B' ' 269' ' ' LEU . 5.6 p -74.92 175.5 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -59.07 -24.45 62.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 209' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -89.96 8.38 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.17 69.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -89.66 108.49 19.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.555 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.43 131.85 35.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.181 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.714 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -128.91 115.23 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 214' ' ' THR . . . . . 0.599 ' C ' HD12 ' B' ' 215' ' ' LEU . 5.8 m -79.44 128.46 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.638 ' CD1' HG22 ' B' ' 213' ' ' ILE . 10.8 mp -126.67 134.1 50.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.13 98.86 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.835 HG11 HG22 ' B' ' 226' ' ' VAL . 18.9 m -131.37 -179.04 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.587 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.3 mt-10 -130.58 160.56 65.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -9.29 25.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.248 . . . . 0.0 112.39 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -100.6 -24.88 14.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 221' ' ' ASP . . . . . 0.478 ' O ' HG22 ' B' ' 255' ' ' THR . 17.9 m-20 -63.4 175.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.0 157.93 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.07 -32.52 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -56.74 -35.85 69.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -43.11 63.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.835 HG22 HG11 ' B' ' 217' ' ' VAL . 21.7 t -63.15 -43.38 98.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.618 ' CE ' HD11 ' B' ' 243' ' ' LEU . 17.1 ttmt -61.26 -42.14 98.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.921 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.51 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -63.66 -42.21 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.611 ' CG1' HD21 ' B' ' 215' ' ' LEU . 45.1 mt -59.14 -29.37 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.148 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -67.06 -44.73 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.38 -4.98 45.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.714 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.0 mmmt -99.29 -56.01 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -98.79 -48.66 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.66 19.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' B' ' 237' ' ' PRO . 0.9 OUTLIER -101.14 134.39 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.585 0.707 . . . . 0.0 111.142 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 237' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.5 Cg_endo -69.79 169.6 18.57 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.68 2.253 . . . . 0.0 112.302 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -7.2 20.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.35 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.85 -19.03 25.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -113.21 -15.54 12.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.434 ' OE1' HG22 ' B' ' 230' ' ' ILE . 0.7 OUTLIER -86.97 129.67 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 242' ' ' ARG . . . . . 0.656 ' HD3' HD11 ' A' ' 82' ' ' ILE . 10.9 ttm180 -132.93 112.49 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 243' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' B' ' 227' ' ' LYS . 0.7 OUTLIER -83.72 134.67 34.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 82' ' ' ILE . 23.0 mm -121.41 116.2 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.712 ' HB3' HD21 ' B' ' 250' ' ' LEU . 17.9 t80 -140.45 142.56 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.17 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.06 12.56 67.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 174.14 10.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.74 144.07 25.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.1 mt -97.68 155.59 16.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -111.63 159.95 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.67 -1.78 43.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -109.55 40.66 2.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -152.59 169.39 22.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 255' ' ' THR . . . . . 0.478 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -100.25 152.73 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.824 HD21 HG21 ' B' ' 226' ' ' VAL . 63.8 mt -57.8 -47.06 83.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -55.27 -26.0 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -68.13 -27.64 66.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 87.7 m-85 -98.58 9.12 43.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.47 32.72 11.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.513 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.2 mm -70.04 97.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -89.5 167.31 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -51.2 141.46 14.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 59.13 27.4 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 131.64 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.32 88.87 7.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.19 160.1 17.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.67 127.58 40.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.699 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -99.69 118.31 35.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.949 HG11 HG23 ' A' ' 82' ' ' ILE . 4.3 t -116.64 141.13 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.101 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.429 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.73 128.08 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.429 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.7 mtt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.666 ' HB3' HG11 ' A' ' 70' ' ' VAL . 1.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.641 0.734 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 172.78 11.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.36 145.92 52.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.95 36.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.1 p -70.73 141.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.182 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -50.29 -56.29 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -50.16 -62.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.565 HG13 ' NE2' ' B' ' 268' ' ' HIS . 44.4 t -53.05 -32.18 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.158 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 66' ' ' LEU . 15.7 t80 -63.72 -57.84 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -72.37 -7.67 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -89.33 -18.22 27.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 82' ' ' ILE . 41.5 mt -90.03 158.0 44.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 159.14 54.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.37 -29.28 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.06 -40.11 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 1.053 HG21 HD13 ' A' ' 78' ' ' LEU . 49.7 mm -79.32 -43.08 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -55.6 -50.7 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -64.08 -33.28 75.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.17 -43.1 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.456 ' CD1' HG22 ' A' ' 82' ' ' ILE . 47.2 mt -72.71 -35.47 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -33.6 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.944 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -23.74 67.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.72 58.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.784 0.326 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.74 133.97 37.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 203' ' ' ILE . . . . . 0.629 HD11 HG13 ' B' ' 226' ' ' VAL . 17.7 pt -116.64 148.56 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 204' ' ' PHE . . . . . 0.477 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.5 m-85 -105.3 126.52 52.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.07 107.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 206' ' ' LYS . . . . . 0.469 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -97.97 112.54 24.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 207' ' ' THR . . . . . 0.702 HG22 HD23 ' B' ' 269' ' ' LEU . 2.7 p -77.14 172.44 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.493 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.3 OUTLIER -58.96 -22.03 59.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.9 p -94.29 25.29 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.52 50.84 51.56 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -118.25 108.24 14.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -82.1 134.41 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 213' ' ' ILE . . . . . 0.7 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -130.15 108.17 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.07 130.15 37.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.82 133.65 41.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.8 100.29 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.891 HG11 HG22 ' B' ' 226' ' ' VAL . 16.3 m -129.86 -179.38 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.1 mt-10 -129.84 160.81 63.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -12.04 32.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.3 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.19 175.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.8 156.07 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ILE . . . . . 0.4 HD13 HD23 ' B' ' 256' ' ' LEU . 49.8 mm -51.38 -30.28 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.43 -38.79 85.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 225' ' ' ASN . . . . . 0.477 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -66.31 -38.78 88.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 226' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 217' ' ' VAL . 48.0 t -73.17 -36.92 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' LYS . . . . . 0.62 ' HA ' HD12 ' B' ' 230' ' ' ILE . 17.3 ttpp -71.01 -38.81 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.01 75.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' LYS . . . . . 0.784 ' HE3' HG12 ' B' ' 217' ' ' VAL . 42.8 mttm -54.52 -45.24 73.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' B' ' 227' ' ' LYS . 46.3 mt -53.93 -33.35 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -63.64 -46.64 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.59 -6.08 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' LYS . . . . . 0.7 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.9 mmmt -96.87 -53.73 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -101.99 -49.05 4.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.01 31.68 2.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 236' ' ' ILE . . . . . 0.64 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.68 130.65 22.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.519 0.676 . . . . 0.0 111.142 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 162.96 40.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.629 2.219 . . . . 0.0 112.38 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.4 -28.85 23.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 11.4 mp0 -112.8 -2.3 14.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' GLN . . . . . 0.498 ' HG3' HD13 ' B' ' 269' ' ' LEU . 12.4 tt0 -94.76 128.39 41.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -133.33 136.98 45.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.6 155.83 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 82' ' ' ILE . 21.8 mm -140.07 115.4 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 245' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.3 t80 -146.35 143.83 29.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.45 14.92 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.29 14.84 70.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -132.6 -175.64 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.308 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -107.51 125.96 51.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 250' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.9 mt -82.54 160.27 22.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.48 161.41 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.17 0.58 40.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.12 43.82 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -152.52 169.4 22.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.47 147.06 26.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.771 HD21 HG21 ' B' ' 226' ' ' VAL . 70.6 mt -52.65 -44.98 66.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -57.45 -28.0 62.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.2 -32.82 74.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 259' ' ' TYR . . . . . 0.543 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.8 m-85 -96.63 8.18 44.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.989 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.0 m120 63.32 36.22 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 261' ' ' ILE . . . . . 0.557 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.6 mm -68.79 95.56 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -83.05 163.84 20.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.16 145.55 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.07 26.46 15.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 135.51 54.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -89.2 83.91 6.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 267' ' ' LEU . . . . . 0.53 HD21 HD12 ' B' ' 261' ' ' ILE . 3.8 mm? -82.86 155.51 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 268' ' ' HIS . . . . . 0.565 ' NE2' HG13 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -128.93 121.91 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 269' ' ' LEU . . . . . 0.702 HD23 HG22 ' B' ' 207' ' ' THR . 2.9 tp -91.72 126.3 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 270' ' ' VAL . . . . . 0.779 HG11 HD12 ' A' ' 82' ' ' ILE . 21.9 t -123.78 148.15 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 271' ' ' LEU . . . . . 0.483 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -77.79 134.85 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 272' ' ' ARG . . . . . 0.483 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.8 mtt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.818 0.257 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD22 ' CD2' ' A' ' 75' ' ' PHE . 12.1 mt -108.17 45.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.8 m -91.68 -24.43 19.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -120.23 93.57 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.8 mt -111.37 153.27 44.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.626 0.727 . . . . 0.0 110.964 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.41 9.59 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.74 145.05 52.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.18 20.7 36.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.8 p -69.09 144.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -103.86 108.43 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -51.27 -50.16 59.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -53.07 -45.98 68.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 64.3 t -69.38 -33.21 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.618 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.5 t80 -66.77 -56.32 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -13.82 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -88.66 -27.49 21.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.98 HD13 HG21 ' A' ' 82' ' ' ILE . 22.1 mt -75.66 158.84 82.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.651 0.738 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.14 31.97 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.359 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.75 -29.79 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.98 HG21 HD13 ' A' ' 78' ' ' LEU . 39.2 mm -78.84 -29.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.448 ' O ' HD23 ' A' ' 87' ' ' LEU . 47.8 mt-30 -69.61 -26.58 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -88.68 -25.81 22.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.5 -40.14 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG21 ' HE1' ' A' ' 75' ' ' PHE . 17.1 mt -78.15 -30.86 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.7 mm? -70.69 -33.52 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.44 -21.3 66.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.78 23.98 40.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.414 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' NZ ' HD21 ' B' ' 273' ' ' LEU . 1.7 ptmt -111.86 -177.98 3.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m 53.89 70.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -132.82 97.17 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -110.93 -44.59 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.806 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -53.65 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -116.33 174.33 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -99.43 129.71 45.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.32 152.43 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -103.75 75.3 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.736 0.303 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 134.05 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.443 HD11 HG13 ' B' ' 226' ' ' VAL . 31.7 pt -117.24 149.35 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.1 m-85 -105.13 124.25 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 205' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 215' ' ' LEU . 21.3 t -106.23 108.1 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.719 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.86 110.85 23.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.672 HG22 HD23 ' B' ' 269' ' ' LEU . 5.2 p -73.6 173.36 9.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -23.86 58.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.27 12.24 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.08 31.69 72.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.533 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -97.25 108.59 21.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.719 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.34 133.36 35.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.74 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.53 115.38 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.52 125.16 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 205' ' ' VAL . 9.9 mt -127.72 134.31 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.09 102.93 15.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.757 HG11 HG22 ' B' ' 226' ' ' VAL . 18.1 m -131.19 -179.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.9 mt-10 -132.75 160.6 67.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -10.67 29.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.398 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.1 m -98.18 -24.89 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 255' ' ' THR . 19.3 m-20 -63.91 174.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.86 156.52 21.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.56 -34.73 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -55.68 -35.42 66.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -39.92 69.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.781 HG21 HD21 ' B' ' 256' ' ' LEU . 46.2 t -65.66 -42.42 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.785 ' HG3' HD11 ' B' ' 243' ' ' LEU . 3.2 mtmm -63.65 -42.4 98.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.964 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.61 73.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -56.64 -50.1 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.6 -31.17 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -63.57 -45.71 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -4.6 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.74 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.5 mmmt -99.09 -56.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -100.31 -48.43 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.14 32.26 2.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.674 HD12 HD21 ' B' ' 269' ' ' LEU . 10.7 mt -104.64 130.04 23.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.654 0.74 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 164.31 35.07 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.706 2.271 . . . . 0.0 112.385 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -8.04 22.59 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.14 -30.35 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.53 -1.38 14.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -92.45 128.78 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.571 ' HD3' HD11 ' A' ' 82' ' ' ILE . 12.3 ttm180 -133.75 140.96 47.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.785 HD11 ' HG3' ' B' ' 227' ' ' LYS . 2.7 mp -108.4 151.06 26.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.575 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.5 mm -137.9 117.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.809 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.4 t80 -148.22 143.32 26.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.79 13.82 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.28 3.88 74.94 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.493 ' CE ' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -135.86 158.5 44.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.745 0.307 . . . . 0.0 110.862 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.02 145.54 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.809 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.4 mt -96.14 163.24 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.73 157.27 28.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.94 -13.64 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.47 39.52 2.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -152.58 169.72 21.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.4 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.464 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -102.34 152.98 20.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.134 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.781 HD21 HG21 ' B' ' 226' ' ' VAL . 32.8 mt -56.5 -46.47 80.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.6 t -58.87 -25.07 62.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.02 -32.14 73.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.452 ' CG ' HD22 ' B' ' 250' ' ' LEU . 71.9 m-85 -98.64 11.88 37.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.06 31.74 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.626 HG21 HD22 ' B' ' 256' ' ' LEU . 13.4 mm -68.89 95.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -84.5 -179.09 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 150.33 48.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 54.45 27.02 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.62 134.63 54.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -87.47 86.78 7.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.62 158.33 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -130.76 117.67 19.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.674 HD21 HD12 ' B' ' 236' ' ' ILE . 8.5 tp -87.11 128.98 35.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 82' ' ' ILE . 13.9 t -126.59 148.19 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.412 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -81.08 127.36 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.412 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.4 mtt180 -85.81 167.84 14.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.451 HD21 ' NZ ' ' A' ' 90' ' ' LYS . 3.8 mm? -49.24 123.07 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.79 154.53 40.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -51.66 -56.68 14.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.398 -179.844 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.232 0.221 0 CA-C-O 120.872 0.28 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.624 ' HG ' HD21 ' A' ' 66' ' ' LEU . 3.0 mm? -79.99 178.53 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 67.1 m -75.6 -59.1 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 m -144.55 109.35 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.708 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.1 mt -111.33 152.25 43.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 174.52 9.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.624 2.216 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.0 145.28 51.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.39 20.72 38.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.708 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -70.27 144.9 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.569 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.1 t0 -102.76 106.37 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.605 ' NE2' HD23 ' A' ' 63' ' ' LEU . 15.4 tp60 -50.64 -52.65 37.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -51.55 -37.23 48.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG23 ' CG ' ' A' ' 71' ' ' ASP . 74.7 t -76.85 -33.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -56.57 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -13.79 60.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -90.17 -18.27 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.846 HD13 HG21 ' A' ' 82' ' ' ILE . 41.3 mt -87.92 157.39 51.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 52.9 Cg_endo -69.79 165.33 31.37 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.383 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.02 -27.94 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.099 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -43.42 95.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.846 HG21 HD13 ' A' ' 78' ' ' LEU . 44.7 mm -79.39 -28.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 87' ' ' LEU . 34.1 mt-30 -69.59 -23.95 63.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.2 -26.7 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.17 -37.85 63.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.05 -42.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.6 mm? -56.71 -34.46 67.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 t -65.16 -21.9 66.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.98 14.93 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.792 ' HD3' HD11 ' B' ' 273' ' ' LEU . 3.0 ptpt -98.48 -176.48 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.09 70.14 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -131.15 69.52 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.532 ' HB3' HD11 ' B' ' 271' ' ' LEU . 7.5 tm-20 -100.02 -35.72 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' CE ' HD11 ' B' ' 236' ' ' ILE . 0.0 OUTLIER -51.33 -50.28 59.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.29 174.27 10.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -117.48 157.55 26.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.27 105.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -81.11 95.46 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.878 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.749 0.309 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -95.54 134.18 38.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.446 HD11 HG13 ' B' ' 226' ' ' VAL . 25.8 pt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.438 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.7 m-85 -105.49 124.47 49.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 205' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' B' ' 269' ' ' LEU . 11.3 t -107.22 108.16 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.97 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.647 HG22 ' HB3' ' B' ' 269' ' ' LEU . 6.1 p -71.63 174.71 6.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -25.42 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 4.7 p -88.75 10.81 19.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.52 30.16 69.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -94.58 108.71 20.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.611 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.22 132.54 35.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.504 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -129.48 111.45 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.02 128.54 34.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 9.6 mt -132.36 134.19 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -90.21 103.03 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.859 HG11 HG22 ' B' ' 226' ' ' VAL . 21.7 m -130.77 -179.51 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.4 mt-10 -132.21 160.32 68.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.649 0.738 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 51.8 p -97.11 -24.79 15.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.4 ' O ' HG22 ' B' ' 255' ' ' THR . 41.0 m-20 -61.65 175.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.23 156.85 20.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.3 mm -53.56 -27.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.64 -29.85 71.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -37.56 44.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.868 HG21 HD21 ' B' ' 256' ' ' LEU . 94.9 t -67.87 -49.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -60.72 -34.61 74.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.44 98.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' B' ' 217' ' ' VAL . 9.4 mttt -57.24 -46.91 82.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' B' ' 269' ' ' LEU . 71.1 mt -53.76 -36.87 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -58.7 -44.87 90.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -4.75 44.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.504 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.0 mmmt -98.44 -56.6 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -101.4 -47.87 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.11 26.48 3.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.585 HD11 ' CE ' ' A' ' 94' ' ' LYS . 13.7 mt -98.08 128.88 32.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 164.3 35.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.575 2.184 . . . . 0.0 112.355 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.94 -29.37 25.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.55 -5.34 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.451 ' OE1' HD12 ' B' ' 230' ' ' ILE . 11.1 tt0 -88.92 130.44 35.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.447 ' HD3' HD11 ' A' ' 82' ' ' ILE . 3.3 ttm180 -133.81 141.18 47.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.612 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -109.87 149.79 29.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.612 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.8 mm -135.85 118.78 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.166 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.713 ' HB3' HD21 ' B' ' 250' ' ' LEU . 25.8 t80 -149.27 142.71 25.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.7 14.91 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.73 17.95 64.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.45 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.34 171.62 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -91.43 139.53 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -94.17 151.26 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.43 155.32 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -78.25 -4.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -106.12 39.55 2.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -152.44 169.44 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.4 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -99.72 152.08 20.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.868 HD21 HG21 ' B' ' 226' ' ' VAL . 64.9 mt -56.33 -43.8 79.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 t -57.36 -23.63 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.28 -32.97 74.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.589 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.9 m-85 -97.41 10.25 40.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 62.45 35.79 14.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 245' ' ' PHE . 14.5 mm -68.69 95.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -84.87 167.37 16.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.57 148.55 9.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 55.56 26.56 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.13 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 85.47 6.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.461 HD11 HD11 ' B' ' 250' ' ' LEU . 3.9 mm? -84.02 159.29 21.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.495 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -129.32 129.56 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.647 ' HB3' HG22 ' B' ' 207' ' ' THR . 5.7 tt -96.03 134.7 38.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.817 HG11 HG23 ' A' ' 82' ' ' ILE . 17.2 t -133.89 140.35 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -75.18 129.8 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.434 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.5 mtt180 -90.28 165.5 13.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.792 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.9 mm? -51.72 124.67 12.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -95.37 137.22 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 146.39 -17.81 1.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.793 0.247 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 75' ' ' PHE . 14.6 mt -106.15 48.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.5 m -89.76 -26.71 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -118.17 93.72 4.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.3 mt -111.2 153.58 43.92 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.681 0.753 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 173.76 10.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 0.0 112.265 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.04 145.26 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.3 20.69 37.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.552 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.04 144.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' HG23 ' A' ' 74' ' ' VAL . 62.6 t0 -103.55 108.96 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -51.25 -52.05 48.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -51.41 -45.72 62.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.464 HG23 ' OD2' ' A' ' 71' ' ' ASP . 67.0 t -69.72 -33.13 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.2 t80 -67.14 -56.02 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -13.84 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -88.83 -25.93 21.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.045 HD13 HG21 ' A' ' 82' ' ' ILE . 24.3 mt -78.43 158.67 76.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 165.13 32.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.62 -30.42 44.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -61.96 -41.38 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.045 HG21 HD13 ' A' ' 78' ' ' LEU . 39.6 mm -78.88 -27.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.577 ' OE1' HD21 ' A' ' 63' ' ' LEU . 17.7 mt-30 -69.67 -45.69 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.77 -29.44 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.81 -43.02 80.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.475 HG21 ' HE1' ' A' ' 75' ' ' PHE . 39.4 mt -77.91 -30.6 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.8 mm? -70.2 -35.72 74.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -65.45 -20.78 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.14 18.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.567 ' CE ' HD11 ' B' ' 273' ' ' LEU . 0.9 OUTLIER -114.42 179.42 3.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.882 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 p 45.72 65.64 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -140.18 82.54 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -23.77 8.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -51.54 -48.48 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -127.37 174.41 9.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.27 127.62 32.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.92 179.72 1.44 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.529 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.64 88.41 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -94.84 137.78 33.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 10.0 pt -120.59 147.19 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.3 m-85 -105.54 121.93 44.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.7 107.95 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.649 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.29 109.55 22.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 5.8 p -71.43 172.41 9.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.62 -24.0 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -89.21 10.12 23.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.3 66.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.508 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -101.89 108.88 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.649 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.02 132.71 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.1 mt -128.52 110.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 127.52 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 7.9 mt -133.08 134.1 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.36 102.4 15.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.927 HG11 HG22 ' B' ' 226' ' ' VAL . 22.9 m -128.03 -179.24 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.597 ' O ' HD12 ' B' ' 256' ' ' LEU . 9.7 mt-10 -134.75 160.38 68.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.628 0.728 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -11.23 30.4 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.26 . . . . 0.0 112.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 p -97.16 -26.42 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.76 173.14 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.02 156.96 20.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -52.14 -31.22 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.96 -32.57 70.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -38.17 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.927 HG22 HG11 ' B' ' 217' ' ' VAL . 65.1 t -67.11 -49.06 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' B' ' 230' ' ' ILE . 1.7 ptpt -59.32 -37.02 76.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.18 70.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.0 mttm -56.5 -43.06 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' B' ' 227' ' ' LYS . 80.5 mt -55.33 -34.31 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.168 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -62.11 -48.08 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.12 -8.36 52.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -95.21 -56.33 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -100.35 -49.2 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.33 33.32 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.682 HD12 HD21 ' B' ' 269' ' ' LEU . 9.5 mt -106.41 130.68 22.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.605 0.717 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 163.31 38.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.4 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -8.18 22.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -84.95 -30.44 24.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.66 -1.67 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -91.97 126.85 37.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -133.79 135.17 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 244' ' ' ILE . 0.7 OUTLIER -101.14 155.92 17.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 82' ' ' ILE . 29.0 mm -140.56 117.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.749 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.1 t80 -146.6 145.05 29.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.83 14.46 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.63 15.51 68.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -133.6 -176.07 4.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -107.58 127.87 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.6 mt -84.48 153.06 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.34 163.31 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -81.97 -0.47 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.68 39.89 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.54 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -152.52 164.98 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.32 150.49 20.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.797 HD21 HG21 ' B' ' 226' ' ' VAL . 52.2 mt -54.73 -48.78 72.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -54.72 -26.18 32.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.4 -28.2 68.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.639 ' CG ' HD22 ' B' ' 250' ' ' LEU . 86.7 m-85 -98.86 11.88 37.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 63.96 31.25 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.485 HD12 HD11 ' B' ' 267' ' ' LEU . 16.0 mm -68.73 106.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.9 168.43 9.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.18 142.0 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.05 28.86 18.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 131.57 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.55 87.8 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.485 HD11 HD12 ' B' ' 261' ' ' ILE . 2.9 mp -89.3 159.25 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.413 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -128.66 122.98 32.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.682 HD21 HD12 ' B' ' 236' ' ' ILE . 8.7 tp -90.07 122.4 33.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 82' ' ' ILE . 13.8 t -120.59 147.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.476 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.76 132.09 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.476 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.9 mtt180 -91.09 163.17 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.567 HD11 ' CE ' ' A' ' 90' ' ' LYS . 4.4 mm? -50.43 128.92 21.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 43.7 tpt85 -100.36 129.17 46.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -89.56 48.7 3.35 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.455 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.428 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.843 0.268 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.645 HD22 ' CD2' ' A' ' 75' ' ' PHE . 10.4 mt -110.67 47.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.03 -22.73 17.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.58 93.77 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.709 ' HB3' HG11 ' A' ' 70' ' ' VAL . 7.4 mt -111.28 153.02 44.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 175.16 8.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.288 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.18 145.09 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.96 20.63 34.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.531 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.5 p -68.65 144.6 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -104.28 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -51.33 -51.29 55.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -51.44 -39.81 58.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.8 t -76.36 -33.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.078 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.6 t80 -67.11 -56.14 11.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -14.8 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -89.17 -25.57 21.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 82' ' ' ILE . 21.4 mt -77.58 157.82 79.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.6 Cg_endo -69.76 165.27 31.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.702 2.268 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.77 -26.89 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -64.73 -42.56 95.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 78' ' ' LEU . 41.2 mm -78.41 -29.58 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.73 -25.89 64.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.97 -24.69 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -72.29 -39.74 68.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.1 mt -78.26 -34.86 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.15 -32.43 73.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -67.83 -18.4 64.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.59 37.38 17.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CE ' HD11 ' B' ' 273' ' ' LEU . 1.5 ptmt -119.36 -175.91 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 p 46.8 66.02 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.818 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.0 81.8 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HG2' HD11 ' B' ' 271' ' ' LEU . 0.5 OUTLIER -107.87 -19.92 13.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.93 -57.13 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -120.45 173.97 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -80.4 111.23 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.99 168.41 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.65 ' C ' HD12 ' A' ' 99' ' ' LEU . 6.2 mmtp -103.4 133.36 48.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 98' ' ' LYS . 10.3 mp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.06 134.1 42.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -117.38 149.9 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.0 m-85 -106.58 128.56 54.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.29 107.75 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.92 111.04 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -72.76 174.26 7.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -25.53 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.4 p -88.04 8.14 28.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.7 31.98 59.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -97.52 108.88 21.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.634 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.26 133.81 35.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.56 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.7 mt -129.95 111.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 128.14 32.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.492 HD21 HG22 ' B' ' 213' ' ' ILE . 9.9 mt -130.71 134.25 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.1 104.02 16.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 226' ' ' VAL . 25.1 m -131.61 -179.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.564 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.5 mt-10 -131.35 160.87 65.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -11.73 31.44 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -28.98 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.4 175.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.503 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.8 OUTLIER -114.6 157.97 22.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.13 -25.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.69 -35.47 80.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 217' ' ' VAL . 91.0 t -69.17 -39.16 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.39 -39.83 92.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.78 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.529 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.5 mttt -56.56 -50.15 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 69.9 mt -53.31 -33.41 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -60.41 -48.58 81.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -72.6 -7.34 49.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.56 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.6 mmmt -95.37 -54.59 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.34 -48.91 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.38 29.97 2.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.492 HD12 HD21 ' B' ' 269' ' ' LEU . 9.2 mt -102.52 130.54 23.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.515 0.674 . . . . 0.0 111.105 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 163.78 36.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.703 2.268 . . . . 0.0 112.428 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -7.88 22.17 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.802 2.335 . . . . 0.0 112.335 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -85.91 -30.54 22.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.29 -0.46 15.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.43 131.91 43.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.47 ' HD3' HD11 ' A' ' 82' ' ' ILE . 17.5 ttm180 -133.73 147.12 51.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.611 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.7 mp -115.06 150.43 35.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 243' ' ' LEU . 22.7 mm -136.8 115.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.791 ' HB3' HD21 ' B' ' 250' ' ' LEU . 40.4 t80 -145.74 144.25 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.19 13.29 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.5 5.09 72.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.482 ' HE2' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -137.05 163.47 30.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.928 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.78 145.9 30.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -98.32 154.43 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -111.67 155.61 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.44 -5.39 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.39 2.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.503 ' O ' HG22 ' B' ' 222' ' ' THR . 5.3 ttt180 -152.53 169.42 22.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 149.61 23.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.73 HD21 HG21 ' B' ' 226' ' ' VAL . 44.7 mt -55.2 -47.59 75.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -57.39 -25.68 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.08 -30.87 71.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -98.81 11.04 39.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.9 m120 63.98 32.49 13.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.535 HG21 HD22 ' B' ' 256' ' ' LEU . 14.3 mm -68.77 95.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -86.98 170.64 11.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 152.17 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 53.64 27.45 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.78 133.48 54.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -90.14 85.77 6.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.58 159.63 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.401 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.9 OUTLIER -128.11 122.77 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.633 HD23 HG22 ' B' ' 207' ' ' THR . 5.8 tp -89.74 122.27 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.781 HG11 HD12 ' A' ' 82' ' ' ILE . 10.8 t -119.91 147.93 23.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.71 135.65 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.4 mtt180 -97.03 166.45 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.478 HD11 ' CE ' ' A' ' 90' ' ' LYS . 4.2 mm? -51.95 130.33 29.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -95.07 98.55 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -160.75 24.4 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.838 0.266 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD22 ' CD2' ' A' ' 75' ' ' PHE . 11.9 mt -108.46 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.0 m -93.47 -22.87 18.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -121.57 93.49 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.734 ' HB3' HG11 ' A' ' 70' ' ' VAL . 4.9 mt -111.42 153.05 44.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.554 0.692 . . . . 0.0 110.996 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 174.11 10.03 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.719 2.279 . . . . 0.0 112.339 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.42 146.32 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.51 21.03 33.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.2 p -71.6 145.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.41 108.85 20.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -51.39 -52.09 48.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -51.4 -40.05 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG22 ' HE2' ' B' ' 206' ' ' LYS . 80.2 t -76.04 -33.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.097 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.644 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.6 t80 -67.23 -56.35 10.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -15.26 60.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -88.81 -27.49 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.995 HD13 HG21 ' A' ' 82' ' ' ILE . 28.3 mt -75.88 158.29 82.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.637 0.732 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' HG21 ' B' ' 244' ' ' ILE . 54.0 Cg_endo -69.73 165.16 31.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.35 -29.19 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.19 -39.69 95.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.995 HG21 HD13 ' A' ' 78' ' ' LEU . 36.8 mm -78.9 -29.65 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.142 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 63.4 mt-30 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.56 -32.48 74.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.84 -42.93 76.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.5 mt -77.91 -29.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -61.77 -38.9 89.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -65.58 -25.08 67.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.42 55.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.674 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.6 OUTLIER -69.88 -176.52 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.911 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m 54.25 70.21 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.9 ptt85 -139.09 69.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' HB3' HD11 ' B' ' 271' ' ' LEU . 4.4 tm-20 -97.35 -33.39 11.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -50.37 -53.62 27.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -130.09 174.06 10.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -102.51 135.78 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.978 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.48 106.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 76.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.3 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.63 133.79 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.479 HD11 HG13 ' B' ' 226' ' ' VAL . 17.0 pt -116.67 148.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -104.85 126.87 52.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' VAL . . . . . 0.468 HG21 HD11 ' B' ' 215' ' ' LEU . 21.2 t -110.02 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.448 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.94 111.17 23.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.824 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.754 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -73.14 175.0 7.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -23.9 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.2 p -90.07 7.66 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.41 65.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -91.76 109.47 20.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.424 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.71 132.37 35.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.194 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.46 111.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.06 127.61 32.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.468 HD11 HG21 ' B' ' 205' ' ' VAL . 9.4 mt -129.9 134.3 47.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.47 102.46 15.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.911 HG11 HG22 ' B' ' 226' ' ' VAL . 21.6 m -131.44 -179.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.557 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -131.94 160.34 68.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.628 0.728 . . . . 0.0 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -10.16 27.86 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -99.54 -24.6 14.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.38 175.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.15 155.07 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' B' ' 256' ' ' LEU . 50.5 mm -52.11 -29.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.27 -34.2 74.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -72.7 -37.91 67.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 217' ' ' VAL . 62.2 t -69.66 -42.7 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -64.37 -38.93 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.7 87.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.0 mttt -57.35 -49.86 74.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.411 HG21 HD22 ' B' ' 269' ' ' LEU . 65.7 mt -53.33 -32.72 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.53 -47.53 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.69 -4.74 42.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.1 mmmt -96.68 -50.34 4.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -106.94 -47.31 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.79 29.59 2.82 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.17 132.24 21.33 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.515 0.674 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 164.83 33.03 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.633 2.222 . . . . 0.0 112.375 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -6.45 18.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.695 2.263 . . . . 0.0 112.336 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -90.17 -23.74 21.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -113.02 -7.73 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.546 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -89.12 130.11 35.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -133.69 132.38 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.9 mp -101.73 149.1 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 26.1 mm -136.38 119.72 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.726 ' HB3' HD21 ' B' ' 250' ' ' LEU . 30.2 t80 -148.23 142.09 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.84 14.99 9.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.082 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.02 12.4 68.28 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.79 21.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.87 143.72 26.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' B' ' 245' ' ' PHE . 2.4 mt -99.88 148.34 24.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -108.2 157.41 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.15 -16.11 61.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.68 38.14 3.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -152.59 168.54 25.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.36 154.39 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.817 HD21 HG21 ' B' ' 226' ' ' VAL . 49.6 mt -57.8 -48.67 79.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.0 t -54.41 -27.28 35.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.32 -34.51 72.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.0 m-85 -98.15 9.85 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.76 40.36 7.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CD2' ' B' ' 245' ' ' PHE . 16.0 mm -72.28 95.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.25 167.34 16.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 146.68 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 58.83 26.43 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.97 133.87 55.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.95 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.488 HD11 HD11 ' B' ' 250' ' ' LEU . 3.7 mm? -84.09 159.3 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.412 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.3 OUTLIER -129.42 118.8 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.754 HD23 HG22 ' B' ' 207' ' ' THR . 2.8 tp -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.825 HG11 HD12 ' A' ' 82' ' ' ILE . 26.8 t -112.73 148.14 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -80.14 130.97 35.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.453 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.9 mtt180 -92.25 163.76 13.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.674 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.3 mm? -50.2 121.66 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -100.34 116.96 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -111.61 -26.67 4.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.454 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 CA-C-O 120.83 0.263 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' A' ' 75' ' ' PHE . 4.4 mt -92.67 47.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 67.3 m -88.17 -25.33 22.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 m -118.93 94.18 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.768 ' CB ' HG11 ' A' ' 70' ' ' VAL . 9.2 mt -111.01 152.56 43.74 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.587 0.708 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.16 8.46 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.08 147.01 52.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' B' ' 209' ' ' THR . . . 55.84 21.11 28.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.506 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.7 p -72.52 145.34 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 111.112 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.1 t0 -103.81 106.14 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -50.06 -52.97 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.5 -38.99 47.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.497 HG23 ' OD2' ' A' ' 71' ' ' ASP . 98.9 t -76.72 -33.24 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.614 ' CD1' HD22 ' A' ' 63' ' ' LEU . 1.5 t80 -65.57 -56.56 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -13.95 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -88.93 -25.88 21.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 82' ' ' ILE . 25.8 mt -78.13 158.41 77.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.661 0.744 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.17 31.91 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.56 -31.45 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.78 -42.48 93.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.922 HG21 HD13 ' A' ' 78' ' ' LEU . 37.0 mm -78.94 -29.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.603 ' O ' HD23 ' A' ' 87' ' ' LEU . 65.6 mt-30 -69.76 -27.69 65.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.1 -26.76 23.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.88 -40.2 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.41 HG21 ' HE2' ' A' ' 75' ' ' PHE . 65.5 mt -78.13 -31.55 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -62.7 -38.34 90.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -65.43 -23.6 66.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.08 -1.95 65.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.51 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.806 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.2 ptpt -78.2 -176.71 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 m 53.31 70.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 78.43 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.622 ' HB3' HD11 ' B' ' 271' ' ' LEU . 3.9 tm-20 -117.71 -32.45 4.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' HB2' HD23 ' B' ' 271' ' ' LEU . 0.2 OUTLIER -51.11 -43.08 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -136.96 174.27 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -113.06 160.1 18.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.13 113.62 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -55.21 135.37 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.714 0.293 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.35 136.19 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.8 pt -118.27 148.67 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.178 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' B' ' 212' ' ' THR . 12.9 m-85 -105.15 121.5 43.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.09 108.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.13 111.96 23.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.909 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.816 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -74.42 172.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.401 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -58.87 -24.52 62.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.9 p -89.61 12.22 17.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.02 89.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -108.23 110.96 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.772 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -82.31 134.43 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.704 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.0 mt -129.85 112.11 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.69 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.456 HD21 HG22 ' B' ' 213' ' ' ILE . 9.8 mt -131.42 134.84 46.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -89.83 104.4 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.945 HG11 HG22 ' B' ' 226' ' ' VAL . 21.2 m -134.45 174.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.535 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.8 mt-10 -125.71 160.95 53.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -8.58 23.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.55 -24.01 14.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.436 ' O ' HG22 ' B' ' 255' ' ' THR . 20.9 m-20 -62.3 175.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.13 154.97 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -51.29 -35.05 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.87 -34.42 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -38.96 67.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.945 HG22 HG11 ' B' ' 217' ' ' VAL . 62.9 t -67.92 -43.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.172 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.532 ' HD2' HD11 ' B' ' 243' ' ' LEU . 7.8 mtpm? -62.47 -41.65 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.29 -42.17 73.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.41 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.7 mttt -58.55 -48.17 81.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.58 -31.3 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -48.54 79.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.04 -5.04 41.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.704 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.72 -51.29 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -105.75 -47.42 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.08 27.64 3.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.541 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.445 HD12 HD21 ' B' ' 269' ' ' LEU . 11.9 mt -101.61 132.38 21.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.23 31.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -6.93 19.78 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.737 2.291 . . . . 0.0 112.29 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.35 -21.39 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -112.95 -8.69 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -87.31 130.82 34.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.554 ' HD3' HD11 ' A' ' 82' ' ' ILE . 4.0 ttm180 -134.01 128.4 34.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.2 mp -98.61 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.1 mm -136.92 114.92 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.699 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.5 t80 -143.16 143.05 31.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.46 15.14 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.86 75.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.14 168.86 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.728 0.299 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -89.39 142.77 27.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.3 mt -97.37 151.32 20.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 161.01 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.58 -9.88 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.65 2.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.53 169.66 22.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.381 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.436 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -101.4 151.54 21.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 57.3 mt -56.19 -45.22 79.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.2 t -56.08 -24.1 37.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.789 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.16 -30.58 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' B' ' 250' ' ' LEU . 49.7 m-85 -98.41 9.88 42.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.4 34.09 13.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.524 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.4 mm -68.92 100.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -95.11 170.67 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.37 144.22 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 58.11 28.24 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.438 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.69 125.4 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -80.84 85.7 6.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.59 HD11 HD11 ' B' ' 250' ' ' LEU . 3.0 mm? -85.39 158.52 20.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.435 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -129.69 119.86 24.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.816 HD23 HG22 ' B' ' 207' ' ' THR . 7.5 tp -89.99 128.05 36.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 82' ' ' ILE . 21.2 t -125.81 144.62 35.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -76.3 134.12 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.498 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 -96.69 162.87 13.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.806 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.2 mm? -49.85 127.06 15.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -101.18 137.72 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -79.15 57.63 4.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.496 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.848 0.27 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 75' ' ' PHE . 5.5 mp -71.72 81.48 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.17 -22.45 9.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -132.47 100.87 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.826 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.719 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.2 mt -110.65 153.16 43.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 174.97 8.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.712 2.275 . . . . 0.0 112.316 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.08 144.33 52.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 19.99 30.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -65.98 144.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -104.3 108.59 20.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.94 -52.92 37.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -51.29 -38.61 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.466 HG23 ' CG ' ' A' ' 71' ' ' ASP . 96.9 t -76.12 -33.1 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.5 t80 -68.0 -55.98 10.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -14.27 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -88.64 -23.5 23.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.973 HD13 HG21 ' A' ' 82' ' ' ILE . 22.7 mt -81.23 158.46 69.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 165.15 31.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.41 -31.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.15 -41.23 92.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.973 HG21 HD13 ' A' ' 78' ' ' LEU . 35.9 mm -78.99 -28.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.57 -47.73 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.28 -32.19 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.41 -41.69 84.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 75' ' ' PHE . 56.5 mt -77.8 -33.99 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.38 -35.69 81.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 -23.22 66.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.64 -2.28 69.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.64 ' HD3' HD11 ' B' ' 273' ' ' LEU . 2.3 ptpt -75.7 -176.33 3.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.0 p 46.99 70.75 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.99 70.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.813 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -92.44 -45.55 8.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -53.09 -66.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -106.45 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.92 126.11 35.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.34 172.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.632 ' C ' HD12 ' A' ' 99' ' ' LEU . 13.6 pttp -155.38 95.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 98' ' ' LYS . 10.2 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.794 0.33 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.55 134.09 42.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.621 HD12 HD13 ' B' ' 267' ' ' LEU . 24.3 pt -118.74 148.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.538 ' HB3' HG22 ' B' ' 212' ' ' THR . 6.8 m-85 -105.77 127.63 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.76 108.65 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.3 108.84 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.568 HG22 ' HB3' ' B' ' 269' ' ' LEU . 8.7 p -67.49 173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -27.97 66.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.8 p -83.53 -1.41 53.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.36 31.74 24.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -98.77 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.364 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.678 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -81.67 134.3 35.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.099 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.57 114.43 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 125.16 29.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.505 HD11 HG12 ' B' ' 230' ' ' ILE . 8.6 mt -129.09 134.11 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.06 102.66 15.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 226' ' ' VAL . 22.6 m -127.77 178.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.604 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.8 mt-10 -132.88 160.33 69.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.73 24.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.1 p -110.27 17.33 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.68 ' O ' HG22 ' B' ' 255' ' ' THR . 24.0 m-20 -100.2 173.28 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.26 149.57 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.867 HD12 HD23 ' B' ' 250' ' ' LEU . 46.2 mm -51.64 -35.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -61.25 -34.35 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 217' ' ' VAL . 88.5 t -66.72 -45.76 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.2 OUTLIER -59.94 -38.41 82.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -49.99 70.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.728 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -57.43 -39.73 76.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 227' ' ' LYS . 86.0 mt -58.84 -28.1 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.66 -47.98 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.66 -7.74 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -96.11 -56.01 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -99.18 -48.87 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 33.15 1.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 5.7 mt -112.45 131.21 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.728 . . . . 0.0 111.096 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' B' ' 240' ' ' GLN . 54.0 Cg_endo -69.86 163.52 38.05 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.374 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' PRO . . . . . 0.429 ' HA ' ' HG2' ' B' ' 241' ' ' GLN . 54.1 Cg_endo -69.73 -1.65 8.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.64 2.227 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -99.4 -26.15 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' B' ' 237' ' ' PRO . 1.2 mp0 -113.01 -5.71 13.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.429 ' HG2' ' HA ' ' B' ' 238' ' ' PRO . 2.8 pt20 -111.96 136.01 51.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.29 147.87 49.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.516 HD23 ' H ' ' B' ' 243' ' ' LEU . 2.1 pt? -113.8 135.6 53.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 82' ' ' ILE . 20.7 mm -119.59 131.66 71.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.507 ' CD2' HD13 ' B' ' 261' ' ' ILE . 56.9 t80 -148.52 144.03 27.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.37 15.15 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 17.97 70.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 166.4 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.667 0.27 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -94.39 110.12 21.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.93 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.867 HD23 HD12 ' B' ' 223' ' ' ILE . 9.4 mp -67.34 163.62 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.48 153.13 48.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.88 -9.91 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.74 35.72 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -152.69 168.51 25.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.68 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -103.01 158.44 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.134 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.745 HD21 HG21 ' B' ' 226' ' ' VAL . 25.9 mt -58.28 -41.12 83.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -63.26 -22.16 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.26 -35.91 82.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -98.94 17.03 20.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.36 35.53 26.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.589 HG21 HD22 ' B' ' 256' ' ' LEU . 9.0 mm -68.6 95.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.96 -174.21 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.17 152.93 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 54.15 26.78 6.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.75 132.36 51.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -91.23 89.59 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.621 HD13 HD12 ' B' ' 203' ' ' ILE . 4.0 mp -91.93 165.27 13.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -129.6 145.35 51.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.568 ' HB3' HG22 ' B' ' 207' ' ' THR . 3.4 tt -105.38 133.05 50.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.81 HG11 HG23 ' A' ' 82' ' ' ILE . 5.2 t -133.44 143.9 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.16 135.37 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.0 mtt180 -90.25 167.18 12.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.64 HD11 ' HD3' ' A' ' 90' ' ' LYS . 2.3 mm? -52.5 131.63 34.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -132.01 111.33 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -113.94 45.66 1.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.467 -179.895 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' O ' HD12 ' A' ' 63' ' ' LEU . 54.7 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.803 0.251 . . . . 0.0 112.423 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 75' ' ' PHE . 6.5 mp -130.92 78.4 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.48 -19.82 9.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 m -131.9 99.72 4.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.687 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.9 mt -110.96 152.88 43.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.607 0.718 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.8 Cg_endo -69.81 173.64 10.72 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 144.88 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.99 20.66 34.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.5 p -69.23 146.24 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 0.0 111.1 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.9 t0 -104.31 106.62 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.38 -52.46 28.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -51.64 -38.08 53.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' OD2' ' A' ' 71' ' ' ASP . 96.3 t -76.03 -33.28 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.2 t80 -64.92 -56.58 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -13.2 61.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -88.44 -23.88 23.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 82' ' ' ILE . 21.1 mt -80.99 159.16 69.07 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.3 31.53 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.291 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.93 -33.68 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.72 -43.58 85.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.815 HD12 HG11 ' B' ' 270' ' ' VAL . 30.9 mm -77.69 -28.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 87' ' ' LEU . 31.8 mt-30 -70.4 -37.26 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.22 -30.2 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.44 -51.75 18.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 75' ' ' PHE . 58.6 mt -62.5 -28.85 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.2 mm? -75.41 -23.35 57.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.6 m -76.79 -19.34 57.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 14.44 59.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.492 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' HE3' HD21 ' B' ' 273' ' ' LEU . 0.0 OUTLIER -97.59 -176.13 3.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.317 . . . . 0.0 110.983 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.64 70.76 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -134.15 87.66 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HB3' HD11 ' B' ' 271' ' ' LEU . 5.1 tm-20 -120.36 -32.15 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.41 -60.27 3.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -107.6 174.6 5.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -86.62 145.13 26.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.14 170.28 0.29 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -84.61 134.59 34.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.74 0.305 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -95.02 134.99 37.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.426 HD11 HG13 ' B' ' 226' ' ' VAL . 25.3 pt -117.9 148.77 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.452 ' HB3' HG22 ' B' ' 212' ' ' THR . 18.7 m-85 -104.9 122.31 45.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.57 108.36 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.2 OUTLIER -97.47 112.65 24.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.772 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -73.3 171.69 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.235 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -59.25 -27.4 65.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.4 p -84.64 0.7 49.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.93 39.34 13.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.372 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.487 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.3 131.77 35.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.672 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.3 mt -129.37 110.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.452 ' O ' HD23 ' B' ' 215' ' ' LEU . 0.2 OUTLIER -78.46 131.6 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.512 HD21 HG22 ' B' ' 213' ' ' ILE . 8.1 mt -135.87 133.95 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.81 105.81 18.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.795 HG11 HG22 ' B' ' 226' ' ' VAL . 20.4 m -134.0 171.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.575 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.8 mt-10 -118.47 160.33 40.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.92 33.88 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.611 2.207 . . . . 0.0 112.372 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 -25.33 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.1 175.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.2 p -111.98 156.83 21.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.142 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.422 HG21 HD13 ' B' ' 243' ' ' LEU . 48.4 mm -51.59 -33.63 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.65 -35.08 67.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.949 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -39.28 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.839 HG21 HD21 ' B' ' 256' ' ' LEU . 56.0 t -67.1 -44.1 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' B' ' 230' ' ' ILE . 28.2 ttmt -62.84 -41.73 99.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.22 -42.19 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.518 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.6 mttt -57.8 -48.62 79.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' B' ' 227' ' ' LYS . 14.5 mt -54.66 -31.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -61.48 -49.02 78.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.3 -5.28 41.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.672 ' HE3' HG23 ' B' ' 213' ' ' ILE . 17.1 mmmt -95.74 -53.56 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -104.7 -46.2 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.15 24.2 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.0 mt -98.32 132.27 24.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.61 0.719 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 167.8 23.25 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.74 2.293 . . . . 0.0 112.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.67 19.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.03 -23.47 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 1.6 mp0 -113.14 0.58 14.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.624 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -100.8 128.17 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -133.89 133.45 41.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' B' ' 227' ' ' LYS . 1.1 mp -101.01 141.09 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.73 116.34 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.744 ' HB3' HD21 ' B' ' 250' ' ' LEU . 24.1 t80 -141.59 144.2 34.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.29 15.17 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.55 8.61 73.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.445 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 172.82 12.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.74 142.8 26.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.9 mt -96.2 161.22 14.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -118.05 157.42 26.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.02 -8.36 58.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.4 39.62 2.71 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -152.53 169.87 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.2 151.09 22.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.839 HD21 HG21 ' B' ' 226' ' ' VAL . 71.5 mt -56.24 -45.42 80.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -55.63 -26.51 44.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.55 -26.8 65.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 89.5 m-85 -98.8 7.72 45.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.9 m120 64.66 33.7 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.534 HD13 ' CD2' ' B' ' 245' ' ' PHE . 18.4 mm -69.53 109.17 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.11 168.44 9.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 145.31 9.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 58.53 28.31 16.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.412 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.6 OUTLIER -56.77 130.01 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -86.66 81.94 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.507 HD11 HD11 ' B' ' 250' ' ' LEU . 2.7 mm? -83.36 159.82 21.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.42 115.91 18.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.772 HD23 HG22 ' B' ' 207' ' ' THR . 2.0 tp -83.85 116.56 22.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 82' ' ' ILE . 15.0 t -112.9 148.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -80.84 126.82 31.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' B' ' 240' ' ' GLN . 2.8 mtt-85 -84.12 167.46 16.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.519 HD21 ' HE3' ' A' ' 90' ' ' LYS . 3.0 mm? -55.16 121.73 9.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.3 112.55 23.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -105.27 23.79 29.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.865 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.808 0.253 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.447 HD21 ' HD1' ' A' ' 75' ' ' PHE . 7.1 mp -128.06 73.48 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.2 m -117.04 -16.38 10.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -135.48 100.55 4.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.735 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.8 mt -110.95 152.65 43.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.677 0.751 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 174.69 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.708 2.272 . . . . 0.0 112.324 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.12 145.99 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.05 21.03 29.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.735 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -70.37 143.73 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 111.153 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.27 110.59 22.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.77 -52.89 45.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.91 -43.24 59.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.31 -32.83 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.447 ' HD1' HD21 ' A' ' 63' ' ' LEU . 3.0 t80 -65.13 -56.99 9.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -15.29 62.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -88.14 -15.97 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -85.05 155.24 60.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.3 Cg_endo -69.83 165.15 32.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.642 2.228 . . . . 0.0 112.345 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 -33.67 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.97 -38.86 76.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 78' ' ' LEU . 8.5 mm -78.83 -44.04 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.582 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.2 mt-30 -51.46 -46.21 63.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -28.32 62.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -71.5 -41.14 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.18 -32.32 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.3 mm? -63.47 -39.03 93.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.9 m -65.2 -22.91 66.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.15 37.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.796 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.5 ptpt -102.41 -177.2 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.558 ' OG ' HD22 ' B' ' 273' ' ' LEU . 2.3 m 51.74 57.66 6.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.7 81.89 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.32 -29.95 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -65.68 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -103.8 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -119.97 158.22 27.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.01 105.86 0.28 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' C ' HD12 ' A' ' 99' ' ' LEU . 23.9 mttm -74.67 90.16 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 98' ' ' LYS . 9.5 mp . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.812 0.339 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.39 134.07 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.4 HD12 HD13 ' B' ' 267' ' ' LEU . 25.0 pt -117.76 150.1 19.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.2 m-85 -106.16 126.49 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.23 107.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.688 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.08 110.97 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.692 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -73.17 174.21 8.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.408 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -60.71 -22.95 64.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -90.99 17.4 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.16 49.93 72.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -118.44 107.84 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.688 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -81.09 133.03 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.656 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.27 107.19 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.54 132.29 43.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -137.28 134.09 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -88.02 102.19 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.805 HG11 HG22 ' B' ' 226' ' ' VAL . 26.2 m -127.81 178.99 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.616 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -135.15 160.18 69.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -11.09 30.18 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.403 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -26.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.65 169.44 4.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.47 157.56 17.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.1 mm -53.71 -31.96 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -60.15 -31.33 70.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -36.36 57.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.838 HG21 HD21 ' B' ' 256' ' ' LEU . 63.4 t -68.57 -48.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' B' ' 230' ' ' ILE . 7.4 ptpp? -62.1 -30.46 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.29 -50.52 73.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -56.18 -42.08 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' B' ' 227' ' ' LYS . 57.6 mt -55.55 -34.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -61.89 -47.74 83.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -71.45 -8.18 52.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.656 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -95.48 -56.37 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -99.8 -49.24 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.89 2.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.653 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.27 130.96 22.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.64 0.733 . . . . 0.0 111.087 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 163.69 37.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 0.0 112.332 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -7.64 21.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.5 -31.11 22.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -112.51 0.63 15.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.72 127.05 40.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -133.88 136.13 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.403 ' H ' HD12 ' B' ' 243' ' ' LEU . 1.1 mp -105.09 136.27 44.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.4 mm -117.91 114.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.3 t80 -144.65 143.87 30.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.68 15.08 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.83 22.26 55.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.534 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 177.99 9.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -97.9 140.93 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -97.63 147.68 24.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -105.9 166.2 10.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -82.07 -18.6 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -91.51 40.49 2.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -152.97 167.88 27.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.93 152.43 21.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 65.2 mt -55.09 -47.42 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 t -55.75 -25.4 40.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.6 -30.42 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.6 m-85 -98.65 12.49 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.61 33.79 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.539 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.2 mm -68.69 95.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.42 166.07 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.35 149.79 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 54.99 27.51 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.61 134.47 54.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.4 m -91.95 86.0 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.415 HD11 HD12 ' B' ' 261' ' ' ILE . 3.0 mp -87.03 157.19 19.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.42 117.24 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.692 HD23 HG22 ' B' ' 207' ' ' THR . 8.5 tp -83.67 133.26 34.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.813 HG11 HD12 ' A' ' 82' ' ' ILE . 4.9 t -134.22 142.63 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.524 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.99 134.2 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.524 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.8 mtt180 -92.74 159.0 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.796 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.2 mm? -51.5 123.16 9.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.73 113.09 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -158.99 22.2 0.3 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' HG2' HD22 ' A' ' 63' ' ' LEU . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.85 0.271 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.782 ' HG ' HD21 ' A' ' 66' ' ' LEU . 1.2 mm? -101.64 136.27 41.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.32 -19.13 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.413 ' O ' HD13 ' A' ' 87' ' ' LEU . 71.8 m -139.22 95.53 2.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.781 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.782 HD21 ' HG ' ' A' ' 63' ' ' LEU . 5.0 mt -111.04 153.44 43.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.595 0.712 . . . . 0.0 110.946 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.01 11.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.6 146.16 50.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.4 20.73 38.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -70.6 143.81 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.542 ' OD2' HG23 ' A' ' 74' ' ' VAL . 66.0 t0 -104.57 109.39 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.437 ' OE1' HD23 ' A' ' 63' ' ' LEU . 1.7 tp-100 -51.32 -53.53 35.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -50.45 -39.78 48.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.542 HG23 ' OD2' ' A' ' 71' ' ' ASP . 91.0 t -74.87 -33.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -66.72 -56.08 12.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -14.03 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -87.99 -28.41 21.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 82' ' ' ILE . 27.7 mt -77.92 158.31 77.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.705 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.28 31.49 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.34 -31.91 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.23 -42.28 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 78' ' ' LEU . 37.9 mm -77.93 -27.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.55 -50.71 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.46 -32.71 74.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.57 -47.09 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.835 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG21 ' HE2' ' A' ' 75' ' ' PHE . 52.0 mt -70.35 -43.17 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD21 HD12 ' A' ' 63' ' ' LEU . 1.2 mm? -58.86 -33.79 70.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.27 -23.52 67.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.44 25.39 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.3 OUTLIER -109.44 -176.68 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p 47.09 70.47 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 71.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HB3' HD11 ' B' ' 271' ' ' LEU . 14.2 tp10 -112.19 -21.5 11.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' HB2' HD23 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -52.36 -53.67 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.03 174.07 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -109.16 147.73 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.72 105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -72.54 81.42 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.59 134.81 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -117.7 148.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.446 ' HB3' HG22 ' B' ' 212' ' ' THR . 14.4 m-85 -105.3 121.42 43.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.4 t -105.09 113.05 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -101.09 114.0 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 269' ' ' LEU . 3.6 p -77.77 170.71 16.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -22.43 54.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 69' ' ' GLY . 3.0 p -94.22 23.54 5.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 55.15 55.35 28.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -121.58 108.97 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.446 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.3 OUTLIER -81.7 132.3 35.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.684 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.29 109.6 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.3 m -77.4 127.14 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.203 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.476 HD21 HG22 ' B' ' 213' ' ' ILE . 10.7 mt -129.63 134.36 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.37 102.23 14.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 23.0 m -131.54 -179.49 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.609 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.3 mt-10 -131.24 160.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.751 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -13.74 35.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -95.93 -24.88 16.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.452 ' O ' HG22 ' B' ' 255' ' ' THR . 27.5 m-20 -61.67 173.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.01 154.56 23.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.06 -31.14 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.72 -35.17 72.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -42.13 64.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.84 HG22 HG11 ' B' ' 217' ' ' VAL . 57.3 t -62.89 -42.17 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.581 ' CD ' HD11 ' B' ' 243' ' ' LEU . 32.1 mtpt -63.97 -41.65 97.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.27 72.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.3 mttt -57.79 -49.89 75.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 62.3 mt -54.05 -32.11 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -61.68 -47.18 86.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.52 -4.68 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.684 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.1 mmmt -97.4 -56.48 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -101.51 -48.4 4.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.55 35.03 1.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.609 HD12 HD21 ' B' ' 269' ' ' LEU . 12.7 mt -107.52 130.61 22.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.669 0.747 . . . . 0.0 111.132 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 163.41 38.37 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.603 2.202 . . . . 0.0 112.415 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 -7.42 21.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.36 -29.72 24.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.36 -3.43 14.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -88.79 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -133.85 147.98 51.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.598 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.2 mp -117.35 148.87 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 243' ' ' LEU . 25.1 mm -136.89 120.31 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.079 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.731 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.7 t80 -146.03 140.77 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.95 14.31 9.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.58 15.61 63.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 171.63 14.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.71 134.1 37.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -93.78 143.58 26.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -102.2 167.69 9.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -82.26 -20.27 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.16 45.04 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.399 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -153.02 169.67 22.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.452 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.2 OUTLIER -105.42 152.08 23.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 68.2 mt -56.75 -45.14 82.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -58.17 -22.93 53.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.62 -29.85 67.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.601 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.9 m-85 -98.43 10.06 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.73 33.31 13.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.554 HD12 HD21 ' B' ' 267' ' ' LEU . 14.3 mm -68.75 97.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -88.91 167.34 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 143.5 12.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 58.69 29.61 18.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.87 130.6 47.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -83.11 84.45 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.554 HD21 HD12 ' B' ' 261' ' ' ILE . 3.6 mm? -84.33 159.62 20.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.403 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -129.08 127.55 41.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.704 HD23 HG22 ' B' ' 207' ' ' THR . 9.0 tp -96.65 119.52 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.768 HG11 HD12 ' A' ' 82' ' ' ILE . 12.7 t -117.82 147.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.517 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.08 137.24 37.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.517 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.2 mtt180 -96.53 162.25 13.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.513 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.3 mm? -50.92 124.33 11.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -100.41 96.4 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 94.47 -28.03 12.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.437 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.512 -179.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.187 0 CA-C-O 120.76 0.233 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.633 HD22 ' CE2' ' A' ' 75' ' ' PHE . 6.3 mt -85.81 52.61 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.3 m -87.86 -28.01 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.7 m -115.82 93.67 4.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.9 mt -111.17 153.24 44.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 174.99 8.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -69.55 144.98 52.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.27 20.36 35.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.445 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.5 p -68.51 142.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG23 ' A' ' 74' ' ' VAL . 10.3 t0 -102.33 110.62 22.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -51.64 -52.62 46.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -51.33 -47.77 62.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.407 HG23 ' CG ' ' A' ' 71' ' ' ASP . 57.7 t -67.51 -33.2 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.18 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.633 ' CE2' HD22 ' A' ' 63' ' ' LEU . 1.6 t80 -68.05 -56.16 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -13.67 60.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -88.1 -20.21 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.051 HD13 HG21 ' A' ' 82' ' ' ILE . 36.1 mt -84.8 157.6 60.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 162.53 41.67 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.14 -33.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -58.99 -41.23 87.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.051 HG21 HD13 ' A' ' 78' ' ' LEU . 35.0 mm -78.21 -27.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.541 ' OE1' HD21 ' A' ' 63' ' ' LEU . 27.7 mt-30 -69.64 -50.55 43.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.74 -32.91 74.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.69 -50.37 67.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 75' ' ' PHE . 27.7 mt -71.4 -30.73 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.0 mm? -68.28 -35.14 77.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.78 -23.75 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.87 29.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HD3' HD11 ' B' ' 273' ' ' LEU . 9.5 ptpt -108.09 -176.36 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 p 46.83 70.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 104.6 8.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' HD11 ' B' ' 271' ' ' LEU . 1.0 OUTLIER -133.89 -178.68 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.968 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.25 -66.51 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -95.36 173.7 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -89.72 145.75 24.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.85 174.45 1.62 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 75.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.6 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.87 133.79 38.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.459 HD11 HG13 ' B' ' 226' ' ' VAL . 17.9 pt -116.37 150.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -106.35 123.18 47.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 t -107.62 108.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 111.61 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -75.38 171.02 14.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.78 -23.2 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.1 p -93.91 25.17 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.0 51.76 44.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -116.55 108.99 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 131.34 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.194 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.583 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.95 106.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.84 126.52 31.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.409 HD21 HG22 ' B' ' 213' ' ' ILE . 9.1 mt -129.91 134.11 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.58 101.04 13.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 21.9 m -128.04 -179.48 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.173 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.57 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.4 mt-10 -134.08 160.78 67.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.715 0.769 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.35 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -21.63 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.415 ' O ' HG22 ' B' ' 255' ' ' THR . 29.3 m-20 -64.13 175.17 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.32 157.36 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.442 HG23 HD22 ' B' ' 243' ' ' LEU . 45.6 mm -54.24 -26.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -65.29 -29.38 70.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.33 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.86 HG21 HD21 ' B' ' 256' ' ' LEU . 87.0 t -69.13 -47.42 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.71 ' HA ' HD12 ' B' ' 230' ' ' ILE . 19.6 ptmt -63.46 -36.95 85.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.62 -50.27 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.706 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.6 mttm -56.46 -42.11 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' B' ' 227' ' ' LYS . 59.9 mt -56.91 -29.33 30.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -66.6 -46.51 75.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.33 -5.08 42.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.583 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.82 -52.94 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -102.94 -47.1 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.78 3.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.53 HD12 HD21 ' B' ' 269' ' ' LEU . 10.2 mt -104.58 132.23 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.695 0.76 . . . . 0.0 111.14 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 167.39 24.66 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -7.34 20.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.72 -21.66 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.0 -11.32 13.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.554 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -83.26 126.57 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.625 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.8 ttm180 -133.61 121.02 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.517 ' CB ' HD12 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -92.84 134.56 34.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.439 HD11 HD11 ' A' ' 82' ' ' ILE . 29.8 mm -121.1 119.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.746 ' HB3' HD21 ' B' ' 250' ' ' LEU . 16.7 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.54 14.91 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.18 21.85 53.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.63 169.12 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -89.15 139.19 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.0 mt -94.02 152.73 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.972 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -106.27 159.33 16.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.55 -0.21 41.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.01 3.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -146.37 169.87 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.415 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -103.28 151.5 22.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.86 HD21 HG21 ' B' ' 226' ' ' VAL . 72.9 mt -57.35 -35.43 69.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -67.11 -21.38 65.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.02 -32.24 68.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.477 ' CG ' HD22 ' B' ' 250' ' ' LEU . 78.8 m-85 -96.39 8.35 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 63.07 35.82 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.51 HD13 ' CD2' ' B' ' 245' ' ' PHE . 15.0 mm -68.55 95.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -83.21 162.62 21.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 146.71 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.29 24.7 13.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.5 136.44 56.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -90.2 84.3 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.462 HD11 HD11 ' B' ' 250' ' ' LEU . 4.1 mm? -82.22 160.88 22.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' B' ' 244' ' ' ILE . 0.5 OUTLIER -130.66 119.59 22.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 3.5 tp -90.17 115.48 27.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 82' ' ' ILE . 22.0 t -111.54 148.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -79.9 124.46 28.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.407 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.9 mtt180 -86.66 164.51 16.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.494 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.3 mm? -48.97 119.99 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -101.58 108.04 19.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.812 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -141.57 28.54 2.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 -179.904 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.793 0.247 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 66' ' ' LEU . 4.0 mm? -98.74 179.08 4.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.76 -59.37 2.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 t -144.37 110.45 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 2.8 mt -110.98 152.32 43.56 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 0.0 111.0 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.7 Cg_endo -69.74 174.66 9.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.48 146.41 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.98 21.25 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.66 144.76 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.422 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.1 t0 -103.74 115.59 30.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -54.76 -55.06 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.79 -45.72 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 71' ' ' ASP . 50.1 t -70.87 -32.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CZ ' HD23 ' A' ' 66' ' ' LEU . 2.7 t80 -68.35 -57.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.61 59.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -88.17 -18.89 27.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.787 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -80.69 153.6 73.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.8 Cg_endo -69.75 165.32 31.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.367 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.03 -34.07 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.07 -38.78 77.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.787 HG21 HD23 ' A' ' 78' ' ' LEU . 9.6 mm -78.89 -45.77 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -51.38 -50.77 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -32.39 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -69.54 -40.75 76.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 82' ' ' ILE . 63.3 mt -78.22 -30.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.17 -37.26 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -25.01 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.63 24.41 25.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.463 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.549 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.5 OUTLIER -103.07 -179.01 3.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.662 ' OG ' HD22 ' B' ' 273' ' ' LEU . 11.3 m 51.28 59.62 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.48 77.23 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.44 -23.21 8.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -51.62 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -105.25 174.18 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -96.76 128.12 43.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.24 132.21 33.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 94.14 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.958 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -98.39 138.98 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.86 147.97 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.56 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.8 m-85 -104.21 123.7 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -105.07 108.12 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.697 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.51 109.24 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.85 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -69.19 174.33 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.166 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -26.01 65.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.6 p -86.24 3.05 44.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.139 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.12 49.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -94.9 108.42 20.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.335 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.697 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.03 131.11 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.701 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.38 116.23 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.573 ' C ' HD12 ' B' ' 215' ' ' LEU . 7.5 m -78.48 128.11 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' B' ' 230' ' ' ILE . 10.2 mp -125.61 133.44 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.2 99.07 11.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.808 HG11 HG22 ' B' ' 226' ' ' VAL . 14.7 m -131.2 -179.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.554 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.7 mt-10 -127.99 160.56 60.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -8.84 24.62 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.685 2.256 . . . . 0.0 112.296 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.3 m -102.15 -24.8 13.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -60.46 175.03 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.68 156.67 19.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.5 mm -53.34 -30.73 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.06 -40.25 84.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -41.87 90.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.861 HG21 HD21 ' B' ' 256' ' ' LEU . 25.6 t -64.01 -46.12 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.655 ' HE3' HD11 ' B' ' 243' ' ' LEU . 22.4 ttmt -60.48 -41.91 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.91 70.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -63.07 -42.37 99.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.605 ' CG1' HD21 ' B' ' 215' ' ' LEU . 52.7 mt -57.74 -28.75 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.78 -44.73 73.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.54 -5.77 44.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.701 ' HE3' HG23 ' B' ' 213' ' ' ILE . 23.4 mmmt -99.55 -54.57 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.11 -48.0 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.37 19.81 6.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.559 HD12 HD21 ' B' ' 269' ' ' LEU . 8.1 mt -94.1 132.56 29.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.181 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.17 25.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.13 20.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.623 2.216 . . . . 0.0 112.366 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -90.07 -20.68 22.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -113.21 -14.88 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.91 126.8 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.509 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 3.2 ttm180 -134.0 118.29 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.655 HD11 ' HE3' ' B' ' 227' ' ' LYS . 0.8 OUTLIER -88.26 147.68 24.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 243' ' ' LEU . 21.8 mm -135.96 115.65 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.9 t80 -141.12 141.93 34.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.81 14.29 9.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.21 15.14 65.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -134.31 170.3 15.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -94.85 128.69 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.5 mt -86.21 155.62 20.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.85 157.16 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.93 -6.51 52.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -103.45 41.22 2.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -152.65 168.52 25.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 148.33 25.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.861 HD21 HG21 ' B' ' 226' ' ' VAL . 69.6 mt -53.53 -44.39 69.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.2 t -57.68 -26.59 61.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.86 -33.2 75.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.549 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.4 6.72 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 4.2 m120 63.6 36.77 10.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.556 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.5 mm -68.73 96.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -82.99 166.58 18.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.33 149.4 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 54.22 26.27 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 143.28 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.06 86.92 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -82.36 158.88 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.01 115.07 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.85 HD23 HG22 ' B' ' 207' ' ' THR . 10.2 tp -85.59 134.67 34.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 82' ' ' ILE . 39.8 t -132.81 146.85 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.449 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.2 127.15 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.509 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.1 mtt180 -88.96 163.91 15.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.662 HD22 ' OG ' ' A' ' 91' ' ' SER . 2.0 mm? -50.75 136.05 22.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -99.41 141.97 31.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 154.66 -19.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.914 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HB2' HD22 ' A' ' 63' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.815 0.256 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.916 HD12 HD21 ' A' ' 87' ' ' LEU . 2.4 mm? -117.18 136.6 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -119.4 -21.73 7.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.84 93.62 3.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.0 mt -112.49 152.47 44.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.557 0.694 . . . . 0.0 110.949 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 86' ' ' ILE . 53.8 Cg_endo -69.77 175.01 8.68 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.754 2.303 . . . . 0.0 112.347 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.68 144.45 51.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.41 20.68 30.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -66.4 145.42 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.169 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' CG ' HG23 ' A' ' 74' ' ' VAL . 12.5 t0 -104.47 108.39 19.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -51.64 -53.28 40.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -50.11 -43.21 51.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.448 HG13 ' CD2' ' B' ' 268' ' ' HIS . 99.7 t -70.85 -32.69 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -66.72 -56.88 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -14.27 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -89.97 -23.25 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 82' ' ' ILE . 20.8 mt -80.85 158.96 69.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.644 0.735 . . . . 0.0 110.846 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.1 Cg_endo -69.83 165.27 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.288 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.86 -32.78 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.92 -43.52 94.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 78' ' ' LEU . 34.3 mm -78.89 -29.1 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 87' ' ' LEU . 32.9 mt-30 -69.74 -25.96 64.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -89.71 -25.97 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.83 -38.85 64.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.457 HG21 ' HE2' ' A' ' 75' ' ' PHE . 50.1 mt -78.07 -40.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.916 HD21 HD12 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -53.87 -37.59 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.06 -25.75 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.63 61.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.608 ' CD ' HD11 ' B' ' 273' ' ' LEU . 2.1 pttt -70.99 -175.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.733 0.302 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m 57.96 69.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -139.6 90.68 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' CG ' HD21 ' B' ' 271' ' ' LEU . 1.3 pp20? -112.0 -30.86 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -60.52 -63.93 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -109.28 166.22 11.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -86.95 124.0 32.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.56 169.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' C ' HD23 ' A' ' 99' ' ' LEU . 14.2 mttt -129.15 91.83 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.76 0.314 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.37 134.09 41.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.589 HD11 HG13 ' B' ' 226' ' ' VAL . 31.6 pt -117.03 150.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.0 m-85 -106.75 130.55 54.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -113.06 107.89 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.66 110.48 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -71.51 174.28 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.69 -25.73 63.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.55 5.8 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.206 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.35 29.34 58.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -94.73 108.83 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.586 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.06 133.5 35.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.52 111.68 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.49 128.2 33.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.441 HD21 HG22 ' B' ' 213' ' ' ILE . 8.6 mt -131.4 134.19 46.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -90.22 103.9 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.914 HG11 HG22 ' B' ' 226' ' ' VAL . 24.3 m -130.06 -179.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.9 mt-10 -132.2 160.73 66.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -12.11 32.11 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.72 2.28 . . . . 0.0 112.312 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.1 p -97.96 -25.31 15.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.42 175.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -112.8 157.64 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.464 ' CG2' HD13 ' B' ' 243' ' ' LEU . 48.5 mm -52.86 -29.24 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.49 -30.28 70.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -38.07 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.914 HG22 HG11 ' B' ' 217' ' ' VAL . 96.0 t -67.21 -51.73 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' B' ' 230' ' ' ILE . 15.4 ptmt -59.26 -35.04 72.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.25 92.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.06 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.64 -46.78 83.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 227' ' ' LYS . 44.6 mt -54.41 -32.8 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -61.79 -47.28 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.14 -5.4 44.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -97.18 -54.52 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.38 -48.72 3.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.7 34.88 1.64 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.531 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.628 HD12 HD21 ' B' ' 269' ' ' LEU . 7.7 mt -108.45 131.32 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 164.58 33.98 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.632 2.221 . . . . 0.0 112.345 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -6.98 19.9 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.76 -30.84 19.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.522 ' O ' HD22 ' B' ' 271' ' ' LEU . 2.3 mp0 -113.73 6.36 16.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.562 ' HG3' HD13 ' B' ' 269' ' ' LEU . 8.4 tt0 -116.63 125.75 52.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -134.7 148.0 50.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.828 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.543 ' HB2' HD12 ' B' ' 250' ' ' LEU . 0.4 OUTLIER -105.36 133.9 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.4 mm -111.78 123.65 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.786 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.8 t80 -151.64 144.75 24.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.936 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' ALA . . . . . 0.575 ' HB3' ' HZ3' ' B' ' 248' ' ' LYS . . . 64.14 15.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.49 8.17 74.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.441 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' LYS . . . . . 0.575 ' HZ3' ' HB3' ' B' ' 246' ' ' ALA . 0.0 OUTLIER -141.15 157.99 44.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -77.31 146.77 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -94.7 163.31 13.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -118.28 154.01 32.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -76.25 -5.54 47.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.805 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.81 39.28 2.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.506 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -152.69 169.89 21.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 152.71 21.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.192 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.853 HD21 HG21 ' B' ' 226' ' ' VAL . 52.8 mt -56.92 -43.82 81.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.0 t -60.69 -26.37 67.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -63.83 -31.65 72.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.79 9.73 42.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 63.72 34.89 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.519 HD13 ' CE2' ' B' ' 245' ' ' PHE . 15.9 mm -68.58 96.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -82.95 165.68 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 150.77 7.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 55.82 26.03 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.45 133.72 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.99 88.33 7.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.18 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.527 HD13 HD12 ' B' ' 203' ' ' ILE . 3.7 mp -89.32 158.82 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.448 ' CD2' HG13 ' A' ' 74' ' ' VAL . 0.7 OUTLIER -127.99 125.63 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 4.6 tp -92.58 125.61 37.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 82' ' ' ILE . 11.1 t -121.78 149.26 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.44 144.03 25.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.55 ' N ' HD13 ' B' ' 271' ' ' LEU . 38.0 mtt180 -105.12 169.27 8.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.608 HD11 ' CD ' ' A' ' 90' ' ' LYS . 3.0 mm? -48.96 127.31 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 39.6 tpt85 -116.85 99.82 7.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -141.22 15.28 2.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.814 0.256 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.545 HD21 ' CD1' ' A' ' 75' ' ' PHE . 5.6 mp -86.78 77.25 9.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.53 -18.78 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -131.31 97.79 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.9 mt -110.98 153.05 43.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.68 0.752 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.56 10.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.01 146.15 51.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.15 20.7 36.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -70.43 143.57 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 111.098 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.6 t0 -102.84 108.63 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.418 HE22 HD23 ' A' ' 63' ' ' LEU . 4.2 tp-100 -51.68 -52.65 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.36 -38.69 54.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG23 ' CG ' ' A' ' 71' ' ' ASP . 97.2 t -76.15 -33.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.5 t80 -66.36 -56.3 11.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -14.85 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -87.37 -25.91 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 82' ' ' ILE . 28.7 mt -78.4 158.06 76.95 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.628 0.728 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 164.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.367 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.13 -28.36 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.3 -42.56 99.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 78' ' ' LEU . 41.8 mm -78.85 -27.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.73 -42.88 77.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -27.03 60.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.47 -41.19 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.08 -34.12 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.47 -35.82 82.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.96 20.82 41.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.687 ' HD3' HD11 ' B' ' 273' ' ' LEU . 2.6 ptpt -99.76 -176.64 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.4 p 46.48 67.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.796 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.4 ptt85 -139.3 91.51 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -109.58 -33.13 6.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -59.18 -57.85 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -116.17 174.62 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -108.45 150.76 26.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.47 172.88 0.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.528 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -123.98 87.33 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.77 0.319 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -98.2 134.4 41.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.692 HD12 HD13 ' B' ' 267' ' ' LEU . 23.3 pt -118.39 151.75 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.522 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.0 m-85 -106.45 123.35 47.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.7 113.0 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.3 OUTLIER -100.85 112.14 24.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.657 HG22 HD23 ' B' ' 269' ' ' LEU . 3.2 p -75.9 171.18 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.56 -22.01 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.3 23.56 5.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 53.76 38.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -120.04 108.31 14.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.522 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -81.91 130.91 35.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.171 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.641 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.7 mt -129.66 112.41 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.42 130.45 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.8 mt -132.53 134.55 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.24 104.66 17.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.828 HG11 HG22 ' B' ' 226' ' ' VAL . 28.5 m -133.91 178.48 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.602 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.1 mt-10 -128.69 160.75 61.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -13.94 35.31 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 5.7 m -96.23 -24.45 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.39 175.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.07 156.49 21.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.466 HG22 ' HE2' ' B' ' 227' ' ' LYS . 49.1 mm -53.2 -28.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -62.98 -31.19 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -38.05 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.865 HG21 HD21 ' B' ' 256' ' ' LEU . 88.2 t -67.41 -48.17 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.466 ' HE2' HG22 ' B' ' 223' ' ' ILE . 1.1 ptpt -60.59 -38.94 86.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.55 76.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.497 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.4 mttt -58.91 -48.07 82.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.1 mt -55.23 -31.02 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.062 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -62.7 -47.55 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.81 -5.08 44.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.641 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.9 mmmt -97.27 -56.5 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.81 -48.63 4.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.56 35.34 1.59 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.673 HD12 HD21 ' B' ' 269' ' ' LEU . 11.3 mt -108.17 130.54 22.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.734 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 163.44 38.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.241 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -7.95 22.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.53 -30.15 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.6 -3.22 14.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -89.31 131.35 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -133.75 147.52 51.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.536 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -116.36 146.53 42.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.536 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.9 mm -133.69 120.67 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 39.2 t80 -148.4 141.3 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.33 14.02 9.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.051 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.63 64.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.495 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -134.78 176.07 8.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.709 0.29 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.5 131.7 47.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.2 mt -86.66 158.73 19.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.45 162.13 18.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.48 0.73 41.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.48 42.86 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -152.75 167.96 27.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.0 110.835 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.57 147.25 26.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 80.2 mt -52.46 -44.37 65.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -56.61 -26.07 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -67.72 -31.41 71.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.53 6.5 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 6.0 m120 63.83 35.66 10.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.2 mm -68.54 96.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -83.22 163.9 20.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.48 148.44 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 58.98 22.84 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.544 ' OG ' HD12 ' B' ' 267' ' ' LEU . 0.1 OUTLIER -56.46 144.68 30.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -103.43 92.24 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.692 HD13 HD12 ' B' ' 203' ' ' ILE . 1.4 mp -87.31 162.75 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.468 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.2 OUTLIER -130.14 116.04 17.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.673 HD21 HD12 ' B' ' 236' ' ' ILE . 10.5 tp -83.9 125.45 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.786 HG11 HD12 ' A' ' 82' ' ' ILE . 15.5 t -124.85 146.88 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.441 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.14 135.4 37.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.441 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.2 mtt180 -95.59 167.25 11.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.687 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.2 mm? -51.35 126.46 17.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -103.63 120.13 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.01 37.18 2.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.499 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.427 -179.884 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.791 0.246 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.731 HD13 ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -104.48 47.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 m -70.77 -21.4 62.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -108.37 94.0 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.686 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.0 mt -107.95 152.48 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 173.84 10.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.681 2.254 . . . . 0.0 112.393 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.72 146.8 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.2 20.91 30.44 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -71.12 143.92 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 111.069 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -103.4 107.85 18.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -51.44 -51.8 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -51.2 -40.41 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.795 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 HG13 ' NE2' ' B' ' 268' ' ' HIS . 63.6 t -76.42 -33.04 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.731 ' CD1' HD13 ' A' ' 63' ' ' LEU . 4.2 t80 -66.99 -56.08 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -14.4 60.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -89.4 -23.4 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.892 HD13 HG21 ' A' ' 82' ' ' ILE . 21.9 mt -80.4 158.23 71.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.24 31.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.342 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.55 -32.31 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -58.85 -41.42 86.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.892 HG21 HD13 ' A' ' 78' ' ' LEU . 34.8 mm -79.08 -29.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.68 -30.8 68.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.23 -29.07 31.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -73.2 -38.93 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 -26.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -39.88 80.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.58 -22.15 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.09 28.84 24.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.56 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.5 OUTLIER -103.72 -176.23 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p 46.2 70.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -133.46 69.88 1.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.568 ' HG3' HD21 ' B' ' 271' ' ' LEU . 0.5 OUTLIER -100.34 -29.53 12.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -50.39 -46.93 56.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.69 174.29 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -96.21 116.2 28.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.15 122.27 13.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.52 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.04 87.65 3.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.99 134.21 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.9 pt -115.35 148.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.187 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -105.22 121.97 44.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.18 108.0 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.88 110.53 23.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.679 HG22 HD23 ' B' ' 269' ' ' LEU . 6.3 p -72.07 174.77 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -24.54 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -89.97 8.25 33.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.09 63.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -93.18 110.54 22.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.442 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.28 132.71 35.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.22 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.403 HG23 ' HE3' ' B' ' 233' ' ' LYS . 5.6 mt -129.8 106.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.74 133.12 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -137.21 134.13 35.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -89.19 100.94 13.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.946 HG11 HG22 ' B' ' 226' ' ' VAL . 22.8 m -128.49 175.73 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.598 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.2 mt-10 -128.55 160.29 63.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.628 0.727 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -11.45 30.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.736 2.291 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -27.14 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 255' ' ' THR . 14.7 m-20 -61.98 175.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -113.44 158.45 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.4 mm -52.07 -33.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.34 -31.72 66.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -36.28 46.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.946 HG22 HG11 ' B' ' 217' ' ' VAL . 99.0 t -70.43 -51.23 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.5 OUTLIER -58.97 -33.91 71.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.49 73.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.711 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.4 mttm -55.66 -43.22 76.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' B' ' 227' ' ' LYS . 63.0 mt -55.17 -32.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -63.46 -45.59 90.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -74.72 -5.83 45.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.403 ' HE3' HG23 ' B' ' 213' ' ' ILE . 0.5 OUTLIER -97.93 -48.19 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -108.37 -48.65 3.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.57 1.71 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.477 HD12 HD21 ' B' ' 269' ' ' LEU . 11.6 mt -108.36 132.13 21.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.621 0.724 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 163.4 38.44 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.362 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.378 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.19 -22.87 18.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -113.18 -5.56 13.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -91.68 131.3 37.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.506 ' HD3' HD11 ' A' ' 82' ' ' ILE . 9.0 ttm180 -133.89 124.49 26.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.537 ' H ' HD12 ' B' ' 243' ' ' LEU . 0.6 OUTLIER -97.42 134.18 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.13 115.19 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.66 ' HB3' HD21 ' B' ' 250' ' ' LEU . 33.9 t80 -143.04 145.19 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.53 15.45 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.26 20.63 58.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 173.88 12.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 140.82 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -96.24 153.28 17.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.41 161.79 14.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 0.37 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.75 41.44 2.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -152.5 168.57 25.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.964 0.412 . . . . 0.0 110.84 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.485 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -98.98 151.36 21.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.869 HD21 HG21 ' B' ' 226' ' ' VAL . 55.5 mt -56.42 -47.33 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.8 t -55.43 -25.15 34.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.79 -28.8 67.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.63 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.1 m-85 -98.67 11.21 39.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 63.82 33.47 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 267' ' ' LEU . 13.8 mm -71.81 97.82 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -93.52 170.21 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.72 143.89 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 58.21 29.02 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.479 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.58 126.57 27.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -84.6 83.92 7.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.533 HD11 HD12 ' B' ' 261' ' ' ILE . 2.5 mp -85.75 160.76 19.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.424 ' NE2' HG13 ' A' ' 74' ' ' VAL . 0.6 OUTLIER -129.0 119.9 25.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.679 HD23 HG22 ' B' ' 207' ' ' THR . 6.1 tp -89.21 120.97 31.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 82' ' ' ILE . 18.8 t -118.83 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -76.19 135.2 39.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.49 ' N ' HD13 ' B' ' 271' ' ' LEU . 6.4 mtt180 -97.63 165.78 11.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.56 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.9 mm? -51.03 124.23 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -109.15 102.54 11.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 88.34 -47.62 3.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.47 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' O ' HD11 ' A' ' 87' ' ' LEU . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.876 0.282 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.634 HD22 ' CD2' ' A' ' 75' ' ' PHE . 5.7 mt -89.81 48.33 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.64 -25.55 19.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.8 m -120.6 93.9 4.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.914 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.688 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.4 mt -110.94 153.12 43.93 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.591 0.71 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 174.61 9.14 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 0.0 112.394 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.02 144.66 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.84 18.71 40.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 66' ' ' LEU . 8.0 p -67.62 142.88 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -103.36 109.71 21.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.41 -53.01 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -51.27 -37.84 49.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' CG ' ' A' ' 71' ' ' ASP . 93.8 t -76.62 -33.29 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.3 t80 -67.74 -56.23 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -14.78 59.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -87.55 -23.93 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.05 HD13 HG21 ' A' ' 82' ' ' ILE . 34.6 mt -81.34 157.74 70.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.709 . . . . 0.0 110.934 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.12 31.99 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.399 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.17 -34.4 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -58.15 -39.94 80.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.05 HG21 HD13 ' A' ' 78' ' ' LEU . 31.7 mm -78.56 -32.64 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.203 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -64.8 -49.9 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -65.25 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.31 -43.1 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.451 HG21 ' HE1' ' A' ' 75' ' ' PHE . 55.9 mt -78.24 -31.37 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 62' ' ' PRO . 1.9 mm? -68.92 -35.23 76.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -65.25 -24.39 67.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.1 18.57 49.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.811 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.3 ptpt -99.08 179.99 4.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 80.6 p 46.13 66.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -140.15 80.92 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.9 -5.2 9.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -50.93 20.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -117.64 174.12 6.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -69.37 109.59 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.94 115.77 6.38 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -62.83 94.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.801 0.334 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.18 133.77 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.603 HD12 HD13 ' B' ' 267' ' ' LEU . 27.9 pt -116.25 147.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -104.99 125.05 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.04 109.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.408 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -96.65 111.15 23.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.732 HG22 HD23 ' B' ' 269' ' ' LEU . 5.4 p -71.78 174.24 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -23.4 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.3 p -89.48 7.56 35.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.59 35.2 52.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -102.81 112.35 25.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.24 134.66 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.754 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.75 110.86 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.472 ' O ' HD23 ' B' ' 215' ' ' LEU . 1.0 OUTLIER -79.81 132.3 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.213 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 HG22 ' B' ' 213' ' ' ILE . 5.9 mt -136.45 134.03 37.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.28 102.17 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 1.052 HG11 HG22 ' B' ' 226' ' ' VAL . 27.7 m -127.37 179.96 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -137.18 161.34 61.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -14.74 36.81 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.727 2.285 . . . . 0.0 112.379 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -26.8 16.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.686 ' O ' HG22 ' B' ' 255' ' ' THR . 18.4 m-20 -61.98 174.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 255' ' ' THR . 0.2 OUTLIER -108.09 152.23 24.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -50.2 -30.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 -37.98 86.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.18 96.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 1.052 HG22 HG11 ' B' ' 217' ' ' VAL . 96.9 t -66.06 -50.98 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.61 ' HD3' HD22 ' B' ' 243' ' ' LEU . 12.6 mmmm -57.24 -38.68 74.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.07 -50.23 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.134 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.624 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.2 mttm -56.42 -43.17 79.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 227' ' ' LYS . 75.8 mt -56.29 -28.79 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.129 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.2 -45.96 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -74.66 -5.34 42.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.754 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.5 mmmt -97.01 -49.56 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.66 -48.27 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.75 34.9 1.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.6 mt -110.14 132.66 21.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.149 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.91 164.5 34.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.632 2.222 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -5.0 15.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.62 2.213 . . . . 0.0 112.344 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.78 -24.91 17.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -113.47 -2.15 13.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.99 129.81 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.462 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 8.1 ttm180 -133.9 122.43 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' B' ' 250' ' ' LEU . 2.3 pt? -103.5 133.81 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 82' ' ' ILE . 15.8 mm -114.68 141.52 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.738 ' HB3' HD21 ' B' ' 250' ' ' LEU . 41.7 t80 -156.64 137.4 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 14.63 9.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.82 16.16 60.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -136.75 168.6 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.01 122.09 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' B' ' 243' ' ' LEU . 2.3 mt -83.25 152.48 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 161.13 16.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.94 -12.38 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.4 3.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -152.9 170.75 19.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.356 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.686 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -102.94 158.08 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.884 HD11 HG21 ' B' ' 226' ' ' VAL . 4.1 mm? -55.29 -50.61 69.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 44.4 t -57.47 -30.45 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.83 -37.5 63.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.7 ' CD1' HD22 ' B' ' 250' ' ' LEU . 97.1 m-85 -98.85 16.48 22.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.17 32.42 19.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.701 HG21 HD12 ' B' ' 256' ' ' LEU . 8.6 mm -68.15 95.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 147.43 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 59.72 25.62 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.514 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.63 135.67 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -92.39 84.24 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.205 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.603 HD13 HD12 ' B' ' 203' ' ' ILE . 4.7 mp -86.33 162.99 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.462 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -129.81 129.08 43.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.732 HD23 HG22 ' B' ' 207' ' ' THR . 12.2 tp -96.06 131.21 42.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.596 HG11 HG23 ' A' ' 82' ' ' ILE . 19.6 t -133.81 148.19 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.424 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.37 128.06 33.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.462 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.8 mtt180 -88.45 165.21 15.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.811 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.3 mm? -51.07 127.12 18.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -91.71 99.1 12.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -113.88 37.31 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.886 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.219 0 CA-C-O 120.861 0.275 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.616 HD22 ' CD2' ' A' ' 75' ' ' PHE . 6.1 mt -89.09 49.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.9 m -92.57 -16.9 25.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.95 96.25 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.756 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt -110.68 152.32 43.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.593 0.711 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 175.06 8.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.54 147.27 51.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.33 21.01 31.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -73.82 145.28 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' CG ' HG23 ' A' ' 74' ' ' VAL . 14.2 t0 -104.31 107.34 18.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -50.89 -53.88 28.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.44 -40.76 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.444 HG22 ' HE2' ' B' ' 206' ' ' LYS . 65.2 t -75.75 -32.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.4 t80 -65.7 -56.81 10.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -14.74 61.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -87.66 -23.75 24.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.066 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.83 157.55 69.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.611 0.72 . . . . 0.0 110.957 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.8 Cg_endo -69.79 165.21 31.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 0.0 112.362 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.6 -29.95 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -61.73 -40.59 95.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.066 HG21 HD13 ' A' ' 78' ' ' LEU . 40.0 mm -79.19 -27.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.7 -47.88 61.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.89 -33.05 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.92 -42.56 85.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.477 HG21 ' HE1' ' A' ' 75' ' ' PHE . 57.5 mt -77.47 -37.14 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.49 -32.83 63.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -71.48 -24.56 62.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.16 -15.61 58.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.594 ' HE3' HD11 ' B' ' 273' ' ' LEU . 0.0 OUTLIER -70.16 -176.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 m 55.71 64.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -140.06 70.33 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.734 ' HG3' HD21 ' B' ' 271' ' ' LEU . 0.4 OUTLIER -96.4 -29.13 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -50.71 -47.93 58.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -135.25 174.56 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -117.29 152.46 34.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.08 105.71 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.55 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' C ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.5 96.04 9.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.861 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 98' ' ' LYS . 9.8 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.14 135.65 42.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 265' ' ' SER . 21.5 pt -117.09 148.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.85 126.29 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.837 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -108.78 108.19 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.444 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.64 110.34 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.583 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -71.95 174.06 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -25.12 63.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -87.43 3.19 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.81 24.77 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -89.89 109.91 20.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.427 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -83.72 130.93 34.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.15 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.699 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.9 mt -128.32 113.68 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.586 ' C ' HD12 ' B' ' 215' ' ' LEU . 10.2 m -78.61 127.69 32.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.659 HD21 HG13 ' B' ' 230' ' ' ILE . 10.8 mp -126.36 133.4 51.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.62 98.58 10.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.848 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -129.77 -179.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.475 ' O ' HD12 ' B' ' 256' ' ' LEU . 2.9 mt-10 -126.22 160.77 55.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -8.65 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.65 2.233 . . . . 0.0 112.384 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.77 -25.5 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.77 174.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' THR . . . . . 0.441 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -111.76 163.38 14.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.766 HD12 HD23 ' B' ' 250' ' ' LEU . 47.8 mm -59.3 -40.79 82.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -52.37 -29.76 25.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.72 44.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.848 HG22 HG11 ' B' ' 217' ' ' VAL . 48.7 t -66.07 -47.42 85.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.9 ttmt -58.01 -39.17 77.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.81 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.816 ' HE3' HG12 ' B' ' 217' ' ' VAL . 41.0 mttm -57.2 -42.06 80.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.659 HG13 HD21 ' B' ' 215' ' ' LEU . 67.8 mt -56.37 -30.61 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -66.74 -43.92 82.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.699 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.3 mmmt -97.93 -47.96 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -109.51 -48.52 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.96 32.91 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.35 132.86 20.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.701 0.763 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 162.62 41.34 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.248 . . . . 0.0 112.363 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -4.6 14.32 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.687 2.258 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.56 -27.0 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -113.43 -2.34 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 127.43 40.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.9 ttm180 -134.31 145.51 49.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.649 HD13 ' CB ' ' B' ' 250' ' ' LEU . 0.0 OUTLIER -116.3 155.96 27.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 82' ' ' ILE . 24.5 mm -137.67 114.05 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.473 ' CD1' HD13 ' B' ' 261' ' ' ILE . 31.5 t80 -144.43 145.77 32.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.08 14.41 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.07 39.4 16.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.64 20.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.282 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.49 126.67 35.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.766 HD23 HD12 ' B' ' 223' ' ' ILE . 7.0 mp -74.47 163.69 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -131.1 157.64 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -82.2 1.06 38.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.75 37.69 3.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' ARG . . . . . 0.441 ' O ' HG22 ' B' ' 222' ' ' THR . 6.9 ttt180 -153.1 169.88 21.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 157.15 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 39.1 mt -60.01 -43.43 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t -59.14 -20.58 54.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.92 -32.13 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.551 ' CE1' HD11 ' B' ' 223' ' ' ILE . 15.8 m-85 -98.44 10.57 40.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 63.57 33.94 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.676 HD12 HD11 ' B' ' 267' ' ' LEU . 10.8 mm -68.69 100.71 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.5 175.98 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -54.95 145.06 21.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 57.95 28.5 16.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' SER . . . . . 0.445 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -58.05 128.69 38.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -87.81 84.3 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.676 HD11 HD12 ' B' ' 261' ' ' ILE . 2.6 mp -88.57 161.12 17.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.447 ' HB3' HD21 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -127.73 121.78 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.583 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -90.17 108.03 19.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.769 HG11 HD12 ' A' ' 82' ' ' ILE . 21.8 t -104.94 148.77 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.734 HD21 ' HG3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -81.26 135.03 35.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.505 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.1 mtt180 -94.89 163.84 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.594 HD11 ' HE3' ' A' ' 90' ' ' LYS . 3.2 mm? -50.45 122.29 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -103.78 123.18 46.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -112.37 56.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.449 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.472 ' O ' HD11 ' A' ' 87' ' ' LEU . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.855 0.273 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.65 HD22 ' CD1' ' A' ' 75' ' ' PHE . 4.1 mt -84.44 54.06 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.28 -19.34 13.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 93.8 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.752 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.5 mt -110.21 152.71 43.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 175.14 8.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.686 2.258 . . . . 0.0 112.335 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.22 146.09 52.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.53 20.67 31.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.752 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.9 p -70.74 144.48 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.28 108.92 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.71 -50.69 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -39.12 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.426 HG22 ' HE2' ' B' ' 206' ' ' LYS . 88.4 t -76.63 -33.51 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CD1' HD22 ' A' ' 63' ' ' LEU . 2.7 t80 -66.86 -56.17 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -15.07 61.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -87.0 -26.8 23.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.948 HD13 HG21 ' A' ' 82' ' ' ILE . 29.7 mt -79.5 158.18 74.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 153.31 68.55 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.696 2.264 . . . . 0.0 112.264 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.49 -29.83 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -60.61 -41.56 95.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 78' ' ' LEU . 30.2 mm -76.28 -30.97 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.85 -42.47 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.57 -31.72 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -74.08 -54.58 7.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.6 -40.97 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -68.56 -30.22 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -66.09 -24.66 66.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 9.35 63.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.63 ' HE3' HD11 ' B' ' 273' ' ' LEU . 2.3 ptmt -93.07 176.63 6.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.6 p 46.53 61.33 2.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -140.32 81.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.6 -25.91 7.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -51.79 -53.93 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -120.8 173.97 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -67.87 105.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.47 172.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -103.49 132.11 50.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 99' ' ' LEU . 4.4 mm? . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -94.83 133.91 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.577 HD11 HG13 ' B' ' 226' ' ' VAL . 27.0 pt -116.75 149.66 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.482 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.0 m-85 -106.07 124.34 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.47 108.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.55 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.0 113.19 24.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.746 HG22 HD23 ' B' ' 269' ' ' LEU . 5.0 p -76.91 174.7 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.68 -22.58 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -92.72 17.7 9.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.3 97.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -104.72 108.01 19.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.55 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.69 132.48 35.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.686 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.8 mt -129.49 108.79 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 130.47 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' B' ' 229' ' ' LYS . 7.7 mt -135.88 135.83 40.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -89.27 101.82 14.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.783 HG11 HG22 ' B' ' 226' ' ' VAL . 25.3 m -128.22 -178.95 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.558 ' O ' HD12 ' B' ' 256' ' ' LEU . 8.7 mt-10 -135.08 160.45 68.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -11.44 30.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.655 2.237 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.2 m -98.1 -25.54 14.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.49 ' O ' HG22 ' B' ' 255' ' ' THR . 42.0 m-20 -63.5 174.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.4 p -111.25 155.98 22.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.494 HG22 ' HZ2' ' B' ' 227' ' ' LYS . 48.2 mm -50.57 -36.92 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -53.25 -36.68 61.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.29 -34.25 65.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.926 HG21 HD21 ' B' ' 256' ' ' LEU . 98.6 t -69.94 -46.86 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 230' ' ' ILE . 8.7 ptpp? -64.76 -35.63 81.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.932 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.97 76.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' B' ' 215' ' ' LEU . 13.3 mttt -59.31 -43.61 92.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 227' ' ' LYS . 42.3 mt -56.54 -29.45 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.86 -48.73 73.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.21 -8.08 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.686 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -96.73 -56.34 2.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -96.14 -49.48 5.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 20.9 5.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.515 HD12 HD21 ' B' ' 269' ' ' LEU . 1.1 mt -99.22 134.05 21.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.415 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.4 Cg_endo -69.85 166.42 27.79 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -7.85 22.11 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.36 -23.01 28.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 1.3 mp0 -112.47 -8.57 13.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.6 HE21 ' HB2' ' B' ' 227' ' ' LYS . 1.1 tt0 -87.19 127.19 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -134.21 118.0 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.406 HD22 ' N ' ' B' ' 243' ' ' LEU . 3.7 mm? -80.36 150.37 29.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 78' ' ' LEU . 30.3 mm -137.98 114.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.185 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.479 ' HB3' HD21 ' B' ' 250' ' ' LEU . 21.5 t80 -145.87 144.41 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.84 15.08 8.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.6 5.67 78.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.498 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.5 170.4 13.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.739 0.304 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -95.2 139.8 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.502 HD22 ' CD1' ' B' ' 259' ' ' TYR . 1.5 mt -91.45 155.71 18.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -111.57 161.8 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -81.68 -0.9 44.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.46 41.07 2.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.429 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -152.85 169.75 22.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.49 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -99.47 153.25 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.926 HD21 HG21 ' B' ' 226' ' ' VAL . 41.9 mt -57.41 -44.87 84.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.6 t -58.88 -24.48 62.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.09 -32.47 73.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.814 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.502 ' CD1' HD22 ' B' ' 250' ' ' LEU . 45.2 m-85 -98.7 12.5 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 64.02 33.79 11.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.484 HD12 HD21 ' B' ' 267' ' ' LEU . 9.1 mm -70.81 95.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.87 174.14 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 147.53 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 55.94 25.02 8.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.66 133.11 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -85.32 86.04 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.484 HD21 HD12 ' B' ' 261' ' ' ILE . 4.0 mm? -81.9 157.24 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.44 ' HB2' ' HB ' ' B' ' 244' ' ' ILE . 0.2 OUTLIER -130.46 121.44 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.746 HD23 HG22 ' B' ' 207' ' ' THR . 4.4 tp -91.98 127.16 37.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 82' ' ' ILE . 11.6 t -125.49 148.46 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.484 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -75.73 130.08 38.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.484 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 -91.72 161.97 14.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.63 HD11 ' HE3' ' A' ' 90' ' ' LYS . 4.2 mm? -50.16 127.72 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -91.85 100.3 13.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.52 20.62 2.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.54 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.495 -179.931 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' O ' HD11 ' A' ' 87' ' ' LEU . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.822 0.259 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.597 HD22 ' CD2' ' A' ' 75' ' ' PHE . 3.0 mt -78.68 58.47 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 31.9 m -110.6 -17.62 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.488 ' HB2' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -135.78 93.75 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.718 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt -108.68 152.86 42.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 174.22 9.74 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 147.71 50.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.81 20.88 34.58 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.488 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.718 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.1 p -74.45 142.55 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -101.87 108.11 19.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -50.59 -51.92 43.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.18 -40.08 57.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG22 ' HE2' ' B' ' 206' ' ' LYS . 87.0 t -76.42 -32.92 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.597 ' CD2' HD22 ' A' ' 63' ' ' LEU . 3.7 t80 -67.71 -56.6 8.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -15.78 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -87.55 -22.78 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.96 158.04 68.05 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.729 2.286 . . . . 0.0 112.324 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.93 -31.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.13 -38.76 87.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.033 HG21 HD13 ' A' ' 78' ' ' LEU . 33.0 mm -78.79 -31.08 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -67.73 -49.94 59.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -32.9 74.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.6 -43.4 80.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.7 mt -74.6 -44.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 65' ' ' SER . 0.6 OUTLIER -64.75 -30.18 71.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -64.91 -27.6 68.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.97 41.82 5.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 -177.91 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p 46.13 64.62 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.19 78.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -21.68 9.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.815 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -48.61 75.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -125.84 174.38 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -106.82 150.01 26.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.971 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.1 105.87 0.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -87.72 110.73 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 179.86 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -95.51 138.5 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.67 147.17 24.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.465 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.7 m-85 -105.36 127.51 53.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 16.2 t -109.86 108.19 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.555 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.24 112.47 24.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.699 HG22 HD23 ' B' ' 269' ' ' LEU . 5.6 p -74.92 175.5 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -59.07 -24.45 62.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 209' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -89.96 8.38 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.17 69.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -89.66 108.49 19.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.555 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.43 131.85 35.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.181 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.714 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -128.91 115.23 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 214' ' ' THR . . . . . 0.599 ' C ' HD12 ' B' ' 215' ' ' LEU . 5.8 m -79.44 128.46 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.638 ' CD1' HG22 ' B' ' 213' ' ' ILE . 10.8 mp -126.67 134.1 50.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.13 98.86 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.835 HG11 HG22 ' B' ' 226' ' ' VAL . 18.9 m -131.37 -179.04 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.587 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.3 mt-10 -130.58 160.56 65.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -9.29 25.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.248 . . . . 0.0 112.39 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -100.6 -24.88 14.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' ASP . . . . . 0.478 ' O ' HG22 ' B' ' 255' ' ' THR . 17.9 m-20 -63.4 175.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.0 157.93 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.07 -32.52 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -56.74 -35.85 69.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -43.11 63.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.835 HG22 HG11 ' B' ' 217' ' ' VAL . 21.7 t -63.15 -43.38 98.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.618 ' CE ' HD11 ' B' ' 243' ' ' LEU . 17.1 ttmt -61.26 -42.14 98.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.921 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.51 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -63.66 -42.21 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.611 ' CG1' HD21 ' B' ' 215' ' ' LEU . 45.1 mt -59.14 -29.37 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.148 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -67.06 -44.73 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.38 -4.98 45.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.714 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.0 mmmt -99.29 -56.01 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -98.79 -48.66 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.66 19.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' B' ' 237' ' ' PRO . 0.9 OUTLIER -101.14 134.39 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.585 0.707 . . . . 0.0 111.142 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 237' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.5 Cg_endo -69.79 169.6 18.57 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.68 2.253 . . . . 0.0 112.302 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -7.2 20.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.35 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.85 -19.03 25.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.21 -15.54 12.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.434 ' OE1' HG22 ' B' ' 230' ' ' ILE . 0.7 OUTLIER -86.97 129.67 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 242' ' ' ARG . . . . . 0.656 ' HD3' HD11 ' A' ' 82' ' ' ILE . 10.9 ttm180 -132.93 112.49 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 243' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' B' ' 227' ' ' LYS . 0.7 OUTLIER -83.72 134.67 34.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 82' ' ' ILE . 23.0 mm -121.41 116.2 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.712 ' HB3' HD21 ' B' ' 250' ' ' LEU . 17.9 t80 -140.45 142.56 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.17 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.06 12.56 67.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 174.14 10.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.74 144.07 25.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.1 mt -97.68 155.59 16.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -111.63 159.95 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.67 -1.78 43.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -109.55 40.66 2.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -152.59 169.39 22.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' THR . . . . . 0.478 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -100.25 152.73 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.824 HD21 HG21 ' B' ' 226' ' ' VAL . 63.8 mt -57.8 -47.06 83.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -55.27 -26.0 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -68.13 -27.64 66.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 87.7 m-85 -98.58 9.12 43.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.47 32.72 11.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.513 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.2 mm -70.04 97.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -89.5 167.31 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -51.2 141.46 14.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 59.13 27.4 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 131.64 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.32 88.87 7.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.19 160.1 17.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.67 127.58 40.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.699 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -99.69 118.31 35.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.949 HG11 HG23 ' A' ' 82' ' ' ILE . 4.3 t -116.64 141.13 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.101 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.429 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.73 128.08 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.429 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.7 mtt180 -90.42 163.67 14.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 273' ' ' LEU . 4.3 mm? -51.17 131.02 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -96.78 101.79 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -123.16 18.19 7.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.485 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.83 0.262 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mt -99.89 50.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.2 m -103.27 -18.63 14.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.71 94.37 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.666 ' HB3' HG11 ' A' ' 70' ' ' VAL . 1.1 mt -111.54 152.28 43.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.641 0.734 . . . . 0.0 110.894 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 172.78 11.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.36 145.92 52.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.95 36.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.1 p -70.73 141.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.182 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -50.29 -56.29 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -50.16 -62.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.565 HG13 ' NE2' ' B' ' 268' ' ' HIS . 44.4 t -53.05 -32.18 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.158 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 66' ' ' LEU . 15.7 t80 -63.72 -57.84 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -72.37 -7.67 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -89.33 -18.22 27.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 82' ' ' ILE . 41.5 mt -90.03 158.0 44.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 159.14 54.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.37 -29.28 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.06 -40.11 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 1.053 HG21 HD13 ' A' ' 78' ' ' LEU . 49.7 mm -79.32 -43.08 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -55.6 -50.7 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -64.08 -33.28 75.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.17 -43.1 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.456 ' CD1' HG22 ' A' ' 82' ' ' ILE . 47.2 mt -72.71 -35.47 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -33.6 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.944 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -23.74 67.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.72 58.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.727 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.5 ptpt -96.68 -176.36 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 p 46.01 62.39 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.38 85.92 2.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -117.42 -27.56 6.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.4 -63.88 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -108.05 170.6 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -64.17 114.18 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.23 169.66 6.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -141.68 99.65 3.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.784 0.326 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.784 0.326 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.74 133.97 37.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' ILE . . . . . 0.629 HD11 HG13 ' B' ' 226' ' ' VAL . 17.7 pt -116.64 148.56 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 204' ' ' PHE . . . . . 0.477 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.5 m-85 -105.3 126.52 52.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.07 107.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' LYS . . . . . 0.469 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -97.97 112.54 24.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 207' ' ' THR . . . . . 0.702 HG22 HD23 ' B' ' 269' ' ' LEU . 2.7 p -77.14 172.44 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.493 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.3 OUTLIER -58.96 -22.03 59.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.9 p -94.29 25.29 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.52 50.84 51.56 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -118.25 108.24 14.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -82.1 134.41 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 213' ' ' ILE . . . . . 0.7 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -130.15 108.17 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.07 130.15 37.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.82 133.65 41.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.8 100.29 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.891 HG11 HG22 ' B' ' 226' ' ' VAL . 16.3 m -129.86 -179.38 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.1 mt-10 -129.84 160.81 63.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -12.04 32.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.3 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.19 175.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.8 156.07 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ILE . . . . . 0.4 HD13 HD23 ' B' ' 256' ' ' LEU . 49.8 mm -51.38 -30.28 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.43 -38.79 85.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' ASN . . . . . 0.477 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -66.31 -38.78 88.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 226' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 217' ' ' VAL . 48.0 t -73.17 -36.92 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' LYS . . . . . 0.62 ' HA ' HD12 ' B' ' 230' ' ' ILE . 17.3 ttpp -71.01 -38.81 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.01 75.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' LYS . . . . . 0.784 ' HE3' HG12 ' B' ' 217' ' ' VAL . 42.8 mttm -54.52 -45.24 73.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' B' ' 227' ' ' LYS . 46.3 mt -53.93 -33.35 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -63.64 -46.64 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.59 -6.08 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' LYS . . . . . 0.7 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.9 mmmt -96.87 -53.73 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -101.99 -49.05 4.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.01 31.68 2.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 236' ' ' ILE . . . . . 0.64 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.68 130.65 22.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.519 0.676 . . . . 0.0 111.142 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 162.96 40.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.629 2.219 . . . . 0.0 112.38 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.4 -28.85 23.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.8 -2.3 14.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' GLN . . . . . 0.498 ' HG3' HD13 ' B' ' 269' ' ' LEU . 12.4 tt0 -94.76 128.39 41.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -133.33 136.98 45.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.6 155.83 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 82' ' ' ILE . 21.8 mm -140.07 115.4 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 245' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.3 t80 -146.35 143.83 29.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.45 14.92 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.29 14.84 70.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -132.6 -175.64 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.308 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -107.51 125.96 51.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 250' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.9 mt -82.54 160.27 22.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.48 161.41 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.17 0.58 40.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.12 43.82 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -152.52 169.4 22.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.47 147.06 26.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.771 HD21 HG21 ' B' ' 226' ' ' VAL . 70.6 mt -52.65 -44.98 66.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -57.45 -28.0 62.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.2 -32.82 74.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 259' ' ' TYR . . . . . 0.543 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.8 m-85 -96.63 8.18 44.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.989 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.0 m120 63.32 36.22 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' ILE . . . . . 0.557 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.6 mm -68.79 95.56 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -83.05 163.84 20.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.16 145.55 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.07 26.46 15.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 135.51 54.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -89.2 83.91 6.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' LEU . . . . . 0.53 HD21 HD12 ' B' ' 261' ' ' ILE . 3.8 mm? -82.86 155.51 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 268' ' ' HIS . . . . . 0.565 ' NE2' HG13 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -128.93 121.91 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 269' ' ' LEU . . . . . 0.702 HD23 HG22 ' B' ' 207' ' ' THR . 2.9 tp -91.72 126.3 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 270' ' ' VAL . . . . . 0.779 HG11 HD12 ' A' ' 82' ' ' ILE . 21.9 t -123.78 148.15 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 271' ' ' LEU . . . . . 0.483 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -77.79 134.85 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 272' ' ' ARG . . . . . 0.483 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.8 mtt180 -95.39 167.02 11.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 273' ' ' LEU . . . . . 0.727 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.0 mm? -53.27 125.68 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.957 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -93.53 98.82 11.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.56 25.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 -179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.8 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.626 0.727 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.41 9.59 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.74 145.05 52.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.18 20.7 36.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.8 p -69.09 144.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -103.86 108.43 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -51.27 -50.16 59.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -53.07 -45.98 68.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.526 HG13 ' CE1' ' B' ' 268' ' ' HIS . 64.3 t -69.38 -33.21 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.439 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.5 t80 -66.77 -56.32 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -13.82 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -88.66 -27.49 21.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.98 HD13 HG21 ' A' ' 82' ' ' ILE . 22.1 mt -75.66 158.84 82.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.651 0.738 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.14 31.97 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.359 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.75 -29.79 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.98 HG21 HD13 ' A' ' 78' ' ' LEU . 39.2 mm -78.84 -29.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.448 ' O ' HD23 ' A' ' 87' ' ' LEU . 47.8 mt-30 -69.61 -26.58 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -88.68 -25.81 22.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.5 -40.14 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.439 HG21 ' HE1' ' A' ' 75' ' ' PHE . 17.1 mt -78.15 -30.86 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.7 mm? -70.69 -33.52 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.44 -21.3 66.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.78 23.98 40.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.414 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.736 0.303 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 134.05 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.443 HD11 HG13 ' B' ' 226' ' ' VAL . 31.7 pt -117.24 149.35 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.1 m-85 -105.13 124.25 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 215' ' ' LEU . 21.3 t -106.23 108.1 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.719 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.86 110.85 23.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.672 HG22 HD23 ' B' ' 269' ' ' LEU . 5.2 p -73.6 173.36 9.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -23.86 58.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.27 12.24 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.08 31.69 72.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.533 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -97.25 108.59 21.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.719 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.34 133.36 35.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.74 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.53 115.38 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.52 125.16 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 205' ' ' VAL . 9.9 mt -127.72 134.31 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.09 102.93 15.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.757 HG11 HG22 ' B' ' 226' ' ' VAL . 18.1 m -131.19 -179.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.9 mt-10 -132.75 160.6 67.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -10.67 29.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.398 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.1 m -98.18 -24.89 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 255' ' ' THR . 19.3 m-20 -63.91 174.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.86 156.52 21.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.56 -34.73 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -55.68 -35.42 66.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -39.92 69.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.781 HG21 HD21 ' B' ' 256' ' ' LEU . 46.2 t -65.66 -42.42 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.785 ' HG3' HD11 ' B' ' 243' ' ' LEU . 3.2 mtmm -63.65 -42.4 98.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.964 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.61 73.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -56.64 -50.1 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.6 -31.17 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -63.57 -45.71 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -4.6 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.74 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.5 mmmt -99.09 -56.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -100.31 -48.43 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.14 32.26 2.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.674 HD12 HD21 ' B' ' 269' ' ' LEU . 10.7 mt -104.64 130.04 23.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.654 0.74 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 164.31 35.07 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.706 2.271 . . . . 0.0 112.385 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -8.04 22.59 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.14 -30.35 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.53 -1.38 14.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -92.45 128.78 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.571 ' HD3' HD11 ' A' ' 82' ' ' ILE . 12.3 ttm180 -133.75 140.96 47.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.785 HD11 ' HG3' ' B' ' 227' ' ' LYS . 2.7 mp -108.4 151.06 26.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.575 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.5 mm -137.9 117.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.809 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.4 t80 -148.22 143.32 26.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.79 13.82 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.28 3.88 74.94 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.493 ' CE ' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -135.86 158.5 44.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.745 0.307 . . . . 0.0 110.862 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.02 145.54 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.809 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.4 mt -96.14 163.24 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.73 157.27 28.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.94 -13.64 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.47 39.52 2.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -152.58 169.72 21.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.4 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.464 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -102.34 152.98 20.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.134 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.781 HD21 HG21 ' B' ' 226' ' ' VAL . 32.8 mt -56.5 -46.47 80.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.6 t -58.87 -25.07 62.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.02 -32.14 73.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.452 ' CG ' HD22 ' B' ' 250' ' ' LEU . 71.9 m-85 -98.64 11.88 37.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.06 31.74 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.626 HG21 HD22 ' B' ' 256' ' ' LEU . 13.4 mm -68.89 95.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -84.5 -179.09 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 150.33 48.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 54.45 27.02 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.62 134.63 54.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -87.47 86.78 7.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.62 158.33 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.526 ' CE1' HG13 ' A' ' 74' ' ' VAL . 4.0 m170 -130.76 117.67 19.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.674 HD21 HD12 ' B' ' 236' ' ' ILE . 8.5 tp -87.11 128.98 35.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 82' ' ' ILE . 13.9 t -126.59 148.19 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.412 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -81.08 127.36 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.412 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.4 mtt180 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.708 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.1 mt . . . . . 0 C--O 1.23 0.04 0 CA-C-O 121.654 0.74 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 174.52 9.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.624 2.216 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.0 145.28 51.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.39 20.72 38.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.708 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -70.27 144.9 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.569 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.1 t0 -102.76 106.37 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.4 tp60 -50.64 -52.65 37.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.855 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -51.55 -37.23 48.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.662 HG13 ' CE1' ' B' ' 268' ' ' HIS . 74.7 t -76.85 -33.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -56.57 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -13.79 60.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -90.17 -18.27 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.846 HD13 HG21 ' A' ' 82' ' ' ILE . 41.3 mt -87.92 157.39 51.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 52.9 Cg_endo -69.79 165.33 31.37 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.383 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.02 -27.94 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.099 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -43.42 95.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.846 HG21 HD13 ' A' ' 78' ' ' LEU . 44.7 mm -79.39 -28.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 87' ' ' LEU . 34.1 mt-30 -69.59 -23.95 63.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.2 -26.7 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.17 -37.85 63.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.05 -42.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.6 mm? -56.71 -34.46 67.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 t -65.16 -21.9 66.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.98 14.93 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.0 ptpt . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.749 0.309 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -95.54 134.18 38.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.446 HD11 HG13 ' B' ' 226' ' ' VAL . 25.8 pt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.438 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.7 m-85 -105.49 124.47 49.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' B' ' 269' ' ' LEU . 11.3 t -107.22 108.16 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.97 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.647 HG22 ' HB3' ' B' ' 269' ' ' LEU . 6.1 p -71.63 174.71 6.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -25.42 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 4.7 p -88.75 10.81 19.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.52 30.16 69.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -94.58 108.71 20.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.611 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.22 132.54 35.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.504 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -129.48 111.45 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.02 128.54 34.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 9.6 mt -132.36 134.19 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -90.21 103.03 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.859 HG11 HG22 ' B' ' 226' ' ' VAL . 21.7 m -130.77 -179.51 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.4 mt-10 -132.21 160.32 68.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.649 0.738 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 51.8 p -97.11 -24.79 15.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.4 ' O ' HG22 ' B' ' 255' ' ' THR . 41.0 m-20 -61.65 175.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.23 156.85 20.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.3 mm -53.56 -27.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.64 -29.85 71.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -37.56 44.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.868 HG21 HD21 ' B' ' 256' ' ' LEU . 94.9 t -67.87 -49.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -60.72 -34.61 74.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.44 98.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' B' ' 217' ' ' VAL . 9.4 mttt -57.24 -46.91 82.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' B' ' 269' ' ' LEU . 71.1 mt -53.76 -36.87 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -58.7 -44.87 90.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -4.75 44.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.504 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.0 mmmt -98.44 -56.6 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -101.4 -47.87 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.11 26.48 3.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.7 mt -98.08 128.88 32.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.124 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 164.3 35.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.575 2.184 . . . . 0.0 112.355 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.94 -29.37 25.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.55 -5.34 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.451 ' OE1' HD12 ' B' ' 230' ' ' ILE . 11.1 tt0 -88.92 130.44 35.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.447 ' HD3' HD11 ' A' ' 82' ' ' ILE . 3.3 ttm180 -133.81 141.18 47.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.612 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -109.87 149.79 29.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.612 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.8 mm -135.85 118.78 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.166 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.713 ' HB3' HD21 ' B' ' 250' ' ' LEU . 25.8 t80 -149.27 142.71 25.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.7 14.91 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.73 17.95 64.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.45 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.34 171.62 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -91.43 139.53 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -94.17 151.26 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.43 155.32 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -78.25 -4.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -106.12 39.55 2.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -152.44 169.44 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.4 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -99.72 152.08 20.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.868 HD21 HG21 ' B' ' 226' ' ' VAL . 64.9 mt -56.33 -43.8 79.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 t -57.36 -23.63 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.28 -32.97 74.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.589 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.9 m-85 -97.41 10.25 40.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 62.45 35.79 14.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 245' ' ' PHE . 14.5 mm -68.69 95.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -84.87 167.37 16.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.57 148.55 9.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 55.56 26.56 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.13 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 85.47 6.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.461 HD11 HD11 ' B' ' 250' ' ' LEU . 3.9 mm? -84.02 159.29 21.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.662 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.9 m170 -129.32 129.56 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.647 ' HB3' HG22 ' B' ' 207' ' ' THR . 5.7 tt -96.03 134.7 38.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.817 HG11 HG23 ' A' ' 82' ' ' ILE . 17.2 t -133.89 140.35 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.434 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -75.18 129.8 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.434 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.5 mtt180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.3 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.681 0.753 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 173.76 10.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 0.0 112.265 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.04 145.26 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.3 20.69 37.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.552 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.04 144.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' HG23 ' A' ' 74' ' ' VAL . 62.6 t0 -103.55 108.96 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -51.25 -52.05 48.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -51.41 -45.72 62.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG13 ' CE1' ' B' ' 268' ' ' HIS . 67.0 t -69.72 -33.13 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.2 t80 -67.14 -56.02 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -13.84 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -88.83 -25.93 21.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.045 HD13 HG21 ' A' ' 82' ' ' ILE . 24.3 mt -78.43 158.67 76.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 165.13 32.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.62 -30.42 44.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -61.96 -41.38 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.045 HG21 HD13 ' A' ' 78' ' ' LEU . 39.6 mm -78.88 -27.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.449 ' O ' HD23 ' A' ' 87' ' ' LEU . 17.7 mt-30 -69.67 -45.69 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.77 -29.44 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.81 -43.02 80.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.475 HG21 ' HE1' ' A' ' 75' ' ' PHE . 39.4 mt -77.91 -30.6 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.8 mm? -70.2 -35.72 74.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -65.45 -20.78 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.14 18.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -94.84 137.78 33.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 10.0 pt -120.59 147.19 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.3 m-85 -105.54 121.93 44.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.7 107.95 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.649 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.29 109.55 22.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 5.8 p -71.43 172.41 9.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.62 -24.0 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -89.21 10.12 23.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.3 66.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.508 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -101.89 108.88 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.649 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.02 132.71 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.1 mt -128.52 110.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 127.52 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 7.9 mt -133.08 134.1 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.36 102.4 15.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.927 HG11 HG22 ' B' ' 226' ' ' VAL . 22.9 m -128.03 -179.24 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.597 ' O ' HD12 ' B' ' 256' ' ' LEU . 9.7 mt-10 -134.75 160.38 68.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.628 0.728 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -11.23 30.4 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.26 . . . . 0.0 112.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 p -97.16 -26.42 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.76 173.14 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.02 156.96 20.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -52.14 -31.22 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.96 -32.57 70.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -38.17 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.927 HG22 HG11 ' B' ' 217' ' ' VAL . 65.1 t -67.11 -49.06 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' B' ' 230' ' ' ILE . 1.7 ptpt -59.32 -37.02 76.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.18 70.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.0 mttm -56.5 -43.06 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' B' ' 227' ' ' LYS . 80.5 mt -55.33 -34.31 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.168 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -62.11 -48.08 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.12 -8.36 52.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -95.21 -56.33 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -100.35 -49.2 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.33 33.32 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.682 HD12 HD21 ' B' ' 269' ' ' LEU . 9.5 mt -106.41 130.68 22.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.605 0.717 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 163.31 38.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.4 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -8.18 22.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -84.95 -30.44 24.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.66 -1.67 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -91.97 126.85 37.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -133.79 135.17 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 244' ' ' ILE . 0.7 OUTLIER -101.14 155.92 17.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 82' ' ' ILE . 29.0 mm -140.56 117.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.749 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.1 t80 -146.6 145.05 29.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.83 14.46 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.63 15.51 68.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -133.6 -176.07 4.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -107.58 127.87 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.6 mt -84.48 153.06 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.34 163.31 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -81.97 -0.47 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.68 39.89 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.54 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -152.52 164.98 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.32 150.49 20.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.797 HD21 HG21 ' B' ' 226' ' ' VAL . 52.2 mt -54.73 -48.78 72.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -54.72 -26.18 32.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.4 -28.2 68.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.639 ' CG ' HD22 ' B' ' 250' ' ' LEU . 86.7 m-85 -98.86 11.88 37.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 63.96 31.25 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.485 HD12 HD11 ' B' ' 267' ' ' LEU . 16.0 mm -68.73 106.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.9 168.43 9.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.18 142.0 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.05 28.86 18.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 131.57 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.55 87.8 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.485 HD11 HD12 ' B' ' 261' ' ' ILE . 2.9 mp -89.3 159.25 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.508 ' CE1' HG13 ' A' ' 74' ' ' VAL . 7.5 m170 -128.66 122.98 32.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.682 HD21 HD12 ' B' ' 236' ' ' ILE . 8.7 tp -90.07 122.4 33.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 82' ' ' ILE . 13.8 t -120.59 147.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.476 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.76 132.09 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.476 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.9 mtt180 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.709 ' HB3' HG11 ' A' ' 70' ' ' VAL . 7.4 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 121.62 0.724 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 175.16 8.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.288 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.18 145.09 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.96 20.63 34.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.531 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.5 p -68.65 144.6 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -104.28 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -51.33 -51.29 55.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -51.44 -39.81 58.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' CE1' ' B' ' 268' ' ' HIS . 94.8 t -76.36 -33.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.078 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.11 -56.14 11.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -14.8 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.17 -25.57 21.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 82' ' ' ILE . 21.4 mt -77.58 157.82 79.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.6 Cg_endo -69.76 165.27 31.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.702 2.268 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.77 -26.89 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -64.73 -42.56 95.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 78' ' ' LEU . 41.2 mm -78.41 -29.58 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.73 -25.89 64.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.97 -24.69 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -72.29 -39.74 68.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.1 mt -78.26 -34.86 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.15 -32.43 73.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -67.83 -18.4 64.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.59 37.38 17.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.853 -179.946 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.06 134.1 42.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -117.38 149.9 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.0 m-85 -106.58 128.56 54.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.29 107.75 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.92 111.04 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -72.76 174.26 7.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -25.53 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.4 p -88.04 8.14 28.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.7 31.98 59.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -97.52 108.88 21.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.634 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.26 133.81 35.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.56 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.7 mt -129.95 111.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 128.14 32.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.492 HD21 HG22 ' B' ' 213' ' ' ILE . 9.9 mt -130.71 134.25 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.1 104.02 16.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 226' ' ' VAL . 25.1 m -131.61 -179.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.564 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.5 mt-10 -131.35 160.87 65.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -11.73 31.44 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -28.98 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.4 175.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.503 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.8 OUTLIER -114.6 157.97 22.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.13 -25.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.69 -35.47 80.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 217' ' ' VAL . 91.0 t -69.17 -39.16 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.39 -39.83 92.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.78 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.529 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.5 mttt -56.56 -50.15 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 69.9 mt -53.31 -33.41 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -60.41 -48.58 81.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -72.6 -7.34 49.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.56 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.6 mmmt -95.37 -54.59 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.34 -48.91 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.38 29.97 2.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.492 HD12 HD21 ' B' ' 269' ' ' LEU . 9.2 mt -102.52 130.54 23.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.515 0.674 . . . . 0.0 111.105 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 163.78 36.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.703 2.268 . . . . 0.0 112.428 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -7.88 22.17 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.802 2.335 . . . . 0.0 112.335 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -85.91 -30.54 22.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.29 -0.46 15.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.43 131.91 43.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.47 ' HD3' HD11 ' A' ' 82' ' ' ILE . 17.5 ttm180 -133.73 147.12 51.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.611 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.7 mp -115.06 150.43 35.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 243' ' ' LEU . 22.7 mm -136.8 115.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.791 ' HB3' HD21 ' B' ' 250' ' ' LEU . 40.4 t80 -145.74 144.25 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.19 13.29 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.5 5.09 72.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.482 ' HE2' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -137.05 163.47 30.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.928 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.78 145.9 30.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -98.32 154.43 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -111.67 155.61 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.44 -5.39 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.39 2.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . 0.503 ' O ' HG22 ' B' ' 222' ' ' THR . 5.3 ttt180 -152.53 169.42 22.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 149.61 23.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.73 HD21 HG21 ' B' ' 226' ' ' VAL . 44.7 mt -55.2 -47.59 75.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -57.39 -25.68 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.08 -30.87 71.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -98.81 11.04 39.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.9 m120 63.98 32.49 13.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.535 HG21 HD22 ' B' ' 256' ' ' LEU . 14.3 mm -68.77 95.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -86.98 170.64 11.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 152.17 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 53.64 27.45 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.78 133.48 54.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -90.14 85.77 6.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.58 159.63 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.591 ' CE1' HG13 ' A' ' 74' ' ' VAL . 9.2 m170 -128.11 122.77 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.633 HD23 HG22 ' B' ' 207' ' ' THR . 5.8 tp -89.74 122.27 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.781 HG11 HD12 ' A' ' 82' ' ' ILE . 10.8 t -119.91 147.93 23.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.71 135.65 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.4 mtt180 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.734 ' HB3' HG11 ' A' ' 70' ' ' VAL . 4.9 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.554 0.692 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 174.11 10.03 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.719 2.279 . . . . 0.0 112.339 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.42 146.32 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.51 21.03 33.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.2 p -71.6 145.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.41 108.85 20.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -51.39 -52.09 48.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -51.4 -40.05 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' B' ' 268' ' ' HIS . 80.2 t -76.04 -33.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.097 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.23 -56.35 10.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -15.26 60.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -88.81 -27.49 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.995 HD13 HG21 ' A' ' 82' ' ' ILE . 28.3 mt -75.88 158.29 82.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.637 0.732 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' HG21 ' B' ' 244' ' ' ILE . 54.0 Cg_endo -69.73 165.16 31.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.35 -29.19 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.19 -39.69 95.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.995 HG21 HD13 ' A' ' 78' ' ' LEU . 36.8 mm -78.9 -29.65 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.142 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 63.4 mt-30 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.56 -32.48 74.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.84 -42.93 76.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.5 mt -77.91 -29.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -61.77 -38.9 89.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -65.58 -25.08 67.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.42 55.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.911 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.3 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.63 133.79 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.479 HD11 HG13 ' B' ' 226' ' ' VAL . 17.0 pt -116.67 148.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -104.85 126.87 52.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . 0.468 HG21 HD11 ' B' ' 215' ' ' LEU . 21.2 t -110.02 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.448 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.94 111.17 23.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.824 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.754 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -73.14 175.0 7.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -23.9 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.2 p -90.07 7.66 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.41 65.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -91.76 109.47 20.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.424 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.71 132.37 35.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.194 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.46 111.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.06 127.61 32.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.468 HD11 HG21 ' B' ' 205' ' ' VAL . 9.4 mt -129.9 134.3 47.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.47 102.46 15.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.911 HG11 HG22 ' B' ' 226' ' ' VAL . 21.6 m -131.44 -179.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.557 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -131.94 160.34 68.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.628 0.728 . . . . 0.0 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -10.16 27.86 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -99.54 -24.6 14.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.38 175.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.15 155.07 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' B' ' 256' ' ' LEU . 50.5 mm -52.11 -29.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.27 -34.2 74.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -72.7 -37.91 67.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 217' ' ' VAL . 62.2 t -69.66 -42.7 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -64.37 -38.93 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.7 87.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.0 mttt -57.35 -49.86 74.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.411 HG21 HD22 ' B' ' 269' ' ' LEU . 65.7 mt -53.33 -32.72 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.53 -47.53 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.69 -4.74 42.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.1 mmmt -96.68 -50.34 4.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -106.94 -47.31 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.79 29.59 2.82 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.17 132.24 21.33 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.515 0.674 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 164.83 33.03 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.633 2.222 . . . . 0.0 112.375 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -6.45 18.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.695 2.263 . . . . 0.0 112.336 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -90.17 -23.74 21.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.02 -7.73 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.546 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -89.12 130.11 35.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -133.69 132.38 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.9 mp -101.73 149.1 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 26.1 mm -136.38 119.72 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.726 ' HB3' HD21 ' B' ' 250' ' ' LEU . 30.2 t80 -148.23 142.09 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.84 14.99 9.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.082 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.02 12.4 68.28 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.79 21.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.87 143.72 26.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' B' ' 245' ' ' PHE . 2.4 mt -99.88 148.34 24.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -108.2 157.41 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.15 -16.11 61.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.68 38.14 3.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -152.59 168.54 25.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.36 154.39 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.817 HD21 HG21 ' B' ' 226' ' ' VAL . 49.6 mt -57.8 -48.67 79.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.0 t -54.41 -27.28 35.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.32 -34.51 72.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.0 m-85 -98.15 9.85 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.76 40.36 7.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CD2' ' B' ' 245' ' ' PHE . 16.0 mm -72.28 95.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.25 167.34 16.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 146.68 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 58.83 26.43 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.97 133.87 55.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.95 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.488 HD11 HD11 ' B' ' 250' ' ' LEU . 3.7 mm? -84.09 159.3 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.569 ' CE1' HG13 ' A' ' 74' ' ' VAL . 5.3 m170 -129.42 118.8 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.754 HD23 HG22 ' B' ' 207' ' ' THR . 2.8 tp -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.825 HG11 HD12 ' A' ' 82' ' ' ILE . 26.8 t -112.73 148.14 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.453 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -80.14 130.97 35.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.453 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.9 mtt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.768 ' CB ' HG11 ' A' ' 70' ' ' VAL . 9.2 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.587 0.708 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.16 8.46 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.08 147.01 52.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' B' ' 209' ' ' THR . . . 55.84 21.11 28.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.506 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.7 p -72.52 145.34 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 111.112 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.1 t0 -103.81 106.14 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -50.06 -52.97 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.5 -38.99 47.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' CE1' ' B' ' 268' ' ' HIS . 98.9 t -76.72 -33.24 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' CD2' HD22 ' A' ' 66' ' ' LEU . 1.5 t80 -65.57 -56.56 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -13.95 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -88.93 -25.88 21.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 82' ' ' ILE . 25.8 mt -78.13 158.41 77.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.661 0.744 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.17 31.91 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.56 -31.45 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.78 -42.48 93.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.922 HG21 HD13 ' A' ' 78' ' ' LEU . 37.0 mm -78.94 -29.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.603 ' O ' HD23 ' A' ' 87' ' ' LEU . 65.6 mt-30 -69.76 -27.69 65.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.1 -26.76 23.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.88 -40.2 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.41 HG21 ' HE2' ' A' ' 75' ' ' PHE . 65.5 mt -78.13 -31.55 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -62.7 -38.34 90.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -65.43 -23.6 66.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.08 -1.95 65.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.51 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 -179.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.714 0.293 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.35 136.19 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.8 pt -118.27 148.67 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.178 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' B' ' 212' ' ' THR . 12.9 m-85 -105.15 121.5 43.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.09 108.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.13 111.96 23.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.909 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.816 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -74.42 172.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.401 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -58.87 -24.52 62.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.9 p -89.61 12.22 17.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.02 89.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -108.23 110.96 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.772 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -82.31 134.43 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.704 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.0 mt -129.85 112.11 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.69 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.456 HD21 HG22 ' B' ' 213' ' ' ILE . 9.8 mt -131.42 134.84 46.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -89.83 104.4 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.945 HG11 HG22 ' B' ' 226' ' ' VAL . 21.2 m -134.45 174.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.535 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.8 mt-10 -125.71 160.95 53.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -8.58 23.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.55 -24.01 14.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.436 ' O ' HG22 ' B' ' 255' ' ' THR . 20.9 m-20 -62.3 175.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.13 154.97 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -51.29 -35.05 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.87 -34.42 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -38.96 67.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.945 HG22 HG11 ' B' ' 217' ' ' VAL . 62.9 t -67.92 -43.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.172 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.532 ' HD2' HD11 ' B' ' 243' ' ' LEU . 7.8 mtpm? -62.47 -41.65 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.29 -42.17 73.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.41 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.7 mttt -58.55 -48.17 81.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.58 -31.3 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -48.54 79.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.04 -5.04 41.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.704 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.72 -51.29 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -105.75 -47.42 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.08 27.64 3.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.541 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.445 HD12 HD21 ' B' ' 269' ' ' LEU . 11.9 mt -101.61 132.38 21.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.23 31.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -6.93 19.78 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.737 2.291 . . . . 0.0 112.29 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.35 -21.39 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.95 -8.69 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -87.31 130.82 34.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.554 ' HD3' HD11 ' A' ' 82' ' ' ILE . 4.0 ttm180 -134.01 128.4 34.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.2 mp -98.61 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.1 mm -136.92 114.92 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.699 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.5 t80 -143.16 143.05 31.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.46 15.14 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.86 75.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.14 168.86 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.728 0.299 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -89.39 142.77 27.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.3 mt -97.37 151.32 20.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 161.01 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.58 -9.88 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.65 2.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.53 169.66 22.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.381 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.436 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -101.4 151.54 21.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 57.3 mt -56.19 -45.22 79.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.2 t -56.08 -24.1 37.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.789 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.16 -30.58 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' B' ' 250' ' ' LEU . 49.7 m-85 -98.41 9.88 42.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.4 34.09 13.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.524 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.4 mm -68.92 100.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -95.11 170.67 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.37 144.22 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 58.11 28.24 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.438 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.69 125.4 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -80.84 85.7 6.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.59 HD11 HD11 ' B' ' 250' ' ' LEU . 3.0 mm? -85.39 158.52 20.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.591 ' CE1' HG13 ' A' ' 74' ' ' VAL . 2.3 m170 -129.69 119.86 24.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.816 HD23 HG22 ' B' ' 207' ' ' THR . 7.5 tp -89.99 128.05 36.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 82' ' ' ILE . 21.2 t -125.81 144.62 35.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.498 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -76.3 134.12 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.498 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.719 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.2 mt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.563 0.697 . . . . 0.0 110.924 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 174.97 8.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.712 2.275 . . . . 0.0 112.316 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.08 144.33 52.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 19.99 30.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -65.98 144.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -104.3 108.59 20.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -52.92 37.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -51.29 -38.61 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.466 HG23 ' CG ' ' A' ' 71' ' ' ASP . 96.9 t -76.12 -33.1 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' HE2' HG21 ' A' ' 86' ' ' ILE . 1.5 t80 -68.0 -55.98 10.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -14.27 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -88.64 -23.5 23.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.973 HD13 HG21 ' A' ' 82' ' ' ILE . 22.7 mt -81.23 158.46 69.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 165.15 31.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.41 -31.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.15 -41.23 92.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.973 HG21 HD13 ' A' ' 78' ' ' LEU . 35.9 mm -78.99 -28.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.57 -47.73 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.28 -32.19 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.41 -41.69 84.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 75' ' ' PHE . 56.5 mt -77.8 -33.99 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.38 -35.69 81.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 -23.22 66.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.64 -2.28 69.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.794 0.33 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.55 134.09 42.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.621 HD12 HD13 ' B' ' 267' ' ' LEU . 24.3 pt -118.74 148.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.538 ' HB3' HG22 ' B' ' 212' ' ' THR . 6.8 m-85 -105.77 127.63 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.76 108.65 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.3 108.84 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.568 HG22 ' HB3' ' B' ' 269' ' ' LEU . 8.7 p -67.49 173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -27.97 66.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.8 p -83.53 -1.41 53.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.36 31.74 24.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -98.77 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.364 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.678 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -81.67 134.3 35.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.099 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.57 114.43 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 125.16 29.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.505 HD11 HG12 ' B' ' 230' ' ' ILE . 8.6 mt -129.09 134.11 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.06 102.66 15.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 226' ' ' VAL . 22.6 m -127.77 178.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.604 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.8 mt-10 -132.88 160.33 69.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.73 24.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.1 p -110.27 17.33 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.68 ' O ' HG22 ' B' ' 255' ' ' THR . 24.0 m-20 -100.2 173.28 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.26 149.57 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.867 HD12 HD23 ' B' ' 250' ' ' LEU . 46.2 mm -51.64 -35.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -61.25 -34.35 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 217' ' ' VAL . 88.5 t -66.72 -45.76 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.2 OUTLIER -59.94 -38.41 82.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -49.99 70.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.728 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -57.43 -39.73 76.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 227' ' ' LYS . 86.0 mt -58.84 -28.1 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.66 -47.98 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.66 -7.74 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -96.11 -56.01 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -99.18 -48.87 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 33.15 1.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 5.7 mt -112.45 131.21 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.728 . . . . 0.0 111.096 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' B' ' 240' ' ' GLN . 54.0 Cg_endo -69.86 163.52 38.05 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.374 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . 0.429 ' HA ' ' HG2' ' B' ' 241' ' ' GLN . 54.1 Cg_endo -69.73 -1.65 8.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.64 2.227 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -99.4 -26.15 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' B' ' 237' ' ' PRO . 1.2 mp0 -113.01 -5.71 13.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.429 ' HG2' ' HA ' ' B' ' 238' ' ' PRO . 2.8 pt20 -111.96 136.01 51.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.4 ' NE ' HE21 ' B' ' 249' ' ' GLN . 0.0 OUTLIER -135.29 147.87 49.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.516 HD23 ' H ' ' B' ' 243' ' ' LEU . 2.1 pt? -113.8 135.6 53.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 82' ' ' ILE . 20.7 mm -119.59 131.66 71.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.507 ' CD2' HD13 ' B' ' 261' ' ' ILE . 56.9 t80 -148.52 144.03 27.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.37 15.15 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 17.97 70.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 166.4 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.667 0.27 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.4 HE21 ' NE ' ' B' ' 242' ' ' ARG . 27.3 mt-30 -94.39 110.12 21.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.867 HD23 HD12 ' B' ' 223' ' ' ILE . 9.4 mp -67.34 163.62 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.48 153.13 48.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.88 -9.91 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.74 35.72 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -152.69 168.51 25.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.68 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -103.01 158.44 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.134 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.745 HD21 HG21 ' B' ' 226' ' ' VAL . 25.9 mt -58.28 -41.12 83.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -63.26 -22.16 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.26 -35.91 82.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -98.94 17.03 20.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.36 35.53 26.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.589 HG21 HD22 ' B' ' 256' ' ' LEU . 9.0 mm -68.6 95.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.96 -174.21 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.17 152.93 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 54.15 26.78 6.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.75 132.36 51.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -91.23 89.59 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.621 HD13 HD12 ' B' ' 203' ' ' ILE . 4.0 mp -91.93 165.27 13.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.454 ' CE1' HG13 ' A' ' 74' ' ' VAL . 10.1 m170 -129.6 145.35 51.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.568 ' HB3' HG22 ' B' ' 207' ' ' THR . 3.4 tt -105.38 133.05 50.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.81 HG11 HG23 ' A' ' 82' ' ' ILE . 5.2 t -133.44 143.9 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.16 135.37 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.0 mtt180 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.825 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.687 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.9 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.607 0.718 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.8 Cg_endo -69.81 173.64 10.72 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 144.88 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.99 20.66 34.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.5 p -69.23 146.24 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 0.0 111.1 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.9 t0 -104.31 106.62 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -49.38 -52.46 28.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -51.64 -38.08 53.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' OD2' ' A' ' 71' ' ' ASP . 96.3 t -76.03 -33.28 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' HE2' HG21 ' A' ' 86' ' ' ILE . 1.2 t80 -64.92 -56.58 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -13.2 61.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.44 -23.88 23.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 82' ' ' ILE . 21.1 mt -80.99 159.16 69.07 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.3 31.53 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.291 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.93 -33.68 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.72 -43.58 85.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.815 HD12 HG11 ' B' ' 270' ' ' VAL . 30.9 mm -77.69 -28.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 87' ' ' LEU . 31.8 mt-30 -70.4 -37.26 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.22 -30.2 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.44 -51.75 18.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 75' ' ' PHE . 58.6 mt -62.5 -28.85 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.2 mm? -75.41 -23.35 57.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.6 m -76.79 -19.34 57.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 14.44 59.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.492 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.317 . . . . 0.0 110.983 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.74 0.305 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -95.02 134.99 37.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.426 HD11 HG13 ' B' ' 226' ' ' VAL . 25.3 pt -117.9 148.77 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.452 ' HB3' HG22 ' B' ' 212' ' ' THR . 18.7 m-85 -104.9 122.31 45.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.57 108.36 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.2 OUTLIER -97.47 112.65 24.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.772 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -73.3 171.69 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.235 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -59.25 -27.4 65.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.4 p -84.64 0.7 49.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.93 39.34 13.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.372 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.487 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.3 131.77 35.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.672 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.3 mt -129.37 110.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . 0.452 ' O ' HD23 ' B' ' 215' ' ' LEU . 0.2 OUTLIER -78.46 131.6 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.512 HD21 HG22 ' B' ' 213' ' ' ILE . 8.1 mt -135.87 133.95 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.81 105.81 18.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.795 HG11 HG22 ' B' ' 226' ' ' VAL . 20.4 m -134.0 171.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.575 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.8 mt-10 -118.47 160.33 40.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.92 33.88 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.611 2.207 . . . . 0.0 112.372 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 -25.33 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.1 175.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.2 p -111.98 156.83 21.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.142 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.422 HG21 HD13 ' B' ' 243' ' ' LEU . 48.4 mm -51.59 -33.63 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.65 -35.08 67.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.949 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -39.28 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.839 HG21 HD21 ' B' ' 256' ' ' LEU . 56.0 t -67.1 -44.1 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' B' ' 230' ' ' ILE . 28.2 ttmt -62.84 -41.73 99.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.22 -42.19 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.518 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.6 mttt -57.8 -48.62 79.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' B' ' 227' ' ' LYS . 14.5 mt -54.66 -31.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -61.48 -49.02 78.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.3 -5.28 41.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.672 ' HE3' HG23 ' B' ' 213' ' ' ILE . 17.1 mmmt -95.74 -53.56 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -104.7 -46.2 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.15 24.2 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.0 mt -98.32 132.27 24.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.61 0.719 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 167.8 23.25 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.74 2.293 . . . . 0.0 112.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.67 19.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.03 -23.47 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 1.6 mp0 -113.14 0.58 14.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.624 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -100.8 128.17 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -133.89 133.45 41.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' B' ' 227' ' ' LYS . 1.1 mp -101.01 141.09 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.73 116.34 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.744 ' HB3' HD21 ' B' ' 250' ' ' LEU . 24.1 t80 -141.59 144.2 34.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.29 15.17 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.55 8.61 73.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.445 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 172.82 12.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.74 142.8 26.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.9 mt -96.2 161.22 14.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -118.05 157.42 26.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.02 -8.36 58.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.4 39.62 2.71 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -152.53 169.87 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.2 151.09 22.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.839 HD21 HG21 ' B' ' 226' ' ' VAL . 71.5 mt -56.24 -45.42 80.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -55.63 -26.51 44.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.55 -26.8 65.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 89.5 m-85 -98.8 7.72 45.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.9 m120 64.66 33.7 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.534 HD13 ' CD2' ' B' ' 245' ' ' PHE . 18.4 mm -69.53 109.17 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.11 168.44 9.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 145.31 9.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 58.53 28.31 16.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.412 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.6 OUTLIER -56.77 130.01 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -86.66 81.94 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.507 HD11 HD11 ' B' ' 250' ' ' LEU . 2.7 mm? -83.36 159.82 21.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.467 ' CE1' HG13 ' A' ' 74' ' ' VAL . 4.9 m170 -129.42 115.91 18.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.772 HD23 HG22 ' B' ' 207' ' ' THR . 2.0 tp -83.85 116.56 22.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 82' ' ' ILE . 15.0 t -112.9 148.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' B' ' 271' ' ' LEU . 0.3 OUTLIER -80.84 126.82 31.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' B' ' 240' ' ' GLN . 2.8 mtt-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.735 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.8 mt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.677 0.751 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 174.69 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.708 2.272 . . . . 0.0 112.324 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.12 145.99 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.62 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.05 21.03 29.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.735 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -70.37 143.73 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 111.153 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.27 110.59 22.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.77 -52.89 45.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.91 -43.24 59.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.31 -32.83 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' CD2' HD22 ' A' ' 66' ' ' LEU . 3.0 t80 -65.13 -56.99 9.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -15.29 62.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -88.14 -15.97 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -85.05 155.24 60.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.3 Cg_endo -69.83 165.15 32.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.642 2.228 . . . . 0.0 112.345 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 -33.67 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.97 -38.86 76.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 78' ' ' LEU . 8.5 mm -78.83 -44.04 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.582 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.2 mt-30 -51.46 -46.21 63.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -28.32 62.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -71.5 -41.14 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.18 -32.32 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.3 mm? -63.47 -39.03 93.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.9 m -65.2 -22.91 66.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.15 37.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.922 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.812 0.339 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.39 134.07 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.4 HD12 HD13 ' B' ' 267' ' ' LEU . 25.0 pt -117.76 150.1 19.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.2 m-85 -106.16 126.49 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.23 107.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.688 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.08 110.97 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.692 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -73.17 174.21 8.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.408 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -60.71 -22.95 64.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -90.99 17.4 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.16 49.93 72.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -118.44 107.84 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.688 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -81.09 133.03 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.656 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.27 107.19 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.54 132.29 43.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -137.28 134.09 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -88.02 102.19 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.805 HG11 HG22 ' B' ' 226' ' ' VAL . 26.2 m -127.81 178.99 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.616 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -135.15 160.18 69.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -11.09 30.18 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.403 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -26.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.65 169.44 4.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.47 157.56 17.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.1 mm -53.71 -31.96 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -60.15 -31.33 70.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -36.36 57.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.838 HG21 HD21 ' B' ' 256' ' ' LEU . 63.4 t -68.57 -48.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' B' ' 230' ' ' ILE . 7.4 ptpp? -62.1 -30.46 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.29 -50.52 73.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -56.18 -42.08 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' B' ' 227' ' ' LYS . 57.6 mt -55.55 -34.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -61.89 -47.74 83.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -71.45 -8.18 52.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.656 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -95.48 -56.37 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -99.8 -49.24 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.89 2.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.653 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.27 130.96 22.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.64 0.733 . . . . 0.0 111.087 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 163.69 37.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 0.0 112.332 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -7.64 21.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.5 -31.11 22.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -112.51 0.63 15.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.72 127.05 40.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -133.88 136.13 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.403 ' H ' HD12 ' B' ' 243' ' ' LEU . 1.1 mp -105.09 136.27 44.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.4 mm -117.91 114.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.3 t80 -144.65 143.87 30.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.68 15.08 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.83 22.26 55.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.534 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 177.99 9.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -97.9 140.93 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -97.63 147.68 24.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -105.9 166.2 10.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -82.07 -18.6 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -91.51 40.49 2.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -152.97 167.88 27.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.93 152.43 21.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 65.2 mt -55.09 -47.42 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 t -55.75 -25.4 40.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.6 -30.42 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.6 m-85 -98.65 12.49 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.61 33.79 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.539 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.2 mm -68.69 95.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.42 166.07 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.35 149.79 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 54.99 27.51 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.61 134.47 54.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.4 m -91.95 86.0 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.415 HD11 HD12 ' B' ' 261' ' ' ILE . 3.0 mp -87.03 157.19 19.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -128.42 117.24 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.692 HD23 HG22 ' B' ' 207' ' ' THR . 8.5 tp -83.67 133.26 34.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.813 HG11 HD12 ' A' ' 82' ' ' ILE . 4.9 t -134.22 142.63 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.524 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.99 134.2 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.524 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.8 mtt180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.75 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.0 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.595 0.712 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.01 11.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.6 146.16 50.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.4 20.73 38.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -70.6 143.81 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.542 ' OD2' HG23 ' A' ' 74' ' ' VAL . 66.0 t0 -104.57 109.39 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -51.32 -53.53 35.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -50.45 -39.78 48.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.542 HG23 ' OD2' ' A' ' 71' ' ' ASP . 91.0 t -74.87 -33.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -66.72 -56.08 12.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -14.03 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -87.99 -28.41 21.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 82' ' ' ILE . 27.7 mt -77.92 158.31 77.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.705 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.28 31.49 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.34 -31.91 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.23 -42.28 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 78' ' ' LEU . 37.9 mm -77.93 -27.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.55 -50.71 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.46 -32.71 74.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.57 -47.09 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.835 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG21 ' HE2' ' A' ' 75' ' ' PHE . 52.0 mt -70.35 -43.17 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -58.86 -33.79 70.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.27 -23.52 67.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.44 25.39 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.886 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.59 134.81 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -117.7 148.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.446 ' HB3' HG22 ' B' ' 212' ' ' THR . 14.4 m-85 -105.3 121.42 43.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.4 t -105.09 113.05 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -101.09 114.0 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 269' ' ' LEU . 3.6 p -77.77 170.71 16.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -22.43 54.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 69' ' ' GLY . 3.0 p -94.22 23.54 5.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 55.15 55.35 28.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -121.58 108.97 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.446 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.3 OUTLIER -81.7 132.3 35.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.684 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.29 109.6 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.3 m -77.4 127.14 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.203 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.476 HD21 HG22 ' B' ' 213' ' ' ILE . 10.7 mt -129.63 134.36 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.37 102.23 14.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 23.0 m -131.54 -179.49 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.609 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.3 mt-10 -131.24 160.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.751 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -13.74 35.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -95.93 -24.88 16.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.452 ' O ' HG22 ' B' ' 255' ' ' THR . 27.5 m-20 -61.67 173.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.01 154.56 23.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.06 -31.14 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.72 -35.17 72.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -42.13 64.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.84 HG22 HG11 ' B' ' 217' ' ' VAL . 57.3 t -62.89 -42.17 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.581 ' CD ' HD11 ' B' ' 243' ' ' LEU . 32.1 mtpt -63.97 -41.65 97.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.27 72.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.3 mttt -57.79 -49.89 75.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 62.3 mt -54.05 -32.11 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -61.68 -47.18 86.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.52 -4.68 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.684 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.1 mmmt -97.4 -56.48 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -101.51 -48.4 4.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.55 35.03 1.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.609 HD12 HD21 ' B' ' 269' ' ' LEU . 12.7 mt -107.52 130.61 22.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.669 0.747 . . . . 0.0 111.132 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 163.41 38.37 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.603 2.202 . . . . 0.0 112.415 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 -7.42 21.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.36 -29.72 24.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.36 -3.43 14.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -88.79 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -133.85 147.98 51.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.598 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.2 mp -117.35 148.87 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 243' ' ' LEU . 25.1 mm -136.89 120.31 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.079 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.731 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.7 t80 -146.03 140.77 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.95 14.31 9.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.58 15.61 63.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 171.63 14.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.71 134.1 37.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -93.78 143.58 26.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -102.2 167.69 9.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -82.26 -20.27 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.16 45.04 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.399 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -153.02 169.67 22.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.452 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.2 OUTLIER -105.42 152.08 23.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 68.2 mt -56.75 -45.14 82.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -58.17 -22.93 53.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.62 -29.85 67.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.601 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.9 m-85 -98.43 10.06 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.73 33.31 13.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.554 HD12 HD21 ' B' ' 267' ' ' LEU . 14.3 mm -68.75 97.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -88.91 167.34 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 143.5 12.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 58.69 29.61 18.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.87 130.6 47.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -83.11 84.45 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.554 HD21 HD12 ' B' ' 261' ' ' ILE . 3.6 mm? -84.33 159.62 20.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.422 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.4 m170 -129.08 127.55 41.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.704 HD23 HG22 ' B' ' 207' ' ' THR . 9.0 tp -96.65 119.52 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.768 HG11 HD12 ' A' ' 82' ' ' ILE . 12.7 t -117.82 147.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.517 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.08 137.24 37.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.517 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.2 mtt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.9 mt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 174.99 8.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -69.55 144.98 52.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.27 20.36 35.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.445 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.5 p -68.51 142.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG23 ' A' ' 74' ' ' VAL . 10.3 t0 -102.33 110.62 22.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -51.64 -52.62 46.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -51.33 -47.77 62.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.456 HG13 ' CE1' ' B' ' 268' ' ' HIS . 57.7 t -67.51 -33.2 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.18 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.6 t80 -68.05 -56.16 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -13.67 60.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -88.1 -20.21 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.051 HD13 HG21 ' A' ' 82' ' ' ILE . 36.1 mt -84.8 157.6 60.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 162.53 41.67 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.14 -33.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -58.99 -41.23 87.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.051 HG21 HD13 ' A' ' 78' ' ' LEU . 35.0 mm -78.21 -27.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.516 ' O ' HD23 ' A' ' 87' ' ' LEU . 27.7 mt-30 -69.64 -50.55 43.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.74 -32.91 74.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.69 -50.37 67.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 75' ' ' PHE . 27.7 mt -71.4 -30.73 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.0 mm? -68.28 -35.14 77.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.78 -23.75 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.87 29.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.6 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.87 133.79 38.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.459 HD11 HG13 ' B' ' 226' ' ' VAL . 17.9 pt -116.37 150.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -106.35 123.18 47.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 t -107.62 108.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 111.61 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -75.38 171.02 14.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.78 -23.2 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.1 p -93.91 25.17 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.0 51.76 44.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -116.55 108.99 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 131.34 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.194 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.583 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.95 106.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.84 126.52 31.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.409 HD21 HG22 ' B' ' 213' ' ' ILE . 9.1 mt -129.91 134.11 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.58 101.04 13.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 21.9 m -128.04 -179.48 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.173 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.57 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.4 mt-10 -134.08 160.78 67.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.715 0.769 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.35 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -21.63 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.415 ' O ' HG22 ' B' ' 255' ' ' THR . 29.3 m-20 -64.13 175.17 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.32 157.36 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.442 HG23 HD22 ' B' ' 243' ' ' LEU . 45.6 mm -54.24 -26.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -65.29 -29.38 70.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.33 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.86 HG21 HD21 ' B' ' 256' ' ' LEU . 87.0 t -69.13 -47.42 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.71 ' HA ' HD12 ' B' ' 230' ' ' ILE . 19.6 ptmt -63.46 -36.95 85.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.62 -50.27 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.706 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.6 mttm -56.46 -42.11 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' B' ' 227' ' ' LYS . 59.9 mt -56.91 -29.33 30.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -66.6 -46.51 75.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.33 -5.08 42.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.583 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.82 -52.94 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -102.94 -47.1 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.78 3.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.53 HD12 HD21 ' B' ' 269' ' ' LEU . 10.2 mt -104.58 132.23 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.695 0.76 . . . . 0.0 111.14 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 167.39 24.66 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -7.34 20.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.72 -21.66 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.0 -11.32 13.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.554 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -83.26 126.57 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.625 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.8 ttm180 -133.61 121.02 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.517 ' CB ' HD12 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -92.84 134.56 34.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.439 HD11 HD11 ' A' ' 82' ' ' ILE . 29.8 mm -121.1 119.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.746 ' HB3' HD21 ' B' ' 250' ' ' LEU . 16.7 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.54 14.91 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.18 21.85 53.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.63 169.12 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.15 139.19 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.0 mt -94.02 152.73 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.972 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -106.27 159.33 16.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.55 -0.21 41.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.01 3.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -146.37 169.87 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.415 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -103.28 151.5 22.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.86 HD21 HG21 ' B' ' 226' ' ' VAL . 72.9 mt -57.35 -35.43 69.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -67.11 -21.38 65.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.02 -32.24 68.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.477 ' CG ' HD22 ' B' ' 250' ' ' LEU . 78.8 m-85 -96.39 8.35 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 63.07 35.82 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.51 HD13 ' CD2' ' B' ' 245' ' ' PHE . 15.0 mm -68.55 95.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -83.21 162.62 21.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 146.71 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.29 24.7 13.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.5 136.44 56.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -90.2 84.3 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.462 HD11 HD11 ' B' ' 250' ' ' LEU . 4.1 mm? -82.22 160.88 22.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.456 ' CE1' HG13 ' A' ' 74' ' ' VAL . 5.6 m170 -130.66 119.59 22.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 3.5 tp -90.17 115.48 27.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 82' ' ' ILE . 22.0 t -111.54 148.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.407 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -79.9 124.46 28.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.407 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.9 mtt180 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 2.8 mt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.608 0.718 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.7 Cg_endo -69.74 174.66 9.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.48 146.41 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.98 21.25 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.66 144.76 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.422 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.1 t0 -103.74 115.59 30.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -54.76 -55.06 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.79 -45.72 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 71' ' ' ASP . 50.1 t -70.87 -32.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CZ ' HD23 ' A' ' 66' ' ' LEU . 2.7 t80 -68.35 -57.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.61 59.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -88.17 -18.89 27.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.787 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -80.69 153.6 73.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.8 Cg_endo -69.75 165.32 31.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.367 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.03 -34.07 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.07 -38.78 77.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.787 HG21 HD23 ' A' ' 78' ' ' LEU . 9.6 mm -78.89 -45.77 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -51.38 -50.77 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -32.39 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -69.54 -40.75 76.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 82' ' ' ILE . 63.3 mt -78.22 -30.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.17 -37.26 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -25.01 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.63 24.41 25.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.463 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -98.39 138.98 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.86 147.97 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.56 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.8 m-85 -104.21 123.7 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -105.07 108.12 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.697 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.51 109.24 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.85 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -69.19 174.33 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.166 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -26.01 65.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.6 p -86.24 3.05 44.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.139 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.12 49.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -94.9 108.42 20.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.335 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.697 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.03 131.11 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.701 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.38 116.23 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . 0.573 ' C ' HD12 ' B' ' 215' ' ' LEU . 7.5 m -78.48 128.11 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' B' ' 230' ' ' ILE . 10.2 mp -125.61 133.44 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.2 99.07 11.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.808 HG11 HG22 ' B' ' 226' ' ' VAL . 14.7 m -131.2 -179.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.554 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.7 mt-10 -127.99 160.56 60.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -8.84 24.62 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.685 2.256 . . . . 0.0 112.296 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.3 m -102.15 -24.8 13.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -60.46 175.03 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.68 156.67 19.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.5 mm -53.34 -30.73 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.06 -40.25 84.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -41.87 90.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.861 HG21 HD21 ' B' ' 256' ' ' LEU . 25.6 t -64.01 -46.12 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.655 ' HE3' HD11 ' B' ' 243' ' ' LEU . 22.4 ttmt -60.48 -41.91 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.91 70.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -63.07 -42.37 99.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.605 ' CG1' HD21 ' B' ' 215' ' ' LEU . 52.7 mt -57.74 -28.75 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.78 -44.73 73.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.54 -5.77 44.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.701 ' HE3' HG23 ' B' ' 213' ' ' ILE . 23.4 mmmt -99.55 -54.57 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.11 -48.0 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.37 19.81 6.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.559 HD12 HD21 ' B' ' 269' ' ' LEU . 8.1 mt -94.1 132.56 29.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.181 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.17 25.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.13 20.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.623 2.216 . . . . 0.0 112.366 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -90.07 -20.68 22.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -113.21 -14.88 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.91 126.8 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.509 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 3.2 ttm180 -134.0 118.29 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.655 HD11 ' HE3' ' B' ' 227' ' ' LYS . 0.8 OUTLIER -88.26 147.68 24.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 243' ' ' LEU . 21.8 mm -135.96 115.65 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.9 t80 -141.12 141.93 34.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.81 14.29 9.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.21 15.14 65.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -134.31 170.3 15.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . 0.446 HE21 ' NE ' ' B' ' 242' ' ' ARG . 9.5 mt-30 -94.85 128.69 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.5 mt -86.21 155.62 20.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.85 157.16 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.93 -6.51 52.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -103.45 41.22 2.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -152.65 168.52 25.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 148.33 25.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.861 HD21 HG21 ' B' ' 226' ' ' VAL . 69.6 mt -53.53 -44.39 69.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.2 t -57.68 -26.59 61.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.86 -33.2 75.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.549 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.4 6.72 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 4.2 m120 63.6 36.77 10.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.556 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.5 mm -68.73 96.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -82.99 166.58 18.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.33 149.4 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 54.22 26.27 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 143.28 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.06 86.92 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -82.36 158.88 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -133.01 115.07 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.85 HD23 HG22 ' B' ' 207' ' ' THR . 10.2 tp -85.59 134.67 34.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 82' ' ' ILE . 39.8 t -132.81 146.85 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.449 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.2 127.15 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.509 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.1 mtt180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.0 mt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 121.557 0.694 . . . . 0.0 110.949 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 86' ' ' ILE . 53.8 Cg_endo -69.77 175.01 8.68 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.754 2.303 . . . . 0.0 112.347 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.68 144.45 51.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.41 20.68 30.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -66.4 145.42 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.169 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' CG ' HG23 ' A' ' 74' ' ' VAL . 12.5 t0 -104.47 108.39 19.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -51.64 -53.28 40.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -50.11 -43.21 51.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.621 HG13 ' CE1' ' B' ' 268' ' ' HIS . 99.7 t -70.85 -32.69 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -66.72 -56.88 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -14.27 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.97 -23.25 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 82' ' ' ILE . 20.8 mt -80.85 158.96 69.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.644 0.735 . . . . 0.0 110.846 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.1 Cg_endo -69.83 165.27 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.288 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.86 -32.78 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.92 -43.52 94.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 78' ' ' LEU . 34.3 mm -78.89 -29.1 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 87' ' ' LEU . 32.9 mt-30 -69.74 -25.96 64.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -89.71 -25.97 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.83 -38.85 64.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.457 HG21 ' HE2' ' A' ' 75' ' ' PHE . 50.1 mt -78.07 -40.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 83' ' ' GLN . 0.9 OUTLIER -53.87 -37.59 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.06 -25.75 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.63 61.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.1 pttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-O 120.733 0.302 . . . . 0.0 110.953 179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.76 0.314 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.37 134.09 41.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.589 HD11 HG13 ' B' ' 226' ' ' VAL . 31.6 pt -117.03 150.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.0 m-85 -106.75 130.55 54.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -113.06 107.89 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.66 110.48 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -71.51 174.28 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.69 -25.73 63.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.55 5.8 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.206 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.35 29.34 58.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -94.73 108.83 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.586 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.06 133.5 35.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.52 111.68 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.49 128.2 33.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.441 HD21 HG22 ' B' ' 213' ' ' ILE . 8.6 mt -131.4 134.19 46.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -90.22 103.9 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.914 HG11 HG22 ' B' ' 226' ' ' VAL . 24.3 m -130.06 -179.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.9 mt-10 -132.2 160.73 66.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -12.11 32.11 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.72 2.28 . . . . 0.0 112.312 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.1 p -97.96 -25.31 15.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.42 175.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -112.8 157.64 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.464 ' CG2' HD13 ' B' ' 243' ' ' LEU . 48.5 mm -52.86 -29.24 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.49 -30.28 70.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -38.07 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.914 HG22 HG11 ' B' ' 217' ' ' VAL . 96.0 t -67.21 -51.73 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' B' ' 230' ' ' ILE . 15.4 ptmt -59.26 -35.04 72.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.25 92.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.06 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.64 -46.78 83.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 227' ' ' LYS . 44.6 mt -54.41 -32.8 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -61.79 -47.28 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.14 -5.4 44.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -97.18 -54.52 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.38 -48.72 3.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.7 34.88 1.64 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.531 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.628 HD12 HD21 ' B' ' 269' ' ' LEU . 7.7 mt -108.45 131.32 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 164.58 33.98 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.632 2.221 . . . . 0.0 112.345 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -6.98 19.9 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.76 -30.84 19.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.522 ' O ' HD22 ' B' ' 271' ' ' LEU . 2.3 mp0 -113.73 6.36 16.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.562 ' HG3' HD13 ' B' ' 269' ' ' LEU . 8.4 tt0 -116.63 125.75 52.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -134.7 148.0 50.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.828 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.543 ' HB2' HD12 ' B' ' 250' ' ' LEU . 0.4 OUTLIER -105.36 133.9 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.4 mm -111.78 123.65 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.786 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.8 t80 -151.64 144.75 24.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.936 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . 0.575 ' HB3' ' HZ3' ' B' ' 248' ' ' LYS . . . 64.14 15.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.49 8.17 74.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.441 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . 0.575 ' HZ3' ' HB3' ' B' ' 246' ' ' ALA . 0.0 OUTLIER -141.15 157.99 44.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -77.31 146.77 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -94.7 163.31 13.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -118.28 154.01 32.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -76.25 -5.54 47.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.805 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.81 39.28 2.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.506 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -152.69 169.89 21.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 152.71 21.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.192 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.853 HD21 HG21 ' B' ' 226' ' ' VAL . 52.8 mt -56.92 -43.82 81.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.0 t -60.69 -26.37 67.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -63.83 -31.65 72.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.79 9.73 42.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 63.72 34.89 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.519 HD13 ' CE2' ' B' ' 245' ' ' PHE . 15.9 mm -68.58 96.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -82.95 165.68 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 150.77 7.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 55.82 26.03 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.45 133.72 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.99 88.33 7.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.18 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.527 HD13 HD12 ' B' ' 203' ' ' ILE . 3.7 mp -89.32 158.82 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.621 ' CE1' HG13 ' A' ' 74' ' ' VAL . 8.6 m170 -127.99 125.63 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 4.6 tp -92.58 125.61 37.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 82' ' ' ILE . 11.1 t -121.78 149.26 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.55 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -91.44 144.03 25.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.55 ' N ' HD13 ' B' ' 271' ' ' LEU . 38.0 mtt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.9 mt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.68 0.752 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.56 10.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.01 146.15 51.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.15 20.7 36.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -70.43 143.57 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 111.098 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.6 t0 -102.84 108.63 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -51.68 -52.65 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.36 -38.69 54.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 HG13 ' CE1' ' B' ' 268' ' ' HIS . 97.2 t -76.15 -33.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' CD2' HD22 ' A' ' 66' ' ' LEU . 1.5 t80 -66.36 -56.3 11.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -14.85 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -87.37 -25.91 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 82' ' ' ILE . 28.7 mt -78.4 158.06 76.95 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.628 0.728 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 164.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.367 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.13 -28.36 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.3 -42.56 99.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 78' ' ' LEU . 41.8 mm -78.85 -27.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.73 -42.88 77.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -27.03 60.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.47 -41.19 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.08 -34.12 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.47 -35.82 82.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.96 20.82 41.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 ptpt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 179.989 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.77 0.319 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -98.2 134.4 41.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.692 HD12 HD13 ' B' ' 267' ' ' LEU . 23.3 pt -118.39 151.75 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.522 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.0 m-85 -106.45 123.35 47.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.7 113.0 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.3 OUTLIER -100.85 112.14 24.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.657 HG22 HD23 ' B' ' 269' ' ' LEU . 3.2 p -75.9 171.18 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.56 -22.01 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.3 23.56 5.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 53.76 38.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -120.04 108.31 14.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.522 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -81.91 130.91 35.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.171 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.641 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.7 mt -129.66 112.41 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.42 130.45 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.8 mt -132.53 134.55 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.24 104.66 17.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.828 HG11 HG22 ' B' ' 226' ' ' VAL . 28.5 m -133.91 178.48 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.602 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.1 mt-10 -128.69 160.75 61.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -13.94 35.31 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 5.7 m -96.23 -24.45 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.39 175.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.07 156.49 21.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.466 HG22 ' HE2' ' B' ' 227' ' ' LYS . 49.1 mm -53.2 -28.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -62.98 -31.19 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -38.05 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.865 HG21 HD21 ' B' ' 256' ' ' LEU . 88.2 t -67.41 -48.17 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.466 ' HE2' HG22 ' B' ' 223' ' ' ILE . 1.1 ptpt -60.59 -38.94 86.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.55 76.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.497 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.4 mttt -58.91 -48.07 82.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.1 mt -55.23 -31.02 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.062 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -62.7 -47.55 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.81 -5.08 44.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.641 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.9 mmmt -97.27 -56.5 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.81 -48.63 4.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.56 35.34 1.59 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.673 HD12 HD21 ' B' ' 269' ' ' LEU . 11.3 mt -108.17 130.54 22.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.734 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 163.44 38.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.241 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -7.95 22.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.53 -30.15 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.6 -3.22 14.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -89.31 131.35 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -133.75 147.52 51.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.536 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -116.36 146.53 42.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.536 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.9 mm -133.69 120.67 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 39.2 t80 -148.4 141.3 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.33 14.02 9.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.051 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.63 64.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.495 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -134.78 176.07 8.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.709 0.29 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.5 131.7 47.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.2 mt -86.66 158.73 19.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.45 162.13 18.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.48 0.73 41.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.48 42.86 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -152.75 167.96 27.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.0 110.835 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.57 147.25 26.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 80.2 mt -52.46 -44.37 65.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -56.61 -26.07 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -67.72 -31.41 71.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.53 6.5 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 6.0 m120 63.83 35.66 10.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.2 mm -68.54 96.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -83.22 163.9 20.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.48 148.44 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 58.98 22.84 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.544 ' OG ' HD12 ' B' ' 267' ' ' LEU . 0.1 OUTLIER -56.46 144.68 30.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -103.43 92.24 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.692 HD13 HD12 ' B' ' 203' ' ' ILE . 1.4 mp -87.31 162.75 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.543 ' CE1' HG13 ' A' ' 74' ' ' VAL . 2.5 m170 -130.14 116.04 17.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.673 HD21 HD12 ' B' ' 236' ' ' ILE . 10.5 tp -83.9 125.45 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.786 HG11 HD12 ' A' ' 82' ' ' ILE . 15.5 t -124.85 146.88 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.441 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.14 135.4 37.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.441 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.2 mtt180 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.686 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.0 mt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.598 0.713 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 173.84 10.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.681 2.254 . . . . 0.0 112.393 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.72 146.8 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.2 20.91 30.44 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -71.12 143.92 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 111.069 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -103.4 107.85 18.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -51.44 -51.8 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -51.2 -40.41 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.795 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' B' ' 268' ' ' HIS . 63.6 t -76.42 -33.04 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -66.99 -56.08 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -14.4 60.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -89.4 -23.4 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.892 HD13 HG21 ' A' ' 82' ' ' ILE . 21.9 mt -80.4 158.23 71.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.24 31.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.342 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.55 -32.31 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -58.85 -41.42 86.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.892 HG21 HD13 ' A' ' 78' ' ' LEU . 34.8 mm -79.08 -29.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.68 -30.8 68.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.23 -29.07 31.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -73.2 -38.93 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 -26.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -39.88 80.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.58 -22.15 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.09 28.84 24.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.99 134.21 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.9 pt -115.35 148.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.187 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -105.22 121.97 44.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.18 108.0 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.88 110.53 23.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.679 HG22 HD23 ' B' ' 269' ' ' LEU . 6.3 p -72.07 174.77 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -24.54 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -89.97 8.25 33.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.09 63.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -93.18 110.54 22.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.442 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.28 132.71 35.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.22 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.403 HG23 ' HE3' ' B' ' 233' ' ' LYS . 5.6 mt -129.8 106.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.74 133.12 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -137.21 134.13 35.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -89.19 100.94 13.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.946 HG11 HG22 ' B' ' 226' ' ' VAL . 22.8 m -128.49 175.73 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.598 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.2 mt-10 -128.55 160.29 63.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.628 0.727 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -11.45 30.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.736 2.291 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -27.14 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 255' ' ' THR . 14.7 m-20 -61.98 175.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -113.44 158.45 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.4 mm -52.07 -33.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.34 -31.72 66.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -36.28 46.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.946 HG22 HG11 ' B' ' 217' ' ' VAL . 99.0 t -70.43 -51.23 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.5 OUTLIER -58.97 -33.91 71.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.49 73.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.711 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.4 mttm -55.66 -43.22 76.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' B' ' 227' ' ' LYS . 63.0 mt -55.17 -32.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -63.46 -45.59 90.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -74.72 -5.83 45.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.403 ' HE3' HG23 ' B' ' 213' ' ' ILE . 0.5 OUTLIER -97.93 -48.19 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -108.37 -48.65 3.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.57 1.71 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.477 HD12 HD21 ' B' ' 269' ' ' LEU . 11.6 mt -108.36 132.13 21.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.621 0.724 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 163.4 38.44 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.362 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.378 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.19 -22.87 18.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.18 -5.56 13.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -91.68 131.3 37.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.506 ' HD3' HD11 ' A' ' 82' ' ' ILE . 9.0 ttm180 -133.89 124.49 26.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.537 ' H ' HD12 ' B' ' 243' ' ' LEU . 0.6 OUTLIER -97.42 134.18 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.13 115.19 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.66 ' HB3' HD21 ' B' ' 250' ' ' LEU . 33.9 t80 -143.04 145.19 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.53 15.45 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.26 20.63 58.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 173.88 12.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 140.82 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -96.24 153.28 17.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.41 161.79 14.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 0.37 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.75 41.44 2.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -152.5 168.57 25.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.964 0.412 . . . . 0.0 110.84 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.485 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -98.98 151.36 21.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.869 HD21 HG21 ' B' ' 226' ' ' VAL . 55.5 mt -56.42 -47.33 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.8 t -55.43 -25.15 34.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.79 -28.8 67.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.63 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.1 m-85 -98.67 11.21 39.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 63.82 33.47 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 267' ' ' LEU . 13.8 mm -71.81 97.82 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -93.52 170.21 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.72 143.89 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 58.21 29.02 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.479 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.58 126.57 27.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -84.6 83.92 7.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.533 HD11 HD12 ' B' ' 261' ' ' ILE . 2.5 mp -85.75 160.76 19.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.624 ' CE1' HG13 ' A' ' 74' ' ' VAL . 7.1 m170 -129.0 119.9 25.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.679 HD23 HG22 ' B' ' 207' ' ' THR . 6.1 tp -89.21 120.97 31.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 82' ' ' ILE . 18.8 t -118.83 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.49 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -76.19 135.2 39.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.49 ' N ' HD13 ' B' ' 271' ' ' LEU . 6.4 mtt180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.688 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.4 mt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.591 0.71 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 174.61 9.14 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 0.0 112.394 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.02 144.66 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.84 18.71 40.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 66' ' ' LEU . 8.0 p -67.62 142.88 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -103.36 109.71 21.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.41 -53.01 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -51.27 -37.84 49.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' CG ' ' A' ' 71' ' ' ASP . 93.8 t -76.62 -33.29 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.451 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.3 t80 -67.74 -56.23 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -14.78 59.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -87.55 -23.93 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.05 HD13 HG21 ' A' ' 82' ' ' ILE . 34.6 mt -81.34 157.74 70.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.709 . . . . 0.0 110.934 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.12 31.99 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.399 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.17 -34.4 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -58.15 -39.94 80.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.05 HG21 HD13 ' A' ' 78' ' ' LEU . 31.7 mm -78.56 -32.64 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.203 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -64.8 -49.9 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -65.25 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.31 -43.1 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.451 HG21 ' HE1' ' A' ' 75' ' ' PHE . 55.9 mt -78.24 -31.37 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -68.92 -35.23 76.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -65.25 -24.39 67.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.1 18.57 49.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.801 0.334 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.18 133.77 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.603 HD12 HD13 ' B' ' 267' ' ' LEU . 27.9 pt -116.25 147.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -104.99 125.05 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.04 109.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.408 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -96.65 111.15 23.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.732 HG22 HD23 ' B' ' 269' ' ' LEU . 5.4 p -71.78 174.24 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -23.4 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.3 p -89.48 7.56 35.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.59 35.2 52.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -102.81 112.35 25.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.24 134.66 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.754 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.75 110.86 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . 0.472 ' O ' HD23 ' B' ' 215' ' ' LEU . 1.0 OUTLIER -79.81 132.3 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.213 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 HG22 ' B' ' 213' ' ' ILE . 5.9 mt -136.45 134.03 37.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.28 102.17 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 1.052 HG11 HG22 ' B' ' 226' ' ' VAL . 27.7 m -127.37 179.96 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -137.18 161.34 61.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -14.74 36.81 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.727 2.285 . . . . 0.0 112.379 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -26.8 16.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.686 ' O ' HG22 ' B' ' 255' ' ' THR . 18.4 m-20 -61.98 174.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 255' ' ' THR . 0.2 OUTLIER -108.09 152.23 24.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -50.2 -30.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 -37.98 86.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.18 96.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 1.052 HG22 HG11 ' B' ' 217' ' ' VAL . 96.9 t -66.06 -50.98 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.61 ' HD3' HD22 ' B' ' 243' ' ' LEU . 12.6 mmmm -57.24 -38.68 74.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.07 -50.23 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.134 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.624 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.2 mttm -56.42 -43.17 79.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 227' ' ' LYS . 75.8 mt -56.29 -28.79 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.129 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.2 -45.96 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -74.66 -5.34 42.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.754 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.5 mmmt -97.01 -49.56 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.66 -48.27 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.75 34.9 1.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.6 mt -110.14 132.66 21.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.149 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.91 164.5 34.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.632 2.222 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -5.0 15.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.62 2.213 . . . . 0.0 112.344 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.78 -24.91 17.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -113.47 -2.15 13.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.99 129.81 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.462 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 8.1 ttm180 -133.9 122.43 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' B' ' 250' ' ' LEU . 2.3 pt? -103.5 133.81 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 82' ' ' ILE . 15.8 mm -114.68 141.52 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.738 ' HB3' HD21 ' B' ' 250' ' ' LEU . 41.7 t80 -156.64 137.4 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 14.63 9.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.82 16.16 60.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -136.75 168.6 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.01 122.09 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' B' ' 243' ' ' LEU . 2.3 mt -83.25 152.48 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 161.13 16.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.94 -12.38 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.4 3.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -152.9 170.75 19.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.356 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.686 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -102.94 158.08 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.884 HD11 HG21 ' B' ' 226' ' ' VAL . 4.1 mm? -55.29 -50.61 69.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 44.4 t -57.47 -30.45 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.83 -37.5 63.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.7 ' CD1' HD22 ' B' ' 250' ' ' LEU . 97.1 m-85 -98.85 16.48 22.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.17 32.42 19.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.701 HG21 HD12 ' B' ' 256' ' ' LEU . 8.6 mm -68.15 95.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 147.43 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 59.72 25.62 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.514 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.63 135.67 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -92.39 84.24 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.205 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.603 HD13 HD12 ' B' ' 203' ' ' ILE . 4.7 mp -86.33 162.99 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.462 ' HB3' HD21 ' A' ' 78' ' ' LEU . 5.6 m170 -129.81 129.08 43.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.732 HD23 HG22 ' B' ' 207' ' ' THR . 12.2 tp -96.06 131.21 42.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.596 HG11 HG23 ' A' ' 82' ' ' ILE . 19.6 t -133.81 148.19 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.424 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.37 128.06 33.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.462 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.8 mtt180 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.756 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 121.593 0.711 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 175.06 8.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.54 147.27 51.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.64 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.33 21.01 31.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -73.82 145.28 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.41 ' CG ' HG23 ' A' ' 74' ' ' VAL . 14.2 t0 -104.31 107.34 18.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -50.89 -53.88 28.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.44 -40.76 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' B' ' 268' ' ' HIS . 65.2 t -75.75 -32.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' HE1' HG21 ' A' ' 86' ' ' ILE . 1.4 t80 -65.7 -56.81 10.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -14.74 61.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -87.66 -23.75 24.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.066 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.83 157.55 69.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.611 0.72 . . . . 0.0 110.957 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.8 Cg_endo -69.79 165.21 31.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 0.0 112.362 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.6 -29.95 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -61.73 -40.59 95.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.066 HG21 HD13 ' A' ' 78' ' ' LEU . 40.0 mm -79.19 -27.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.7 -47.88 61.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.89 -33.05 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.92 -42.56 85.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.477 HG21 ' HE1' ' A' ' 75' ' ' PHE . 57.5 mt -77.47 -37.14 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.49 -32.83 63.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -71.48 -24.56 62.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.16 -15.61 58.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.14 135.65 42.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 265' ' ' SER . 21.5 pt -117.09 148.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.85 126.29 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.837 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -108.78 108.19 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.444 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.64 110.34 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.583 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -71.95 174.06 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -25.12 63.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -87.43 3.19 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.81 24.77 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -89.89 109.91 20.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.427 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -83.72 130.93 34.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.15 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.699 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.9 mt -128.32 113.68 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . 0.586 ' C ' HD12 ' B' ' 215' ' ' LEU . 10.2 m -78.61 127.69 32.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.659 HD21 HG13 ' B' ' 230' ' ' ILE . 10.8 mp -126.36 133.4 51.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.62 98.58 10.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.848 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -129.77 -179.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.475 ' O ' HD12 ' B' ' 256' ' ' LEU . 2.9 mt-10 -126.22 160.77 55.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -8.65 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.65 2.233 . . . . 0.0 112.384 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.77 -25.5 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.77 174.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . 0.441 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -111.76 163.38 14.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.766 HD12 HD23 ' B' ' 250' ' ' LEU . 47.8 mm -59.3 -40.79 82.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -52.37 -29.76 25.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.72 44.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.848 HG22 HG11 ' B' ' 217' ' ' VAL . 48.7 t -66.07 -47.42 85.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.9 ttmt -58.01 -39.17 77.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.81 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.816 ' HE3' HG12 ' B' ' 217' ' ' VAL . 41.0 mttm -57.2 -42.06 80.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.659 HG13 HD21 ' B' ' 215' ' ' LEU . 67.8 mt -56.37 -30.61 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -66.74 -43.92 82.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.699 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.3 mmmt -97.93 -47.96 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -109.51 -48.52 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.96 32.91 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.35 132.86 20.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.701 0.763 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 162.62 41.34 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.248 . . . . 0.0 112.363 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -4.6 14.32 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.687 2.258 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.56 -27.0 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -113.43 -2.34 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 127.43 40.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.9 ttm180 -134.31 145.51 49.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.649 HD13 ' CB ' ' B' ' 250' ' ' LEU . 0.0 OUTLIER -116.3 155.96 27.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 82' ' ' ILE . 24.5 mm -137.67 114.05 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.473 ' CD1' HD13 ' B' ' 261' ' ' ILE . 31.5 t80 -144.43 145.77 32.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.08 14.41 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.07 39.4 16.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.64 20.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.282 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.49 126.67 35.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.766 HD23 HD12 ' B' ' 223' ' ' ILE . 7.0 mp -74.47 163.69 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -131.1 157.64 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -82.2 1.06 38.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.75 37.69 3.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . 0.441 ' O ' HG22 ' B' ' 222' ' ' THR . 6.9 ttt180 -153.1 169.88 21.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 157.15 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 39.1 mt -60.01 -43.43 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t -59.14 -20.58 54.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.92 -32.13 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.551 ' CE1' HD11 ' B' ' 223' ' ' ILE . 15.8 m-85 -98.44 10.57 40.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 63.57 33.94 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.676 HD12 HD11 ' B' ' 267' ' ' LEU . 10.8 mm -68.69 100.71 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.5 175.98 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -54.95 145.06 21.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 57.95 28.5 16.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . 0.445 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -58.05 128.69 38.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -87.81 84.3 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.676 HD11 HD12 ' B' ' 261' ' ' ILE . 2.6 mp -88.57 161.12 17.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.624 ' CE1' HG13 ' A' ' 74' ' ' VAL . 8.5 m170 -127.73 121.78 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.583 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -90.17 108.03 19.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.769 HG11 HD12 ' A' ' 82' ' ' ILE . 21.8 t -104.94 148.77 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.505 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.3 OUTLIER -81.26 135.03 35.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.505 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.1 mtt180 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.752 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.5 mt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 121.628 0.728 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 175.14 8.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.686 2.258 . . . . 0.0 112.335 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.22 146.09 52.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.53 20.67 31.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.752 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.9 p -70.74 144.48 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.28 108.92 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.71 -50.69 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -39.12 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG13 ' CE1' ' B' ' 268' ' ' HIS . 88.4 t -76.63 -33.51 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.458 ' CD2' HD22 ' A' ' 66' ' ' LEU . 2.7 t80 -66.86 -56.17 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -15.07 61.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.0 -26.8 23.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.948 HD13 HG21 ' A' ' 82' ' ' ILE . 29.7 mt -79.5 158.18 74.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 153.31 68.55 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.696 2.264 . . . . 0.0 112.264 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.49 -29.83 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -60.61 -41.56 95.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 78' ' ' LEU . 30.2 mm -76.28 -30.97 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.85 -42.47 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.57 -31.72 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -74.08 -54.58 7.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.6 -40.97 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.56 -30.22 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -66.09 -24.66 66.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 9.35 63.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -94.83 133.91 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.577 HD11 HG13 ' B' ' 226' ' ' VAL . 27.0 pt -116.75 149.66 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.482 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.0 m-85 -106.07 124.34 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.47 108.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.55 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.0 113.19 24.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.746 HG22 HD23 ' B' ' 269' ' ' LEU . 5.0 p -76.91 174.7 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.68 -22.58 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -92.72 17.7 9.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.3 97.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -104.72 108.01 19.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.55 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.69 132.48 35.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.686 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.8 mt -129.49 108.79 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 130.47 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' B' ' 229' ' ' LYS . 7.7 mt -135.88 135.83 40.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -89.27 101.82 14.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.783 HG11 HG22 ' B' ' 226' ' ' VAL . 25.3 m -128.22 -178.95 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.558 ' O ' HD12 ' B' ' 256' ' ' LEU . 8.7 mt-10 -135.08 160.45 68.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -11.44 30.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.655 2.237 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.2 m -98.1 -25.54 14.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.49 ' O ' HG22 ' B' ' 255' ' ' THR . 42.0 m-20 -63.5 174.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.4 p -111.25 155.98 22.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.494 HG22 ' HZ2' ' B' ' 227' ' ' LYS . 48.2 mm -50.57 -36.92 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -53.25 -36.68 61.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -34.25 65.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.926 HG21 HD21 ' B' ' 256' ' ' LEU . 98.6 t -69.94 -46.86 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 230' ' ' ILE . 8.7 ptpp? -64.76 -35.63 81.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.932 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.97 76.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' B' ' 215' ' ' LEU . 13.3 mttt -59.31 -43.61 92.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 227' ' ' LYS . 42.3 mt -56.54 -29.45 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.86 -48.73 73.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.21 -8.08 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.686 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -96.73 -56.34 2.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -96.14 -49.48 5.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 20.9 5.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.515 HD12 HD21 ' B' ' 269' ' ' LEU . 1.1 mt -99.22 134.05 21.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.415 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.4 Cg_endo -69.85 166.42 27.79 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -7.85 22.11 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.36 -23.01 28.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 1.3 mp0 -112.47 -8.57 13.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.441 ' HG2' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -87.19 127.19 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -134.21 118.0 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.406 ' N ' HD22 ' B' ' 243' ' ' LEU . 3.7 mm? -80.36 150.37 29.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 78' ' ' LEU . 30.3 mm -137.98 114.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.185 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.479 ' HB3' HD21 ' B' ' 250' ' ' LEU . 21.5 t80 -145.87 144.41 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.84 15.08 8.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.6 5.67 78.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.498 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.5 170.4 13.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.739 0.304 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -95.2 139.8 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.502 HD22 ' CD1' ' B' ' 259' ' ' TYR . 1.5 mt -91.45 155.71 18.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -111.57 161.8 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -81.68 -0.9 44.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.46 41.07 2.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.429 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -152.85 169.75 22.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.49 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -99.47 153.25 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.926 HD21 HG21 ' B' ' 226' ' ' VAL . 41.9 mt -57.41 -44.87 84.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.6 t -58.88 -24.48 62.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.09 -32.47 73.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.814 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.502 ' CD1' HD22 ' B' ' 250' ' ' LEU . 45.2 m-85 -98.7 12.5 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 64.02 33.79 11.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.484 HD12 HD21 ' B' ' 267' ' ' LEU . 9.1 mm -70.81 95.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.87 174.14 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 147.53 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 55.94 25.02 8.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.66 133.11 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -85.32 86.04 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.484 HD21 HD12 ' B' ' 261' ' ' ILE . 4.0 mm? -81.9 157.24 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.465 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.0 m170 -130.46 121.44 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.746 HD23 HG22 ' B' ' 207' ' ' THR . 4.4 tp -91.98 127.16 37.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 82' ' ' ILE . 11.6 t -125.49 148.46 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.484 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -75.73 130.08 38.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.484 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.718 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 174.22 9.74 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 147.71 50.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.537 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.81 20.88 34.58 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.488 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.718 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.1 p -74.45 142.55 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -101.87 108.11 19.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -50.59 -51.92 43.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.18 -40.08 57.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.524 HG13 ' CE1' ' B' ' 268' ' ' HIS . 87.0 t -76.42 -32.92 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -67.71 -56.6 8.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -15.78 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -87.55 -22.78 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.96 158.04 68.05 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.729 2.286 . . . . 0.0 112.324 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.93 -31.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.13 -38.76 87.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.033 HG21 HD13 ' A' ' 78' ' ' LEU . 33.0 mm -78.79 -31.08 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -67.73 -49.94 59.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -32.9 74.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.6 -43.4 80.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.7 mt -74.6 -44.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.75 -30.18 71.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -64.91 -27.6 68.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.97 41.82 5.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -95.51 138.5 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.67 147.17 24.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.465 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.7 m-85 -105.36 127.51 53.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 16.2 t -109.86 108.19 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.555 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.24 112.47 24.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.699 HG22 HD23 ' B' ' 269' ' ' LEU . 5.6 p -74.92 175.5 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -59.07 -24.45 62.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -89.96 8.38 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.17 69.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -89.66 108.49 19.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.555 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.43 131.85 35.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.181 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.714 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -128.91 115.23 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . 0.599 ' C ' HD12 ' B' ' 215' ' ' LEU . 5.8 m -79.44 128.46 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.638 ' CD1' HG22 ' B' ' 213' ' ' ILE . 10.8 mp -126.67 134.1 50.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.13 98.86 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.835 HG11 HG22 ' B' ' 226' ' ' VAL . 18.9 m -131.37 -179.04 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.587 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.3 mt-10 -130.58 160.56 65.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -9.29 25.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.248 . . . . 0.0 112.39 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -100.6 -24.88 14.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . 0.478 ' O ' HG22 ' B' ' 255' ' ' THR . 17.9 m-20 -63.4 175.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.0 157.93 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.07 -32.52 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -56.74 -35.85 69.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -43.11 63.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.835 HG22 HG11 ' B' ' 217' ' ' VAL . 21.7 t -63.15 -43.38 98.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.618 ' CE ' HD11 ' B' ' 243' ' ' LEU . 17.1 ttmt -61.26 -42.14 98.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.921 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.51 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -63.66 -42.21 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.611 ' CG1' HD21 ' B' ' 215' ' ' LEU . 45.1 mt -59.14 -29.37 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.148 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -67.06 -44.73 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.38 -4.98 45.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.714 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.0 mmmt -99.29 -56.01 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -98.79 -48.66 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.66 19.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' B' ' 237' ' ' PRO . 0.9 OUTLIER -101.14 134.39 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.585 0.707 . . . . 0.0 111.142 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.5 Cg_endo -69.79 169.6 18.57 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.68 2.253 . . . . 0.0 112.302 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -7.2 20.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.35 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.85 -19.03 25.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.21 -15.54 12.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.434 ' OE1' HG22 ' B' ' 230' ' ' ILE . 0.7 OUTLIER -86.97 129.67 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . 0.656 ' HD3' HD11 ' A' ' 82' ' ' ILE . 10.9 ttm180 -132.93 112.49 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' B' ' 227' ' ' LYS . 0.7 OUTLIER -83.72 134.67 34.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 82' ' ' ILE . 23.0 mm -121.41 116.2 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.712 ' HB3' HD21 ' B' ' 250' ' ' LEU . 17.9 t80 -140.45 142.56 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.17 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.06 12.56 67.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 174.14 10.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -94.74 144.07 25.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.1 mt -97.68 155.59 16.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -111.63 159.95 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.67 -1.78 43.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -109.55 40.66 2.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -152.59 169.39 22.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . 0.478 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -100.25 152.73 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.824 HD21 HG21 ' B' ' 226' ' ' VAL . 63.8 mt -57.8 -47.06 83.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -55.27 -26.0 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -68.13 -27.64 66.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 87.7 m-85 -98.58 9.12 43.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.47 32.72 11.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.513 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.2 mm -70.04 97.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -89.5 167.31 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -51.2 141.46 14.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 59.13 27.4 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 131.64 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.32 88.87 7.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.19 160.1 17.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.524 ' CE1' HG13 ' A' ' 74' ' ' VAL . 5.7 m170 -129.67 127.58 40.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.699 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -99.69 118.31 35.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.949 HG11 HG23 ' A' ' 82' ' ' ILE . 4.3 t -116.64 141.13 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.101 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.429 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.73 128.08 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.429 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.7 mtt180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.666 ' HB3' HG11 ' A' ' 70' ' ' VAL . 1.1 mt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 121.641 0.734 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 172.78 11.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.36 145.92 52.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.95 36.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.1 p -70.73 141.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.182 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -50.29 -56.29 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -50.16 -62.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.765 HG13 ' CE1' ' B' ' 268' ' ' HIS . 44.4 t -53.05 -32.18 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.158 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 66' ' ' LEU . 15.7 t80 -63.72 -57.84 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -72.37 -7.67 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -89.33 -18.22 27.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 82' ' ' ILE . 41.5 mt -90.03 158.0 44.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 159.14 54.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.37 -29.28 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.06 -40.11 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 1.053 HG21 HD13 ' A' ' 78' ' ' LEU . 49.7 mm -79.32 -43.08 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -55.6 -50.7 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -64.08 -33.28 75.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.17 -43.1 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.456 ' CD1' HG22 ' A' ' 82' ' ' ILE . 47.2 mt -72.71 -35.47 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -33.6 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.944 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -23.74 67.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.72 58.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.784 0.326 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.74 133.97 37.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' ILE . . . . . 0.629 HD11 HG13 ' B' ' 226' ' ' VAL . 17.7 pt -116.64 148.56 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' PHE . . . . . 0.477 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.5 m-85 -105.3 126.52 52.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.07 107.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' LYS . . . . . 0.469 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -97.97 112.54 24.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' THR . . . . . 0.702 HG22 HD23 ' B' ' 269' ' ' LEU . 2.7 p -77.14 172.44 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.493 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.3 OUTLIER -58.96 -22.03 59.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.9 p -94.29 25.29 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.52 50.84 51.56 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -118.25 108.24 14.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -82.1 134.41 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' ILE . . . . . 0.7 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -130.15 108.17 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.07 130.15 37.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.82 133.65 41.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.8 100.29 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.891 HG11 HG22 ' B' ' 226' ' ' VAL . 16.3 m -129.86 -179.38 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.1 mt-10 -129.84 160.81 63.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -12.04 32.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.3 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.19 175.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.8 156.07 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . 0.4 HD13 HD23 ' B' ' 256' ' ' LEU . 49.8 mm -51.38 -30.28 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.43 -38.79 85.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' ASN . . . . . 0.477 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -66.31 -38.78 88.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 217' ' ' VAL . 48.0 t -73.17 -36.92 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' LYS . . . . . 0.62 ' HA ' HD12 ' B' ' 230' ' ' ILE . 17.3 ttpp -71.01 -38.81 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.01 75.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' LYS . . . . . 0.784 ' HE3' HG12 ' B' ' 217' ' ' VAL . 42.8 mttm -54.52 -45.24 73.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' B' ' 227' ' ' LYS . 46.3 mt -53.93 -33.35 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -63.64 -46.64 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.59 -6.08 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . 0.7 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.9 mmmt -96.87 -53.73 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -101.99 -49.05 4.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.01 31.68 2.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' ILE . . . . . 0.64 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.68 130.65 22.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.519 0.676 . . . . 0.0 111.142 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 162.96 40.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.629 2.219 . . . . 0.0 112.38 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.4 -28.85 23.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.8 -2.3 14.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' GLN . . . . . 0.498 ' HG3' HD13 ' B' ' 269' ' ' LEU . 12.4 tt0 -94.76 128.39 41.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -133.33 136.98 45.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.6 155.83 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 82' ' ' ILE . 21.8 mm -140.07 115.4 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.3 t80 -146.35 143.83 29.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.45 14.92 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.29 14.84 70.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -132.6 -175.64 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.308 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -107.51 125.96 51.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.9 mt -82.54 160.27 22.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.48 161.41 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.17 0.58 40.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.12 43.82 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -152.52 169.4 22.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.47 147.06 26.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.771 HD21 HG21 ' B' ' 226' ' ' VAL . 70.6 mt -52.65 -44.98 66.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -57.45 -28.0 62.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.2 -32.82 74.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 259' ' ' TYR . . . . . 0.543 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.8 m-85 -96.63 8.18 44.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.989 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.0 m120 63.32 36.22 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 261' ' ' ILE . . . . . 0.557 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.6 mm -68.79 95.56 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -83.05 163.84 20.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.16 145.55 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.07 26.46 15.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 135.51 54.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -89.2 83.91 6.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 267' ' ' LEU . . . . . 0.53 HD21 HD12 ' B' ' 261' ' ' ILE . 3.8 mm? -82.86 155.51 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 268' ' ' HIS . . . . . 0.765 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.0 m170 -128.93 121.91 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 269' ' ' LEU . . . . . 0.702 HD23 HG22 ' B' ' 207' ' ' THR . 2.9 tp -91.72 126.3 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 270' ' ' VAL . . . . . 0.779 HG11 HD12 ' A' ' 82' ' ' ILE . 21.9 t -123.78 148.15 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 271' ' ' LEU . . . . . 0.483 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -77.79 134.85 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 272' ' ' ARG . . . . . 0.483 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.8 mtt180 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo . . . . . 0 C--O 1.231 0.155 0 CA-C-O 120.818 0.257 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD22 ' CD2' ' A' ' 75' ' ' PHE . 12.1 mt -108.17 45.87 0.99 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 23.8 m -91.68 -24.43 19.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.5 m -120.23 93.57 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.825 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.8 mt -111.37 153.27 44.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.626 0.727 . . . . 0.0 110.964 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 174.41 9.59 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.27 . . . . 0.0 112.309 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -69.74 145.05 52.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.548 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.18 20.7 36.52 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.517 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.8 p -69.09 144.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.854 0.359 . . . . 0.0 111.157 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -103.86 108.43 19.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -51.27 -50.16 59.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -53.07 -45.98 68.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.526 HG13 ' CE1' ' B' ' 268' ' ' HIS . 64.3 t -69.38 -33.21 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.182 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.618 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.5 t80 -66.77 -56.32 10.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.53 -13.82 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -88.66 -27.49 21.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.98 HD13 HG21 ' A' ' 82' ' ' ILE . 22.1 mt -75.66 158.84 82.58 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.651 0.738 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.14 31.97 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.359 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.75 -29.79 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.075 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.86 -42.82 99.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.98 HG21 HD13 ' A' ' 78' ' ' LEU . 39.2 mm -78.84 -29.55 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.152 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.448 ' O ' HD23 ' A' ' 87' ' ' LEU . 47.8 mt-30 -69.61 -26.58 64.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -88.68 -25.81 22.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.5 -40.14 67.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.881 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.439 HG21 ' HE1' ' A' ' 75' ' ' PHE . 17.1 mt -78.15 -30.86 16.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.174 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.7 mm? -70.69 -33.52 70.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.44 -21.3 66.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.846 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.78 23.98 40.21 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.414 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' NZ ' HD21 ' B' ' 273' ' ' LEU . 1.7 ptmt -111.86 -177.98 3.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.2 m 53.89 70.5 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.868 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.7 ptt180 -132.82 97.17 3.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -110.93 -44.59 3.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.806 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -53.65 -61.6 2.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -116.33 174.33 6.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -99.43 129.71 45.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.92 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.32 152.43 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -103.75 75.3 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.2 tt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.736 0.303 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -97.86 134.05 41.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.443 HD11 HG13 ' B' ' 226' ' ' VAL . 31.7 pt -117.24 149.35 19.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.103 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.527 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.1 m-85 -105.13 124.25 49.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . 0.403 HG21 HD11 ' B' ' 215' ' ' LEU . 21.3 t -106.23 108.1 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.087 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.719 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.86 110.85 23.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.672 HG22 HD23 ' B' ' 269' ' ' LEU . 5.2 p -73.6 173.36 9.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.127 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.37 -23.86 58.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.882 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -90.27 12.24 18.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.204 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 69.08 31.69 72.4 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.533 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -97.25 108.59 21.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.952 0.406 . . . . 0.0 110.882 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.719 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.34 133.36 35.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.74 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.53 115.38 34.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.52 125.16 30.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.403 HD11 HG21 ' B' ' 205' ' ' VAL . 9.9 mt -127.72 134.31 49.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -90.09 102.93 15.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.757 HG11 HG22 ' B' ' 226' ' ' VAL . 18.1 m -131.19 -179.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.136 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.9 mt-10 -132.75 160.6 67.79 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.634 0.73 . . . . 0.0 110.924 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 -10.67 29.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.25 . . . . 0.0 112.398 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.1 m -98.18 -24.89 15.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 255' ' ' THR . 19.3 m-20 -63.91 174.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -110.86 156.52 21.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.181 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 49.5 mm -51.56 -34.73 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.138 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -55.68 -35.42 66.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.8 -39.92 69.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.781 HG21 HD21 ' B' ' 256' ' ' LEU . 46.2 t -65.66 -42.42 92.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.145 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.785 ' HG3' HD11 ' B' ' 243' ' ' LEU . 3.2 mtmm -63.65 -42.4 98.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.964 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -42.61 73.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt -56.64 -50.1 73.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 49.0 mt -53.6 -31.17 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -63.57 -45.71 89.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.932 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.77 -4.6 44.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.876 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.74 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.5 mmmt -99.09 -56.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -100.31 -48.43 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.14 32.26 2.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.531 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.674 HD12 HD21 ' B' ' 269' ' ' LEU . 10.7 mt -104.64 130.04 23.92 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.654 0.74 . . . . 0.0 111.088 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.82 164.31 35.07 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.706 2.271 . . . . 0.0 112.385 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -8.04 22.59 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.14 -30.35 24.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -112.53 -1.38 14.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.965 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -92.45 128.78 38.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.571 ' HD3' HD11 ' A' ' 82' ' ' ILE . 12.3 ttm180 -133.75 140.96 47.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.785 HD11 ' HG3' ' B' ' 227' ' ' LYS . 2.7 mp -108.4 151.06 26.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.575 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.5 mm -137.9 117.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.809 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.4 t80 -148.22 143.32 26.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.79 13.82 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.077 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.28 3.88 74.94 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.515 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.493 ' CE ' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -135.86 158.5 44.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.745 0.307 . . . . 0.0 110.862 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.02 145.54 33.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.941 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.809 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.4 mt -96.14 163.24 13.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -119.73 157.27 28.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -76.94 -13.64 59.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.932 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.47 39.52 2.79 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.5 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.5 ttt180 -152.58 169.72 21.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.939 0.4 . . . . 0.0 110.816 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.464 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -102.34 152.98 20.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.134 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.781 HD21 HG21 ' B' ' 226' ' ' VAL . 32.8 mt -56.5 -46.47 80.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.6 t -58.87 -25.07 62.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -64.02 -32.14 73.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.452 ' CG ' HD22 ' B' ' 250' ' ' LEU . 71.9 m-85 -98.64 11.88 37.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.978 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.4 m120 64.06 31.74 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.949 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.626 HG21 HD22 ' B' ' 256' ' ' LEU . 13.4 mm -68.89 95.58 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -84.5 -179.09 7.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.99 150.33 48.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 54.45 27.02 7.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.62 134.63 54.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.899 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -87.47 86.78 7.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.117 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.62 158.33 20.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.526 ' CE1' HG13 ' A' ' 74' ' ' VAL . 4.0 m170 -130.76 117.67 19.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.86 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.674 HD21 HD12 ' B' ' 236' ' ' ILE . 8.5 tp -87.11 128.98 35.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 82' ' ' ILE . 13.9 t -126.59 148.19 31.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.412 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -81.08 127.36 32.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.882 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.412 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.4 mtt180 -85.81 167.84 14.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.451 HD21 ' NZ ' ' A' ' 90' ' ' LYS . 3.8 mm? -49.24 123.07 6.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.79 154.53 40.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.98 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -51.66 -56.68 14.65 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.398 -179.844 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo . . . . . 0 C--O 1.232 0.221 0 CA-C-O 120.872 0.28 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.624 ' HG ' HD21 ' A' ' 66' ' ' LEU . 3.0 mm? -79.99 178.53 8.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.953 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 67.1 m -75.6 -59.1 2.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.794 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.4 m -144.55 109.35 4.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.708 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.1 mt -111.33 152.25 43.74 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.654 0.74 . . . . 0.0 110.922 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 174.52 9.41 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.624 2.216 . . . . 0.0 112.345 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -70.0 145.28 51.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.39 20.72 38.25 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.708 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -70.27 144.9 13.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.735 0.302 . . . . 0.0 111.184 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.569 ' CG ' HG23 ' A' ' 74' ' ' VAL . 11.1 t0 -102.76 106.37 16.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.605 ' NE2' HD23 ' A' ' 63' ' ' LEU . 15.4 tp60 -50.64 -52.65 37.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -51.55 -37.23 48.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.662 HG13 ' CE1' ' B' ' 268' ' ' HIS . 74.7 t -76.85 -33.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.98 -56.57 14.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -13.79 60.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -90.17 -18.27 26.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.935 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.846 HD13 HG21 ' A' ' 82' ' ' ILE . 41.3 mt -87.92 157.39 51.64 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.59 0.709 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 52.9 Cg_endo -69.79 165.33 31.37 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.383 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.02 -27.94 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.099 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -60.15 -43.42 95.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.846 HG21 HD13 ' A' ' 78' ' ' LEU . 44.7 mm -79.39 -28.9 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.497 ' O ' HD23 ' A' ' 87' ' ' LEU . 34.1 mt-30 -69.59 -23.95 63.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.923 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -92.2 -26.7 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.17 -37.85 63.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.05 -42.91 28.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.159 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.6 mm? -56.71 -34.46 67.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 t -65.16 -21.9 66.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.98 14.93 63.77 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.792 ' HD3' HD11 ' B' ' 273' ' ' LEU . 3.0 ptpt -98.48 -176.48 3.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 51.09 70.14 0.57 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -131.15 69.52 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.532 ' HB3' HD11 ' B' ' 271' ' ' LEU . 7.5 tm-20 -100.02 -35.72 9.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.585 ' CE ' HD11 ' B' ' 236' ' ' ILE . 0.0 OUTLIER -51.33 -50.28 59.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.915 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -133.29 174.27 10.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -117.48 157.55 26.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.27 105.86 0.24 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.511 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -81.11 95.46 6.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.849 0.357 . . . . 0.0 110.856 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 179.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.749 0.309 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -95.54 134.18 38.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.446 HD11 HG13 ' B' ' 226' ' ' VAL . 25.8 pt -117.04 148.91 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.136 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.438 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.7 m-85 -105.49 124.47 49.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . 0.412 HG12 ' HB2' ' B' ' 269' ' ' LEU . 11.3 t -107.22 108.16 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.15 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.611 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.97 109.45 22.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.647 HG22 ' HB3' ' B' ' 269' ' ' LEU . 6.1 p -71.63 174.71 6.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.111 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.67 -25.42 62.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 4.7 p -88.75 10.81 19.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.52 30.16 69.15 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.457 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.8 tptm -94.58 108.71 20.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.87 0.367 . . . . 0.0 110.869 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.611 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.22 132.54 35.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.167 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.504 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -129.48 111.45 22.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.062 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.02 128.54 34.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.125 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 9.6 mt -132.36 134.19 44.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -90.21 103.03 15.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.859 HG11 HG22 ' B' ' 226' ' ' VAL . 21.7 m -130.77 -179.51 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.4 mt-10 -132.21 160.32 68.45 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.649 0.738 . . . . 0.0 110.907 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.74 -12.55 33.17 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.698 2.265 . . . . 0.0 112.359 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 51.8 p -97.11 -24.79 15.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.4 ' O ' HG22 ' B' ' 255' ' ' THR . 41.0 m-20 -61.65 175.1 0.67 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.23 156.85 20.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.137 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.3 mm -53.56 -27.7 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.137 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -63.64 -29.85 71.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -37.56 44.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.868 HG21 HD21 ' B' ' 256' ' ' LEU . 94.9 t -67.87 -49.73 66.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.156 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -60.72 -34.61 74.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.82 -43.44 98.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.417 ' HE3' HG12 ' B' ' 217' ' ' VAL . 9.4 mttt -57.24 -46.91 82.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' B' ' 269' ' ' LEU . 71.1 mt -53.76 -36.87 30.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.102 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -58.7 -44.87 90.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.852 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.69 -4.75 44.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.858 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.504 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.0 mmmt -98.44 -56.6 2.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -101.4 -47.87 4.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.945 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.11 26.48 3.77 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.486 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.585 HD11 ' CE ' ' A' ' 94' ' ' LYS . 13.7 mt -98.08 128.88 32.28 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 0.0 111.124 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 164.3 35.14 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.575 2.184 . . . . 0.0 112.355 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -8.26 23.16 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.652 2.235 . . . . 0.0 112.338 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -84.94 -29.37 25.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.893 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.55 -5.34 14.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.451 ' OE1' HD12 ' B' ' 230' ' ' ILE . 11.1 tt0 -88.92 130.44 35.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.447 ' HD3' HD11 ' A' ' 82' ' ' ILE . 3.3 ttm180 -133.81 141.18 47.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.612 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -109.87 149.79 29.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.612 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.8 mm -135.85 118.78 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.166 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.713 ' HB3' HD21 ' B' ' 250' ' ' LEU . 25.8 t80 -149.27 142.71 25.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.7 14.91 9.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.142 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.73 17.95 64.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.45 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.34 171.62 13.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.88 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -91.43 139.53 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.713 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -94.17 151.26 19.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.885 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -109.43 155.32 21.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.874 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -78.25 -4.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.911 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -106.12 39.55 2.82 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.463 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -152.44 169.44 22.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.816 0.341 . . . . 0.0 110.913 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.4 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -99.72 152.08 20.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.162 -179.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.868 HD21 HG21 ' B' ' 226' ' ' VAL . 64.9 mt -56.33 -43.8 79.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.931 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.7 t -57.36 -23.63 50.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -66.28 -32.97 74.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.841 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.589 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.9 m-85 -97.41 10.25 40.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.969 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 29.4 m-20 62.45 35.79 14.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.934 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.53 HD13 ' CD2' ' B' ' 245' ' ' PHE . 14.5 mm -68.69 95.87 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -84.87 167.37 16.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.57 148.55 9.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.923 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 55.56 26.56 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.63 135.13 54.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.5 m -89.27 85.47 6.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.145 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.461 HD11 HD11 ' B' ' 250' ' ' LEU . 3.9 mm? -84.02 159.29 21.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.662 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.9 m170 -129.32 129.56 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.647 ' HB3' HG22 ' B' ' 207' ' ' THR . 5.7 tt -96.03 134.7 38.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.817 HG11 HG23 ' A' ' 82' ' ' ILE . 17.2 t -133.89 140.35 46.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.118 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.532 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -75.18 129.8 38.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.434 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.5 mtt180 -90.28 165.5 13.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.792 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.9 mm? -51.72 124.67 12.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.913 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -95.37 137.22 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.942 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 146.39 -17.81 1.68 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.461 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.459 -179.958 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 N--CA 1.465 -0.165 0 CA-C-O 120.793 0.247 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 75' ' ' PHE . 14.6 mt -106.15 48.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 56.5 m -89.76 -26.71 20.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.2 m -118.17 93.72 4.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.725 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.3 mt -111.2 153.58 43.92 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.681 0.753 . . . . 0.0 110.916 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 173.76 10.53 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.73 2.287 . . . . 0.0 112.265 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.04 145.26 51.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.868 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.3 20.69 37.45 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.552 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.725 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.04 144.17 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.36 . . . . 0.0 111.081 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.464 ' OD2' HG23 ' A' ' 74' ' ' VAL . 62.6 t0 -103.55 108.96 20.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.809 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 31.7 tp60 -51.25 -52.05 48.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -51.41 -45.72 62.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG13 ' CE1' ' B' ' 268' ' ' HIS . 67.0 t -69.72 -33.13 54.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.615 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.2 t80 -67.14 -56.02 11.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -13.84 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.844 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -88.83 -25.93 21.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.045 HD13 HG21 ' A' ' 82' ' ' ILE . 24.3 mt -78.43 158.67 76.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.657 0.742 . . . . 0.0 110.928 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 165.13 32.05 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.723 2.282 . . . . 0.0 112.29 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 p -59.62 -30.42 44.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -61.96 -41.38 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.045 HG21 HD13 ' A' ' 78' ' ' LEU . 39.6 mm -78.88 -27.89 13.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.577 ' OE1' HD21 ' A' ' 63' ' ' LEU . 17.7 mt-30 -69.67 -45.69 67.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.85 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -69.77 -29.44 66.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -67.81 -43.02 80.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.475 HG21 ' HE1' ' A' ' 75' ' ' PHE . 39.4 mt -77.91 -30.6 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.8 mm? -70.2 -35.72 74.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -65.45 -20.78 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.84 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.85 32.14 18.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.532 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.567 ' CE ' HD11 ' B' ' 273' ' ' LEU . 0.9 OUTLIER -114.42 179.42 3.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.779 0.323 . . . . 0.0 110.882 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.0 p 45.72 65.64 1.1 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.907 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -140.18 82.54 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -23.77 8.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.853 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -51.54 -48.48 63.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -127.37 174.41 9.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 46.0 mm-40 -63.27 127.62 32.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.834 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.92 179.72 1.44 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.529 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.64 88.41 2.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.948 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.1 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.965 179.907 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -94.84 137.78 33.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.895 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 10.0 pt -120.59 147.19 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.161 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.46 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.3 m-85 -105.54 121.93 44.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.927 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 19.7 t -105.7 107.95 23.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.108 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.649 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.29 109.55 22.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 5.8 p -71.43 172.41 9.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.62 -24.0 60.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER -89.21 10.12 23.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.094 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 70.77 35.3 66.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.508 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -101.89 108.88 20.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.844 0.354 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.649 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.02 132.71 35.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.1 mt -128.52 110.69 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.076 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.92 127.52 32.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.444 HD11 HG12 ' B' ' 230' ' ' ILE . 7.9 mt -133.08 134.1 43.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -89.36 102.4 15.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.927 HG11 HG22 ' B' ' 226' ' ' VAL . 22.9 m -128.03 -179.24 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.597 ' O ' HD12 ' B' ' 256' ' ' LEU . 9.7 mt-10 -134.75 160.38 68.65 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.628 0.728 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 -11.23 30.4 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.691 2.26 . . . . 0.0 112.304 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 p -97.16 -26.42 14.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -63.76 173.14 1.86 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.888 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.02 156.96 20.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.111 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 46.1 mm -52.14 -31.22 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.127 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -59.96 -32.57 70.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -38.17 56.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.927 HG22 HG11 ' B' ' 217' ' ' VAL . 65.1 t -67.11 -49.06 76.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.167 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' B' ' 230' ' ' ILE . 1.7 ptpt -59.32 -37.02 76.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.884 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -50.18 70.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.719 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.0 mttm -56.5 -43.06 79.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.579 HD12 ' HA ' ' B' ' 227' ' ' LYS . 80.5 mt -55.33 -34.31 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.168 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -62.11 -48.08 81.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.923 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -71.12 -8.36 52.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.862 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -95.21 -56.33 2.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -100.35 -49.2 4.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.33 33.32 1.97 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.429 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.682 HD12 HD21 ' B' ' 269' ' ' LEU . 9.5 mt -106.41 130.68 22.57 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.605 0.717 . . . . 0.0 111.19 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.73 163.31 38.72 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.69 2.26 . . . . 0.0 112.4 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.64 -8.18 22.93 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -84.95 -30.44 24.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.919 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -112.66 -1.67 14.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -91.97 126.85 37.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -133.79 135.17 43.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 244' ' ' ILE . 0.7 OUTLIER -101.14 155.92 17.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.919 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.558 HD11 HD11 ' A' ' 82' ' ' ILE . 29.0 mm -140.56 117.36 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.149 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.749 ' HB3' HD21 ' B' ' 250' ' ' LEU . 35.1 t80 -146.6 145.05 29.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.927 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.83 14.46 9.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.63 15.51 68.08 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.512 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmt -133.6 -176.07 4.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.735 0.302 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -107.58 127.87 54.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.6 mt -84.48 153.06 23.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -114.34 163.31 15.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.9 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -81.97 -0.47 44.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.68 39.89 2.73 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.54 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -152.52 164.98 36.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.905 0.383 . . . . 0.0 110.896 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.32 150.49 20.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.142 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.797 HD21 HG21 ' B' ' 226' ' ' VAL . 52.2 mt -54.73 -48.78 72.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -54.72 -26.18 32.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -66.4 -28.2 68.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.924 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.639 ' CG ' HD22 ' B' ' 250' ' ' LEU . 86.7 m-85 -98.86 11.88 37.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.871 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 63.96 31.25 13.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.485 HD12 HD11 ' B' ' 267' ' ' LEU . 16.0 mm -68.73 106.86 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.9 168.43 9.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.942 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.18 142.0 13.48 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 59.05 28.86 18.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.66 131.57 51.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.55 87.8 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.128 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.485 HD11 HD12 ' B' ' 261' ' ' ILE . 2.9 mp -89.3 159.25 17.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.508 ' CE1' HG13 ' A' ' 74' ' ' VAL . 7.5 m170 -128.66 122.98 32.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.682 HD21 HD12 ' B' ' 236' ' ' ILE . 8.7 tp -90.07 122.4 33.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.994 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.746 HG11 HD12 ' A' ' 82' ' ' ILE . 13.8 t -120.59 147.17 24.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.476 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.76 132.09 36.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.476 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.9 mtt180 -91.09 163.17 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.567 HD11 ' CE ' ' A' ' 90' ' ' LYS . 4.4 mm? -50.43 128.92 21.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.942 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 43.7 tpt85 -100.36 129.17 46.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -89.56 48.7 3.35 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.455 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.428 -179.891 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.843 0.268 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.645 HD22 ' CD2' ' A' ' 75' ' ' PHE . 10.4 mt -110.67 47.01 1.0 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.946 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.03 -22.73 17.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.58 93.77 4.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.837 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.709 ' HB3' HG11 ' A' ' 70' ' ' VAL . 7.4 mt -111.28 153.02 44.21 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.62 0.724 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.83 175.16 8.54 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.288 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -70.18 145.09 51.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.96 20.63 34.63 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.531 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.709 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.5 p -68.65 144.6 14.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.777 0.322 . . . . 0.0 111.144 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -104.28 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -51.33 -51.29 55.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -51.44 -39.81 58.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.952 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' CE1' ' B' ' 268' ' ' HIS . 94.8 t -76.36 -33.31 23.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.078 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.645 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.6 t80 -67.11 -56.14 11.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -14.8 60.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.17 -25.57 21.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.894 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.939 HD13 HG21 ' A' ' 82' ' ' ILE . 21.4 mt -77.58 157.82 79.43 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.635 0.731 . . . . 0.0 110.892 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.6 Cg_endo -69.76 165.27 31.53 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.702 2.268 . . . . 0.0 112.363 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.4 p -60.77 -26.89 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.0 m-20 -64.73 -42.56 95.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.939 HG21 HD13 ' A' ' 78' ' ' LEU . 41.2 mm -78.41 -29.58 15.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.131 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -69.73 -25.89 64.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.97 -24.69 21.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -72.29 -39.74 68.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.826 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 13.1 mt -78.26 -34.86 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -67.15 -32.43 73.52 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.924 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -67.83 -18.4 64.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.59 37.38 17.22 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CE ' HD11 ' B' ' 273' ' ' LEU . 1.5 ptmt -119.36 -175.91 3.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.8 p 46.8 66.02 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.818 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.0 81.8 1.84 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HG2' HD11 ' B' ' 271' ' ' LEU . 0.5 OUTLIER -107.87 -19.92 13.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -68.93 -57.13 5.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.92 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -120.45 173.97 6.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -80.4 111.23 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.99 168.41 3.01 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.453 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.65 ' C ' HD12 ' A' ' 99' ' ' LEU . 6.2 mmtp -103.4 133.36 48.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.847 0.356 . . . . 0.0 110.837 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 98' ' ' LYS . 10.3 mp . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.669 0.271 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -99.06 134.1 42.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 27.5 pt -117.38 149.9 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.094 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.0 m-85 -106.58 128.56 54.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.852 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.6 t -110.29 107.75 23.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.634 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.92 111.04 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.633 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -72.76 174.26 7.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -25.53 64.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.4 p -88.04 8.14 28.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.11 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.7 31.98 59.85 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.523 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.3 tptm -97.52 108.88 21.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.853 0.358 . . . . 0.0 110.884 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.634 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.26 133.81 35.26 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.56 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.7 mt -129.95 111.53 21.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.9 128.14 32.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.492 HD21 HG22 ' B' ' 213' ' ' ILE . 9.9 mt -130.71 134.25 46.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.945 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -91.1 104.02 16.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.981 HG11 HG22 ' B' ' 226' ' ' VAL . 25.1 m -131.61 -179.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.108 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.564 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.5 mt-10 -131.35 160.87 65.21 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.649 0.738 . . . . 0.0 110.899 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.76 -11.73 31.44 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.676 2.25 . . . . 0.0 112.362 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -95.32 -28.98 14.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -60.4 175.5 0.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.503 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.8 OUTLIER -114.6 157.97 22.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.161 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 40.7 mm -51.13 -25.67 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.122 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -63.69 -35.47 80.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.923 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -73.21 -37.64 66.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.881 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.981 HG22 HG11 ' B' ' 217' ' ' VAL . 91.0 t -69.17 -39.16 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.197 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.39 -39.83 92.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.78 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.152 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.529 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.5 mttt -56.56 -50.15 72.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 69.9 mt -53.31 -33.41 20.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.128 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -60.41 -48.58 81.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -72.6 -7.34 49.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.56 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.6 mmmt -95.37 -54.59 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -104.34 -48.91 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.38 29.97 2.8 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.494 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.492 HD12 HD21 ' B' ' 269' ' ' LEU . 9.2 mt -102.52 130.54 23.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.515 0.674 . . . . 0.0 111.105 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 163.78 36.98 Favored 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.703 2.268 . . . . 0.0 112.428 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -7.88 22.17 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.802 2.335 . . . . 0.0 112.335 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -85.91 -30.54 22.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -112.29 -0.46 15.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -97.43 131.91 43.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.47 ' HD3' HD11 ' A' ' 82' ' ' ILE . 17.5 ttm180 -133.73 147.12 51.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.819 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.611 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.7 mp -115.06 150.43 35.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.611 HD13 ' O ' ' B' ' 243' ' ' LEU . 22.7 mm -136.8 115.65 15.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.135 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.791 ' HB3' HD21 ' B' ' 250' ' ' LEU . 40.4 t80 -145.74 144.25 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 66.19 13.29 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.098 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 89.5 5.09 72.58 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.482 ' HE2' HD23 ' B' ' 250' ' ' LEU . 0.0 OUTLIER -137.05 163.47 30.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.739 0.304 . . . . 0.0 110.928 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -81.78 145.9 30.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.791 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -98.32 154.43 17.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -111.67 155.61 23.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.44 -5.39 49.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.929 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -105.0 40.39 2.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.503 ' O ' HG22 ' B' ' 222' ' ' THR . 5.3 ttt180 -152.53 169.42 22.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.846 0.355 . . . . 0.0 110.876 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 149.61 23.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.124 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.73 HD21 HG21 ' B' ' 226' ' ' VAL . 44.7 mt -55.2 -47.59 75.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.902 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -57.39 -25.68 59.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -65.08 -30.87 71.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 69.0 m-85 -98.81 11.04 39.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.933 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.9 m120 63.98 32.49 13.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.839 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.535 HG21 HD22 ' B' ' 256' ' ' LEU . 14.3 mm -68.77 95.78 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -86.98 170.64 11.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.978 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 152.17 9.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 53.64 27.45 6.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.87 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.78 133.48 54.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -90.14 85.77 6.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.58 159.63 17.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.591 ' CE1' HG13 ' A' ' 74' ' ' VAL . 9.2 m170 -128.11 122.77 32.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.867 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.633 HD23 HG22 ' B' ' 207' ' ' THR . 5.8 tp -89.74 122.27 32.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.975 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.781 HG11 HD12 ' A' ' 82' ' ' ILE . 10.8 t -119.91 147.93 23.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.103 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.71 135.65 36.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.4 mtt180 -97.03 166.45 11.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.478 HD11 ' CE ' ' A' ' 90' ' ' LYS . 4.2 mm? -51.95 130.33 29.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.861 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 41.0 tpt85 -95.07 98.55 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -160.75 24.4 0.26 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.505 -179.926 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.838 0.266 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.644 HD22 ' CD2' ' A' ' 75' ' ' PHE . 11.9 mt -108.46 45.36 1.03 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 26.0 m -93.47 -22.87 18.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -121.57 93.49 4.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.734 ' HB3' HG11 ' A' ' 70' ' ' VAL . 4.9 mt -111.42 153.05 44.29 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.554 0.692 . . . . 0.0 110.996 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 174.11 10.03 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.719 2.279 . . . . 0.0 112.339 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.42 146.32 52.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.51 21.03 33.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.429 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.734 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.2 p -71.6 145.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 0.0 111.125 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -104.41 108.85 20.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.2 tp60 -51.39 -52.09 48.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -51.4 -40.05 58.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.569 HG13 ' CE1' ' B' ' 268' ' ' HIS . 80.2 t -76.04 -33.01 23.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.097 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.644 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.6 t80 -67.23 -56.35 10.2 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.873 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 -15.26 60.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -88.81 -27.49 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.995 HD13 HG21 ' A' ' 82' ' ' ILE . 28.3 mt -75.88 158.29 82.73 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.637 0.732 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.426 ' HD3' HG21 ' B' ' 244' ' ' ILE . 54.0 Cg_endo -69.73 165.16 31.88 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.35 -29.19 45.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -63.19 -39.69 95.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.811 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.995 HG21 HD13 ' A' ' 78' ' ' LEU . 36.8 mm -78.9 -29.65 14.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.142 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.523 ' O ' HD23 ' A' ' 87' ' ' LEU . 63.4 mt-30 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.56 -32.48 74.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.881 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.84 -42.93 76.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.5 mt -77.91 -29.59 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -61.77 -38.9 89.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.0 m -65.58 -25.08 67.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.86 -10.42 55.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.674 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.6 OUTLIER -69.88 -176.52 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.358 . . . . 0.0 110.911 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.6 m 54.25 70.21 0.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.9 ptt85 -139.09 69.58 1.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.874 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.594 ' HB3' HD11 ' B' ' 271' ' ' LEU . 4.4 tm-20 -97.35 -33.39 11.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.6 tptm -50.37 -53.62 27.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.7 p90 -130.09 174.06 10.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.832 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -102.51 135.78 43.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.978 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -50.48 106.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.19 76.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 110.882 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 10.0 mp . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 179.879 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.3 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.63 133.79 37.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.479 HD11 HG13 ' B' ' 226' ' ' VAL . 17.0 pt -116.67 148.62 19.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -104.85 126.87 52.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . 0.468 HG21 HD11 ' B' ' 215' ' ' LEU . 21.2 t -110.02 108.18 24.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.075 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.448 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.94 111.17 23.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.824 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.754 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -73.14 175.0 7.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.31 -23.9 62.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.884 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.2 p -90.07 7.66 36.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.51 27.41 65.53 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.47 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -91.76 109.47 20.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.852 0.358 . . . . 0.0 110.85 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.424 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.71 132.37 35.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.194 179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.64 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.46 111.68 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.116 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.06 127.61 32.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.153 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.468 HD11 HG21 ' B' ' 205' ' ' VAL . 9.4 mt -129.9 134.3 47.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.895 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -90.47 102.46 15.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.911 HG11 HG22 ' B' ' 226' ' ' VAL . 21.6 m -131.44 -179.26 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.18 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.557 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -131.94 160.34 68.15 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.628 0.728 . . . . 0.0 110.942 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -10.16 27.86 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.641 2.227 . . . . 0.0 112.37 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -99.54 -24.6 14.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.862 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -61.38 175.15 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -110.15 155.07 22.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' B' ' 256' ' ' LEU . 50.5 mm -52.11 -29.97 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.127 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.27 -34.2 74.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.402 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -72.7 -37.91 67.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.911 HG22 HG11 ' B' ' 217' ' ' VAL . 62.2 t -69.66 -42.7 80.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.139 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -64.37 -38.93 92.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.72 -41.7 87.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.104 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.48 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.0 mttt -57.35 -49.86 74.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.411 HG21 HD22 ' B' ' 269' ' ' LEU . 65.7 mt -53.33 -32.72 20.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.53 -47.53 85.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -75.69 -4.74 42.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.898 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.64 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.1 mmmt -96.68 -50.34 4.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.852 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -106.94 -47.31 3.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.79 29.59 2.82 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.544 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.17 132.24 21.33 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.515 0.674 . . . . 0.0 111.142 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 164.83 33.03 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.633 2.222 . . . . 0.0 112.375 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.82 -6.45 18.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.695 2.263 . . . . 0.0 112.336 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -90.17 -23.74 21.23 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.813 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -113.02 -7.73 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.922 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.546 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -89.12 130.11 35.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.913 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -133.69 132.38 40.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.9 mp -101.73 149.1 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 26.1 mm -136.38 119.72 22.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.726 ' HB3' HD21 ' B' ' 250' ' ' LEU . 30.2 t80 -148.23 142.09 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.84 14.99 9.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.082 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.02 12.4 68.28 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.455 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.14 167.79 21.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.823 0.344 . . . . 0.0 110.835 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -89.87 143.72 26.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.726 HD21 ' HB3' ' B' ' 245' ' ' PHE . 2.4 mt -99.88 148.34 24.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.916 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -108.2 157.41 18.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.15 -16.11 61.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.878 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.68 38.14 3.24 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.487 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.7 ttt85 -152.59 168.54 25.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.9 0.381 . . . . 0.0 110.86 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.36 154.39 18.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.817 HD21 HG21 ' B' ' 226' ' ' VAL . 49.6 mt -57.8 -48.67 79.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.0 t -54.41 -27.28 35.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.899 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.32 -34.51 72.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.876 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.555 ' CD1' HD22 ' B' ' 250' ' ' LEU . 24.0 m-85 -98.15 9.85 41.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 m120 63.76 40.36 7.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.495 HD13 ' CD2' ' B' ' 245' ' ' PHE . 16.0 mm -72.28 95.59 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.25 167.34 16.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.74 146.68 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.895 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 58.83 26.43 14.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.97 133.87 55.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.871 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.95 86.01 7.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.135 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.488 HD11 HD11 ' B' ' 250' ' ' LEU . 3.7 mm? -84.09 159.3 21.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.569 ' CE1' HG13 ' A' ' 74' ' ' VAL . 5.3 m170 -129.42 118.8 22.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.754 HD23 HG22 ' B' ' 207' ' ' THR . 2.8 tp -89.97 115.91 27.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.825 HG11 HD12 ' A' ' 82' ' ' ILE . 26.8 t -112.73 148.14 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -80.14 130.97 35.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.889 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.453 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.9 mtt180 -92.25 163.76 13.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.674 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.3 mm? -50.2 121.66 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -100.34 116.96 33.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -111.61 -26.67 4.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.454 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.5 -179.921 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.184 0 CA-C-O 120.83 0.263 . . . . 0.0 112.344 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.614 HD22 ' CD1' ' A' ' 75' ' ' PHE . 4.4 mt -92.67 47.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.866 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 67.3 m -88.17 -25.33 22.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.917 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 m -118.93 94.18 4.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.768 ' CB ' HG11 ' A' ' 70' ' ' VAL . 9.2 mt -111.01 152.56 43.74 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.587 0.708 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 175.16 8.46 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.738 2.292 . . . . 0.0 112.307 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.08 147.01 52.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.413 ' O ' HG22 ' B' ' 209' ' ' THR . . . 55.84 21.11 28.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.506 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.7 p -72.52 145.34 12.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 111.112 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.497 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.1 t0 -103.81 106.14 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.2 tp60 -50.06 -52.97 30.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.891 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.5 -38.99 47.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.591 HG13 ' CE1' ' B' ' 268' ' ' HIS . 98.9 t -76.72 -33.24 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.151 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.614 ' CD1' HD22 ' A' ' 63' ' ' LEU . 1.5 t80 -65.57 -56.56 11.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.83 -13.95 60.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -88.93 -25.88 21.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.922 HD13 HG21 ' A' ' 82' ' ' ILE . 25.8 mt -78.13 158.41 77.22 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.661 0.744 . . . . 0.0 110.877 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 165.17 31.91 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.56 -31.45 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.152 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -59.78 -42.48 93.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.888 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.922 HG21 HD13 ' A' ' 78' ' ' LEU . 37.0 mm -78.94 -29.25 14.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.196 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.603 ' O ' HD23 ' A' ' 87' ' ' LEU . 65.6 mt-30 -69.76 -27.69 65.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -87.1 -26.76 23.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -73.88 -40.2 63.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.832 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.41 HG21 ' HE2' ' A' ' 75' ' ' PHE . 65.5 mt -78.13 -31.55 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.114 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.1 mm? -62.7 -38.34 90.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.4 t -65.43 -23.6 66.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.08 -1.95 65.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.51 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.806 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.2 ptpt -78.2 -176.71 4.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 26.7 m 53.31 70.23 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 78.43 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.622 ' HB3' HD11 ' B' ' 271' ' ' LEU . 3.9 tm-20 -117.71 -32.45 4.84 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.872 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.468 ' HB2' HD23 ' B' ' 271' ' ' LEU . 0.2 OUTLIER -51.11 -43.08 61.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -136.96 174.27 10.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.901 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -113.06 160.1 18.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.13 113.62 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -55.21 135.37 49.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.917 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.714 0.293 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -96.35 136.19 37.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.438 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.8 pt -118.27 148.67 20.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.178 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.556 ' HB3' HG22 ' B' ' 212' ' ' THR . 12.9 m-85 -105.15 121.5 43.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.869 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.2 t -104.09 108.95 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.171 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.772 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.13 111.96 23.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.909 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.816 HG22 HD23 ' B' ' 269' ' ' LEU . 6.2 p -74.42 172.62 11.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.138 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.401 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -58.87 -24.52 62.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 69' ' ' GLY . 1.9 p -89.61 12.22 17.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.155 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 67.85 41.02 89.26 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 11.2 tptm -108.23 110.96 22.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.802 0.334 . . . . 0.0 110.912 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.772 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.1 OUTLIER -82.31 134.43 35.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.164 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.704 HG23 ' HE3' ' B' ' 233' ' ' LYS . 4.0 mt -129.85 112.11 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.105 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.69 127.94 32.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.09 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.456 HD21 HG22 ' B' ' 213' ' ' ILE . 9.8 mt -131.42 134.84 46.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -89.83 104.4 16.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.928 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.945 HG11 HG22 ' B' ' 226' ' ' VAL . 21.2 m -134.45 174.0 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.535 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.8 mt-10 -125.71 160.95 53.69 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.665 0.745 . . . . 0.0 110.893 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -8.58 23.96 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.645 2.23 . . . . 0.0 112.394 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.55 -24.01 14.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.846 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.436 ' O ' HG22 ' B' ' 255' ' ' THR . 20.9 m-20 -62.3 175.15 0.78 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.13 154.97 23.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.174 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.6 mm -51.29 -35.05 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.87 -34.42 65.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.7 -38.96 67.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.945 HG22 HG11 ' B' ' 217' ' ' VAL . 62.9 t -67.92 -43.49 85.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.172 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.532 ' HD2' HD11 ' B' ' 243' ' ' LEU . 7.8 mtpm? -62.47 -41.65 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.29 -42.17 73.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.116 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.41 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.7 mttt -58.55 -48.17 81.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 60.6 mt -55.58 -31.3 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.136 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -62.18 -48.54 79.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.9 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -75.04 -5.04 41.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.889 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.704 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.72 -51.29 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -105.75 -47.42 3.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.897 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.08 27.64 3.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.541 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.445 HD12 HD21 ' B' ' 269' ' ' LEU . 11.9 mt -101.61 132.38 21.82 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.7 0.762 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.23 31.64 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.704 2.27 . . . . 0.0 112.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -6.93 19.78 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.737 2.291 . . . . 0.0 112.29 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -92.35 -21.39 20.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.891 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.95 -8.69 13.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -87.31 130.82 34.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 -179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.554 ' HD3' HD11 ' A' ' 82' ' ' ILE . 4.0 ttm180 -134.01 128.4 34.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.852 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.609 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.2 mp -98.61 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.609 HD13 ' O ' ' B' ' 243' ' ' LEU . 24.1 mm -136.92 114.92 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.08 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.699 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.5 t80 -143.16 143.05 31.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.919 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.46 15.14 9.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.41 7.86 75.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.492 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.14 168.86 17.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.728 0.299 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -89.39 142.77 27.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.699 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.3 mt -97.37 151.32 20.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.76 161.01 16.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -80.58 -9.88 59.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -100.22 39.65 2.68 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.49 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -152.53 169.66 22.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.899 0.381 . . . . 0.0 110.911 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.436 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -101.4 151.54 21.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 57.3 mt -56.19 -45.22 79.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 4.2 t -56.08 -24.1 37.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.789 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -67.16 -30.58 70.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.637 ' CD1' HD22 ' B' ' 250' ' ' LEU . 49.7 m-85 -98.41 9.88 42.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.4 34.09 13.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.524 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.4 mm -68.92 100.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.127 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 -95.11 170.67 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.37 144.22 10.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 58.11 28.24 16.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.438 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.69 125.4 22.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.85 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -80.84 85.7 6.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.165 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.59 HD11 HD11 ' B' ' 250' ' ' LEU . 3.0 mm? -85.39 158.52 20.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.895 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.591 ' CE1' HG13 ' A' ' 74' ' ' VAL . 2.3 m170 -129.69 119.86 24.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.902 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.816 HD23 HG22 ' B' ' 207' ' ' THR . 7.5 tp -89.99 128.05 36.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.783 HG11 HD12 ' A' ' 82' ' ' ILE . 21.2 t -125.81 144.62 35.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.138 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -76.3 134.12 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.9 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.498 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 -96.69 162.87 13.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.806 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.2 mm? -49.85 127.06 15.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 2.0 tpm_? -101.18 137.72 39.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.859 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -79.15 57.63 4.36 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.496 -179.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.848 0.27 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 75' ' ' PHE . 5.5 mp -71.72 81.48 0.86 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 74.8 m -115.17 -22.45 9.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.886 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -132.47 100.87 5.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.826 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.719 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.2 mt -110.65 153.16 43.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.563 0.697 . . . . 0.0 110.924 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 174.97 8.73 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.712 2.275 . . . . 0.0 112.316 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -70.08 144.33 52.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.77 19.99 30.78 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.504 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.719 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -65.98 144.45 14.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -104.3 108.59 20.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.872 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.94 -52.92 37.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.86 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -51.29 -38.61 53.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.466 HG23 ' CG ' ' A' ' 71' ' ' ASP . 96.9 t -76.12 -33.1 23.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.058 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.5 t80 -68.0 -55.98 10.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.05 -14.27 60.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.857 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -88.64 -23.5 23.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.973 HD13 HG21 ' A' ' 82' ' ' ILE . 22.7 mt -81.23 158.46 69.46 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.557 0.694 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 165.15 31.95 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.681 2.254 . . . . 0.0 112.306 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.41 -31.7 49.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -60.15 -41.23 92.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.877 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.973 HG21 HD13 ' A' ' 78' ' ' LEU . 35.9 mm -78.99 -28.49 13.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -68.57 -47.73 66.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.953 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -67.28 -32.19 73.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.6 tt0 -67.41 -41.69 84.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.421 HG21 ' HE2' ' A' ' 75' ' ' PHE . 56.5 mt -77.8 -33.99 19.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.179 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -63.38 -35.69 81.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.951 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.1 m -65.84 -23.22 66.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.823 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.64 -2.28 69.93 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.418 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.64 ' HD3' HD11 ' B' ' 273' ' ' LEU . 2.3 ptpt -75.7 -176.33 3.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.0 p 46.99 70.75 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.99 70.07 1.43 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.813 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -92.44 -45.55 8.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.85 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -53.09 -66.22 0.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.906 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -106.45 174.22 5.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -88.92 126.11 35.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.34 172.15 1.34 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.53 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.632 ' C ' HD12 ' A' ' 99' ' ' LEU . 13.6 pttp -155.38 95.88 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 98' ' ' LYS . 10.2 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.5 ptt? . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.794 0.33 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -99.55 134.09 42.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.621 HD12 HD13 ' B' ' 267' ' ' LEU . 24.3 pt -118.74 148.8 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.102 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.538 ' HB3' HG22 ' B' ' 212' ' ' THR . 6.8 m-85 -105.77 127.63 53.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.838 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.1 t -109.76 108.65 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.146 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.678 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -96.3 108.84 21.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.568 HG22 ' HB3' ' B' ' 269' ' ' LEU . 8.7 p -67.49 173.54 4.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.084 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.51 -27.97 66.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.85 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.8 p -83.53 -1.41 53.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.201 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 84.36 31.74 24.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.473 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 4.9 tptm -98.77 109.53 22.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.863 0.364 . . . . 0.0 110.894 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.678 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -81.67 134.3 35.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.099 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . . . . . . . . . 3.3 mt -130.57 114.43 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.78 125.16 29.33 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.505 HD11 HG12 ' B' ' 230' ' ' ILE . 8.6 mt -129.09 134.11 47.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.948 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -90.06 102.66 15.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.914 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.943 HG11 HG22 ' B' ' 226' ' ' VAL . 22.6 m -127.77 178.38 4.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.604 ' O ' HD12 ' B' ' 256' ' ' LEU . 7.8 mt-10 -132.88 160.33 69.0 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 0.0 110.882 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -8.73 24.35 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.632 2.221 . . . . 0.0 112.362 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 3.1 p -110.27 17.33 21.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.793 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.68 ' O ' HG22 ' B' ' 255' ' ' THR . 24.0 m-20 -100.2 173.28 6.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.921 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.26 149.57 25.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.12 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.867 HD12 HD23 ' B' ' 250' ' ' LEU . 46.2 mm -51.64 -35.45 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.09 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -61.25 -34.35 75.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.93 -39.93 90.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.943 HG22 HG11 ' B' ' 217' ' ' VAL . 88.5 t -66.72 -45.76 87.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.095 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.52 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.2 OUTLIER -59.94 -38.41 82.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.15 -49.99 70.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.069 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.728 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -57.43 -39.73 76.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.901 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.52 HD12 ' HA ' ' B' ' 227' ' ' LYS . 86.0 mt -58.84 -28.1 36.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.131 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -68.66 -47.98 65.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -71.66 -7.74 49.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.818 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt -96.11 -56.01 2.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.967 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -99.18 -48.87 4.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 33.15 1.95 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 5.7 mt -112.45 131.21 22.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.63 0.728 . . . . 0.0 111.096 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' B' ' 240' ' ' GLN . 54.0 Cg_endo -69.86 163.52 38.05 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.703 2.269 . . . . 0.0 112.374 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . 0.429 ' HA ' ' HG2' ' B' ' 241' ' ' GLN . 54.1 Cg_endo -69.73 -1.65 8.8 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.64 2.227 . . . . 0.0 112.338 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -99.4 -26.15 14.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' B' ' 237' ' ' PRO . 1.2 mp0 -113.01 -5.71 13.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.429 ' HG2' ' HA ' ' B' ' 238' ' ' PRO . 2.8 pt20 -111.96 136.01 51.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.4 ' NE ' HE21 ' B' ' 249' ' ' GLN . 0.0 OUTLIER -135.29 147.87 49.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.516 HD23 ' H ' ' B' ' 243' ' ' LEU . 2.1 pt? -113.8 135.6 53.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 82' ' ' ILE . 20.7 mm -119.59 131.66 71.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.507 ' CD2' HD13 ' B' ' 261' ' ' ILE . 56.9 t80 -148.52 144.03 27.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.37 15.15 9.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 81.13 17.97 70.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.507 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.67 166.4 22.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.667 0.27 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.4 HE21 ' NE ' ' B' ' 242' ' ' ARG . 27.3 mt-30 -94.39 110.12 21.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.93 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.867 HD23 HD12 ' B' ' 223' ' ' ILE . 9.4 mp -67.34 163.62 20.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -129.48 153.13 48.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -71.88 -9.91 59.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.873 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -96.74 35.72 4.26 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.471 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -152.69 168.51 25.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.383 . . . . 0.0 110.862 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.68 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -103.01 158.44 16.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.134 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.745 HD21 HG21 ' B' ' 226' ' ' VAL . 25.9 mt -58.28 -41.12 83.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -63.26 -22.16 66.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.26 -35.91 82.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -98.94 17.03 20.58 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.918 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 27.0 m120 57.36 35.53 26.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.589 HG21 HD22 ' B' ' 256' ' ' LEU . 9.0 mm -68.6 95.91 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.104 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -85.96 -174.21 4.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.17 152.93 44.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 54.15 26.78 6.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.75 132.36 51.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.864 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -91.23 89.59 7.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.621 HD13 HD12 ' B' ' 203' ' ' ILE . 4.0 mp -91.93 165.27 13.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.454 ' CE1' HG13 ' A' ' 74' ' ' VAL . 10.1 m170 -129.6 145.35 51.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.568 ' HB3' HG22 ' B' ' 207' ' ' THR . 3.4 tt -105.38 133.05 50.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.901 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.81 HG11 HG23 ' A' ' 82' ' ' ILE . 5.2 t -133.44 143.9 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.156 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.486 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.16 135.37 37.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.486 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.0 mtt180 -90.25 167.18 12.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.825 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.64 HD11 ' HD3' ' A' ' 90' ' ' LYS . 2.3 mm? -52.5 131.63 34.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -132.01 111.33 11.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -113.94 45.66 1.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.467 -179.895 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.427 ' O ' HD12 ' A' ' 63' ' ' LEU . 54.7 Cg_endo . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.803 0.251 . . . . 0.0 112.423 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.483 HD21 ' CD1' ' A' ' 75' ' ' PHE . 6.5 mp -130.92 78.4 1.84 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.918 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 5.5 m -116.48 -19.82 9.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 m -131.9 99.72 4.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.687 ' HB3' HG11 ' A' ' 70' ' ' VAL . 6.9 mt -110.96 152.88 43.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.607 0.718 . . . . 0.0 110.878 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.412 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.8 Cg_endo -69.81 173.64 10.72 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.634 2.223 . . . . 0.0 112.398 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 144.88 52.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.99 20.66 34.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.508 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.687 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.5 p -69.23 146.24 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 0.0 111.1 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' HG23 ' A' ' 74' ' ' VAL . 65.9 t0 -104.31 106.62 17.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 10.4 tp60 -49.38 -52.46 28.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -51.64 -38.08 53.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.54 HG23 ' OD2' ' A' ' 71' ' ' ASP . 96.3 t -76.03 -33.28 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.092 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.2 t80 -64.92 -56.58 12.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.797 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -13.2 61.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -88.44 -23.88 23.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD13 HG21 ' A' ' 82' ' ' ILE . 21.1 mt -80.99 159.16 69.07 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.915 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.84 165.3 31.53 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.71 2.273 . . . . 0.0 112.291 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.93 -33.68 56.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.72 -43.58 85.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.866 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.815 HD12 HG11 ' B' ' 270' ' ' VAL . 30.9 mm -77.69 -28.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.097 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 87' ' ' LEU . 31.8 mt-30 -70.4 -37.26 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.22 -30.2 63.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -72.44 -51.75 18.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.449 HG21 ' HE2' ' A' ' 75' ' ' PHE . 58.6 mt -62.5 -28.85 45.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.159 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.2 mm? -75.41 -23.35 57.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.96 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.6 m -76.79 -19.34 57.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.7 14.44 59.67 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.492 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.519 ' HE3' HD21 ' B' ' 273' ' ' LEU . 0.0 OUTLIER -97.59 -176.13 3.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.317 . . . . 0.0 110.983 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.64 70.76 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.811 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -134.15 87.66 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HB3' HD11 ' B' ' 271' ' ' LEU . 5.1 tm-20 -120.36 -32.15 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.41 -60.27 3.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -107.6 174.6 5.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -86.62 145.13 26.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.14 170.28 0.29 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.541 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -84.61 134.59 34.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.6 mp . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.1 ptt? . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.74 0.305 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -95.02 134.99 37.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.964 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.426 HD11 HG13 ' B' ' 226' ' ' VAL . 25.3 pt -117.9 148.77 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.159 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.452 ' HB3' HG22 ' B' ' 212' ' ' THR . 18.7 m-85 -104.9 122.31 45.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.3 t -104.57 108.36 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.143 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.487 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.2 OUTLIER -97.47 112.65 24.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.772 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -73.3 171.69 12.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.235 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.447 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -59.25 -27.4 65.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.978 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 10.4 p -84.64 0.7 49.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.22 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 80.93 39.34 13.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.473 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -106.0 110.44 22.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.88 0.372 . . . . 0.0 110.875 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.487 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.3 131.77 35.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.211 179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.672 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.3 mt -129.37 110.96 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.083 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.452 ' O ' HD23 ' B' ' 215' ' ' LEU . 0.2 OUTLIER -78.46 131.6 36.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.512 HD21 HG22 ' B' ' 213' ' ' ILE . 8.1 mt -135.87 133.95 38.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.952 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.81 105.81 18.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.795 HG11 HG22 ' B' ' 226' ' ' VAL . 20.4 m -134.0 171.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.106 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.575 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.8 mt-10 -118.47 160.33 40.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 0.0 110.926 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -12.92 33.88 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.611 2.207 . . . . 0.0 112.372 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 16.6 m -96.39 -25.33 15.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.874 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -60.1 175.02 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.87 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.2 p -111.98 156.83 21.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.142 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.422 HG21 HD13 ' B' ' 243' ' ' LEU . 48.4 mm -51.59 -33.63 15.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.159 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -56.65 -35.08 67.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.949 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.34 -39.28 68.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.839 HG21 HD21 ' B' ' 256' ' ' LEU . 56.0 t -67.1 -44.1 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.66 ' HA ' HD12 ' B' ' 230' ' ' ILE . 28.2 ttmt -62.84 -41.73 99.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.22 -42.19 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.518 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.6 mttt -57.8 -48.62 79.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.66 HD12 ' HA ' ' B' ' 227' ' ' LYS . 14.5 mt -54.66 -31.47 23.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.103 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -61.48 -49.02 78.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.3 -5.28 41.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.672 ' HE3' HG23 ' B' ' 213' ' ' ILE . 17.1 mmmt -95.74 -53.56 3.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.919 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -104.7 -46.2 4.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.15 24.2 4.59 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 13.0 mt -98.32 132.27 24.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.61 0.719 . . . . 0.0 111.138 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.66 167.8 23.25 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.74 2.293 . . . . 0.0 112.437 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.67 19.14 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.675 2.25 . . . . 0.0 112.33 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.03 -23.47 20.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 1.6 mp0 -113.14 0.58 14.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.624 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -100.8 128.17 46.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 -179.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -133.89 133.45 41.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.522 HD11 ' HE3' ' B' ' 227' ' ' LYS . 1.1 mp -101.01 141.09 34.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.9 mm -127.73 116.34 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.121 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.744 ' HB3' HD21 ' B' ' 250' ' ' LEU . 24.1 t80 -141.59 144.2 34.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.29 15.17 9.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.14 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.55 8.61 73.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.445 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.61 172.82 12.22 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 0.0 110.9 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -93.74 142.8 26.95 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.9 mt -96.2 161.22 14.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -118.05 157.42 26.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -78.02 -8.36 58.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -102.4 39.62 2.71 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.412 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -152.53 169.87 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.358 . . . . 0.0 110.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.2 151.09 22.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.162 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.839 HD21 HG21 ' B' ' 226' ' ' VAL . 71.5 mt -56.24 -45.42 80.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -55.63 -26.51 44.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.893 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -68.55 -26.8 65.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 89.5 m-85 -98.8 7.72 45.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.9 m120 64.66 33.7 10.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.534 HD13 ' CD2' ' B' ' 245' ' ' PHE . 18.4 mm -69.53 109.17 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -102.11 168.44 9.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -51.59 145.31 9.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 58.53 28.31 16.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.412 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.6 OUTLIER -56.77 130.01 43.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.834 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -86.66 81.94 8.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.155 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.507 HD11 HD11 ' B' ' 250' ' ' LEU . 2.7 mm? -83.36 159.82 21.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.467 ' CE1' HG13 ' A' ' 74' ' ' VAL . 4.9 m170 -129.42 115.91 18.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.772 HD23 HG22 ' B' ' 207' ' ' THR . 2.0 tp -83.85 116.56 22.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.815 HG11 HD12 ' A' ' 82' ' ' ILE . 15.0 t -112.9 148.4 15.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.408 HD11 ' HB3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -80.84 126.82 31.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.403 ' HB2' ' HA ' ' B' ' 240' ' ' GLN . 2.8 mtt-85 -84.12 167.46 16.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.835 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.519 HD21 ' HE3' ' A' ' 90' ' ' LYS . 3.0 mm? -55.16 121.73 9.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.921 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 28.0 tpt180 -89.3 112.55 23.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -105.27 23.79 29.43 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.514 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.523 -179.865 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.808 0.253 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.447 HD21 ' HD1' ' A' ' 75' ' ' PHE . 7.1 mp -128.06 73.48 1.47 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 27.2 m -117.04 -16.38 10.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.2 m -135.48 100.55 4.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.892 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.735 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.8 mt -110.95 152.65 43.76 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.677 0.751 . . . . 0.0 110.889 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 174.69 9.14 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.708 2.272 . . . . 0.0 112.324 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.12 145.99 52.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.62 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.05 21.03 29.89 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.436 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.735 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -70.37 143.73 14.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.82 0.343 . . . . 0.0 111.153 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -104.27 110.59 22.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -51.77 -52.89 45.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -50.91 -43.24 59.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.31 -32.83 39.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.175 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.447 ' HD1' HD21 ' A' ' 63' ' ' LEU . 3.0 t80 -65.13 -56.99 9.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -15.29 62.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.896 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -88.14 -15.97 34.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.918 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.881 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -85.05 155.24 60.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.589 0.709 . . . . 0.0 110.934 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.3 Cg_endo -69.83 165.15 32.02 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.642 2.228 . . . . 0.0 112.345 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.5 p -59.86 -33.67 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -57.97 -38.86 76.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.881 HG21 HD23 ' A' ' 78' ' ' LEU . 8.5 mm -78.83 -44.04 25.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.582 ' O ' HD23 ' A' ' 87' ' ' LEU . 16.2 mt-30 -51.46 -46.21 63.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.887 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.35 -28.32 62.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -71.5 -41.14 69.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.4 mt -78.18 -32.32 16.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.074 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.582 HD23 ' O ' ' A' ' 83' ' ' GLN . 1.3 mm? -63.47 -39.03 93.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.9 m -65.2 -22.91 66.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.49 24.15 37.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.501 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.796 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.5 ptpt -102.41 -177.2 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.76 0.314 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.558 ' OG ' HD22 ' B' ' 273' ' ' LEU . 2.3 m 51.74 57.66 6.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.7 81.89 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.9 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -119.32 -29.95 5.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.45 -65.68 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.86 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -103.8 173.55 6.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -119.97 158.22 27.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.01 105.86 0.28 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' C ' HD12 ' A' ' 99' ' ' LEU . 23.9 mttm -74.67 90.16 2.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.738 0.304 . . . . 0.0 110.96 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.468 HD12 ' C ' ' A' ' 98' ' ' LYS . 9.5 mp . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.812 0.339 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.39 134.07 40.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.935 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.4 HD12 HD13 ' B' ' 267' ' ' LEU . 25.0 pt -117.76 150.1 19.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.555 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.2 m-85 -106.16 126.49 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.23 107.95 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.688 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.08 110.97 23.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.967 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.692 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -73.17 174.21 8.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.408 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.4 OUTLIER -60.71 -22.95 64.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -90.99 17.4 7.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 61.16 49.93 72.71 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -118.44 107.84 14.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.688 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -81.09 133.03 35.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.16 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.656 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.27 107.19 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.198 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.54 132.29 43.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.6 mt -137.28 134.09 35.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.942 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -88.02 102.19 14.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.805 HG11 HG22 ' B' ' 226' ' ' VAL . 26.2 m -127.81 178.99 4.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.178 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.616 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.4 mt-10 -135.15 160.18 69.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.614 0.721 . . . . 0.0 110.897 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.71 -11.09 30.18 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.685 2.257 . . . . 0.0 112.403 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.3 -26.09 15.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -64.65 169.44 4.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.915 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.47 157.56 17.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 44.1 mm -53.71 -31.96 20.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.099 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -60.15 -31.33 70.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.68 -36.36 57.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.838 HG21 HD21 ' B' ' 256' ' ' LEU . 63.4 t -68.57 -48.43 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.031 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.739 ' HA ' HD12 ' B' ' 230' ' ' ILE . 7.4 ptpp? -62.1 -30.46 71.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -60.29 -50.52 73.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.088 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.675 ' HE3' HG12 ' B' ' 217' ' ' VAL . 48.2 mttm -56.18 -42.08 76.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' B' ' 227' ' ' LYS . 57.6 mt -55.55 -34.58 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -61.89 -47.74 83.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -71.45 -8.18 52.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.854 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.656 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -95.48 -56.37 2.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.954 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -99.8 -49.24 4.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.964 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.37 31.89 2.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.461 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.653 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.27 130.96 22.22 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.64 0.733 . . . . 0.0 111.087 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 163.69 37.34 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.721 2.281 . . . . 0.0 112.332 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 -7.64 21.57 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.663 2.242 . . . . 0.0 112.361 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -85.5 -31.11 22.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -112.51 0.63 15.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.941 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -94.72 127.05 40.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 8.4 ttm180 -133.88 136.13 44.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.403 ' H ' HD12 ' B' ' 243' ' ' LEU . 1.1 mp -105.09 136.27 44.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 24.4 mm -117.91 114.86 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.174 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.3 t80 -144.65 143.87 30.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.907 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.68 15.08 9.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.086 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 83.83 22.26 55.9 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.534 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.87 177.99 9.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.781 0.324 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -97.9 140.93 31.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.2 mt -97.63 147.68 24.06 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.945 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -105.9 166.2 10.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.891 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -82.07 -18.6 42.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.884 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -91.51 40.49 2.94 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -152.97 167.88 27.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.371 . . . . 0.0 110.861 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.93 152.43 21.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 65.2 mt -55.09 -47.42 74.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.7 t -55.75 -25.4 40.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -66.6 -30.42 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.482 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.6 m-85 -98.65 12.49 35.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.61 33.79 18.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.539 HD13 ' CE2' ' B' ' 245' ' ' PHE . 16.2 mm -68.69 95.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.132 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -86.42 166.07 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.35 149.79 3.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 54.99 27.51 9.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.61 134.47 54.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.884 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.4 m -91.95 86.0 5.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.12 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.415 HD11 HD12 ' B' ' 261' ' ' ILE . 3.0 mp -87.03 157.19 19.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.892 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -128.42 117.24 21.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.822 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.692 HD23 HG22 ' B' ' 207' ' ' THR . 8.5 tp -83.67 133.26 34.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.813 HG11 HD12 ' A' ' 82' ' ' ILE . 4.9 t -134.22 142.63 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.146 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.524 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.99 134.2 48.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.524 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.8 mtt180 -92.74 159.0 15.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.796 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.2 mm? -51.5 123.16 9.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.895 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -79.73 113.09 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.903 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -158.99 22.2 0.3 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.493 -179.87 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.508 ' HG2' HD22 ' A' ' 63' ' ' LEU . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.212 0 CA-C-O 120.85 0.271 . . . . 0.0 112.354 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.782 ' HG ' HD21 ' A' ' 66' ' ' LEU . 1.2 mm? -101.64 136.27 41.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.32 -19.13 9.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.413 ' O ' HD13 ' A' ' 87' ' ' LEU . 71.8 m -139.22 95.53 2.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.781 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.782 HD21 ' HG ' ' A' ' 63' ' ' LEU . 5.0 mt -111.04 153.44 43.87 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.595 0.712 . . . . 0.0 110.946 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 173.01 11.66 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.683 2.255 . . . . 0.0 112.347 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.6 146.16 50.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.867 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' O ' HG22 ' B' ' 209' ' ' THR . . . 57.4 20.73 38.33 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.75 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -70.6 143.81 14.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.885 0.374 . . . . 0.0 111.15 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.542 ' OD2' HG23 ' A' ' 74' ' ' VAL . 66.0 t0 -104.57 109.39 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.872 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.587 ' NE2' HD23 ' A' ' 63' ' ' LEU . 15.5 tp60 -51.32 -53.53 35.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.985 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -50.45 -39.78 48.79 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.001 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.542 HG23 ' OD2' ' A' ' 71' ' ' ASP . 91.0 t -74.87 -33.01 29.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.076 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -66.72 -56.08 12.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.02 -14.03 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -87.99 -28.41 21.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.982 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.049 HD13 HG21 ' A' ' 82' ' ' ILE . 27.7 mt -77.92 158.31 77.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.579 0.705 . . . . 0.0 110.953 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 165.28 31.49 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.703 2.269 . . . . 0.0 112.366 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.7 p -59.34 -31.91 47.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -60.23 -42.28 94.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.049 HG21 HD13 ' A' ' 78' ' ' LEU . 37.9 mm -77.93 -27.94 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.125 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -69.55 -50.71 42.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -63.46 -32.71 74.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -66.57 -47.09 73.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.835 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG21 ' HE2' ' A' ' 75' ' ' PHE . 52.0 mt -70.35 -43.17 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.153 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.456 HD21 HD12 ' A' ' 63' ' ' LEU . 1.2 mm? -58.86 -33.79 70.86 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.27 -23.52 67.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.46 26.44 25.39 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.47 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.3 OUTLIER -109.44 -176.68 3.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.804 0.335 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 p 47.09 70.47 0.4 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.839 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.5 71.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HB3' HD11 ' B' ' 271' ' ' LEU . 14.2 tp10 -112.19 -21.5 11.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.911 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' HB2' HD23 ' B' ' 271' ' ' LEU . 0.0 OUTLIER -52.36 -53.67 41.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.2 p90 -122.03 174.07 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.866 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -109.16 147.73 32.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.72 105.79 0.26 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.531 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -72.54 81.42 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mp . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.892 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.783 0.325 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -94.59 134.81 36.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.927 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 11.3 pt -117.7 148.47 20.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.446 ' HB3' HG22 ' B' ' 212' ' ' THR . 14.4 m-85 -105.3 121.42 43.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.4 t -105.09 113.05 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.129 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.419 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -101.09 114.0 27.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.704 HG22 HD23 ' B' ' 269' ' ' LEU . 3.6 p -77.77 170.71 16.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.47 -22.43 54.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 69' ' ' GLY . 3.0 p -94.22 23.54 5.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.134 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 55.15 55.35 28.64 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -121.58 108.97 14.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.928 0.394 . . . . 0.0 110.934 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.446 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.3 OUTLIER -81.7 132.3 35.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.11 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.684 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.29 109.6 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.132 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.3 m -77.4 127.14 32.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.203 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.476 HD21 HG22 ' B' ' 213' ' ' ILE . 10.7 mt -129.63 134.36 47.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.964 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -89.37 102.23 14.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 23.0 m -131.54 -179.49 3.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.165 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.609 ' O ' HD12 ' B' ' 256' ' ' LEU . 6.3 mt-10 -131.24 160.7 65.88 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.678 0.751 . . . . 0.0 110.831 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -13.74 35.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.685 2.257 . . . . 0.0 112.362 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -95.93 -24.88 16.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.818 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.452 ' O ' HG22 ' B' ' 255' ' ' THR . 27.5 m-20 -61.67 173.6 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.01 154.56 23.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.113 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 50.1 mm -51.06 -31.14 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.167 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -58.72 -35.17 72.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.849 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.69 -42.13 64.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.84 HG22 HG11 ' B' ' 217' ' ' VAL . 57.3 t -62.89 -42.17 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.105 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.581 ' CD ' HD11 ' B' ' 243' ' ' LEU . 32.1 mtpt -63.97 -41.65 97.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.923 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.94 -42.27 72.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.3 mttt -57.79 -49.89 75.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.906 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 62.3 mt -54.05 -32.11 22.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.092 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -61.68 -47.18 86.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.52 -4.68 43.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.684 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.1 mmmt -97.4 -56.48 2.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.873 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -101.51 -48.4 4.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.899 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.55 35.03 1.64 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.478 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.609 HD12 HD21 ' B' ' 269' ' ' LEU . 12.7 mt -107.52 130.61 22.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.669 0.747 . . . . 0.0 111.132 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.77 163.41 38.37 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.603 2.202 . . . . 0.0 112.415 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.88 -7.42 21.05 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.67 2.247 . . . . 0.0 112.322 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -85.36 -29.72 24.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.87 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.36 -3.43 14.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -88.79 130.97 35.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -133.85 147.98 51.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.824 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.598 ' O ' HD13 ' B' ' 244' ' ' ILE . 2.2 mp -117.35 148.87 41.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.926 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 243' ' ' LEU . 25.1 mm -136.89 120.31 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.079 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.731 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.7 t80 -146.03 140.77 27.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.95 14.31 9.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.109 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.58 15.61 63.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.457 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.44 171.63 14.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.729 0.299 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.71 134.1 37.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -93.78 143.58 26.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -102.2 167.69 9.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -82.26 -20.27 37.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.16 45.04 2.64 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.399 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -153.02 169.67 22.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.452 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.2 OUTLIER -105.42 152.08 23.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 68.2 mt -56.75 -45.14 82.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.961 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.2 t -58.17 -22.93 53.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -69.62 -29.85 67.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.899 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.601 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.9 m-85 -98.43 10.06 41.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.903 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.5 m120 63.73 33.31 13.04 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.554 HD12 HD21 ' B' ' 267' ' ' LEU . 14.3 mm -68.75 97.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.135 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -88.91 167.34 13.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.945 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -51.59 143.5 12.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 58.69 29.61 18.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.837 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.87 130.6 47.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.1 m -83.11 84.45 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.554 HD21 HD12 ' B' ' 261' ' ' ILE . 3.6 mm? -84.33 159.62 20.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.422 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.4 m170 -129.08 127.55 41.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.704 HD23 HG22 ' B' ' 207' ' ' THR . 9.0 tp -96.65 119.52 35.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.768 HG11 HD12 ' A' ' 82' ' ' ILE . 12.7 t -117.82 147.4 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.087 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.517 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -79.08 137.24 37.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.877 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.517 ' N ' HD13 ' B' ' 271' ' ' LEU . 3.2 mtt180 -96.53 162.25 13.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.894 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.513 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.3 mm? -50.92 124.33 11.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.875 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? -100.41 96.4 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 94.47 -28.03 12.18 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.437 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.512 -179.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.187 0 CA-C-O 120.76 0.233 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.633 HD22 ' CE2' ' A' ' 75' ' ' PHE . 6.3 mt -85.81 52.61 2.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 7.3 m -87.86 -28.01 21.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 46.7 m -115.82 93.67 4.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.804 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.9 mt -111.17 153.24 44.04 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.75 174.99 8.69 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.637 2.225 . . . . 0.0 112.334 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -69.55 144.98 52.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.27 20.36 35.91 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.445 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.5 p -68.51 142.71 15.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.407 ' CG ' HG23 ' A' ' 74' ' ' VAL . 10.3 t0 -102.33 110.62 22.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.908 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -51.64 -52.62 46.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -51.33 -47.77 62.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.456 HG13 ' CE1' ' B' ' 268' ' ' HIS . 57.7 t -67.51 -33.2 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.18 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.633 ' CE2' HD22 ' A' ' 63' ' ' LEU . 1.6 t80 -68.05 -56.16 9.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.37 -13.67 60.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -88.1 -20.21 25.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.959 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.051 HD13 HG21 ' A' ' 82' ' ' ILE . 36.1 mt -84.8 157.6 60.34 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.568 0.699 . . . . 0.0 110.886 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.69 162.53 41.67 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.725 2.283 . . . . 0.0 112.343 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -56.14 -33.22 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.124 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -58.99 -41.23 87.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.051 HG21 HD13 ' A' ' 78' ' ' LEU . 35.0 mm -78.21 -27.85 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.109 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.541 ' OE1' HD21 ' A' ' 63' ' ' LEU . 27.7 mt-30 -69.64 -50.55 43.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -62.74 -32.91 74.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -64.69 -50.37 67.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.882 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.508 HG21 ' HE1' ' A' ' 75' ' ' PHE . 27.7 mt -71.4 -30.73 40.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.126 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' O ' ' A' ' 83' ' ' GLN . 2.0 mm? -68.28 -35.14 77.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.2 m -65.78 -23.75 66.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.801 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.57 24.87 29.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.486 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.494 ' HD3' HD11 ' B' ' 273' ' ' LEU . 9.5 ptpt -108.09 -176.36 3.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.78 0.324 . . . . 0.0 110.923 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.7 p 46.83 70.17 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.24 104.6 8.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' HD11 ' B' ' 271' ' ' LEU . 1.0 OUTLIER -133.89 -178.68 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.968 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 72.25 -66.51 0.3 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -95.36 173.7 7.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.879 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -89.72 145.75 24.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.902 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.85 174.45 1.62 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 75.36 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.866 0.365 . . . . 0.0 110.878 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 10.6 ptt? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.8 0.333 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -94.87 133.79 38.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.459 HD11 HG13 ' B' ' 226' ' ' VAL . 17.9 pt -116.37 150.75 18.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.109 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -106.35 123.18 47.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 12.6 t -107.62 108.86 26.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.187 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.79 111.61 23.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 3.0 p -75.38 171.02 14.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.144 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.78 -23.2 41.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 6.1 p -93.91 25.17 3.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.172 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.0 51.76 44.0 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.475 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 9.0 tptm -116.55 108.99 16.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.09 131.34 35.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.194 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.583 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.6 mt -129.95 106.62 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.966 0.412 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.84 126.52 31.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.121 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.409 HD21 HG22 ' B' ' 213' ' ' ILE . 9.1 mt -129.91 134.11 47.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.895 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -87.58 101.04 13.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.84 HG11 HG22 ' B' ' 226' ' ' VAL . 21.9 m -128.04 -179.48 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.173 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.57 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.4 mt-10 -134.08 160.78 67.22 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.715 0.769 . . . . 0.0 110.894 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.651 2.234 . . . . 0.0 112.35 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -21.63 16.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.415 ' O ' HG22 ' B' ' 255' ' ' THR . 29.3 m-20 -64.13 175.17 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.847 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -112.32 157.36 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.162 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.442 HG23 HD22 ' B' ' 243' ' ' LEU . 45.6 mm -54.24 -26.5 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -65.29 -29.38 70.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.79 -36.33 42.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.86 HG21 HD21 ' B' ' 256' ' ' LEU . 87.0 t -69.13 -47.42 74.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.064 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.71 ' HA ' HD12 ' B' ' 230' ' ' ILE . 19.6 ptmt -63.46 -36.95 85.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.908 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.62 -50.27 70.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.056 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.706 ' HE3' HG12 ' B' ' 217' ' ' VAL . 47.6 mttm -56.46 -42.11 77.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.866 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' B' ' 227' ' ' LYS . 59.9 mt -56.91 -29.33 30.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 -66.6 -46.51 75.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -75.33 -5.08 42.9 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.916 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.583 ' HE3' HG23 ' B' ' 213' ' ' ILE . 16.9 mmmt -96.82 -52.94 3.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -102.94 -47.1 4.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.92 28.78 3.03 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.454 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.53 HD12 HD21 ' B' ' 269' ' ' LEU . 10.2 mt -104.58 132.23 21.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.695 0.76 . . . . 0.0 111.14 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 167.39 24.66 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.672 2.248 . . . . 0.0 112.326 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -7.34 20.82 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.66 2.24 . . . . 0.0 112.325 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -88.72 -21.66 23.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.837 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -113.0 -11.32 13.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.954 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.554 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -83.26 126.57 32.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.943 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.625 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.8 ttm180 -133.61 121.02 21.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.88 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.517 ' CB ' HD12 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -92.84 134.56 34.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.439 HD11 HD11 ' A' ' 82' ' ' ILE . 29.8 mm -121.1 119.26 58.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.15 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.746 ' HB3' HD21 ' B' ' 250' ' ' LEU . 16.7 t80 -145.9 144.12 30.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.54 14.91 9.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.114 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 85.18 21.85 53.74 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.469 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.63 169.12 20.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.8 0.333 . . . . 0.0 110.834 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -89.15 139.19 30.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.0 mt -94.02 152.73 18.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.972 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -106.27 159.33 16.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.954 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.55 -0.21 41.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -110.37 37.01 3.94 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.439 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.2 ttt180 -146.37 169.87 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 0.0 110.891 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.415 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -103.28 151.5 22.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.132 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.86 HD21 HG21 ' B' ' 226' ' ' VAL . 72.9 mt -57.35 -35.43 69.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.967 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.9 t -67.11 -21.38 65.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -71.02 -32.24 68.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.477 ' CG ' HD22 ' B' ' 250' ' ' LEU . 78.8 m-85 -96.39 8.35 44.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.905 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 2.2 m120 63.07 35.82 12.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.51 HD13 ' CD2' ' B' ' 245' ' ' PHE . 15.0 mm -68.55 95.81 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -83.21 162.62 21.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 146.71 7.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.29 24.7 13.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.5 136.44 56.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -90.2 84.3 6.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.173 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.462 HD11 HD11 ' B' ' 250' ' ' LEU . 4.1 mm? -82.22 160.88 22.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.456 ' CE1' HG13 ' A' ' 74' ' ' VAL . 5.6 m170 -130.66 119.59 22.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 3.5 tp -90.17 115.48 27.44 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 82' ' ' ILE . 22.0 t -111.54 148.42 14.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -79.9 124.46 28.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.407 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.9 mtt180 -86.66 164.51 16.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.494 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.3 mm? -48.97 119.99 3.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 29.4 tpt180 -101.58 108.04 19.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.812 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -141.57 28.54 2.3 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.516 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.506 -179.904 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.793 0.247 . . . . 0.0 112.332 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 66' ' ' LEU . 4.0 mm? -98.74 179.08 4.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.76 -59.37 2.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.7 t -144.37 110.45 5.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.819 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.732 ' HB3' HG11 ' A' ' 70' ' ' VAL . 2.8 mt -110.98 152.32 43.56 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 0.0 111.0 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.409 ' HD2' HG21 ' A' ' 70' ' ' VAL . 53.7 Cg_endo -69.74 174.66 9.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.344 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.48 146.41 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.98 21.25 23.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.489 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.732 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -69.66 144.76 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.865 0.364 . . . . 0.0 111.071 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.422 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.1 t0 -103.74 115.59 30.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.516 ' NE2' HD23 ' A' ' 63' ' ' LEU . 1.9 tp60 -54.76 -55.06 34.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.903 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.79 -45.72 50.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.909 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG23 ' CG ' ' A' ' 71' ' ' ASP . 50.1 t -70.87 -32.54 49.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CZ ' HD23 ' A' ' 66' ' ' LEU . 2.7 t80 -68.35 -57.68 5.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.838 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -16.61 59.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.934 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -88.17 -18.89 27.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.953 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.787 HD23 HG21 ' A' ' 82' ' ' ILE . 0.4 OUTLIER -80.69 153.6 73.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.889 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.8 Cg_endo -69.75 165.32 31.37 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.666 2.244 . . . . 0.0 112.367 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.8 p -60.03 -34.07 55.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.07 -38.78 77.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.787 HG21 HD23 ' A' ' 78' ' ' LEU . 9.6 mm -78.89 -45.77 24.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.115 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -51.38 -50.77 58.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.26 -32.39 74.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.845 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -69.54 -40.75 76.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 82' ' ' ILE . 63.3 mt -78.22 -30.77 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.164 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -67.17 -37.26 83.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -25.01 67.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.63 24.41 25.9 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.463 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.549 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.5 OUTLIER -103.07 -179.01 3.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 0.0 110.902 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.662 ' OG ' HD22 ' B' ' 273' ' ' LEU . 11.3 m 51.28 59.62 4.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.821 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.48 77.23 1.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -116.44 -23.21 8.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -51.62 -64.79 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.94 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -105.25 174.18 5.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.904 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -96.76 128.12 43.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.24 132.21 33.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.423 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.76 94.14 4.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.818 0.342 . . . . 0.0 110.914 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 50.4 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.958 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.4 ptt? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.775 0.321 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -98.39 138.98 34.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 22.9 pt -122.86 147.97 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.56 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.8 m-85 -104.21 123.7 47.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.885 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -105.07 108.12 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.152 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.697 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.51 109.24 21.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.864 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.85 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -69.19 174.33 4.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.166 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.74 -26.01 65.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.6 p -86.24 3.05 44.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.139 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.12 49.08 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.483 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -94.9 108.42 20.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.805 0.335 . . . . 0.0 110.939 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.697 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.03 131.11 35.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.079 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.701 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.1 mt -129.38 116.23 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.156 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.573 ' C ' HD12 ' B' ' 215' ' ' LEU . 7.5 m -78.48 128.11 33.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 ' CG1' ' B' ' 230' ' ' ILE . 10.2 mp -125.61 133.44 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.919 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -94.2 99.07 11.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.808 HG11 HG22 ' B' ' 226' ' ' VAL . 14.7 m -131.2 -179.24 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.554 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.7 mt-10 -127.99 160.56 60.81 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.63 0.729 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -8.84 24.62 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.685 2.256 . . . . 0.0 112.296 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 15.3 m -102.15 -24.8 13.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.9 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -60.46 175.03 0.48 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.68 156.67 19.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.147 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.5 mm -53.34 -30.73 17.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.152 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -59.06 -40.25 84.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -41.87 90.56 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.861 HG21 HD21 ' B' ' 256' ' ' LEU . 25.6 t -64.01 -46.12 94.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.655 ' HE3' HD11 ' B' ' 243' ' ' LEU . 22.4 ttmt -60.48 -41.91 95.21 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.98 -40.91 70.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.074 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -63.07 -42.37 99.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.92 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.605 ' CG1' HD21 ' B' ' 215' ' ' LEU . 52.7 mt -57.74 -28.75 33.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.182 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -68.78 -44.73 73.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.54 -5.77 44.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.701 ' HE3' HG23 ' B' ' 213' ' ' ILE . 23.4 mmmt -99.55 -54.57 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -100.11 -48.0 4.78 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 114.37 19.81 6.1 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.479 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.559 HD12 HD21 ' B' ' 269' ' ' LEU . 8.1 mt -94.1 132.56 29.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 0.0 111.181 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 167.17 25.18 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.655 2.237 . . . . 0.0 112.366 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -7.13 20.26 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.623 2.216 . . . . 0.0 112.366 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -90.07 -20.68 22.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -113.21 -14.88 12.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.91 126.8 31.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.937 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.509 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 3.2 ttm180 -134.0 118.29 17.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.655 HD11 ' HE3' ' B' ' 227' ' ' LYS . 0.8 OUTLIER -88.26 147.68 24.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.947 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.431 HD13 ' O ' ' B' ' 243' ' ' LEU . 21.8 mm -135.96 115.65 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.189 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' B' ' 250' ' ' LEU . 29.9 t80 -141.12 141.93 34.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.864 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.81 14.29 9.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.076 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.21 15.14 65.14 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.513 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -134.31 170.3 15.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . 0.446 HE21 ' NE ' ' B' ' 242' ' ' ARG . 9.5 mt-30 -94.85 128.69 41.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.5 mt -86.21 155.62 20.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -113.85 157.16 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.913 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -76.93 -6.51 52.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -103.45 41.22 2.19 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.495 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 2.3 ttt85 -152.65 168.52 25.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.24 148.33 25.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.19 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.861 HD21 HG21 ' B' ' 226' ' ' VAL . 69.6 mt -53.53 -44.39 69.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.2 t -57.68 -26.59 61.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.86 -33.2 75.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.85 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.549 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.4 6.72 48.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.917 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 4.2 m120 63.6 36.77 10.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.919 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.556 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.5 mm -68.73 96.5 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -82.99 166.58 18.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.33 149.4 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.976 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 54.22 26.27 6.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.12 143.28 33.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.06 86.92 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.174 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.401 HD11 HD11 ' B' ' 250' ' ' LEU . 1.0 OUTLIER -82.36 158.88 23.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -133.01 115.07 14.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.818 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.85 HD23 HG22 ' B' ' 207' ' ' THR . 10.2 tp -85.59 134.67 34.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.745 HG11 HD12 ' A' ' 82' ' ' ILE . 39.8 t -132.81 146.85 32.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.449 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.2 127.15 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.923 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.509 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.1 mtt180 -88.96 163.91 15.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.662 HD22 ' OG ' ' A' ' 91' ' ' SER . 2.0 mm? -50.75 136.05 22.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.984 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -99.41 141.97 31.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.898 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 154.66 -19.36 0.59 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.513 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 -179.914 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.685 ' HB2' HD22 ' A' ' 63' ' ' LEU . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.815 0.256 . . . . 0.0 112.307 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.916 HD12 HD21 ' A' ' 87' ' ' LEU . 2.4 mm? -117.18 136.6 52.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 19.9 t -119.4 -21.73 7.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.905 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.84 93.62 3.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 70' ' ' VAL . 3.0 mt -112.49 152.47 44.63 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.557 0.694 . . . . 0.0 110.949 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HD3' HG22 ' A' ' 86' ' ' ILE . 53.8 Cg_endo -69.77 175.01 8.68 Favored 'Trans proline' 0 N--CA 1.466 -0.144 0 C-N-CA 122.754 2.303 . . . . 0.0 112.347 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.68 144.45 51.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.41 20.68 30.96 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.454 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 66' ' ' LEU . 9.9 p -66.4 145.42 13.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.835 0.35 . . . . 0.0 111.169 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' CG ' HG23 ' A' ' 74' ' ' VAL . 12.5 t0 -104.47 108.39 19.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.864 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 tp60 -51.64 -53.28 40.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.907 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -50.11 -43.21 51.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.621 HG13 ' CE1' ' B' ' 268' ' ' HIS . 99.7 t -70.85 -32.69 49.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HE2' HG21 ' A' ' 86' ' ' ILE . 0.4 OUTLIER -66.72 -56.88 8.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.92 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -14.27 60.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -89.97 -23.25 21.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.822 HD13 HG21 ' A' ' 82' ' ' ILE . 20.8 mt -80.85 158.96 69.86 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.644 0.735 . . . . 0.0 110.846 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.4 ' HG2' HG12 ' A' ' 82' ' ' ILE . 53.1 Cg_endo -69.83 165.27 31.61 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.288 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.86 -32.78 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.181 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.92 -43.52 94.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.822 HG21 HD13 ' A' ' 78' ' ' LEU . 34.3 mm -78.89 -29.1 14.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.17 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.451 ' O ' HD23 ' A' ' 87' ' ' LEU . 32.9 mt-30 -69.74 -25.96 64.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -89.71 -25.97 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.83 -38.85 64.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.457 HG21 ' HE2' ' A' ' 75' ' ' PHE . 50.1 mt -78.07 -40.82 26.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.076 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.916 HD21 HD12 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -53.87 -37.59 63.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.894 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.06 -25.75 67.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.66 -12.63 61.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.608 ' CD ' HD11 ' B' ' 273' ' ' LEU . 2.1 pttt -70.99 -175.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.733 0.302 . . . . 0.0 110.953 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.8 m 57.96 69.06 0.77 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -139.6 90.68 2.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' CG ' HD21 ' B' ' 271' ' ' LEU . 1.3 pp20? -112.0 -30.86 7.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -60.52 -63.93 1.13 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -109.28 166.22 11.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.877 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -86.95 124.0 32.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.925 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.56 169.7 1.02 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.474 ' C ' HD23 ' A' ' 99' ' ' LEU . 14.2 mttt -129.15 91.83 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.354 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.76 0.314 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -98.37 134.09 41.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.589 HD11 HG13 ' B' ' 226' ' ' VAL . 31.6 pt -117.03 150.09 19.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.145 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.478 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.0 m-85 -106.75 130.55 54.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 22.9 t -113.06 107.89 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.09 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.586 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -96.66 110.48 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.66 HG22 HD23 ' B' ' 269' ' ' LEU . 7.3 p -71.51 174.28 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.112 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.69 -25.73 63.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.55 5.8 37.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.206 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 76.35 29.34 58.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.527 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.9 tptm -94.73 108.83 20.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.839 0.352 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.586 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.06 133.5 35.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.161 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.695 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.0 mt -129.52 111.68 22.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.145 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 1.2 m -78.49 128.2 33.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.441 HD21 HG22 ' B' ' 213' ' ' ILE . 8.6 mt -131.4 134.19 46.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -90.22 103.9 16.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.922 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.914 HG11 HG22 ' B' ' 226' ' ' VAL . 24.3 m -130.06 -179.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.586 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.9 mt-10 -132.2 160.73 66.7 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.628 0.728 . . . . 0.0 110.924 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 -12.11 32.11 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.72 2.28 . . . . 0.0 112.312 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 23.1 p -97.96 -25.31 15.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -61.42 175.09 0.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.1 p -112.8 157.64 21.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.1 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.464 ' CG2' HD13 ' B' ' 243' ' ' LEU . 48.5 mm -52.86 -29.24 14.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -61.49 -30.28 70.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -38.07 44.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.914 HG22 HG11 ' B' ' 217' ' ' VAL . 96.0 t -67.21 -51.73 50.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.102 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.526 ' HA ' HD12 ' B' ' 230' ' ' ILE . 15.4 ptmt -59.26 -35.04 72.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.21 -43.25 92.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.06 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 7.4 mttt -57.64 -46.78 83.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.86 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' B' ' 227' ' ' LYS . 44.6 mt -54.41 -32.8 24.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.21 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -61.79 -47.28 85.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -75.14 -5.4 44.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.695 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.0 mmmt -97.18 -54.52 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.38 -48.72 3.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.7 34.88 1.64 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.531 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.628 HD12 HD21 ' B' ' 269' ' ' LEU . 7.7 mt -108.45 131.32 21.84 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.635 0.731 . . . . 0.0 111.085 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.72 164.58 33.98 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.632 2.221 . . . . 0.0 112.345 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.74 -6.98 19.9 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.237 . . . . 0.0 112.383 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.76 -30.84 19.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.522 ' O ' HD22 ' B' ' 271' ' ' LEU . 2.3 mp0 -113.73 6.36 16.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.904 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.562 ' HG3' HD13 ' B' ' 269' ' ' LEU . 8.4 tt0 -116.63 125.75 52.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.829 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -134.7 148.0 50.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.828 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.543 ' HB2' HD12 ' B' ' 250' ' ' LEU . 0.4 OUTLIER -105.36 133.9 49.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 21.4 mm -111.78 123.65 67.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.102 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.786 ' HB3' HD21 ' B' ' 250' ' ' LEU . 20.8 t80 -151.64 144.75 24.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.936 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . 0.575 ' HB3' ' HZ3' ' B' ' 248' ' ' LYS . . . 64.14 15.05 9.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.104 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.49 8.17 74.57 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.441 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . 0.575 ' HZ3' ' HB3' ' B' ' 246' ' ' ALA . 0.0 OUTLIER -141.15 157.99 44.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.801 0.334 . . . . 0.0 110.83 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -77.31 146.77 36.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.786 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.8 mt -94.7 163.31 13.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.883 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -118.28 154.01 32.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -76.25 -5.54 47.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.805 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -104.81 39.28 2.89 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.506 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 4.6 ttt180 -152.69 169.89 21.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.898 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.03 152.71 21.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.192 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.853 HD21 HG21 ' B' ' 226' ' ' VAL . 52.8 mt -56.92 -43.82 81.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.0 t -60.69 -26.37 67.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.823 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -63.83 -31.65 72.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.82 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -98.79 9.73 42.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.6 m-80 63.72 34.89 11.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.519 HD13 ' CE2' ' B' ' 245' ' ' PHE . 15.9 mm -68.58 96.32 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.121 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -82.95 165.68 19.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.942 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 150.77 7.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.914 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 55.82 26.03 9.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.45 133.72 53.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.858 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.99 88.33 7.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.18 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.527 HD13 HD12 ' B' ' 203' ' ' ILE . 3.7 mp -89.32 158.82 17.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.621 ' CE1' HG13 ' A' ' 74' ' ' VAL . 8.6 m170 -127.99 125.63 39.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.66 HD23 HG22 ' B' ' 207' ' ' THR . 4.6 tp -92.58 125.61 37.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.79 HG11 HD12 ' A' ' 82' ' ' ILE . 11.1 t -121.78 149.26 25.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.155 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.612 HD21 ' CG ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -91.44 144.03 25.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.55 ' N ' HD13 ' B' ' 271' ' ' LEU . 38.0 mtt180 -105.12 169.27 8.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.845 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.608 HD11 ' CD ' ' A' ' 90' ' ' LYS . 3.0 mm? -48.96 127.31 13.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 39.6 tpt85 -116.85 99.82 7.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -141.22 15.28 2.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.532 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.152 0 CA-C-O 120.814 0.256 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.545 HD21 ' CD1' ' A' ' 75' ' ' PHE . 5.6 mp -86.78 77.25 9.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.928 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 61.5 m -116.53 -18.78 10.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.892 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.2 m -131.31 97.79 4.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.9 mt -110.98 153.05 43.99 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.68 0.752 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 173.56 10.86 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.68 2.253 . . . . 0.0 112.356 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -70.01 146.15 51.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.15 20.7 36.33 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.489 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.675 HG11 ' HB3' ' A' ' 66' ' ' LEU . 8.1 p -70.43 143.57 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.899 0.38 . . . . 0.0 111.098 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.478 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.6 t0 -102.84 108.63 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.903 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.418 HE22 HD23 ' A' ' 63' ' ' LEU . 4.2 tp-100 -51.68 -52.65 46.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.942 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.36 -38.69 54.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.964 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 HG13 ' CE1' ' B' ' 268' ' ' HIS . 97.2 t -76.15 -33.24 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD1' HD21 ' A' ' 63' ' ' LEU . 1.5 t80 -66.36 -56.3 11.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -14.85 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -87.37 -25.91 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.873 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.989 HD13 HG21 ' A' ' 82' ' ' ILE . 28.7 mt -78.4 158.06 76.95 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.628 0.728 . . . . 0.0 110.933 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 164.96 32.64 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.663 2.242 . . . . 0.0 112.367 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.3 p -59.13 -28.36 38.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -63.3 -42.56 99.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.989 HG21 HD13 ' A' ' 78' ' ' LEU . 41.8 mm -78.85 -27.74 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.135 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -68.73 -42.88 77.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -27.03 60.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.47 -41.19 73.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.08 -34.12 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.151 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.47 -35.82 82.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.5 m -65.21 -24.01 67.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.816 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.96 20.82 41.49 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.438 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.687 ' HD3' HD11 ' B' ' 273' ' ' LEU . 2.6 ptpt -99.76 -176.64 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 4.4 p 46.48 67.66 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.796 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.4 ptt85 -139.3 91.51 2.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.835 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -109.58 -33.13 6.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -59.18 -57.85 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.923 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -116.17 174.62 5.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -108.45 150.76 26.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -52.47 172.88 0.32 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.528 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -123.98 87.33 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.764 0.316 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.7 ptt? . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.77 0.319 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -98.2 134.4 41.3 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.692 HD12 HD13 ' B' ' 267' ' ' LEU . 23.3 pt -118.39 151.75 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.522 ' HB3' HG22 ' B' ' 212' ' ' THR . 9.0 m-85 -106.45 123.35 47.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.868 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.7 113.0 41.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.21 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.426 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.3 OUTLIER -100.85 112.14 24.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.657 HG22 HD23 ' B' ' 269' ' ' LEU . 3.2 p -75.9 171.18 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.215 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.56 -22.01 54.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.938 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -94.3 23.56 5.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 54.99 53.76 38.05 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -120.04 108.31 14.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.895 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.522 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -81.91 130.91 35.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.171 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.641 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.7 mt -129.66 112.41 24.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.42 130.45 36.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.8 mt -132.53 134.55 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -90.24 104.66 17.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.828 HG11 HG22 ' B' ' 226' ' ' VAL . 28.5 m -133.91 178.48 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.602 ' O ' HD12 ' B' ' 256' ' ' LEU . 4.1 mt-10 -128.69 160.75 61.31 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.623 0.725 . . . . 0.0 110.876 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -13.94 35.31 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.718 2.279 . . . . 0.0 112.337 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 5.7 m -96.23 -24.45 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -60.39 175.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.802 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.07 156.49 21.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.173 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.466 HG22 ' HE2' ' B' ' 227' ' ' LYS . 49.1 mm -53.2 -28.13 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -62.98 -31.19 72.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -38.05 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.865 HG21 HD21 ' B' ' 256' ' ' LEU . 88.2 t -67.41 -48.17 78.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.171 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.466 ' HE2' HG22 ' B' ' 223' ' ' ILE . 1.1 ptpt -60.59 -38.94 86.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.55 76.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.132 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.497 ' HE3' HG12 ' B' ' 217' ' ' VAL . 8.4 mttt -58.91 -48.07 82.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.939 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . . . . . . . . . 59.1 mt -55.23 -31.02 25.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.062 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -62.7 -47.55 83.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.928 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -75.81 -5.08 44.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.853 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.641 ' HE3' HG23 ' B' ' 213' ' ' ILE . 14.9 mmmt -97.27 -56.5 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.892 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -100.81 -48.63 4.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.56 35.34 1.59 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.673 HD12 HD21 ' B' ' 269' ' ' LEU . 11.3 mt -108.17 130.54 22.64 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.64 0.734 . . . . 0.0 111.104 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.87 163.44 38.33 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.716 2.277 . . . . 0.0 112.241 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 -7.95 22.37 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.671 2.247 . . . . 0.0 112.332 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.53 -30.15 25.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.6 -3.22 14.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -89.31 131.35 35.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -133.75 147.52 51.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.536 ' O ' HD13 ' B' ' 244' ' ' ILE . 1.9 mp -116.36 146.53 42.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.536 HD13 ' O ' ' B' ' 243' ' ' LEU . 23.9 mm -133.69 120.67 37.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.178 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.73 ' HB3' HD21 ' B' ' 250' ' ' LEU . 39.2 t80 -148.4 141.3 24.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.33 14.02 9.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.051 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.29 15.63 64.06 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.495 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -134.78 176.07 8.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.709 0.29 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.5 131.7 47.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.73 HD21 ' HB3' ' B' ' 245' ' ' PHE . 5.2 mt -86.66 158.73 19.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.45 162.13 18.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.48 0.73 41.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.48 42.86 1.82 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -152.75 167.96 27.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.934 0.397 . . . . 0.0 110.835 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.57 147.25 26.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.865 HD21 HG21 ' B' ' 226' ' ' VAL . 80.2 mt -52.46 -44.37 65.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.849 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -56.61 -26.07 54.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.84 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -67.72 -31.41 71.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.553 ' CD1' HD22 ' B' ' 250' ' ' LEU . 90.5 m-85 -95.53 6.5 48.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 6.0 m120 63.83 35.66 10.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.571 HD13 ' CD2' ' B' ' 245' ' ' PHE . 12.2 mm -68.54 96.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.145 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -83.22 163.9 20.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.48 148.44 9.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.946 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 58.98 22.84 10.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.544 ' OG ' HD12 ' B' ' 267' ' ' LEU . 0.1 OUTLIER -56.46 144.68 30.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.851 -179.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 2.2 m -103.43 92.24 4.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.132 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.692 HD13 HD12 ' B' ' 203' ' ' ILE . 1.4 mp -87.31 162.75 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.879 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.543 ' CE1' HG13 ' A' ' 74' ' ' VAL . 2.5 m170 -130.14 116.04 17.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.673 HD21 HD12 ' B' ' 236' ' ' ILE . 10.5 tp -83.9 125.45 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.786 HG11 HD12 ' A' ' 82' ' ' ILE . 15.5 t -124.85 146.88 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.117 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.441 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.14 135.4 37.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.894 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.441 ' N ' HD13 ' B' ' 271' ' ' LEU . 4.2 mtt180 -95.59 167.25 11.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.864 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.687 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.2 mm? -51.35 126.46 17.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -103.63 120.13 40.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.846 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -126.01 37.18 2.53 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.499 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.427 -179.884 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.158 0 CA-C-O 120.791 0.246 . . . . 0.0 112.351 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.731 HD13 ' CD1' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -104.48 47.9 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 9.9 m -70.77 -21.4 62.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.906 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -108.37 94.0 4.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.686 ' HB3' HG11 ' A' ' 70' ' ' VAL . 5.0 mt -107.95 152.48 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.894 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.66 173.84 10.3 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.681 2.254 . . . . 0.0 112.393 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -69.72 146.8 51.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.806 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.2 20.91 30.44 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.686 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.9 p -71.12 143.92 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.912 0.387 . . . . 0.0 111.069 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -103.4 107.85 18.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.823 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -51.44 -51.8 51.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -51.2 -40.41 58.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.795 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' B' ' 268' ' ' HIS . 63.6 t -76.42 -33.04 22.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.731 ' CD1' HD13 ' A' ' 63' ' ' LEU . 4.2 t80 -66.99 -56.08 11.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -14.4 60.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -89.4 -23.4 22.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.869 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.892 HD13 HG21 ' A' ' 82' ' ' ILE . 21.9 mt -80.4 158.23 71.8 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.613 0.721 . . . . 0.0 110.886 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 165.24 31.7 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.685 2.257 . . . . 0.0 112.342 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 p -60.55 -32.31 51.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.137 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -58.85 -41.42 86.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.892 HG21 HD13 ' A' ' 78' ' ' LEU . 34.8 mm -79.08 -29.54 13.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -69.68 -30.8 68.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.954 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -82.23 -29.07 31.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -73.2 -38.93 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 58.2 mt -78.26 -26.66 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.65 -39.88 80.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.926 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.6 m -65.58 -22.15 66.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.09 28.84 24.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.488 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.56 ' HD3' HD11 ' B' ' 273' ' ' LEU . 0.5 OUTLIER -103.72 -176.23 3.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 0.0 110.909 -179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.8 p 46.2 70.72 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -133.46 69.88 1.47 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.568 ' HG3' HD21 ' B' ' 271' ' ' LEU . 0.5 OUTLIER -100.34 -29.53 12.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.913 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -50.39 -46.93 56.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -135.69 174.29 10.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -96.21 116.2 28.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.15 122.27 13.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.52 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.04 87.65 3.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.78 0.324 . . . . 0.0 110.915 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.5 tp . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.922 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 5.2 ptt? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.696 0.284 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.99 134.21 37.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.965 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.479 HG22 ' HB2' ' B' ' 265' ' ' SER . 29.9 pt -115.35 148.34 18.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.187 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -105.22 121.97 44.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 15.1 t -105.18 108.0 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.442 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.88 110.53 23.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.679 HG22 HD23 ' B' ' 269' ' ' LEU . 6.3 p -72.07 174.77 6.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.9 -24.54 62.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.872 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.8 p -89.97 8.25 33.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.084 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 73.68 29.09 63.98 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.443 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -93.18 110.54 22.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.809 0.338 . . . . 0.0 110.902 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.442 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.28 132.71 35.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.22 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.403 HG23 ' HE3' ' B' ' 233' ' ' LYS . 5.6 mt -129.8 106.4 13.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.74 133.12 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -137.21 134.13 35.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.963 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -89.19 100.94 13.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.862 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.946 HG11 HG22 ' B' ' 226' ' ' VAL . 22.8 m -128.49 175.73 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.598 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.2 mt-10 -128.55 160.29 63.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.628 0.727 . . . . 0.0 110.917 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -11.45 30.87 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.736 2.291 . . . . 0.0 112.37 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.26 -27.14 14.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.485 ' O ' HG22 ' B' ' 255' ' ' THR . 14.7 m-20 -61.98 175.12 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 2.0 p -113.44 158.45 20.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 47.4 mm -52.07 -33.37 16.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.109 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -57.34 -31.72 66.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -36.28 46.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.946 HG22 HG11 ' B' ' 217' ' ' VAL . 99.0 t -70.43 -51.23 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.105 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.666 ' HA ' HD12 ' B' ' 230' ' ' ILE . 0.5 OUTLIER -58.97 -33.91 71.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.905 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.08 -50.49 73.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.115 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.711 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.4 mttm -55.66 -43.22 76.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.855 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.666 HD12 ' HA ' ' B' ' 227' ' ' LYS . 63.0 mt -55.17 -32.67 28.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -63.46 -45.59 90.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -74.72 -5.83 45.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.403 ' HE3' HG23 ' B' ' 213' ' ' ILE . 0.5 OUTLIER -97.93 -48.19 5.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -108.37 -48.65 3.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.851 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.57 34.57 1.71 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.494 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.477 HD12 HD21 ' B' ' 269' ' ' LEU . 11.6 mt -108.36 132.13 21.3 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.621 0.724 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 163.4 38.44 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.687 2.258 . . . . 0.0 112.362 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -6.38 18.44 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.739 2.293 . . . . 0.0 112.378 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -93.19 -22.87 18.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.88 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -113.18 -5.56 13.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.891 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.439 ' HG3' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -91.68 131.3 37.17 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.875 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.506 ' HD3' HD11 ' A' ' 82' ' ' ILE . 9.0 ttm180 -133.89 124.49 26.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.537 ' H ' HD12 ' B' ' 243' ' ' LEU . 0.6 OUTLIER -97.42 134.18 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 -179.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.13 115.19 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.191 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.66 ' HB3' HD21 ' B' ' 250' ' ' LEU . 33.9 t80 -143.04 145.19 32.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.53 15.45 9.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.005 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.26 20.63 58.55 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.561 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.89 173.88 12.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.768 0.318 . . . . 0.0 110.871 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.48 140.82 29.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.91 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' B' ' 245' ' ' PHE . 3.7 mt -96.24 153.28 17.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.946 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -108.41 161.79 14.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.11 0.37 41.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.75 41.44 2.22 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -152.5 168.57 25.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.964 0.412 . . . . 0.0 110.84 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.485 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.0 OUTLIER -98.98 151.36 21.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.182 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.869 HD21 HG21 ' B' ' 226' ' ' VAL . 55.5 mt -56.42 -47.33 79.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.959 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 11.8 t -55.43 -25.15 34.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.79 -28.8 67.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.63 ' CG ' HD22 ' B' ' 250' ' ' LEU . 84.1 m-85 -98.67 11.21 39.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 63.82 33.47 12.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.928 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.533 HD12 HD11 ' B' ' 267' ' ' LEU . 13.8 mm -71.81 97.82 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -93.52 170.21 9.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.72 143.89 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.944 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 58.21 29.02 17.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.479 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.58 126.57 27.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.7 m -84.6 83.92 7.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.533 HD11 HD12 ' B' ' 261' ' ' ILE . 2.5 mp -85.75 160.76 19.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.948 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.624 ' CE1' HG13 ' A' ' 74' ' ' VAL . 7.1 m170 -129.0 119.9 25.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.822 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.679 HD23 HG22 ' B' ' 207' ' ' THR . 6.1 tp -89.21 120.97 31.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 82' ' ' ILE . 18.8 t -118.83 143.47 29.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.191 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.568 HD21 ' HG3' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -76.19 135.2 39.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.903 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.49 ' N ' HD13 ' B' ' 271' ' ' LEU . 6.4 mtt180 -97.63 165.78 11.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.821 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.56 HD11 ' HD3' ' A' ' 90' ' ' LYS . 3.9 mm? -51.03 124.23 10.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.898 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -109.15 102.54 11.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . 88.34 -47.62 3.5 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.47 -179.886 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.425 ' O ' HD11 ' A' ' 87' ' ' LEU . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.876 0.282 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.634 HD22 ' CD2' ' A' ' 75' ' ' PHE . 5.7 mt -89.81 48.33 1.57 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.64 -25.55 19.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.8 m -120.6 93.9 4.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.914 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.688 ' CB ' HG11 ' A' ' 70' ' ' VAL . 5.4 mt -110.94 153.12 43.93 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.591 0.71 . . . . 0.0 110.967 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.64 174.61 9.14 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.691 2.261 . . . . 0.0 112.394 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.02 144.66 52.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 58.84 18.71 40.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.451 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 66' ' ' LEU . 8.0 p -67.62 142.88 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.797 0.332 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' CG ' HG23 ' A' ' 74' ' ' VAL . 9.5 t0 -103.36 109.71 21.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.892 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.41 -53.01 41.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -51.27 -37.84 49.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.439 HG23 ' CG ' ' A' ' 71' ' ' ASP . 93.8 t -76.62 -33.29 22.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.17 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.634 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.3 t80 -67.74 -56.23 10.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.6 -14.78 59.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.949 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -87.55 -23.93 24.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.05 HD13 HG21 ' A' ' 82' ' ' ILE . 34.6 mt -81.34 157.74 70.1 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.588 0.709 . . . . 0.0 110.934 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 165.12 31.99 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.662 2.241 . . . . 0.0 112.399 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.17 -34.4 53.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.126 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -58.15 -39.94 80.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.91 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.05 HG21 HD13 ' A' ' 78' ' ' LEU . 31.7 mm -78.56 -32.64 16.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.203 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -64.8 -49.9 68.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -65.25 -32.03 73.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -66.31 -43.1 87.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.451 HG21 ' HE1' ' A' ' 75' ' ' PHE . 55.9 mt -78.24 -31.37 16.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.154 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 62' ' ' PRO . 1.9 mm? -68.92 -35.23 76.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.4 m -65.25 -24.39 67.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.1 18.57 49.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.493 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.811 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.3 ptpt -99.08 179.99 4.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.794 0.331 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 80.6 p 46.13 66.44 0.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -140.15 80.92 1.79 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.9 -5.2 9.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.99 -50.93 20.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.946 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 p90 -117.64 174.12 6.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -69.37 109.59 4.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.94 115.77 6.38 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.49 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -62.83 94.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.795 0.331 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.945 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.801 0.334 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -97.18 133.77 41.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.603 HD12 HD13 ' B' ' 267' ' ' LEU . 27.9 pt -116.25 147.76 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -104.99 125.05 50.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.8 t -108.04 109.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.408 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -96.65 111.15 23.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.876 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.732 HG22 HD23 ' B' ' 269' ' ' LEU . 5.4 p -71.78 174.24 7.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.153 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.13 -23.4 66.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.92 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 7.3 p -89.48 7.56 35.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.134 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.59 35.2 52.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 7.8 tptm -102.81 112.35 25.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.85 0.357 . . . . 0.0 110.837 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.24 134.66 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.147 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.754 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.8 mt -130.75 110.86 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.139 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.472 ' O ' HD23 ' B' ' 215' ' ' LEU . 1.0 OUTLIER -79.81 132.3 36.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.213 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.605 HD21 HG22 ' B' ' 213' ' ' ILE . 5.9 mt -136.45 134.03 37.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -87.28 102.17 14.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 1.052 HG11 HG22 ' B' ' 226' ' ' VAL . 27.7 m -127.37 179.96 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.117 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -137.18 161.34 61.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.6 0.714 . . . . 0.0 110.951 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 -14.74 36.81 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.727 2.285 . . . . 0.0 112.379 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.63 -26.8 16.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.686 ' O ' HG22 ' B' ' 255' ' ' THR . 18.4 m-20 -61.98 174.96 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.852 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' B' ' 255' ' ' THR . 0.2 OUTLIER -108.09 152.23 24.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 42.3 mm -50.2 -30.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.76 -37.98 86.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.999 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.18 96.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 1.052 HG22 HG11 ' B' ' 217' ' ' VAL . 96.9 t -66.06 -50.98 65.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.148 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.61 ' HD3' HD22 ' B' ' 243' ' ' LEU . 12.6 mmmm -57.24 -38.68 74.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -54.07 -50.23 67.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.134 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.624 ' HE3' HG12 ' B' ' 217' ' ' VAL . 46.2 mttm -56.42 -43.17 79.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.865 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' B' ' 227' ' ' LYS . 75.8 mt -56.29 -28.79 26.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.129 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -67.2 -45.96 75.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -74.66 -5.34 42.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.754 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.5 mmmt -97.01 -49.56 4.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -106.66 -48.27 3.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.75 34.9 1.62 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.424 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 10.6 mt -110.14 132.66 21.34 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.553 0.692 . . . . 0.0 111.149 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.91 164.5 34.46 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.632 2.222 . . . . 0.0 112.313 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 -5.0 15.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.62 2.213 . . . . 0.0 112.344 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -93.78 -24.91 17.62 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.916 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.419 ' NE2' HH11 ' B' ' 274' ' ' ARG . 1.6 mp0 -113.47 -2.15 13.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.99 129.81 41.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.925 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.462 ' NE ' ' HE ' ' B' ' 272' ' ' ARG . 8.1 ttm180 -133.9 122.43 23.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.899 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.757 ' CD1' HD12 ' B' ' 250' ' ' LEU . 2.3 pt? -103.5 133.81 47.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 82' ' ' ILE . 15.8 mm -114.68 141.52 30.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.078 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.738 ' HB3' HD21 ' B' ' 250' ' ' LEU . 41.7 t80 -156.64 137.4 13.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.9 14.63 9.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.82 16.16 60.22 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.526 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -136.75 168.6 19.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.703 0.287 . . . . 0.0 110.933 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -98.01 122.09 40.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.901 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' B' ' 243' ' ' LEU . 2.3 mt -83.25 152.48 25.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -111.07 161.13 16.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -75.94 -12.38 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.955 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -92.52 37.4 3.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -152.9 170.75 19.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.849 0.356 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.686 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.5 OUTLIER -102.94 158.08 16.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 -179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.884 HD11 HG21 ' B' ' 226' ' ' VAL . 4.1 mm? -55.29 -50.61 69.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.833 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 44.4 t -57.47 -30.45 65.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.849 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -53.83 -37.5 63.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.7 ' CD1' HD22 ' B' ' 250' ' ' LEU . 97.1 m-85 -98.85 16.48 22.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.957 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 61.17 32.42 19.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.701 HG21 HD12 ' B' ' 256' ' ' LEU . 8.6 mm -68.15 95.65 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.126 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -88.12 165.72 14.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.929 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.19 147.43 5.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.909 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 59.72 25.62 14.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.873 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.514 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -56.63 135.67 54.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.3 m -92.39 84.24 5.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.205 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.603 HD13 HD12 ' B' ' 203' ' ' ILE . 4.7 mp -86.33 162.99 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.462 ' HB3' HD21 ' A' ' 78' ' ' LEU . 5.6 m170 -129.81 129.08 43.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.732 HD23 HG22 ' B' ' 207' ' ' THR . 12.2 tp -96.06 131.21 42.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.596 HG11 HG23 ' A' ' 82' ' ' ILE . 19.6 t -133.81 148.19 30.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.424 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -78.37 128.06 33.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.912 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.462 ' HE ' ' NE ' ' B' ' 242' ' ' ARG . 4.8 mtt180 -88.45 165.21 15.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.858 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.811 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.3 mm? -51.07 127.12 18.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . 0.419 HH11 ' NE2' ' B' ' 240' ' ' GLN . 18.5 tpt180 -91.71 99.1 12.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.822 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -113.88 37.31 3.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.528 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.485 -179.886 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.232 0.219 0 CA-C-O 120.861 0.275 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.616 HD22 ' CD2' ' A' ' 75' ' ' PHE . 6.1 mt -89.09 49.64 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 25.9 m -92.57 -16.9 25.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.95 96.25 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.756 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt -110.68 152.32 43.39 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.593 0.711 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 175.06 8.6 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.667 2.245 . . . . 0.0 112.357 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.54 147.27 51.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.897 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.64 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.33 21.01 31.72 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.47 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.756 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.2 p -73.82 145.28 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.798 0.332 . . . . 0.0 111.152 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.41 ' CG ' HG23 ' A' ' 74' ' ' VAL . 14.2 t0 -104.31 107.34 18.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -50.89 -53.88 28.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -49.44 -40.76 37.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.924 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.624 HG13 ' CE1' ' B' ' 268' ' ' HIS . 65.2 t -75.75 -32.98 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.13 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.616 ' CD2' HD22 ' A' ' 63' ' ' LEU . 1.4 t80 -65.7 -56.81 10.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -14.74 61.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.959 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -87.66 -23.75 24.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.881 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.066 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.83 157.55 69.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.611 0.72 . . . . 0.0 110.957 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.453 ' HD3' HG21 ' B' ' 244' ' ' ILE . 53.8 Cg_endo -69.79 165.21 31.77 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.271 . . . . 0.0 112.362 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.9 p -59.6 -29.95 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -61.73 -40.59 95.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.066 HG21 HD13 ' A' ' 78' ' ' LEU . 40.0 mm -79.19 -27.64 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.073 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -69.7 -47.88 61.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -65.89 -33.05 74.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -66.92 -42.56 85.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.845 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.477 HG21 ' HE1' ' A' ' 75' ' ' PHE . 57.5 mt -77.47 -37.14 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.49 -32.83 63.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 m -71.48 -24.56 62.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.16 -15.61 58.97 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.568 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.594 ' HE3' HD11 ' B' ' 273' ' ' LEU . 0.0 OUTLIER -70.16 -176.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.814 0.34 . . . . 0.0 110.873 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.5 m 55.71 64.29 1.79 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.839 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.7 ptt85 -140.06 70.33 1.36 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.87 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.734 ' HG3' HD21 ' B' ' 271' ' ' LEU . 0.4 OUTLIER -96.4 -29.13 14.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.936 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -50.71 -47.93 58.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.878 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -135.25 174.56 10.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -117.29 152.46 34.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.924 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -49.08 105.71 0.15 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.55 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' C ' HD12 ' A' ' 99' ' ' LEU . 0.0 OUTLIER -93.5 96.04 9.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.823 0.344 . . . . 0.0 110.861 -179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.534 HD12 ' C ' ' A' ' 98' ' ' LYS . 9.8 mp . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.733 0.301 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -101.14 135.65 42.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' B' ' 265' ' ' SER . 21.5 pt -117.09 148.11 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -104.85 126.29 51.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.837 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 18.4 t -108.78 108.19 24.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.084 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.444 ' HE2' HG22 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -97.64 110.34 22.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.583 HG22 HD23 ' B' ' 269' ' ' LEU . 7.1 p -71.95 174.06 7.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.146 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.25 -25.12 63.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.6 OUTLIER -87.43 3.19 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.133 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 79.81 24.77 59.51 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -89.89 109.91 20.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.931 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.427 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -83.72 130.93 34.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.15 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.699 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.9 mt -128.32 113.68 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.586 ' C ' HD12 ' B' ' 215' ' ' LEU . 10.2 m -78.61 127.69 32.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.659 HD21 HG13 ' B' ' 230' ' ' ILE . 10.8 mp -126.36 133.4 51.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.62 98.58 10.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.848 HG11 HG22 ' B' ' 226' ' ' VAL . 11.4 m -129.77 -179.5 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.085 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.475 ' O ' HD12 ' B' ' 256' ' ' LEU . 2.9 mt-10 -126.22 160.77 55.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.57 0.7 . . . . 0.0 110.912 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -8.65 24.15 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.65 2.233 . . . . 0.0 112.384 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.3 m -101.77 -25.5 13.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -59.77 174.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.82 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . 0.441 HG22 ' O ' ' B' ' 254' ' ' ARG . 0.2 OUTLIER -111.76 163.38 14.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.177 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.766 HD12 HD23 ' B' ' 250' ' ' LEU . 47.8 mm -59.3 -40.79 82.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.127 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -52.37 -29.76 25.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.821 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -40.72 44.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.848 HG22 HG11 ' B' ' 217' ' ' VAL . 48.7 t -66.07 -47.42 85.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.572 ' HA ' HD12 ' B' ' 230' ' ' ILE . 23.9 ttmt -58.01 -39.17 77.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.81 70.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.136 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.816 ' HE3' HG12 ' B' ' 217' ' ' VAL . 41.0 mttm -57.2 -42.06 80.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.659 HG13 HD21 ' B' ' 215' ' ' LEU . 67.8 mt -56.37 -30.61 31.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.152 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -66.74 -43.92 82.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -74.89 -5.58 44.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.919 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.699 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.3 mmmt -97.93 -47.96 5.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.874 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -109.51 -48.52 3.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.87 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.96 32.91 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.49 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . . . . . . . . . 12.4 mt -106.35 132.86 20.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.701 0.763 . . . . 0.0 111.127 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 162.62 41.34 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.671 2.248 . . . . 0.0 112.363 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -4.6 14.32 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.687 2.258 . . . . 0.0 112.381 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.56 -27.0 18.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -113.43 -2.34 13.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 127.43 40.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' A' ' 82' ' ' ILE . 11.9 ttm180 -134.31 145.51 49.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.649 HD13 ' CB ' ' B' ' 250' ' ' LEU . 0.0 OUTLIER -116.3 155.96 27.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.915 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.615 HD11 HD11 ' A' ' 82' ' ' ILE . 24.5 mm -137.67 114.05 11.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.144 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.473 ' CD1' HD13 ' B' ' 261' ' ' ILE . 31.5 t80 -144.43 145.77 32.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.895 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 65.08 14.41 9.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.066 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 80.07 39.4 16.38 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.9 169.64 20.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.693 0.282 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -90.49 126.67 35.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.766 HD23 HD12 ' B' ' 223' ' ' ILE . 7.0 mp -74.47 163.69 27.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -131.1 157.64 42.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.838 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -82.2 1.06 38.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -111.75 37.69 3.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . 0.441 ' O ' HG22 ' B' ' 222' ' ' THR . 6.9 ttt180 -153.1 169.88 21.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.897 0.379 . . . . 0.0 110.878 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.62 157.15 16.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.182 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.838 HD21 HG21 ' B' ' 226' ' ' VAL . 39.1 mt -60.01 -43.43 95.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.7 t -59.14 -20.58 54.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.825 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.92 -32.13 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.551 ' CE1' HD11 ' B' ' 223' ' ' ILE . 15.8 m-85 -98.44 10.57 40.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 63.57 33.94 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.676 HD12 HD11 ' B' ' 267' ' ' LEU . 10.8 mm -68.69 100.71 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.139 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -98.5 175.98 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -54.95 145.06 21.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 57.95 28.5 16.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . 0.445 ' HB2' HG22 ' B' ' 203' ' ' ILE . 0.4 OUTLIER -58.05 128.69 38.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -87.81 84.3 7.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.15 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.676 HD11 HD12 ' B' ' 261' ' ' ILE . 2.6 mp -88.57 161.12 17.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.863 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.624 ' CE1' HG13 ' A' ' 74' ' ' VAL . 8.5 m170 -127.73 121.78 31.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.877 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.583 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -90.17 108.03 19.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.769 HG11 HD12 ' A' ' 82' ' ' ILE . 21.8 t -104.94 148.77 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.734 HD21 ' HG3' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -81.26 135.03 35.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.505 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.1 mtt180 -94.89 163.84 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.808 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.594 HD11 ' HE3' ' A' ' 90' ' ' LYS . 3.2 mm? -50.45 122.29 6.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -103.78 123.18 46.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -112.37 56.89 0.45 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.455 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.245 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.449 -179.982 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.472 ' O ' HD11 ' A' ' 87' ' ' LEU . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.191 0 CA-C-O 120.855 0.273 . . . . 0.0 112.367 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.65 HD22 ' CD1' ' A' ' 75' ' ' PHE . 4.1 mt -84.44 54.06 2.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.946 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.5 m -105.28 -19.34 13.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.66 93.8 3.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.752 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.5 mt -110.21 152.71 43.34 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 0.0 110.893 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.68 175.14 8.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.686 2.258 . . . . 0.0 112.335 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -69.22 146.09 52.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.53 20.67 31.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.752 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.9 p -70.74 144.48 13.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.792 0.329 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -104.28 108.92 20.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -50.71 -50.69 54.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.55 -39.12 61.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG13 ' CE1' ' B' ' 268' ' ' HIS . 88.4 t -76.63 -33.51 22.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.107 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.65 ' CD1' HD22 ' A' ' 63' ' ' LEU . 2.7 t80 -66.86 -56.17 11.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.97 -15.07 61.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.0 -26.8 23.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.887 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.948 HD13 HG21 ' A' ' 82' ' ' ILE . 29.7 mt -79.5 158.18 74.03 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 121.563 0.697 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.87 153.31 68.55 Favored 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.696 2.264 . . . . 0.0 112.264 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -51.49 -29.83 10.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.086 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -60.61 -41.56 95.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.948 HG21 HD13 ' A' ' 78' ' ' LEU . 30.2 mm -76.28 -30.97 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.146 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.85 -42.47 73.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.925 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -65.57 -31.72 72.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -74.08 -54.58 7.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.87 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.4 mt -56.6 -40.97 72.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.1 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -68.56 -30.22 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.917 179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 32.0 t -66.09 -24.66 66.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.812 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.16 9.35 63.65 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.63 ' HE3' HD11 ' B' ' 273' ' ' LEU . 2.3 ptmt -93.07 176.63 6.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.873 0.368 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 78.6 p 46.53 61.33 2.82 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.908 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -140.32 81.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.903 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.6 -25.91 7.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -51.79 -53.93 34.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -120.8 173.97 6.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -67.87 105.32 1.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.47 172.91 0.53 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.0 mmtt -103.49 132.11 50.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.769 0.318 . . . . 0.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 99' ' ' LEU . 4.4 mm? . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.925 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 11.3 ptt? . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -94.83 133.91 38.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.904 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.577 HD11 HG13 ' B' ' 226' ' ' VAL . 27.0 pt -116.75 149.66 18.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.482 ' HB3' HG22 ' B' ' 212' ' ' THR . 10.0 m-85 -106.07 124.34 49.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 17.8 t -105.47 108.02 23.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.55 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -98.0 113.19 24.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.746 HG22 HD23 ' B' ' 269' ' ' LEU . 5.0 p -76.91 174.7 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.138 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.68 -22.58 64.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.943 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -92.72 17.7 9.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 63.14 39.3 97.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.494 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 8.8 tptm -104.72 108.01 19.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.55 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.3 OUTLIER -82.69 132.48 35.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.126 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.686 HG23 ' HE3' ' B' ' 233' ' ' LYS . 2.8 mt -129.49 108.79 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.13 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.54 130.47 38.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.659 HD22 ' HB2' ' B' ' 229' ' ' LYS . 7.7 mt -135.88 135.83 40.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 73.2 mt-10 -89.27 101.82 14.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.783 HG11 HG22 ' B' ' 226' ' ' VAL . 25.3 m -128.22 -178.95 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.558 ' O ' HD12 ' B' ' 256' ' ' LEU . 8.7 mt-10 -135.08 160.45 68.27 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.666 0.746 . . . . 0.0 110.906 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -11.44 30.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.655 2.237 . . . . 0.0 112.356 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.2 m -98.1 -25.54 14.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.49 ' O ' HG22 ' B' ' 255' ' ' THR . 42.0 m-20 -63.5 174.69 1.23 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 1.4 p -111.25 155.98 22.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.108 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.494 HG22 ' HZ2' ' B' ' 227' ' ' LYS . 48.2 mm -50.57 -36.92 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -53.25 -36.68 61.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -34.25 65.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.926 HG21 HD21 ' B' ' 256' ' ' LEU . 98.6 t -69.94 -46.86 72.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.118 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.735 ' HA ' HD12 ' B' ' 230' ' ' ILE . 8.7 ptpp? -64.76 -35.63 81.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.932 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.97 76.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.111 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.659 ' HB2' HD22 ' B' ' 215' ' ' LEU . 13.3 mttt -59.31 -43.61 92.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.735 HD12 ' HA ' ' B' ' 227' ' ' LYS . 42.3 mt -56.54 -29.45 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -64.86 -48.73 73.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -71.21 -8.08 51.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.686 ' HE3' HG23 ' B' ' 213' ' ' ILE . 18.4 mmmt -96.73 -56.34 2.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.883 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -96.14 -49.48 5.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.919 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.59 20.9 5.96 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.487 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.515 HD12 HD21 ' B' ' 269' ' ' LEU . 1.1 mt -99.22 134.05 21.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.621 0.724 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.415 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.4 Cg_endo -69.85 166.42 27.79 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.648 2.232 . . . . 0.0 112.323 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 -7.85 22.11 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.706 2.271 . . . . 0.0 112.374 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -85.36 -23.01 28.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' B' ' 272' ' ' ARG . 1.3 mp0 -112.47 -8.57 13.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.441 ' HG2' HD13 ' B' ' 269' ' ' LEU . 0.0 OUTLIER -87.19 127.19 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.924 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -134.21 118.0 17.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.406 ' N ' HD22 ' B' ' 243' ' ' LEU . 3.7 mm? -80.36 150.37 29.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.604 HG21 HD23 ' A' ' 78' ' ' LEU . 30.3 mm -137.98 114.24 10.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.185 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.479 ' HB3' HD21 ' B' ' 250' ' ' LEU . 21.5 t80 -145.87 144.41 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 63.84 15.08 8.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.094 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.6 5.67 78.2 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.498 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.5 170.4 13.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.739 0.304 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -95.2 139.8 31.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.944 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.502 HD22 ' CD1' ' B' ' 259' ' ' TYR . 1.5 mt -91.45 155.71 18.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -111.57 161.8 15.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.869 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -81.68 -0.9 44.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -112.46 41.07 2.32 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.429 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -152.85 169.75 22.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 0.0 110.886 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.49 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -99.47 153.25 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.124 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.926 HD21 HG21 ' B' ' 226' ' ' VAL . 41.9 mt -57.41 -44.87 84.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.6 t -58.88 -24.48 62.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.82 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.09 -32.47 73.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.814 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.502 ' CD1' HD22 ' B' ' 250' ' ' LEU . 45.2 m-85 -98.7 12.5 35.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.915 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 64.02 33.79 11.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.484 HD12 HD21 ' B' ' 267' ' ' LEU . 9.1 mm -70.81 95.44 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 -85.87 174.14 9.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.932 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.99 147.53 23.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 55.94 25.02 8.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -56.66 133.11 53.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.8 m -85.32 86.04 7.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.155 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.484 HD21 HD12 ' B' ' 261' ' ' ILE . 4.0 mm? -81.9 157.24 24.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.465 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.0 m170 -130.46 121.44 25.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.746 HD23 HG22 ' B' ' 207' ' ' THR . 4.4 tp -91.98 127.16 37.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.728 HG11 HD12 ' A' ' 82' ' ' ILE . 11.6 t -125.49 148.46 30.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.093 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.484 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -75.73 130.08 38.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.92 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.484 ' N ' HD13 ' B' ' 271' ' ' LEU . 5.2 mtt180 -91.72 161.97 14.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.838 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.63 HD11 ' HE3' ' A' ' 90' ' ' LYS . 4.2 mm? -50.16 127.72 17.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.885 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 19.3 tpt180 -91.85 100.3 13.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.89 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -144.52 20.62 2.04 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.54 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.392 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.495 -179.931 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' O ' HD11 ' A' ' 87' ' ' LEU . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.194 0 CA-C-O 120.822 0.259 . . . . 0.0 112.345 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.597 HD22 ' CD2' ' A' ' 75' ' ' PHE . 3.0 mt -78.68 58.47 2.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 31.9 m -110.6 -17.62 13.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.488 ' HB2' HD23 ' A' ' 87' ' ' LEU . 0.8 OUTLIER -135.78 93.75 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.859 -179.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.718 ' CB ' HG11 ' A' ' 70' ' ' VAL . 7.4 mt -108.68 152.86 42.43 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.663 0.744 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 174.22 9.74 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 147.71 50.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.859 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.537 ' O ' HG22 ' B' ' 209' ' ' THR . . . 56.81 20.88 34.58 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.488 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.718 HG11 ' CB ' ' A' ' 66' ' ' LEU . 7.1 p -74.45 142.55 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 0.0 111.147 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -101.87 108.11 19.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -50.59 -51.92 43.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.876 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -51.18 -40.08 57.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.524 HG13 ' CE1' ' B' ' 268' ' ' HIS . 87.0 t -76.42 -32.92 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.187 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.597 ' CD2' HD22 ' A' ' 63' ' ' LEU . 3.7 t80 -67.71 -56.6 8.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.91 -15.78 59.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.914 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -87.55 -22.78 24.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.948 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 82' ' ' ILE . 33.7 mt -81.96 158.04 68.05 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.584 0.707 . . . . 0.0 110.893 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 164.94 32.72 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.729 2.286 . . . . 0.0 112.324 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.3 p -59.93 -31.67 48.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.13 -38.76 87.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.033 HG21 HD13 ' A' ' 78' ' ' LEU . 33.0 mm -78.79 -31.08 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.171 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -67.73 -49.94 59.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -32.9 74.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.858 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -67.6 -43.4 80.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.7 mt -74.6 -44.08 47.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.094 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 65' ' ' SER . 0.6 OUTLIER -64.75 -30.18 71.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.934 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.4 m -64.91 -27.6 68.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.807 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.97 41.82 5.19 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.556 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 -177.91 4.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.5 p 46.13 64.62 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.19 78.63 1.67 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.858 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 -21.68 9.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.815 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.05 -48.61 75.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.859 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -125.84 174.38 8.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -106.82 150.01 26.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.971 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -51.1 105.87 0.23 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -87.72 110.73 20.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.824 0.345 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 20.3 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 179.86 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 7.2 ptt? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.746 0.307 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -95.51 138.5 33.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . . . . . . . . . 12.1 pt -120.67 147.17 24.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.465 ' HB3' HG22 ' B' ' 212' ' ' THR . 13.7 m-85 -105.36 127.51 53.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 16.2 t -109.86 108.19 24.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.149 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.555 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.0 OUTLIER -97.24 112.47 24.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 179.961 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.699 HG22 HD23 ' B' ' 269' ' ' LEU . 5.6 p -74.92 175.5 8.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.144 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.417 ' CD1' HG23 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -59.07 -24.45 62.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 69' ' ' GLY . 0.8 OUTLIER -89.96 8.38 32.65 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.154 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 74.07 26.17 69.38 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -89.66 108.49 19.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.849 0.357 . . . . 0.0 110.855 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.555 HG23 ' HG2' ' B' ' 206' ' ' LYS . 0.2 OUTLIER -82.43 131.85 35.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.181 179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.714 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -128.91 115.23 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.168 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . 0.599 ' C ' HD12 ' B' ' 215' ' ' LEU . 5.8 m -79.44 128.46 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.638 ' CD1' HG22 ' B' ' 213' ' ' ILE . 10.8 mp -126.67 134.1 50.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.957 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -94.13 98.86 11.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.911 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.835 HG11 HG22 ' B' ' 226' ' ' VAL . 18.9 m -131.37 -179.04 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.077 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.587 ' O ' HD12 ' B' ' 256' ' ' LEU . 3.3 mt-10 -130.58 160.56 65.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.681 0.753 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 -9.29 25.73 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.673 2.248 . . . . 0.0 112.39 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.8 p -100.6 -24.88 14.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . 0.478 ' O ' HG22 ' B' ' 255' ' ' THR . 17.9 m-20 -63.4 175.13 1.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.0 157.93 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.15 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 45.8 mm -53.07 -32.52 18.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -56.74 -35.85 69.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -43.11 63.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.856 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.835 HG22 HG11 ' B' ' 217' ' ' VAL . 21.7 t -63.15 -43.38 98.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.169 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.618 ' CE ' HD11 ' B' ' 243' ' ' LEU . 17.1 ttmt -61.26 -42.14 98.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.921 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.51 69.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -63.66 -42.21 98.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.611 ' CG1' HD21 ' B' ' 215' ' ' LEU . 45.1 mt -59.14 -29.37 41.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.148 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -67.06 -44.73 79.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -76.38 -4.98 45.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.714 ' HE3' HG23 ' B' ' 213' ' ' ILE . 22.0 mmmt -99.29 -56.01 2.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -98.79 -48.66 4.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.868 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.66 19.78 6.4 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.515 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.463 HG22 ' HD2' ' B' ' 237' ' ' PRO . 0.9 OUTLIER -101.14 134.39 20.39 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.585 0.707 . . . . 0.0 111.142 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' B' ' 236' ' ' ILE . 53.5 Cg_endo -69.79 169.6 18.57 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.68 2.253 . . . . 0.0 112.302 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.85 -7.2 20.49 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.35 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -89.85 -19.03 25.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -113.21 -15.54 12.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.921 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.434 ' OE1' HG22 ' B' ' 230' ' ' ILE . 0.7 OUTLIER -86.97 129.67 34.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . 0.656 ' HD3' HD11 ' A' ' 82' ' ' ILE . 10.9 ttm180 -132.93 112.49 11.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.875 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . 0.618 HD11 ' CE ' ' B' ' 227' ' ' LYS . 0.7 OUTLIER -83.72 134.67 34.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.94 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.409 HD11 HD11 ' A' ' 82' ' ' ILE . 23.0 mm -121.41 116.2 48.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.14 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.712 ' HB3' HD21 ' B' ' 250' ' ' LEU . 17.9 t80 -140.45 142.56 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.57 15.17 9.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.098 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.06 12.56 67.9 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.455 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 174.14 10.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -94.74 144.07 25.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.712 HD21 ' HB3' ' B' ' 245' ' ' PHE . 4.1 mt -97.68 155.59 16.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -111.63 159.95 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.866 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.67 -1.78 43.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -109.55 40.66 2.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.539 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -152.59 169.39 22.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.949 0.404 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . 0.478 HG22 ' O ' ' B' ' 221' ' ' ASP . 0.1 OUTLIER -100.25 152.73 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.824 HD21 HG21 ' B' ' 226' ' ' VAL . 63.8 mt -57.8 -47.06 83.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 2.0 t -55.27 -26.0 37.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.83 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -68.13 -27.64 66.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.576 ' CD1' HD22 ' B' ' 250' ' ' LEU . 87.7 m-85 -98.58 9.12 43.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.958 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 3.5 m120 64.47 32.72 11.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.513 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.2 mm -70.04 97.3 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -89.5 167.31 13.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 3.7 tppt? -51.2 141.46 14.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 59.13 27.4 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.854 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.73 131.64 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.851 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -84.32 88.87 7.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.138 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -88.19 160.1 17.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.524 ' CE1' HG13 ' A' ' 74' ' ' VAL . 5.7 m170 -129.67 127.58 40.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.699 HD23 HG22 ' B' ' 207' ' ' THR . 5.2 tp -99.69 118.31 35.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.949 HG11 HG23 ' A' ' 82' ' ' ILE . 4.3 t -116.64 141.13 35.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.101 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.429 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -69.73 128.08 35.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.929 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.429 ' N ' HD13 ' B' ' 271' ' ' LEU . 7.7 mtt180 -90.42 163.67 14.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' B' ' 273' ' ' LEU . 4.3 mm? -51.17 131.02 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 28.3 tpt180 -96.78 101.79 13.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.823 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -123.16 18.19 7.9 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.461 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.485 -179.957 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.223 0 CA-C-O 120.83 0.262 . . . . 0.0 112.32 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.452 HD22 ' CD1' ' A' ' 75' ' ' PHE . 4.3 mt -99.89 50.76 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.924 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.2 m -103.27 -18.63 14.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.871 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.71 94.37 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.666 ' HB3' HG11 ' A' ' 70' ' ' VAL . 1.1 mt -111.54 152.28 43.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.641 0.734 . . . . 0.0 110.894 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.7 172.78 11.95 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.263 . . . . 0.0 112.368 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -69.36 145.92 52.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.02 20.95 36.27 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.466 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HB3' ' A' ' 66' ' ' LEU . 7.1 p -70.73 141.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.752 0.311 . . . . 0.0 111.182 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -98.89 111.92 24.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -50.29 -56.29 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -50.16 -62.79 1.37 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.765 HG13 ' CE1' ' B' ' 268' ' ' HIS . 44.4 t -53.05 -32.18 18.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.158 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CE2' HD23 ' A' ' 66' ' ' LEU . 15.7 t80 -63.72 -57.84 8.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -72.37 -7.67 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -89.33 -18.22 27.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.053 HD13 HG21 ' A' ' 82' ' ' ILE . 41.5 mt -90.03 158.0 44.92 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.587 0.708 . . . . 0.0 110.856 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 159.14 54.48 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.639 2.226 . . . . 0.0 112.318 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -51.37 -29.28 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -58.06 -40.11 80.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 1.053 HG21 HD13 ' A' ' 78' ' ' LEU . 49.7 mm -79.32 -43.08 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -55.6 -50.7 69.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -64.08 -33.28 75.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -68.17 -43.1 78.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.456 ' CD1' HG22 ' A' ' 82' ' ' ILE . 47.2 mt -72.71 -35.47 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.14 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.81 -33.6 75.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.944 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.17 -23.74 67.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.3 15.72 58.39 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.416 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.727 ' HD3' HD11 ' B' ' 273' ' ' LEU . 4.5 ptpt -96.68 -176.36 3.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 0.0 110.94 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.2 p 46.01 62.39 2.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.38 85.92 2.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.865 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -117.42 -27.56 6.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.848 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -51.4 -63.88 0.99 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -108.05 170.6 7.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -64.17 114.18 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.23 169.66 6.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.491 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -141.68 99.65 3.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.784 0.326 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.8 mt . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.963 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' MET . . . . . . . . . . . . . 8.1 ptt? . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.784 0.326 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.74 133.97 37.85 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' ILE . . . . . 0.629 HD11 HG13 ' B' ' 226' ' ' VAL . 17.7 pt -116.64 148.56 19.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.199 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' PHE . . . . . 0.477 ' HB3' HG22 ' B' ' 212' ' ' THR . 11.5 m-85 -105.3 126.52 52.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.927 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' VAL . . . . . . . . . . . . . 37.0 t -110.07 107.98 24.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' LYS . . . . . 0.469 ' HG2' HG23 ' B' ' 212' ' ' THR . 0.1 OUTLIER -97.97 112.54 24.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.899 179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' THR . . . . . 0.702 HG22 HD23 ' B' ' 269' ' ' LEU . 2.7 p -77.14 172.44 13.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.11 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.493 ' O ' HD12 ' B' ' 208' ' ' LEU . 0.3 OUTLIER -58.96 -22.03 59.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 5.9 p -94.29 25.29 3.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.162 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 53.52 50.84 51.56 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -118.25 108.24 14.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.889 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' THR . . . . . 0.477 HG22 ' HB3' ' B' ' 204' ' ' PHE . 0.2 OUTLIER -82.1 134.41 35.33 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.15 179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' ILE . . . . . 0.7 HG23 ' HE3' ' B' ' 233' ' ' LYS . 3.5 mt -130.15 108.17 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.07 130.15 37.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 8.2 mt -133.82 133.65 41.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -88.8 100.29 13.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.891 HG11 HG22 ' B' ' 226' ' ' VAL . 16.3 m -129.86 -179.38 3.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.153 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' GLU . . . . . 0.567 ' O ' HD12 ' B' ' 256' ' ' LEU . 5.1 mt-10 -129.84 160.81 63.13 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.619 0.723 . . . . 0.0 110.875 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -12.04 32.06 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.694 2.263 . . . . 0.0 112.379 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' SER . . . . . . . . . . . . . 1.4 m -97.75 -24.3 15.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.19 175.12 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.869 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.8 156.07 20.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . 0.4 HD13 HD23 ' B' ' 256' ' ' LEU . 49.8 mm -51.38 -30.28 10.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -60.43 -38.79 85.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . 0.477 ' ND2' HG23 ' B' ' 226' ' ' VAL . 0.0 OUTLIER -66.31 -38.78 88.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.92 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' VAL . . . . . 0.891 HG22 HG11 ' B' ' 217' ' ' VAL . 48.0 t -73.17 -36.92 51.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' LYS . . . . . 0.62 ' HA ' HD12 ' B' ' 230' ' ' ILE . 17.3 ttpp -71.01 -38.81 72.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.81 -50.01 75.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.107 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' LYS . . . . . 0.784 ' HE3' HG12 ' B' ' 217' ' ' VAL . 42.8 mttm -54.52 -45.24 73.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' B' ' 227' ' ' LYS . 46.3 mt -53.93 -33.35 23.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.102 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -63.64 -46.64 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.59 -6.08 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . 0.7 ' HE3' HG23 ' B' ' 213' ' ' ILE . 20.9 mmmt -96.87 -53.73 3.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -101.99 -49.05 4.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.869 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . . . . . . . . . . . 113.01 31.68 2.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' ILE . . . . . 0.64 HD12 HD21 ' B' ' 269' ' ' LEU . 9.0 mt -105.68 130.65 22.7 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.519 0.676 . . . . 0.0 111.142 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 162.96 40.05 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.629 2.219 . . . . 0.0 112.38 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 -7.87 22.16 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.678 2.252 . . . . 0.0 112.317 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -86.4 -28.85 23.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.872 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -112.8 -2.3 14.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' GLN . . . . . 0.498 ' HG3' HD13 ' B' ' 269' ' ' LEU . 12.4 tt0 -94.76 128.39 41.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -133.33 136.98 45.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' LEU . . . . . . . . . . . . . 1.2 mp -98.6 155.83 17.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' ILE . . . . . 0.68 HD11 HD11 ' A' ' 82' ' ' ILE . 21.8 mm -140.07 115.4 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.089 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' PHE . . . . . 0.819 ' HB3' HD21 ' B' ' 250' ' ' LEU . 19.3 t80 -146.35 143.83 29.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' ALA . . . . . . . . . . . . . . . 64.45 14.92 9.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.077 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.29 14.84 70.52 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.493 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' LYS . . . . . . . . . . . . . 14.2 ptmt -132.6 -175.64 3.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.308 . . . . 0.0 110.873 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -107.51 125.96 51.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' LEU . . . . . 0.819 HD21 ' HB3' ' B' ' 245' ' ' PHE . 6.9 mt -82.54 160.27 22.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -117.48 161.41 19.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -82.17 0.58 40.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' GLY . . . . . . . . . . . . . . . -114.12 43.82 1.62 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.542 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -152.52 169.4 22.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.37 . . . . 0.0 110.827 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.47 147.06 26.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.138 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.771 HD21 HG21 ' B' ' 226' ' ' VAL . 70.6 mt -52.65 -44.98 66.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.873 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.6 t -57.45 -28.0 62.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.2 -32.82 74.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' TYR . . . . . 0.543 ' CG ' HD22 ' B' ' 250' ' ' LEU . 83.8 m-85 -96.63 8.18 44.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.989 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' ASN . . . . . . . . . . . . . 9.0 m120 63.32 36.22 11.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.998 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' ILE . . . . . 0.557 HD13 ' CE2' ' B' ' 245' ' ' PHE . 14.6 mm -68.79 95.56 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -83.05 163.84 20.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.16 145.55 7.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 59.07 26.46 15.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 135.51 54.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.899 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' THR . . . . . . . . . . . . . 1.2 m -89.2 83.91 6.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' LEU . . . . . 0.53 HD21 HD12 ' B' ' 261' ' ' ILE . 3.8 mm? -82.86 155.51 24.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.903 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' HIS . . . . . 0.765 ' CE1' HG13 ' A' ' 74' ' ' VAL . 3.0 m170 -128.93 121.91 29.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' LEU . . . . . 0.702 HD23 HG22 ' B' ' 207' ' ' THR . 2.9 tp -91.72 126.3 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.948 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' VAL . . . . . 0.779 HG11 HD12 ' A' ' 82' ' ' ILE . 21.9 t -123.78 148.15 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.084 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' LEU . . . . . 0.483 HD13 ' N ' ' B' ' 272' ' ' ARG . 0.2 OUTLIER -77.79 134.85 37.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' ARG . . . . . 0.483 ' N ' HD13 ' B' ' 271' ' ' LEU . 8.8 mtt180 -95.39 167.02 11.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.813 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' LEU . . . . . 0.727 HD11 ' HD3' ' A' ' 90' ' ' LYS . 4.0 mm? -53.27 125.68 18.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.957 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' ARG . . . . . . . . . . . . . 46.1 tpt85 -93.53 98.82 11.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' GLY . . . . . . . . . . . . . . . -164.56 25.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.452 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.529 -179.949 . . . . . . . . 0 0 . 1 stop_ save_